<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006185.pub4" GROUP_ID="STROKE" ID="946206011612560297" MERGED_FROM="" MODIFIED="2017-05-05 11:27:54 +0100" MODIFIED_BY="Hazel Fraser" REVIEW_NO="01230001" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2017-05-05 11:27:48 +0100" MODIFIED_BY="Hazel Fraser">
<TITLE>Electromechanical-assisted training for walking after stroke</TITLE>
<CONTACT MODIFIED="2017-05-05 11:27:48 +0100" MODIFIED_BY="Hazel Fraser"><PERSON ID="D2C58DF182E26AA201E74FE96B163441" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jan</FIRST_NAME><LAST_NAME>Mehrholz</LAST_NAME><EMAIL_1>jan.mehrholz@tu-dresden.de</EMAIL_1><EMAIL_2>jan.mehrholz@srh.de</EMAIL_2><ADDRESS><DEPARTMENT>Department of Public Health, Dresden Medical School</DEPARTMENT><ORGANISATION>Technical University Dresden</ORGANISATION><ADDRESS_1>Fetscherstr. 74</ADDRESS_1><CITY>Dresden</CITY><ZIP>01307</ZIP><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-05-05 11:27:48 +0100" MODIFIED_BY="Hazel Fraser"><PERSON ID="D2C58DF182E26AA201E74FE96B163441" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Jan</FIRST_NAME><LAST_NAME>Mehrholz</LAST_NAME><ADDRESS><DEPARTMENT>Department of Public Health, Dresden Medical School</DEPARTMENT><ORGANISATION>Technical University Dresden</ORGANISATION><ADDRESS_1>Fetscherstr. 74</ADDRESS_1><CITY>Dresden</CITY><ZIP>01307</ZIP><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></PERSON><PERSON ID="z1608291224183396232546014127791" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Simone</FIRST_NAME><LAST_NAME>Thomas</LAST_NAME><EMAIL_1>simone.thomas@klinik-bavaria.de</EMAIL_1><ADDRESS><DEPARTMENT>Wissenschaftliches Institut</DEPARTMENT><ORGANISATION>Klinik Bavaria Kreischa</ORGANISATION><CITY>Kreischa</CITY><ZIP>01731</ZIP><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></PERSON><PERSON ID="177016BB82E26AA200831C19D1822E26" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Cordula</FIRST_NAME><LAST_NAME>Werner</LAST_NAME><EMAIL_1>cwerner@reha-hesse.de</EMAIL_1><ADDRESS><ORGANISATION>Medicalpark, Schlaganfallzentrum Berlin</ORGANISATION><CITY>13507 Berlin - Tegel</CITY><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></PERSON><PERSON ID="1774AD2B82E26AA200831C19FEE76BC7" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Joachim</FIRST_NAME><LAST_NAME>Kugler</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>jokugler@aol.com</EMAIL_1><EMAIL_2>kugler@imib.med.tu-dresden.de</EMAIL_2><URL>http://www.imib.med.tu-dresden.de/imib/imib/public_health/index.html</URL><ADDRESS><DEPARTMENT>Department of Public Health, Dresden Medical School</DEPARTMENT><ORGANISATION>Technical University Dresden</ORGANISATION><ADDRESS_1>Löscherstr. 18</ADDRESS_1><CITY>Dresden</CITY><ZIP>D-01307</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 351 3177 217</PHONE_1><FAX_1>+49 351 3177 33 217</FAX_1></ADDRESS></PERSON><PERSON ID="1777C72D82E26AA200831C1926A4C9DA" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Marcus</FIRST_NAME><LAST_NAME>Pohl</LAST_NAME><POSITION>Chief of department</POSITION><EMAIL_1>marcus.pohl@helios-kliniken.de</EMAIL_1><ADDRESS><DEPARTMENT>Neurological Rehabilitation</DEPARTMENT><ORGANISATION>Helios Klinik Schloss Pulsnitz</ORGANISATION><ADDRESS_1>Wittgensteiner Str. 1</ADDRESS_1><CITY>Pulsnitz</CITY><ZIP>01896</ZIP><REGION>Saxony</REGION><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 35955 5-1201</PHONE_1><FAX_1>+49 35955 5-1210</FAX_1></ADDRESS></PERSON><PERSON ID="28690826847602830146110301141953" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Bernhard</FIRST_NAME><LAST_NAME>Elsner</LAST_NAME><POSITION>Research Fellow</POSITION><EMAIL_1>bernhard.elsner@posteo.de</EMAIL_1><ADDRESS><DEPARTMENT>Department of Public Health</DEPARTMENT><ORGANISATION>Dresden Medical School, Technical University Dresden</ORGANISATION><ADDRESS_1>Fetscherstr. 74</ADDRESS_1><CITY>Dresden</CITY><ZIP>01307</ZIP><REGION>Sachsen</REGION><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2017-03-22 11:22:34 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="1" MONTH="9" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="1" MONTH="9" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="12" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="5" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-05-02 14:48:04 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-05-02 14:48:04 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="6" MONTH="12" YEAR="2016"/>
<DESCRIPTION>
<P>We have updated the searches to September 2016 and revised the text as appropriate. We have included 36 studies with 1472 participants in this update, compared with 23 trials with 999 participants in the previous version of this review from 2013.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2017-04-30 23:23:50 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="12" YEAR="2016"/>
<DESCRIPTION>
<P>The conclusions of the review have changed. The previous version of this review concluded that, for the primary outcome (walking), the number needed to treat was five patients to prevent one dependency; this updated version of our review concludes that seven patients need to be treated to prevent one dependency in walking.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2017-04-30 23:24:05 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="23" MONTH="1" YEAR="2013"/>
<DESCRIPTION>
<P>The conclusions of the review have changed. The previous version of this review concluded that, for the primary outcome (walking), the number needed to treat was six patients to prevent one dependency; this updated version of our review concludes that five patients need to be treated to prevent one dependency in walking.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="14" MONTH="1" YEAR="2013"/>
<DESCRIPTION>
<P>We have updated the searches to December 2012 and revised the text as appropriate.</P>
<P>We have included 23 trials with 999 participants in this update, compared with 17 trials with 837 participants in the previous version of this review from 2009.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2013-01-23 10:22:27 +0000" MODIFIED_BY="Hazel Fraser">
<DATE DAY="28" MONTH="7" YEAR="2010"/>
<DESCRIPTION>
<P>Feedback and author response included in the Feedback section, and error corrected in the Abstract.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<DATE DAY="16" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>We have updated the searches to April 2009 and revised the text as appropriate. The conclusions of the review have not changed.</P>
<P>We have included 17 trials with 837 participants in this update, as compared with eight trials with 414 participants in the previous version of this review from 2007.</P>
<P>The previous version of this review concluded that, for the primary outcome (walking), the number needed to treat was four patients to prevent one dependency; this updated version of our review concludes that six patients need to be treated to prevent one dependency in walking.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-01-23 10:22:23 +0000" MODIFIED_BY="Hazel Fraser">
<DATE DAY="6" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-08-12 12:35:52 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2009-08-12 12:35:52 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-08-12 12:35:52 +0100" MODIFIED_BY="[Empty name]">
<NAME>Klinik Bavaria Kreischa, Wissenschaftliches Institut</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2009-08-12 12:35:26 +0100" MODIFIED_BY="[Empty name]">
<NAME>Technical University Dresden, Lehrstuhl Public Health</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2009-08-12 12:35:40 +0100" MODIFIED_BY="[Empty name]">
<NAME>SRH Fachhochschule Gera, Lehrstuhl Therapiewissenschaften</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-05-04 14:40:39 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-05-02 14:49:21 +0100" MODIFIED_BY="Hazel Fraser">
<TITLE MODIFIED="2017-03-21 14:31:22 +0000" MODIFIED_BY="Hazel Fraser">Automated training devices for improving walking after stroke</TITLE>
<SUMMARY_BODY MODIFIED="2017-05-02 14:49:21 +0100" MODIFIED_BY="Hazel Fraser">
<P>
<B>Review question</B>
</P>
<P>Do machine- and robot-assisted walking training devices improve walking after stroke?</P>
<P>
<B>Background</B>
</P>
<P>Many people who have had a stroke have difficulties walking, and improving walking is one of the main goals of rehabilitation. Automated training devices assist walking practice.</P>
<P>
<B>Search date</B>
</P>
<P>The review is current to August 2016.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We included 36 studies involving a total of 1472 participants over the age of 18 years with acute, postacute, or chronic ischaemic or haemorrhagic stroke. The mean age in the included studies ranged from 48 years to 76 years. The majority of studies were conducted in an inpatient setting.</P>
<P>
<B>Key results</B>
</P>
<P>We found moderate-quality evidence that electromechanical-assisted gait training combined with physiotherapy when compared with physiotherapy alone may improve recovery of independent walking in people after stroke.</P>
<P>We determined that for every seven patients treated with electromechanical- and robotic-assisted gait training devices, just one prevention of dependency in walking occurs.</P>
<P>Specifically, people in the first three months after stroke and those who are not able to walk appear to benefit most from this type of intervention. The importance of the type of device is still not clear. Further research should address what frequency or duration of walking training might be most effective and how long the benefit lasts. It also remains unclear how such devices should be used in routine rehabilitation.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>The quality of the evidence for automated electromechanical- and robotic-assisted gait-training devices for improving walking after stroke was moderate. The quality of evidence was low for walking speed, very low for walking capacity, and low for adverse events and people discontinuing treatment.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2017-05-02 14:48:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>Electromechanical- and robotic-assisted gait-training devices are used in rehabilitation and might help to improve walking after stroke. This is an update of a Cochrane Review first published in 2007.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-05-02 14:48:13 +0100" MODIFIED_BY="Hazel Fraser">
<P>To investigate the effects of automated electromechanical- and robotic-assisted gait-training devices for improving walking after stroke.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Stroke Group Trials Register (last searched 9 August 2016), the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library 2016, Issue 8), MEDLINE in Ovid (1950 to 15 August 2016), Embase (1980 to 15 August 2016), CINAHL (1982 to 15 August 2016), AMED (1985 to 15 August 2016), Web of Science (1899 to 16 August 2016), SPORTDiscus (1949 to 15 September 2012), the Physiotherapy Evidence Database (PEDro) (searched 16 August 2016), and the engineering databases COMPENDEX (1972 to 16 November 2012) and Inspec (1969 to 26 August 2016). We handsearched relevant conference proceedings, searched trials and research registers, checked reference lists, and contacted authors in an effort to identify further published, unpublished, and ongoing trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-05-02 14:48:32 +0100" MODIFIED_BY="Hazel Fraser">
<P>We included all randomised controlled trials and randomised controlled cross-over trials in people over the age of 18 years diagnosed with stroke of any severity, at any stage, in any setting, evaluating electromechanical- and robotic-assisted gait training versus normal care.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-03-21 14:32:37 +0000" MODIFIED_BY="Hazel Fraser">
<P>Two review authors independently selected trials for inclusion, assessed methodological quality and risk of bias, and extracted the data. The primary outcome was the proportion of participants walking independently at follow-up.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>We included 36 trials involving 1472 participants in this review update. Electromechanical-assisted gait training in combination with physiotherapy increased the odds of participants becoming independent in walking (odds ratio (random effects) 1.94, 95% confidence interval (CI) 1.39 to 2.71; P &lt; 0.001; I² = 8%; moderate-quality evidence) but did not significantly increase walking velocity (mean difference (MD) 0.04 m/s, 95% CI 0.00 to 0.09; P = 0.08; I² = 65%; low-quality evidence) or walking capacity (MD 5.84 metres walked in 6 minutes, 95% CI -16.73 to 28.40; P = 0.61; I² = 53%; very low-quality evidence). The results must be interpreted with caution because 1) some trials investigated people who were independent in walking at the start of the study, 2) we found variations between the trials with respect to devices used and duration and frequency of treatment, and 3) some trials included devices with functional electrical stimulation. Our planned subgroup analysis suggested that people in the acute phase may benefit, but people in the chronic phase may not benefit from electromechanical-assisted gait training. Post hoc analysis showed that people who are non-ambulatory at intervention onset may benefit, but ambulatory people may not benefit from this type of training. Post hoc analysis showed no differences between the types of devices used in studies regarding ability to walk, but significant differences were found between devices in terms of walking velocity.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-05-02 14:48:56 +0100" MODIFIED_BY="Hazel Fraser">
<P>People who receive electromechanical-assisted gait training in combination with physiotherapy after stroke are more likely to achieve independent walking than people who receive gait training without these devices. We concluded that seven patients need to be treated to prevent one dependency in walking. Specifically, people in the first three months after stroke and those who are not able to walk seem to benefit most from this type of intervention. The role of the type of device is still not clear. Further research should consist of large definitive pragmatic phase III trials undertaken to address specific questions about the most effective frequency and duration of electromechanical-assisted gait training as well as how long any benefit may last.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-05-02 14:50:10 +0100" MODIFIED_BY="Hazel Fraser">
<CONDITION MODIFIED="2017-05-02 14:49:23 +0100" MODIFIED_BY="Hazel Fraser">
<P>A stroke is a sudden, non-convulsive loss of neurological function due to an ischaemic or haemorrhagic intracranial vascular event (<LINK REF="REF-WHO-2006" TYPE="REFERENCE">WHO 2006</LINK>). In general, cerebrovascular accidents are classified by anatomic location in the brain, vascular distribution, aetiology, age of the affected individual, and haemorrhagic versus non-haemorrhagic nature (<LINK REF="REF-Adams-1993" TYPE="REFERENCE">Adams 1993</LINK>). Stroke is a leading cause of death and serious long-term disability in adults. Three months after stroke, 20% of people remain wheelchair bound, and approximately 70% walk at a reduced velocity and capacity (<LINK REF="REF-Jorgensen-1995" TYPE="REFERENCE">Jorgensen 1995</LINK>). Restoration of walking ability and gait rehabilitation are therefore highly relevant for people who are unable to walk independently after stroke (<LINK REF="REF-Bohannon-1991" TYPE="REFERENCE">Bohannon 1991</LINK>), as well as for their relatives. To restore gait, modern concepts of rehabilitation favour a repetitive task-specific approach (<LINK REF="REF-Carr-2003" TYPE="REFERENCE">Carr 2003</LINK>; <LINK REF="REF-French-2007" TYPE="REFERENCE">French 2007</LINK>). In recent years it has also been shown that higher intensities of walking practice (resulting in more repetitions trained) resulted in better outcomes for people after stroke (<LINK REF="REF-Kwakkel-1999" TYPE="REFERENCE">Kwakkel 1999</LINK>; <LINK REF="REF-Van-Peppen-2004" TYPE="REFERENCE">Van Peppen 2004</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-05-02 14:49:46 +0100" MODIFIED_BY="Hazel Fraser">
<P>As an adjunct to overground gait training (<LINK REF="REF-States-2009" TYPE="REFERENCE">States 2009</LINK>), in recent years treadmill training has been introduced for the rehabilitation of people after stroke (<LINK REF="REF-Mehrholz-2014" TYPE="REFERENCE">Mehrholz 2014</LINK>). Treadmill training with and without partial body weight support enables the repetitive practice of complex gait cycles for these people. However, one disadvantage of treadmill training might be the effort required by therapists to set the paretic limbs and to control weight shift, thereby possibly limiting the intensity of therapy, especially in more severely disabled people. Automated electromechanical gait machines were developed to reduce dependence on therapists. They consist of either a robot-driven exoskeleton orthosis or an electromechanical solution, with two driven foot plates simulating the phases of gait (<LINK REF="REF-Colombo-2000" TYPE="REFERENCE">Colombo 2000</LINK>; <LINK REF="REF-Hesse-1999" TYPE="REFERENCE">Hesse 1999</LINK>).</P>
<P>One example of automated electromechanical gait rehabilitation is the Lokomat (<LINK REF="REF-Colombo-2000" TYPE="REFERENCE">Colombo 2000</LINK>). A robotic gait orthosis combined with a harness-supported body weight system is used together with a treadmill. The main difference from treadmill training is that the patient's legs are guided by the robotic device according to a preprogrammed gait pattern. A computer-controlled robotic gait orthosis guides the patient, and the process of gait training is automated.</P>
<P>A second example is the Gait Trainer GT I, which is based on a double crank and rocker gear system (<LINK REF="REF-Hesse-1999" TYPE="REFERENCE">Hesse 1999</LINK>). In contrast to a treadmill, the electromechanical Gait Trainer GT I consists of two foot plates positioned on two bars, two rockers, and two cranks, which provide the propulsion. The harness-secured patient is positioned on the foot plates, which symmetrically simulate the stance and swing phases of walking (<LINK REF="REF-Hesse-1999" TYPE="REFERENCE">Hesse 1999</LINK>). A servo-controlled motor guides the patient during walking exercise. Vertical and horizontal movements of the trunk are controlled in a phase-dependent manner. Again, the main difference from treadmill training is that the process of gait training is automated and is supported by an electromechanical solution.</P>
<P>Other similar electromechanical devices that have been developed in recent years include the Haptic Walker (<LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>), the Anklebot (<LINK REF="REF-MIT-2005" TYPE="REFERENCE">MIT 2005</LINK>), and the LOPES (Lower Extremity Powered Exoskeleton) (<LINK REF="REF-Veneman-2005" TYPE="REFERENCE">Veneman 2005</LINK>). More recently, new so-called powered mobile solutions, <LINK REF="STD-Buesing-2015" TYPE="STUDY">Buesing 2015</LINK>, <LINK REF="STD-Stein-2014" TYPE="STUDY">Stein 2014</LINK>, <LINK REF="STD-Watanabe-2014" TYPE="STUDY">Watanabe 2014</LINK>, and ankle robots, <LINK REF="STD-Forrester-2014" TYPE="STUDY">Forrester 2014</LINK>, <LINK REF="STD-Waldman-2013" TYPE="STUDY">Waldman 2013</LINK>, to improve walking have been described in the literature.</P>
</INTERVENTION>
<THEORY MODIFIED="2017-05-02 14:50:06 +0100" MODIFIED_BY="Hazel Fraser">
<P>Electromechanical devices (such as those previously described) can be used to give non-ambulatory patients intensive practice (in terms of high repetitions) of complex gait cycles. The advantage of these electromechanical devices compared with treadmill training with partial body weight support may be the reduced effort required of therapists, as they no longer need to set the paretic limbs or assist trunk movements (<LINK REF="REF-Hesse-2003" TYPE="REFERENCE">Hesse 2003</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-05-02 14:50:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>Scientific evidence for the benefits of the above-mentioned technologies may have changed since our Cochrane Review was first published in 2007 (<LINK REF="REF-Mehrholz-2007" TYPE="REFERENCE">Mehrholz 2007</LINK>), and so an update of the review was required to justify the large equipment and human resource costs needed to implement electromechanical-assisted gait devices, as well as to confirm the safety and acceptance of this method of training. The aim of this review was therefore to provide an update of the best available evidence about the above-mentioned approach.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-05-02 14:50:12 +0100" MODIFIED_BY="Hazel Fraser">
<P>To investigate the effects of automated electromechanical- and robotic-assisted gait-training devices for improving walking after stroke.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-05-02 14:50:38 +0100" MODIFIED_BY="Hazel Fraser">
<CRIT_STUDIES MODIFIED="2017-05-02 14:50:15 +0100" MODIFIED_BY="Hazel Fraser">
<P>We searched for all randomised controlled trials and randomised controlled cross-over trials for inclusion in this review. If we included randomised controlled cross-over trials, we planned to analyse only the first period as a parallel-group trial.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-05-02 14:50:18 +0100" MODIFIED_BY="Hazel Fraser">
<P>We included studies with participants of any gender over 18 years of age after stroke, using the World Health Organization (WHO) definition of stroke or a clinical definition of stroke if the WHO definition was not specifically stated (<LINK REF="REF-WHO-2006" TYPE="REFERENCE">WHO 2006</LINK>).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-05-02 14:50:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>We included all trials that evaluated electromechanical- and robotic-assisted gait training plus physiotherapy versus physiotherapy (or usual care) for regaining and improving walking after stroke. We also included automated electromechanical devices that were used in combination with therapies such as functional electrical stimulation applied to the legs during gait training (compared with therapies not using electromechanical devices). We defined an automated electromechanical device as any device with an electromechanical solution designed to assist stepping cycles by supporting body weight and automating the walking therapy process in people after stroke. This category included any mechanical or computerised device designed to improve walking function. We also searched for electromechanical devices such as robots for gait training after stroke (<LINK REF="REF-MIT-2005" TYPE="REFERENCE">MIT 2005</LINK>; <LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>; <LINK REF="REF-Veneman-2005" TYPE="REFERENCE">Veneman 2005</LINK>).</P>
<P>Electromechanical devices can principally be differentiated into end-effector and exoskeleton devices. Examples of end-effector devices are the LokoHelp (<LINK REF="REF-Freivogel-2009" TYPE="REFERENCE">Freivogel 2009</LINK>), the Haptic Walker (<LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>), and the Gait Trainer GT I (<LINK REF="REF-Hesse-1999" TYPE="REFERENCE">Hesse 1999</LINK>). The definition of an end-effector principle is that a patient's feet are placed on foot plates, whose trajectories simulate the stance and swing phases during gait training (<LINK REF="REF-Hesse-2010" TYPE="REFERENCE">Hesse 2010</LINK>). An example of exoskeleton devices is the Lokomat (<LINK REF="REF-Colombo-2000" TYPE="REFERENCE">Colombo 2000</LINK>). Such exoskeletons are outfitted with programmable drives or passive elements, which move the knees and hips during the phases of gait (<LINK REF="REF-Hesse-2010" TYPE="REFERENCE">Hesse 2010</LINK>).</P>
<P>We did not include non-weight-bearing interventions such as non-interactive devices that deliver continuous passive motion only (<LINK REF="REF-Nuyens-2002" TYPE="REFERENCE">Nuyens 2002</LINK>). We excluded trials testing the effectiveness of treadmill training or other approaches such as repetitive task training in physiotherapy or electrical stimulation alone (<LINK REF="REF-French-2016" TYPE="REFERENCE">French 2016</LINK>; <LINK REF="REF-Pollock-2014" TYPE="REFERENCE">Pollock 2014</LINK>), to prevent duplication with other Cochrane Reviews and protocols (e.g. <LINK REF="REF-Mehrholz-2014" TYPE="REFERENCE">Mehrholz 2014</LINK>).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-05-02 14:50:38 +0100" MODIFIED_BY="Hazel Fraser">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2017-05-02 14:50:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Regaining the ability to walk is a very important goal for people after stroke (<LINK REF="REF-Bohannon-1988" TYPE="REFERENCE">Bohannon 1988</LINK>). We therefore defined the primary outcome as the ability to walk independently. We measured the ability to walk with the Functional Ambulation Category (FAC) (<LINK REF="REF-Holden-1984" TYPE="REFERENCE">Holden 1984</LINK>). A FAC score of 4 or 5 indicated independent walking over a 15-metre surface, irrespective of aids used such as a cane. A FAC score of less than 4 indicates dependency in walking (supervision or assistance, or both must be given in performing walking).</P>
<P>If the included studies did not report FAC scores, we used alternative indicators of independent walking, such as:<BR/>
</P>
<UL>
<LI>a score of 3 on the ambulation item of the Barthel Index (<LINK REF="REF-Wade-1988" TYPE="REFERENCE">Wade 1988</LINK>); or</LI>
<LI>a score of 6 or 7 for the walking item of the Functional Independence Measure (<LINK REF="REF-Hamilton-1994" TYPE="REFERENCE">Hamilton 1994</LINK>); or</LI>
<LI>a 'yes' response to the item 'walking inside, with an aid if necessary (but with no standby help)' or 'yes' to 'walking on uneven ground' in the Rivermead Mobility Index (<LINK REF="REF-Collen-1991" TYPE="REFERENCE">Collen 1991</LINK>).</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-05-02 14:50:38 +0100" MODIFIED_BY="Hazel Fraser">
<P>We defined secondary outcomes as measures of activity limitations. We used walking speed (in metres per second), walking capacity (metres walked in 6 minutes), and the Rivermead Mobility Index score as relevant measures of activity limitations, if stated by the trialists. Additionally, we used death from all causes as a secondary outcome.</P>
<SUBSECTION>
<HEADING LEVEL="4">Adverse outcomes</HEADING>
<P>We investigated the safety of electromechanical-assisted gait-training devices with the incidence of adverse outcomes such as thrombosis, major cardiovascular events, injuries, pain, and any other reported adverse events. To measure the acceptance of electromechanical-assisted gait-training devices in walking therapies, we used visual analogue scales or withdrawal from the study for any reason (dropout rates), or both during the study period, depending on data provided by the study authors.</P>
<P>Depending on the above-stated categories and the availability of variables used in the included trials, we discussed and reached consensus on which outcome measures should be included in the analysis.</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<P>See the 'Specialized register' section in the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/STROKE/frame.html">Cochrane Stroke Group</A> module. We searched for trials in all languages and arranged for translation of relevant papers published in languages other than English.</P>
<ELECTRONIC_SEARCHES MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Stroke Group Trials Register (last searched August 2016) and the following electronic bibliographic databases:</P>
<UL>
<LI>The Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library<I>,</I> Issue 8, 2016) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>);</LI>
<LI>MEDLINE in Ovid (1950 to 15 August 2016) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>);</LI>
<LI>Embase (1980 to 15 August 2016) (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>);</LI>
<LI>CINAHL (Cumulative Index to Nursing and Allied Health Literature) in EBSCO (1982 to 15 August 2016) (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>);</LI>
<LI>AMED (Allied and Complementary Medicine Database) (1985 to 15 August 2016) (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>);</LI>
<LI>Web of Science (Science Citation Index Expanded, Social Sciences Citation Index, Arts and Humanities Citation Index) (1899 to 16 August 2016) (<LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>);</LI>
<LI>PEDro (Physiotherapy Evidence Database) (searched 16 August 2016) (<LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>);</LI>
<LI>COMPENDEX (1972 to 16 November 2012) (<LINK REF="APP-08" TYPE="APPENDIX">Appendix 8</LINK>);</LI>
<LI>SPORTDiscus (1949 to 15 September 2012) (<LINK REF="APP-09" TYPE="APPENDIX">Appendix 9</LINK>); and</LI>
<LI>Inspec (1969 to 26 August 2016) (<LINK REF="APP-10" TYPE="APPENDIX">Appendix 10</LINK>).</LI>
</UL>
<P>We developed the search strategies with the help of the Cochrane Stroke Group Information Specialist and adapted the MEDLINE search strategy for the other databases.</P>
<P>We identified and searched the following ongoing trials and research registers:</P>
<UL>
<LI>International Standard Randomised Controlled Trial Number Register at <A HREF="http://www.isrctn.com/">www.isrctn.com/</A> (searched August 2016);</LI>
<LI>ClinicalTrials.gov at <A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A> (searched 27 August 2016);</LI>
<LI>Stroke Trials Register at <A HREF="http://www.strokecenter.org">www.strokecenter.org</A> (searched 27 August 2016); and</LI>
<LI>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) at <A HREF="http://apps.who.int/trialsearch/">apps.who.int/trialsearch/</A> (searched 27 August 2016) (<LINK REF="APP-11" TYPE="APPENDIX">Appendix 11</LINK>).</LI>
</UL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2017-05-02 14:50:49 +0100" MODIFIED_BY="Hazel Fraser">
<P>We also:</P>
<UL>
<LI>handsearched the following relevant conference proceedings:</LI>
<UL>
<LI>World Congress of NeuroRehabilitation (2002, 2006, 2008, 2010, 2012, 2014, and 2016);</LI>
<LI>World Congress of Physical Medicine and Rehabilitation (2001, 2003, 2005, 2007, 2009, 2011, 2013, and 2015);</LI>
<LI>World Congress of Physical Therapy (2003, 2007, 2011, and 2015);</LI>
<LI>Deutsche Gesellschaft für Neurotraumatologie und Klinische Neurorehabilitation (2001 to 2015);</LI>
<LI>Deutsche Gesellschaft für Neurologie (2000 to 2016);</LI>
<LI>Deutsche Gesellschaft für Neurorehabilitation (1999 to 2016); and</LI>
<LI>Asia-Oceanian Conference of Physical &amp; Rehabilitation Medicine (2008 to 2016).</LI>
</UL>
<LI>screened reference lists of all relevant articles; and</LI>
<LI>contacted trialists, experts, and researchers in our field of study.</LI>
</UL>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-05-02 14:51:04 +0100" MODIFIED_BY="Hazel Fraser">
<STUDY_SELECTION MODIFIED="2017-05-02 14:50:51 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two review authors (JM, BE) independently read the titles and abstracts of the identified references and eliminated obviously irrelevant studies. We obtained the full text for the remaining studies. Based on our inclusion criteria (types of studies, participants, aims of interventions, outcome measures), the same two review authors independently ranked these studies as relevant, irrelevant, or possibly relevant. We excluded all trials ranked initially as irrelevant but included all other trials at this stage. We excluded all trials of specific treatment components, such as electrical stimulation as stand-alone treatment, treadmill training, and continuous passive motion treatment, because these have been the subject of other Cochrane Reviews (e.g. <LINK REF="REF-Mehrholz-2014" TYPE="REFERENCE">Mehrholz 2014</LINK>). We resolved any disagreements through discussion between all four review authors. If we required further information to reach consensus, we contacted trialists in an attempt to obtain the missing information. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram, and listed all studies that did not match our inclusion criteria regarding types of studies, participants, and aims of interventions in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-05-02 14:50:53 +0100" MODIFIED_BY="Hazel Fraser">
<P>Two review authors (JM, BE) independently extracted trial and outcome data from the selected trials. We established the characteristics of unpublished trials through correspondence with the trial co-ordinator or principal investigator. If any review author was involved in any of the selected studies, another review author not involved in the study extracted the study information. If there was any doubt as to whether a study should be excluded, we retrieved the full text of the article. In cases of disagreement between the two review authors, a third review author (JK) reviewed the information to decide on inclusion or exclusion of a study. We used checklists to independently record the following details.<BR/>
</P>
<UL>
<LI>Methods of generating the randomisation schedule.</LI>
<LI>Method of concealment of allocation.</LI>
<LI>Blinding of assessors.</LI>
<LI>Use of an intention-to-treat analysis (all participants initially randomly assigned were included in the analyses as allocated to groups).</LI>
<LI>Adverse events and dropouts for all reasons.</LI>
<LI>Important imbalance in prognostic factors.</LI>
<LI>Participants (country, number of participants, age, gender, type of stroke, time from stroke onset to entry to the study, inclusion and exclusion criteria).</LI>
<LI>Comparison (details of the intervention in treatment and control groups, details of co-intervention(s) in both groups, duration of treatment).</LI>
<LI>Outcomes and time points of measures (number of participants in each group and outcome, regardless of compliance).</LI>
</UL>
<P>The two review authors checked all of the extracted data for agreement, with a third review author (JK) arbitrating any items for which consensus could not be reached. If necessary, we contacted trialists to request more information, clarification, and missing data.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-03-21 14:59:34 +0000" MODIFIED_BY="Hazel Fraser">
<P>Two review authors (JM, MP) independently evaluated the methodological quality of the included trials using the Cochrane 'Risk of bias' tool, as described in Chapter 8 of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>).</P>
<P>We checked all methodological quality assessments for agreement between review authors. We resolved disagreements by discussion. If one of the review authors was a co-author of an included trial, another review author (BE or JK) conducted the methodological quality assessment for this trial in this case.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-05-02 14:50:54 +0100" MODIFIED_BY="Hazel Fraser">
<P>We planned to compare electromechanical- and robotic-assisted gait training plus physiotherapy versus physiotherapy (or usual care) for primary and secondary outcome parameters. We used the effect measures odds ratio (OR) or mean difference (MD) in the meta-analyses.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2017-05-02 14:50:55 +0100" MODIFIED_BY="Hazel Fraser">
<P>We analysed binary (dichotomous) outcomes with an OR, random-effects model with 95% confidence intervals (CIs). We analysed continuous outcomes with MDs, using the same outcome scale. We used a random-effects model for all analyses. We used Cochrane Review Manager 5 software for all statistical comparisons, (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2017-05-02 14:50:56 +0100" MODIFIED_BY="Hazel Fraser">
<P>In the case of missing outcome data, we attempted to analyse data according to the intention-to-treat approach. We contacted the trial co-ordinator or principal investigator if data were missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-05-02 14:50:56 +0100" MODIFIED_BY="Hazel Fraser">
<P>We used the I² statistic to assess heterogeneity. We used a random-effects model, regardless of the level of heterogeneity.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2017-03-24 11:24:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>We inspected funnel plots to assess the risk of publication bias. </P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-05-02 14:51:01 +0100" MODIFIED_BY="Hazel Fraser">
<SUBSECTION>
<HEADING LEVEL="3">GRADE and 'Summary of findings' table</HEADING>
<P>We created two 'Summary of findings' tables using the following outcomes.</P>
<UL>
<LI>Primary outcome measure: Independent walking at the end of intervention phase, all electromechanical devices used. Scale from 0 to infinity.</LI>
<LI>Primary outcome measure: Recovery of independent walking at follow-up after study end. Scale from 0 to infinity.</LI>
<LI>Primary outcome measure: Walking velocity (metres per second) at the end of intervention phase. Scale from 0 to infinity.</LI>
<LI>Secondary outcome measure: Walking velocity (metres per second) at follow-up. Scale from 0 to infinity.</LI>
<LI>Secondary outcome measure: Walking capacity (metres walked in 6 minutes) at the end of intervention phase. Scale from 0 to infinity.</LI>
<LI>Secondary outcome measure: Walking capacity (metres walked in 6 minutes) at follow-up. Scale from 0 to infinity.</LI>
<LI>Secondary outcome measure: Acceptability of electromechanical-assisted gait-training devices during intervention phase: number of dropouts.</LI>
</UL>
<P>We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to the studies that contribute data to the meta-analyses for the prespecified outcomes (<LINK REF="REF-Atkins-2004" TYPE="REFERENCE">Atkins 2004</LINK>). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011b" TYPE="REFERENCE">Higgins 2011b</LINK>), employing GRADEpro GDT software (<LINK REF="REF-GRADEpro-GDT" TYPE="REFERENCE">GRADEpro GDT</LINK>). We justified all decisions to down- or upgrade the quality of studies using footnotes, and made comments to aid the reader's understanding of the review where necessary.</P>
</SUBSECTION>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2017-05-02 14:51:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>As planned in our protocol (<LINK REF="REF-Mehrholz-2006" TYPE="REFERENCE">Mehrholz 2006</LINK>), we performed a formal subgroup analysis following the guidance in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>), comparing participants treated in the acute and subacute phases of their stroke (within three months) with participants treated in the chronic phase (longer than three months).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-05-02 14:51:04 +0100" MODIFIED_BY="Hazel Fraser">
<P>As planned in our protocol, we performed a sensitivity analysis of methodological quality for each included study.</P>
<P>We carried out the following sensitivity analyses by including only those studies:<BR/>
</P>
<UL>
<LI>with an adequate sequence generation process;</LI>
<LI>with adequate concealed allocation;</LI>
<LI>with blinded assessors for the primary outcome; and</LI>
<LI>without incomplete outcome data.</LI>
</UL>
<P>We considered it necessary to do a further sensitivity analysis by removing the largest study, <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>, because some of the review authors (JM, MP, and CW) were investigators in this large trial. We carried out this sensitivity analysis by including all studies without the largest study (<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>).</P>
<P>We performed two further (post hoc) sensitivity analyses.</P>
<UL>
<LI>Ambulatory status at start of study (including only studies that included an independent walker; including only studies that included dependent and independent walkers; and including only studies that included a dependent walker).</LI>
<LI>Type of device used in trials (including only studies that used end-effector devices and including only studies that used exoskeleton devices).</LI>
</UL>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-05-02 14:51:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>See the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>, and <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK> tables.</P>
<SEARCH_RESULTS MODIFIED="2017-05-02 14:51:06 +0100" MODIFIED_BY="Hazel Fraser">
<P>
<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> shows the flow diagram of the selection of studies for this update.</P>
<P>Searches of the electronic databases and trials registers generated 7083 new unique references for screening. After excluding non-relevant citations, we obtained the full text of 55 new papers, and from these identified and included 13 new trials in the review.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-05-02 14:51:35 +0100" MODIFIED_BY="Hazel Fraser">
<P>We included 36 trials involving a total of 1472 participants (see the 
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>, <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>, and <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). All included studies investigated the effects of electromechanical- or robotic-assisted gait-training devices in improving walking after stroke.</P>
<P>For one of the included studies published only as an abstract we obtained at least some results through correspondence with the trial co-ordinator or principal investigator (<LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>). Another study was not yet published, but the results of the trial were presented orally, and we were able to obtain a handout with information about the study from the principal investigator (<LINK REF="STD-Aschbacher-2006" TYPE="STUDY">Aschbacher 2006</LINK>).</P>
<P>A detailed description of all participant characteristics can be found in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> and <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> (see also the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). The mean age in the included studies ranged from 48 years, in <LINK REF="STD-Kyung-2008" TYPE="STUDY">Kyung 2008</LINK>, to 76 years, in <LINK REF="STD-Watanabe-2014" TYPE="STUDY">Watanabe 2014</LINK> (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). More males than females were included the studies (approximately 60% males). More participants with ischaemic stroke than haemorrhagic stroke lesions (approximately 70% ischaemic stroke) were included, and almost as many participants with left-sided hemiparesis compared with participants with right-sided hemiparesis (approximately 50% left-sided) were included in the studies (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> and <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
<P>Twelve studies provided information about baseline stroke severity (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>), of which seven used the Barthel Index score, ranging from 20 Barthel Index points, in <LINK REF="STD-Kim-2015" TYPE="STUDY">Kim 2015</LINK>, to 75 of 100 Barthel Index points, in <LINK REF="STD-Dias-2006" TYPE="STUDY">Dias 2006</LINK> (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). Details of all inclusion and exclusion criteria used in the studies can be found in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<P>The duration of study intervention (time frame during which experimental interventions were applied) was heterogeneous, ranging from 10 days, in <LINK REF="STD-Chang-2012" TYPE="STUDY">Chang 2012</LINK>, to eight weeks, in <LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>. The study intervention period for most studies was three or four weeks (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). Fifteen of the 36 studies included participants who could walk independently at the start of the study; a further nine studies included participants who were dependent and independent walkers (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>); and 12 studies included only non-ambulatory participants (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). The experimental intervention in 17 studies was the robotic-assisted device Lokomat, and the experimental intervention in nine studies was the electromechanical-assisted device Gait Trainer; a detailed description of devices used in studies can be found in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>Frequency (in terms of therapy provided per week) of treatment ranged from two or three times a week, in <LINK REF="STD-Tanaka-2012" TYPE="STUDY">Tanaka 2012</LINK>, to five times a week (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). Intensity (in terms of duration of experimental therapy provided) of treatment ranged from 20 minutes, in <LINK REF="STD-Werner-2002" TYPE="STUDY">Werner 2002</LINK>, to 60 minutes, in <LINK REF="STD-Forrester-2014" TYPE="STUDY">Forrester 2014</LINK>. In many studies, details of the interventions were unclear or incomplete, for example details about the intensity of the experimental treatment were unclear in some studies (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). Except for <LINK REF="STD-Tanaka-2012" TYPE="STUDY">Tanaka 2012</LINK> and <LINK REF="STD-Picelli-2016" TYPE="STUDY">Picelli 2016</LINK>, the gait training time did not differ between control and experimental groups in the included studies. Eleven included studies used a follow-up assessment after the study ended (<LINK REF="STD-Buesing-2015" TYPE="STUDY">Buesing 2015</LINK>; <LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>; <LINK REF="STD-Dias-2006" TYPE="STUDY">Dias 2006</LINK>; <LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>; <LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>; <LINK REF="STD-Peurala-2005" TYPE="STUDY">Peurala 2005</LINK>; <LINK REF="STD-Peurala-2009" TYPE="STUDY">Peurala 2009</LINK>; <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>; <LINK REF="STD-Schwartz-2006" TYPE="STUDY">Schwartz 2006</LINK>; <LINK REF="STD-Stein-2014" TYPE="STUDY">Stein 2014</LINK>; <LINK REF="STD-Waldman-2013" TYPE="STUDY">Waldman 2013</LINK>). Most studies investigated improvement in walking function as a primary outcome for analysis and used the Functional Ambulation Category (FAC) or comparable scales to assess independent walking. Furthermore, frequently investigated outcomes included assessment of walking function using gait velocity in metres per second. A more detailed description of the primary and secondary outcomes for each trial can be found in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<P>We found the highest dropout rates for all reasons at the end of the treatment phase to be 23%, in <LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>, and 29%, in <LINK REF="STD-Kyung-2008" TYPE="STUDY">Kyung 2008</LINK>. Seventeen trialists reported no dropouts at scheduled follow-up (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>; <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-05-02 14:51:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>We excluded 24 studies (see <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> and <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> for further information).</P>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies and studies awaiting assessment</HEADING>
<P>We identified 16 ongoing studies (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>). Thirteen studies for which we were unable to make contact with the trialists are still awaiting assessment (see <LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>The risk of bias in included studies is described in greater detail in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<P>We wrote to the trialists of all included studies and studies awaiting assessment to request clarification of design features or for missing information to complete the quality ratings. We sent the correspondence via email or letter, followed by reminders every month if we received no response. Most trialists provided at least some of the requested data, but we were not able to obtain all of the required data.</P>
<P>Two review authors (JM, MP) used the 'Risk of bias' assessment tool to independently assess the methodological quality of the studies for the domains random sequence generation, allocation concealment, blinding of outcome assessment, and incomplete outcome data for all of the included trials except two (<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>; <LINK REF="STD-Werner-2002" TYPE="STUDY">Werner 2002</LINK>), which two other review authors (BE, JK) rated in an interview with the trialists. The review authors discussed all disagreements and sought arbitration by another review author (JK or BE) if necessary.</P>
<ALLOCATION MODIFIED="2017-05-02 14:51:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>Of the 36 included studies, 20 described adequate random sequence generation, and 17 described adequate allocation concealment.</P>
</ALLOCATION>
<BLINDING MODIFIED="2017-05-02 14:51:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>Of the 36 included studies, 6 reported blinding of the primary outcome assessment. </P>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-03-24 11:24:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>Of the 36 included studies, 14 reported incomplete outcome data (attrition bias). </P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2017-03-24 11:24:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>For the majority of studies, particularly the older trials, we did not find study protocols. Where study protocols were available, there was no evidence of selective reporting of outcomes relevant to this review.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Five out of 36 included trials used a cross-over design with random allocation to the order of treatment sequences (<LINK REF="STD-Brincks-2011" TYPE="STUDY">Brincks 2011</LINK>; <LINK REF="STD-Cho-2015" TYPE="STUDY">Cho 2015</LINK>; <LINK REF="STD-Saltuari-2004" TYPE="STUDY">Saltuari 2004</LINK>; <LINK REF="STD-Tanaka-2012" TYPE="STUDY">Tanaka 2012</LINK>; <LINK REF="STD-Werner-2002" TYPE="STUDY">Werner 2002</LINK>). We analysed only the first intervention period as a parallel-group trial in this review. All other included studies used a parallel-group design with true randomisation to group allocation.</P>
<P>Three studies used two experimental groups and one control group (<LINK REF="STD-Geroin-2011" TYPE="STUDY">Geroin 2011</LINK>; <LINK REF="STD-Peurala-2005" TYPE="STUDY">Peurala 2005</LINK>; <LINK REF="STD-Tong-2006" TYPE="STUDY">Tong 2006</LINK>), and one study used one experimental group and two control groups (<LINK REF="STD-Peurala-2009" TYPE="STUDY">Peurala 2009</LINK>). In the former three studies (<LINK REF="STD-Geroin-2011" TYPE="STUDY">Geroin 2011</LINK>; <LINK REF="STD-Peurala-2005" TYPE="STUDY">Peurala 2005</LINK>; <LINK REF="STD-Tong-2006" TYPE="STUDY">Tong 2006</LINK>), additional functional electrical stimulation of leg muscles (or transcranial stimulation of the brain in <LINK REF="STD-Geroin-2011" TYPE="STUDY">Geroin 2011</LINK>) during gait training was applied in one of the treatment groups. Because functional electrical stimulation or transcranial stimulation of the brain was done as an adjunct during electromechanical-assisted gait training, and because the results in these experimental groups did not differ significantly, we combined the results of both experimental groups into one (collapsed) group and compared this with the results from the control group. In one study, an electromechanical-assisted device was used in the experimental group and was compared with two control groups that did not use a device (<LINK REF="STD-Peurala-2009" TYPE="STUDY">Peurala 2009</LINK>). Because we were interested in the effects of electromechanical- and robotic-assisted gait-training devices for improving walking after stroke, we combined the results of both control groups without devices into one (collapsed control) group and compared this with results of the one experimental group.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Independent walking at the end of the intervention phase, all electromechanical devices used</HEADING>
<P>Thrity-six trials with a total of 1472 participants measured independent walking at study end, but for 21 included trials, no effect estimate (odds ratio (OR)) was feasible because no events (e.g. no participant reached the ability to walk) or only events (e.g. all participants regained walking) were reported (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) (<LINK REF="REF-Deeks-2011" TYPE="REFERENCE">Deeks 2011</LINK>).</P>
<P>The use of electromechanical devices in gait rehabilitation for people after stroke increased the chance of walking independently (OR 1.94, 95% confidence interval (CI) 1.39 to 2.71; P &lt; 0.001; level of heterogeneity I² = 8%; moderate-quality evidence; <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). However, 15 out of 36 studies investigated at least some participants who were already independent in walking at the start of the study. A further nine studies included participants who were dependent and independent walkers, and 12 studies included only non-ambulatory participants (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). Of the total population of 1472 participants, approximately 39% were independent and approximately 59% were dependent walkers at the start of the study.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Recovery of independent walking at follow-up after study end</HEADING>
<P>Six trials with a total of 496 participants measured recovery of independent walking with follow-up after the study end (<LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>; <LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>; <LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>; <LINK REF="STD-Peurala-2009" TYPE="STUDY">Peurala 2009</LINK>; <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>; <LINK REF="STD-Tong-2006" TYPE="STUDY">Tong 2006</LINK>), but for two included trials (with 125 participants), no effect estimate (OR) was feasible because no events (e.g. no participant reached ability to walk) or only events (e.g. all participants regained walking) were reported (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke did not increase the chance of walking independently at follow-up after study end (OR 1.93, 95% CI 0.72 to 5.13; P = 0.19; level of heterogeneity I² = 79%; moderate-quality evidence). However, some included trials investigated participants who were already independent in walking at the start of the study. We could draw no definitive conclusion regarding a longer-lasting effect of the use of electromechanical devices.<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Walking velocity (metres per second) at the end of the intervention phase</HEADING>
<P>Twenty-four trials with a total of 985 participants provided data for walking velocity (m/s) at study end (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). The use of electromechanical devices for gait rehabilitation did not significantly increase walking velocity. The pooled mean difference (MD) (random-effects model) for walking velocity was 0.04 m/s (95% CI 0.00 to 0.09; P = 0.08; level of heterogeneity I² = 65%; low-quality evidence). Participants who were unable to walk were regarded as having a walking velocity of zero metres per second.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Walking velocity (metres per second) at follow-up</HEADING>
<P>Nine trials with a total of 578 participants provided data for walking velocity (m/s) at follow-up after study end (<LINK REF="STD-Buesing-2015" TYPE="STUDY">Buesing 2015</LINK>; <LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>; <LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>; <LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>; <LINK REF="STD-Kyung-2008" TYPE="STUDY">Kyung 2008</LINK>; <LINK REF="STD-Noser-2012" TYPE="STUDY">Noser 2012</LINK>; <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>; <LINK REF="STD-Stein-2014" TYPE="STUDY">Stein 2014</LINK>; <LINK REF="STD-Tong-2006" TYPE="STUDY">Tong 2006</LINK>). The use of electromechanical devices for gait rehabilitation did not significantly increase the walking velocity at follow-up after study end. The pooled MD (random-effects model) for walking velocity was 0.07 m/s (95% CI -0.05 to 0.19; P = 0.26; level of heterogeneity I² = 80%; moderate-quality evidence; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). Participants who were unable to walk were regarded as having a walking velocity of zero metres per second. We could draw no definitive conclusion regarding a longer-lasting effect of the use of electromechanical devices for walking velocity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Walking capacity (metres walked in 6 minutes) at the end of the intervention phase</HEADING>
<P>Twelve trials with a total of 594 participants provided data for walking capacity (metres walked in 6 minutes) at study end (<LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>; <LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>; <LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>; <LINK REF="STD-Noser-2012" TYPE="STUDY">Noser 2012</LINK>; <LINK REF="STD-Peurala-2005" TYPE="STUDY">Peurala 2005</LINK>; <LINK REF="STD-Picelli-2016" TYPE="STUDY">Picelli 2016</LINK>; <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>; <LINK REF="STD-Saltuari-2004" TYPE="STUDY">Saltuari 2004</LINK>; <LINK REF="STD-Stein-2014" TYPE="STUDY">Stein 2014</LINK>; <LINK REF="STD-Waldman-2013" TYPE="STUDY">Waldman 2013</LINK>; <LINK REF="STD-Watanabe-2014" TYPE="STUDY">Watanabe 2014</LINK>; <LINK REF="STD-Westlake-2009" TYPE="STUDY">Westlake 2009</LINK>). The use of electromechanical devices in gait rehabilitation did not increase the walking capacity of people after stroke. The pooled MD (random-effects model) for walking capacity was 5.84 metres walked in 6 minutes (95% CI -16.73 to 28.40; P = 0.61; level of heterogeneity I² = 53%; very low-quality evidence; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Walking capacity (metres walked in 6 minutes) at follow-up</HEADING>
<P>Seven trials with a total of 463 participants provided data for walking capacity (metres walked in 6 minutes) at follow-up after study end (<LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>; <LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>; <LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>; <LINK REF="STD-Noser-2012" TYPE="STUDY">Noser 2012</LINK>; <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>; <LINK REF="STD-Stein-2014" TYPE="STUDY">Stein 2014</LINK>; <LINK REF="STD-Waldman-2013" TYPE="STUDY">Waldman 2013</LINK>). The use of electromechanical devices for gait rehabilitation did not increase walking capacity at follow-up after study end. The pooled MD (random-effects model) for walking capacity was -0.82 metres walked in 6 minutes (95% CI -32.17 to 30.53; P = 0.96; level of heterogeneity I² = 58%; very low-quality evidence; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3"/>
<P/>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Death from all causes until the end of the intervention phase</HEADING>
<P>Only three larger trials reported any deaths during the intervention period (<LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>; <LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>; <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>). In <LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK> one participant in the control group died as the result of aspiration pneumonia, and one participant in the treatment group died due to recurrent stroke. In <LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>, the group in which the death occurred was not stated. We therefore used a worst-case (conservative) scenario and counted the one death for the experimental group. In the study of <LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK> the deaths occurred after the treatment period. The use of electromechanical devices for gait rehabilitation of non-ambulatory people after stroke did not increase the risk of participants dying during the intervention period (risk difference (random-effects model) 0.00, 95% CI -0.01 to 0.02; P = 0.77; level of heterogeneity I² = 0%; moderate-quality evidence; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse outcomes: acceptability of electromechanical-assisted gait-training devices during the intervention phase in terms of dropouts</HEADING>
<P>All trialists provided information about participants who dropped out from all causes during the trial period, but for 17 of the 36 included trials, no events/dropouts were reported (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). The use of electromechanical devices for gait rehabilitation of non-ambulatory people after stroke did not increase the risk of participants dropping out (OR (random-effects model) 0.67, 95% CI 0.43 to 1.05; P = 0.08; level of heterogeneity I² = 24%; low-quality evidence). The reasons for dropouts and all adverse events are described in detail for each trial in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Regaining independent walking ability: planned sensitivity analysis by trial methodology</HEADING>
<P>To examine the robustness of the results, we specified variables in a sensitivity analysis that we believed could influence the size of the observed effect (adequate sequence generation process, adequate concealed allocation, blinded assessors for the primary outcome, incomplete outcome data, and excluding the largest study). As stated above, for some of the included trials, no effect estimate (OR) was feasible (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Studies with adequate sequence generation process</HEADING>
<P>We included 20 trials with a total of 949 participants with an adequate sequence generation process (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 1.80, 95% CI 1.06 to 3.08; P = 0.03; level of heterogeneity I² = 38%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Studies with adequate concealed allocation</HEADING>
<P>We included 17 trials with a total of 831 participants with adequate concealed allocation (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 1.87, 95% CI 1.12 to 3.12; P = 0.02; level of heterogeneity I² = 37%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Studies with blinded assessors for the primary outcome</HEADING>
<P>Sixteen trials with a total of 762 participants had blinded assessors for the primary outcome (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 1.81, 95% CI 1.10 to 2.98; P = 0.02; level of heterogeneity I² = 31%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Studies with complete outcome data</HEADING>
<P>Fourteen trials with a total of 590 participants adequately described complete outcome data (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 2.23, 95% CI 1.16 to 4.29; P = 0.02; level of heterogeneity I² = 29%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Excluding the largest study (Pohl 2007)</HEADING>
<P>After excluding the largest study (<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>), 35 trials with a total of 1317 participants remained in this analysis. The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 1.65, 95% CI 1.17 to 2.34; P = 0.005; level of heterogeneity I² = 0%).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis comparing participants in the acute and chronic phases of stroke</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Independent walking at the end of the intervention phase, all electromechanical devices used</HEADING>
<P>In our planned subgroup analysis comparing independent walking at the end of the intervention phase in people in the acute and chronic phases of stroke, we attempted to assign all included studies to one of two subgroups (acute and chronic phases).</P>
<P>Twenty trials with a total of 1143 participants investigated people in the acute or subacute phase, defined as less than or equal to three months after stroke (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). As stated in the comparisons above, for some of the included trials no effect estimate (OR) was feasible (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 1.90, 95% CI 1.38 to 2.63; P &lt; 0.001; level of heterogeneity I² = 5%).</P>
<P>Sixteen trials with a total of 461 participants investigated people in the chronic phase, defined as more than three months after stroke (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke did not increase the chance of walking independently (OR (random-effects model) 1.20, 95% CI 0.40 to 3.65; P = 0.74; level of heterogeneity I² = 29%).</P>
<P>In a formal subgroup analysis, we did not find statistically significant differences in regaining independent walking between participants treated in the acute/subacute phase compared with participants treated in the chronic phase after stroke (Chi² = 0.61, df = 1; P = 0.44).<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Post hoc sensitivity analysis by ambulatory status at study onset</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Independent walking at the end of the intervention phase</HEADING>
<P>To examine the robustness of the results and to explore the relationship between the main effect and walking status at the start of the study, we compared independent walking rates at the end of the intervention phase by ambulatory status at start of study.<BR/>
</P>
<SUBSECTION>
<HEADING LEVEL="5">Ambulatory participants at start of study</HEADING>
<P>Fifteen trials with a total of 500 participants investigated independent walkers (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). As stated in the comparisons above, for some of the included trials, no effect estimate (OR) was feasible; the conclusions are therefore based on one trial. The use of electromechanical devices for gait rehabilitation of people after stroke did not increase the chance of walking independently (OR (random-effects model) 1.38, 95% CI 0.45 to 4.20; P = 0.57; level of heterogeneity I² = not applicable).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Ambulatory and non-ambulatory participants at start of study</HEADING>
<P>Nine trials with a total of 340 participants investigated a mixed population of dependent and independent walkers (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 1.90, 95% CI 1.11 to 3.25; P = 0.02; level of heterogeneity I² = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Non-ambulatory participants at start of study</HEADING>
<P>Twelve trials with a total of 632 participants investigated dependent walkers (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 1.90, 95% CI 1.04 to 3.48; P = 0.04; level of heterogeneity I² = 45%).</P>
<P>In a subgroup analysis, we did not find statistically significant differences between people who were dependent or independent walkers at the start of the study in regaining independent walking (Chi² = 0.28, df = 2; P = 0.87).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Walking speed at the end of the intervention phase</HEADING>
<P>To examine the robustness of the results and to explore the relationship between walking velocity and ambulatory status at the start of the study, we compared achieved walking velocity at the end of the intervention phase by ambulatory status at the start of the study.<BR/>
</P>
<SUBSECTION>
<HEADING LEVEL="5">Ambulatory participants at start of study</HEADING>
<P>Ten trials with a total of 317 participants investigated independent walkers at the start of the study and provided data for walking velocity (m/s) at study end (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). The use of electromechanical devices for gait rehabilitation did not significantly increase walking velocity. The pooled MD (random-effects model) for walking velocity was -0.02 m/s (95% CI -0.10 to 0.06; P = 0.66; level of heterogeneity I² = 59%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Ambulatory and non-ambulatory participants at start of study</HEADING>
<P>Five trials with a total of 146 participants investigated dependent and independent walkers at the start of the study and provided data for walking velocity (m/s) at study end (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). The use of electromechanical devices for gait rehabilitation did not significantly increase walking velocity. The pooled MD (random-effects model) for walking velocity was 0.03 m/s (95% CI -0.05 to 0.11; P = 0.44; level of heterogeneity I² = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Non-ambulatory participants at start of study</HEADING>
<P>Nine trials with a total of 522 participants investigated dependent walkers at the start of the study and provided data for walking velocity (m/s) at study end (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). The use of electromechanical devices for gait rehabilitation significantly increased walking velocity. The pooled MD (random-effects model) for walking velocity was 0.10 m/s (95% CI 0.03 to 0.17; P = 0.006; level of heterogeneity I² = 73%).<BR/>
</P>
<P>In a subgroup analysis, we did not find statistically significant differences in regaining independent walking between participants who were dependent or independent walkers at the start of the study (Chi² = 4.55, df = 2; P = 0.10).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Post hoc sensitivity analysis by type of electromechanical device</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Independent walking at the end of the intervention phase</HEADING>
<P/>
<P>To examine the robustness of the results and to explore the relationship between independent walking and type of electromechanical device, we compared achieved independent walking rates at the end of the intervention phase by type of electromechanical device.<BR/>
</P>
<SUBSECTION>
<HEADING LEVEL="5">End-effector devices</HEADING>
<P>Eleven trials with a total of 598 participants used an end-effector device as the experimental intervention (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). As stated in the comparisons above, for some of the included trials, no effect estimate (OR) was feasible (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke did not increase the chance of walking independently (OR (random-effects model) 1.90, 95% CI 0.99 to 3.63; P = 0.05; level of heterogeneity I² = 50%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Exoskeleton devices</HEADING>
<P>Sixteen trials with a total of 585 participants used an exoskeleton device as the experimental intervention (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). The use of electromechanical devices for gait rehabilitation of people after stroke increased the chance of walking independently (OR (random-effects model) 2.05, 95% CI 1.21 to 3.50; P = 0.008; level of heterogeneity I² = 0%).</P>
<P>We did not find statistically significant differences in regaining independent walking between participants treated with end-effector or exoskeleton devices (Chi² = 0.04, df = 1; P = 0.85).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mobile devices</HEADING>
<P>Three trials with a total of 106 participants used powered mobile devices as the experimental intervention (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>), but the effects on walking ability were not estimable.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Ankle devices</HEADING>
<P>Two trials with a total of 63 participants used ankle devices while sitting as the experimental intervention (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>), but the effects on walking ability were not estimable.</P>
<P>We did not find statistically significant differences in regaining independent walking by type of electromechanical device (end-effector, exoskeleton, mobile or ankle device)(Chi² = 0.04, df = 1; P = 0.85).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Walking speed at the end of the intervention phase</HEADING>
<P/>
<P>To examine the robustness of the results and to explore the relationship between independent walking and type of electromechanical device, we compared the walking speed at the end of the intervention phase by type of electromechanical device.</P>
<SUBSECTION>
<HEADING LEVEL="5">End-effector devices</HEADING>
<P>Nine trials with a total of 519 participants used an end-effector device as the experimental intervention and provided data for walking velocity (m/s) at study end (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>). The use of electromechanical devices for gait rehabilitation significantly increased walking velocity. The pooled MD (random-effects model) for walking velocity was 0.11 m/s (95% CI 0.04 to 0.18; P = 0.003; level of heterogeneity I² = 73%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Exoskeleton devices</HEADING>
<P>Twelve trials with a total of 360 participants used an exoskeleton device as the experimental intervention and provided data for walking velocity (m/s) at study end (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>). The use of electromechanical devices for gait rehabilitation did not increase walking velocity. The pooled MD (random-effects model) for walking velocity was -0.02 m/s (95% CI -0.08 to 0.04; P = 0.60; level of heterogeneity I² = 44%).</P>
<P>In a formal subgroup analysis, we found statistically significant differences in improvement in walking velocity between participants treated with an end-effector device or an exoskeleton device (Chi² = 6.79, df = 1; P = 0.009; I² = 85.3%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mobile devices</HEADING>
<P>Three trials with a total of 106 participants used powered mobile devices as the experimental intervention and provided data for walking velocity (m/s) at study end (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>). The use of electromechanical devices for gait rehabilitation did not increase walking velocity. The pooled MD (random-effects model) for walking velocity was 0.02 m/s (95% CI -0.11 to 0.15; P = 0.78; level of heterogeneity I² = 0%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Ankle devices</HEADING>
<P>One trial with 39 participants used an ankle mobile device as the experimental intervention and provided data for walking velocity (m/s) at study end (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>). The use of electromechanical devices for gait rehabilitation increased walking velocity. The MD (random-effects model) for walking velocity was 0.04 m/s (95% CI 0.01 to 0.07; P = 0.02; level of heterogeneity not applicable).</P>
<P>In a subgroup analysis, we did not find statistically significant differences in improvement in walking velocity by type of electromechanical device (end-effector, exoskeleton, mobile or ankle device)(Chi² = 6.56, df = 3; P = 0.09; I² = 54.3%).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Walking capacity at the end of the intervention phase</HEADING>
<P/>
<P>To examine the robustness of the results and to explore the relationship between independent walking and type of electromechanical device, we compared the walking capacity at the end of the intervention phase by type of electromechanical device.</P>
<SUBSECTION>
<HEADING LEVEL="5">End-effector devices</HEADING>
<P>Four trials with a total of 328 participants used an end-effector device as the experimental intervention and provided data for walking capacity (metres) at study end (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). The use of electromechanical devices for gait rehabilitation significantly increased walking capacity. The pooled MD (random-effects model) for walking capacity was 27.5 m (95% CI 3.63 to 51.36; P = 0.02; level of heterogeneity I² = 4%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Exoskeleton devices</HEADING>
<P>Five trials with a total of 186 participants used an exoskeleton device as the experimental intervention and provided data for walking capacity (metres) at study end (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). The use of electromechanical devices for gait rehabilitation did not increase walking capacity. The pooled MD (random-effects model) for walking capacity was -15.64 m (95% CI -46.34 to 15.05; P = 0.32; level of heterogeneity I² = 51%).</P>
<P>In a formal subgroup analysis, we found statistically significant differences in improvement in walking capacity between participants treated with an end-effector device or an exoskeleton device (Chi² = 4.73, df = 1; P = 0.03; I² = 78.9%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Mobile devices</HEADING>
<P>Two trials with a total of 56 participants used powered mobile devices as the experimental intervention and provided data for walking capacity (metres) at study end (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). The use of electromechanical devices for gait rehabilitation did not increase walking capacity. The pooled MD (random-effects model) for walking capacity was 20.06 m (95% CI -39.52 to 79.63; P = 0.51; level of heterogeneity I² = 0%).<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Ankle devices</HEADING>
<P>One trial with 24 participants used an ankle mobile device as the experimental intervention and provided data for walking capacity (metres) at study end (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>). The use of electromechanical devices for gait rehabilitation did not increase walking capacity. The MD (random-effects model) for walking capacity was 8.0 m (95% CI -83.03 to 99.03; P = 0.86; level of heterogeneity not applicable).</P>
<P>In a subgroup analysis, we did not find statistically significant differences in improvement in walking capacity between participants treated by type of electromechanical device (end-effector, exoskeleton, mobile or ankle device) (Chi² = 4.81, df = 3; P = 0.19; I² = 37.7%).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2017-05-02 14:53:35 +0100" MODIFIED_BY="Hazel Fraser">
<P>The aim of this review was to evaluate the effects of electromechanical- and robotic-assisted gait-training devices (with body weight support) for improving walking after stroke. We sought to estimate the likelihood or chance of becoming independent in walking as a result of these interventions, which is a main rehabilitation goal for people who have had a stroke (<LINK REF="REF-Bohannon-1988" TYPE="REFERENCE">Bohannon 1988</LINK>; <LINK REF="REF-Bohannon-1991" TYPE="REFERENCE">Bohannon 1991</LINK>).</P>
<P>We included 36 trials with a total of 1472 participants and found evidence that the use of electromechanical-assisted devices in combination with physiotherapy in rehabilitation settings may improve walking function after stroke.</P>
<P>Furthermore, adverse events, dropouts, and deaths do not appear to be more frequent in participants who received electromechanical- or robotic-assisted gait training, which indicates that the use of electromechanical-assisted gait-training devices was safe and acceptable to most participants included in the trials analysed by this review.</P>
<P>The exclusion of certain patient groups, such as people over 80 years of age, people with unstable cardiovascular conditions, people with cognitive and communication deficits, and people with a limited range of motion in the lower limb joints at the start of the intervention, may limit the general applicability of the findings. However, using the results from the primary outcomes, it is possible to explore the apparent effectiveness of electromechanical-assisted devices for regaining walking ability. Of 761 participants in the treatment group, 412 (54%) were walking independently at the end of the intervention phase. We used the primary outcome of independently walking at the end of the intervention phase for all included participants (OR 1.94) to calculate the number needed to treat for an additional beneficial outcome (NNTB). Together with our control event rate of 45% (325 out of 711 control participants were independently walking), we calculated an NNTB of 7 (95% CI 6 to 8) (<LINK REF="REF-Sackett-1996" TYPE="REFERENCE">Sackett 1996</LINK>). This means that every seventh dependency in walking ability after stroke could be avoided with the use of electromechanical-assisted devices. However, the optimum amount of electromechanical-assisted gait training (optimal frequency, optimal duration in the use of assistive technologies and timing of application) remains unclear.</P>
<P>It appears that people in the acute and subacute phases after stroke profit more than people treated more than three months poststroke from this type of therapy (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>). This means that people may benefit more from electromechanical- and robotic-assisted gait training in the first three months after stroke than after three months poststroke.</P>
<P>We argue that 582 (39%) of the 1472 included participants were independently walking at baseline (see <LINK TAG="STUDY_DESCRIPTION" TYPE="SECTION">Description of studies</LINK> and the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table). Because people who are already ambulatory cannot regain or recover independent walking, our effect estimate could have been influenced by performance bias. We therefore performed two further sensitivity analyses by ambulatory status at the start of the study (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK> and <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
<P>We found that studies that included mainly dependent walkers (i.e. participants who were non-ambulatory at the start of the study) were more likely to report that these participants were able to walk at study end and to reach greater walking velocities at the end of the intervention phase compared with participants who were already ambulatory at the start of the study (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>). This means that ambulatory people do not benefit from electromechanical- and robotic-assisted gait training.</P>
<P>We found that the ability to walk at study end was not dependent on the type of device used in the studies (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). However, walking velocities at the end of the intervention phase were higher when end-effector devices were used compared with participants who received training by an exoskeleton device (<LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>), meaning that the type of device used could play a role in improving walking function after stroke. This is in line with the former version of this review from 2013, <LINK REF="REF-Mehrholz-2013" TYPE="REFERENCE">Mehrholz 2013</LINK>, and another review that compared the effects of different types of devices on walking ability after stroke (<LINK REF="REF-Mehrholz-2012a" TYPE="REFERENCE">Mehrholz 2012a</LINK>). However, in the absence of a direct empirical comparison between electromechanical-assisted gait-training devices, this point warrants further investigation.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-05-02 14:53:41 +0100" MODIFIED_BY="Hazel Fraser">
<P>In all systematic reviews the risk of publication bias is present. However, we performed an extensive search for relevant literature in electronic databases and handsearched conference abstracts. Additionally, we contacted and asked authors, trialists, and experts in the field for other unpublished and ongoing trials.</P>
<P>Upon visual inspection, we did not detect graphical evidence of publication bias (see <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
<P>Given that we found several ongoing studies of substantial size, it is possible that these ongoing studies could potentially impact our overall conclusion when they are included in the review (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
<P>It is not clear whether the observed differences between experimental and control groups depend on the intensity of therapy, in terms of repetitions of gait practice. Time devoted to therapy is a crude measure of intensity. A 30-minute therapy session could include no walking practice or high-intensity walking practice with many steps taken. Reviews of the effectiveness of arm robotic therapy suggest that the positive benefit of robotic therapy may be lost when the intensity of practice is matched between experimental and control groups (<LINK REF="REF-Mehrholz-2012b" TYPE="REFERENCE">Mehrholz 2012b</LINK>). However, the numbers of repetitions in the experimental and control groups were not exactly counted in any of the included studies. Further studies should therefore ascertain whether the benefits described here are still apparent when the intensity of gait practice (e.g. step repetitions) is exactly matched between groups.</P>
<P>It should be mentioned that we do not know yet whether these devices provide any cost benefit. Further studies should investigate, under the premise that gait practice is matched in terms of objective measures of intensity, the long-term costs of regaining walking ability and the cost-effectiveness of these devices.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-05-02 14:53:46 +0100" MODIFIED_BY="Hazel Fraser">
<P>There was heterogeneity between the trials in terms of trial design (two arms, three arms, parallel-group or cross-over trial, duration of follow-up, and selection criteria for participants), characteristics of the therapy interventions (especially duration of the intervention), and participant characteristics (length of time since stroke onset and stroke severity at baseline). We noted methodological differences in the mechanisms of randomisation and in the allocation concealment methods used, as well as in the blinding of primary outcomes and the presence or use of intention-to-treat analysis.</P>
<P>After examining the effects of methodological quality on the odds of independence in walking, we found that the benefits were relatively robust when we removed trials with an inadequate sequence generation process, inadequate concealed allocation, no blinded assessors for the primary outcome, and incomplete outcome data (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). However, we found that the odds of independence in walking were slightly lower after the largest included study (<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>, N = 155) was removed, but a statistically significant and clinically relevant benefit for participants is still observed.</P>
<P>Although the methodological quality of the included trials seemed generally good to moderate (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>), trials investigating electromechanical- and robotic-assisted gait-training devices are subject to potential methodological limitations. These include inability to blind the therapist and participants, so-called contamination (provision of the intervention to the control group), and co-intervention (when the same therapist unintentionally provides additional care to either treatment or comparison group). All these potential methodological limitations introduce the possibility of performance bias. However, as discussed previously, this was not supported in our sensitivity analyses by methodological quality.</P>
<P>The quality of the evidence for automated electromechanical- and robotic-assisted gait-training devices for improving walking after stroke was moderate. The quality of the evidence was low for walking speed, very low for walking capacity, and low for adverse events and people discontinuing treatment.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2017-05-02 14:53:50 +0100" MODIFIED_BY="Hazel Fraser">
<P>In all systematic reviews the risk of publication bias is present. However, we performed an extensive search for relevant literature in electronic databases and handsearched conference abstracts. Additionally, we contacted and asked authors, trialists, and experts in the field for other unpublished and ongoing trials.</P>
<P>Upon visual inspection, we did not detect graphical evidence of publication bias (see <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> and <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>).</P>
<P>Given that we found several ongoing studies of substantial size, it is possible that these ongoing studies could potentially impact our overall conclusion (see <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>The most recent and relevant review describes the effects of new so-called powered mobile solutions (<LINK REF="REF-Louie-2016" TYPE="REFERENCE">Louie 2016</LINK>). We included three studies of mobile devices in this update. When pooling these results, we did not find significant improvements in walking speed and walking capacity; this result is in agreement with the recent review of <LINK REF="REF-Louie-2016" TYPE="REFERENCE">Louie 2016</LINK>. Additionally, there are two new studies describing the effects of ankle robots (<LINK REF="STD-Forrester-2014" TYPE="STUDY">Forrester 2014</LINK>; <LINK REF="STD-Waldman-2013" TYPE="STUDY">Waldman 2013</LINK>) to improve walking were described. When pooling these studies, we did not find significant improvements in walking speed and walking capacity. We are not aware of any systematic review about this type of devices so far.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-05-02 14:54:00 +0100" MODIFIED_BY="Hazel Fraser">
<IMPLICATIONS_PRACTICE MODIFIED="2017-05-02 14:53:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>This systematic review provides moderate-quality evidence that the use of electromechanical-assisted gait-training devices in combination with physiotherapy increases the chance of regaining independent walking ability in people after stroke. These results could be interpreted as preventing one participant from remaining dependent in walking after stroke for every seven treated. However, this apparent benefit for patients is not supported by our secondary outcomes. Gait-training devices were associated with neither improvements in walking velocity nor walking capacity (low- to very low-quality evidence). It appears that the greatest benefits with regard to independence in walking and walking speed were achieved in participants who were non-ambulatory at the start of the study and in those for whom the intervention was applied early poststroke.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-05-02 14:54:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>There is still a need for well-designed, large-scale, multicentre studies to evaluate the benefits and harms of electromechanical-assisted gait training for walking after stroke, including only non-ambulatory people in the very early stages after stroke. Comparisons between different devices are also currently lacking. Future research should include estimates of the costs (or savings) associated with electromechanical gait training. Further analyses should investigate whether non-ambulatory or ambulatory people benefit most, and trials should include outcome measures in the activities of daily living and quality of life domains. In future updates of this review we will consider investigating the effects of different control interventions using subgroup analysis. Additionally, in the next update we will compare the effects of different duration and intensity of treatment (e.g. less than versus more than four weeks; five days per week versus less than five days).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-05-02 14:54:02 +0100" MODIFIED_BY="Hazel Fraser">
<P>We thank Brenda Thomas for help with developing the search strategy and for providing us with relevant trials and systematic reviews from CINAHL, AMED, SPORTDiscus, and Inspec; Hazel Fraser for providing us with relevant information about trials and systematic reviews from the Cochrane Stroke Group Trials Register; and Gabi Voigt for conducting research and for providing us with many helpful studies. We thank Stanley Fisher, Carmen Krewer, Jorge Lians, Andreas Mayer, Stefan Hesse, Joseph Hidler, George Hornby, Yun-Hee Kim, Zeev Meiner, Sinnika Peurala, Leopold Saltuari, Isabella Schwartz, Raymond Tong, John Brincks, Michael van Nunen, and Naoki Tanaka for providing additional information or unpublished data for their trials.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Bernhard Elsner: none known.</P>
<P>Simone Thomas: none known.</P>
<P>Joachim Kugler: none known.</P>
<P>Marcus Pohl was author of one included trial (<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>). </P>
<P>Jan Mehrholz was co-author of one included trial (<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>). </P>
<P>Cordula Werner was an author of two included trials (<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>; <LINK REF="STD-Werner-2002" TYPE="STUDY">Werner 2002</LINK>), and of one excluded trial (<LINK REF="STD-Hesse-2001" TYPE="STUDY">Hesse 2001</LINK>). </P>
<P>These review authors (MP, JM, CW) did not participate in quality assessment and data extraction of these studies.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-05-02 14:54:12 +0100" MODIFIED_BY="Hazel Fraser">
<P>Jan Mehrholz (JM) contributed to the conception and the design of the protocol and drafted the protocol. He searched electronic databases and conference proceedings, screened titles and abstracts of references identified by the search, selected and assessed trials, extracted trial and outcome data, guided the analysis and interpretation of data, and contributed to and approved the final manuscript of the review.</P>
<P>Simone Thomas (ST) evaluated and extracted trial data, assessed the methodological quality of selected trials, contributed to the interpretation of data, and contributed to and approved the final manuscript of the review.</P>
<P>Cordula Werner (CW) screened the titles and abstracts of references identified by the search; located, selected, and assessed trials; extracted trial and outcome data; assessed the methodological quality of selected trials; contributed to the interpretation of data; and contributed to and approved the final manuscript of the review.</P>
<P>Joachim Kugler (JK) evaluated and extracted trial and outcome data, assessed the methodological quality of selected trials, contributed to the interpretation of data, and contributed to and approved the final manuscript of the review.</P>
<P>Marcus Pohl (MP) contributed to the conception and design of the review, drafted the protocol, and assessed the methodological quality of selected trials. Together with JM, he contacted trialists about unpublished data and entered the data, carried out statistical analysis, helped with the interpretation of the data, drafted the review, and approved the final manuscript of the review.</P>
<P>Bernhard Elsner (BE) searched electronic databases and conference proceedings, screened titles and abstracts of references identified by the search, selected and assessed trials, guided analysis and the interpretation of the data, and contributed to and approved the final manuscript of the review.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-05-04 14:40:39 +0100" MODIFIED_BY="[Empty name]">
<P>In our protocol we stated that we would use the PEDro Scale to assess the methodological quality of the included trials. However, Chapter 8 of the latest edition of the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> suggests that scales that yield a summary score should be avoided (<LINK REF="REF-Higgins-2011a" TYPE="REFERENCE">Higgins 2011a</LINK>). In accordance with this suggestion, we no longer used the PEDro Scale to assess the methodological quality of the included trials, instead using the Cochrane 'Risk of bias' tool to analyse trial methodology.</P>
<P>In our protocol we planned to quantify heterogeneity with the I² statistic and to use a cutoff of I² = 50% for all comparisons. Additonally, we planned to calculate the overall effects using a random-effects model instead of a fixed-effect model when we found substantial heterogeneity. However, in this update we calculated the overall effects using a random-effects model, irrespective of the level of heterogeneity.</P>
<P>In this review update we expanded our post-hoc sensitivity analysis: type of device (<LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>; <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>; <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>) by introducing a new subgroup of studies using mobile and ankle devices and adding a new comparison in Analysis 5 (<LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK> Different devices for regaining walking capacity).</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-05-05 11:27:54 +0100" MODIFIED_BY="Hazel Fraser">
<STUDIES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Aschbacher-2006" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Aschbacher 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Aschbacher B</AU>
<TI>Comparing gait training in patients after stroke with task oriented physiotherapy or robot-assisted treadmill training: a feasibility study</TI>
<SO>Unpublished</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290972"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290971"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bang-2016" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Bang 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Bang, Dae-Hyouk&lt;br&gt;Shin, Won-Seob&lt;br&gt;eng&lt;br&gt;Netherlands&lt;br&gt;2016/04/12 06:00&lt;br&gt;NeuroRehabilitation. 2016 Apr 6;38(4):343-9. doi: 10.3233/NRE-161325.&lt;/p&gt;" NOTES_MODIFIED="2017-05-02 14:57:24 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bang DH, Shin WS</AU>
<TI>Effects of robot-assisted gait training on spatiotemporal gait parameters and balance in patients with chronic stroke: a randomized controlled pilot trial</TI>
<SO>NeuroRehabilitation</SO>
<YR>2016</YR>
<VL>38</VL>
<PG>343-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596531"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596530"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brincks-2011" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NAME="Brincks 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Brincks J</AU>
<TI>The order of gait training, including Lokomat<SUP>®</SUP> and Physiotherapy, does not influence gait symmetry in subacute ambulatory persons with stroke</TI>
<SO>Physiotherapy, Supplement S1, 16th World Congress of Physical Therapy, 2011 June 20-23 , Amsterdam</SO>
<YR>2011</YR>
<VL>97</VL>
<ED>World Physical Therapy</ED>
<PB>World Confederation of Physical Therapy</PB>
<IDENTIFIERS MODIFIED="2017-05-03 08:43:49 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596532"/><IDENTIFIER MODIFIED="2017-05-03 08:43:49 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Number: RR-PO-208-17-Tue"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290973"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buesing-2015" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Buesing 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Buesing C, Fisch G, O'Donnell M, Shahidi I, Thomas L, Mummidisetty CK, et al</AU>
<TI>Effects of a wearable exoskeleton stride management assist system (SMA) on spatiotemporal gait characteristics in individuals after stroke: a randomized controlled trial</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2015</YR>
<VL>12</VL>
<NO>69</NO>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596534"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596533"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chang-2012" MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" NAME="Chang 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-06-14 14:05:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chang WH, Kim MS, Huh JP, Lee PK, Kim YH</AU>
<TI>Effects of robot-assisted gait training on cardiopulmonary fitness in subacute stroke patients: a randomized controlled study</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>4</NO>
<PG>318&#8211;24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290976"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim M, Kim YH, Lee PKW, Hyong MK, Jung PH</AU>
<TI>Effect of robot-assisted gait therapy on cardiopulmonary fitness in subacute stroke patients</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2008</YR>
<VL>22</VL>
<PG>594</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290977"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290975"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cho-2015" MODIFIED="2017-03-24 14:39:42 +0000" MODIFIED_BY="Hazel Fraser" NAME="Cho 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-24 14:39:42 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cho DY, Park SW, Lee MJ, Park DS, Kim EJ</AU>
<TI>Effects of robot-assisted gait training on the balance and gait of chronic stroke patients: focus on dependent ambulators</TI>
<SO>Journal of Physical Therapy Science</SO>
<YR>2015</YR>
<VL>27</VL>
<NO>10</NO>
<PG>3053-7</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:12:02 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596536"/><IDENTIFIER TYPE="OTHER" VALUE="0915-5287"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596535"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chua-2016" MODIFIED="2017-03-24 14:40:27 +0000" MODIFIED_BY="Hazel Fraser" NAME="Chua 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 14:40:27 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Chua, Joyce&lt;br&gt;Culpan, Jane&lt;br&gt;Menon, Edward&lt;br&gt;eng&lt;br&gt;2016/01/24 06:00&lt;br&gt;Arch Phys Med Rehabil. 2016 May;97(5):683-90. doi: 10.1016/j.apmr.2015.12.025. Epub 2016 Jan 21.&lt;/p&gt;" NOTES_MODIFIED="2017-03-24 14:40:27 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chua J, Culpan J, Menon E</AU>
<TI>Efficacy of an electromechanical gait trainer poststroke in Singapore: a randomized controlled trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2016</YR>
<VL>97</VL>
<PG>683-90</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596538"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596537"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dias-2006" MODIFIED="2017-05-03 08:47:37 +0100" MODIFIED_BY="[Empty name]" NAME="Dias 2006" YEAR="2006">
<REFERENCE MODIFIED="2010-02-01 15:46:28 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dias D, Laíns J, Pereira A, Nunes R, Caldas J, Amaral C, et al</AU>
<TI>Partial body weight support in chronic hemiplegics: a randomized control trial</TI>
<SO>Europa Medicophysica</SO>
<YR>2007</YR>
<VL>43</VL>
<NO>4</NO>
<PG>499-504</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290979"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290978"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Fisher-2008" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Fisher 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fisher S, Lucas L, Thrasher TA</AU>
<TI>Robot-assisted gait training for patients with hemiparesis due to stroke</TI>
<SO>Topics in Stroke Rehabilitation</SO>
<YR>2011</YR>
<VL>18</VL>
<NO>3</NO>
<PG>269-76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290982"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-14 14:07:04 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fisher S</AU>
<TI>Use of autoambulator for mobility improvement in patients with central nervous system (CNS) injury or disease</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2008</YR>
<VL>22</VL>
<PG>556</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290983"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290981"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forrester-2014" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Forrester 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Forrester LW, Roy A, Krywonis A, Kehs G, Krebs HI, Macko RF</AU>
<TI>Modular ankle robotics training in early subacute stroke: a randomized controlled pilot study</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>7</NO>
<PG>678-87</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:10:15 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596540"/><IDENTIFIER TYPE="OTHER" VALUE="1552-6844"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596539"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geroin-2011" MODIFIED="2013-06-14 14:07:19 +0100" MODIFIED_BY="[Empty name]" NAME="Geroin 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-06-14 14:07:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Geroin C, Picelli A, Munari D, Waldner A, Tomelleri C, Smania N</AU>
<TI>Combined transcranial direct current stimulation and robot-assisted gait training in patients with chronic stroke: a preliminary comparison</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2011</YR>
<VL>25</VL>
<NO>6</NO>
<PG>537-48</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290985"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290984"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Han-2016" MODIFIED="2017-03-24 14:41:40 +0000" MODIFIED_BY="Hazel Fraser" NAME="Han 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 14:41:40 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Han EY, Im SH, Kim BR, Seo MJ, Kim MO</AU>
<TI>Robot-assisted gait training improves brachial-ankle pulse wave velocity and peak aerobic capacity in subacute stroke patients with totally dependent ambulation: Randomized controlled trial</TI>
<SO>Medicine</SO>
<YR>2016</YR>
<VL>95</VL>
<PG>e5078</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596542"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596541"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Hidler-2009" MODIFIED="2010-02-01 15:47:35 +0000" MODIFIED_BY="Hazel Fraser" NAME="Hidler 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-02-01 15:47:35 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hidler J, Nichols D, Pelliccio M, Brady K, Campbell DD, Kahn JH, et al</AU>
<TI>Multicenter randomized clinical trial evaluating the effectiveness of the Lokomat in subacute stroke</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2009</YR>
<VL>23</VL>
<NO>1</NO>
<PG>5-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290987"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290986"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hornby-2008" MODIFIED="2010-02-01 15:47:44 +0000" MODIFIED_BY="Hazel Fraser" NAME="Hornby 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-02-01 15:47:44 +0000" MODIFIED_BY="Hazel Fraser" NOTES="1524-4628 (Electronic)" NOTES_MODIFIED="2010-02-01 15:47:44 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hornby TG, Campbell DD, Kahn JH, Demott T, Moore JL, Roth HR</AU>
<TI>Enhanced gait-related improvements after therapist- versus robotic-assisted locomotor training in subjects with chronic stroke: a randomized controlled study</TI>
<SO>Stroke</SO>
<YR>2008</YR>
<VL>39</VL>
<NO>6</NO>
<PG>1786-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290989"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290988"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Husemann-2007" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Husemann 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-02-01 15:48:02 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Husemann B, Müller F, Krewer C, Laß A, Gille C, Heller S, et al</AU>
<TI>Effects of locomotion training with assistance of a driven gait orthosis in hemiparetic patients after stroke</TI>
<SO>Neurologie &amp; Rehabilitation</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>4</NO>
<PG>25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290991"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Dolores Matthews" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Husemann B, Müller F, Krewer C, Laß A, Gille C, Heller S, et al</AU>
<TI>Effects of locomotion training with assistance of a robot-driven gait orthosis in hemiparetic patients after stroke: a randomized controlled pilot study</TI>
<SO>Stroke</SO>
<YR>2007</YR>
<VL>38</VL>
<NO>2</NO>
<PG>349-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290992"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290990"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2015" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Kim 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim S-Y, Yang L, Park IJ, Kim EJ, Park MS, You SH, et al</AU>
<TI>Effects of innovative WALKBOT robotic-assisted locomotor training on balance and gait recovery in hemiparetic stroke: a prospective, randomized, experimenter blinded case control study with a four-week follow-up</TI>
<SO>IEEE Transactions on Neural Systems &amp; Rehabilitation Engineering</SO>
<YR>2015</YR>
<VL>23</VL>
<NO>4</NO>
<PG>636-42</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:10:15 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596544"/><IDENTIFIER TYPE="OTHER" VALUE="1558-0210"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596543"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Kyung-2008" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Kyung 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-14 14:08:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jung KH, Ha HG, Shin HJ, Ohn SH, Sung DH, Lee PKW, et al</AU>
<TI>Effects of robot-assisted gait therapy on locomotor recovery in stroke patients</TI>
<SO>Journal of Korean Academy of Rehabilitation Medicine</SO>
<YR>2008</YR>
<VL>32</VL>
<PG>258-66</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290994"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Kyung HJ, Kim YH</AU>
<TI>Effects of robot-assisted gait therapy on locomotor recovery in stroke patients</TI>
<SO>Asia-Oceanian Conference of Physical &amp; Rehabilitation Medicine; 2008 May 16-19; Nanjing, China</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290995"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290993"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Mayr-2008" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Mayr 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Mayr A, Quirbach E, Picelli A, Kofler M, Smania N, Saltuari L</AU>
<TI>Effect of early robot-assisted gait retraining in nonambulatory patients with stroke: a single-blind randomized controlled trial</TI>
<SO>Unpublished</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596545"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2010-02-01 15:49:12 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayr A, Saltuari L, Quirbach E</AU>
<TI>Impact of Lokomat training on gait rehabilitation</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>5</NO>
<PG>596</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290997"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290996"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Morone-2011" MODIFIED="2013-06-14 14:09:19 +0100" MODIFIED_BY="[Empty name]" NAME="Morone 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-06-14 14:09:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morone G, Bragoni M, Iosa M, De Angelis D, Venturiero V, Coiro P, et al</AU>
<TI>Who may benefit from robotic-assisted gait training? A randomized clinical trial in patients with subacute stroke</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2011</YR>
<VL>25</VL>
<NO>7</NO>
<PG>636-44</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290999"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3290998"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Noser-2012" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NAME="Noser 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>NCT00975156</AU>
<TI>NCT00975156</TI>
<TO>Improving ambulation post stroke with robotic training</TO>
<SO>clinicaltrials.gov/show/NCT00975156</SO>
<YR>(first received: 10 September 2009)</YR>
<IDENTIFIERS MODIFIED="2013-07-03 12:12:50 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291001"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291000"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ochi-2015" MODIFIED="2017-03-24 14:44:20 +0000" MODIFIED_BY="Hazel Fraser" NAME="Ochi 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-24 14:44:20 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Ochi M, Wada F, Saeki S, Hachisuka K</AU>
<TI>Gait training in subacute non-ambulatory stroke patients using a full weight-bearing gait-assistance robot: a prospective, randomized, open, blinded-endpoint trial</TI>
<SO>Journal of the Neurological Sciences</SO>
<YR>2015</YR>
<VL>353</VL>
<NO>1-2</NO>
<PG>130-6</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:10:15 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596547"/><IDENTIFIER TYPE="OTHER" VALUE="1878-5883"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596546"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peurala-2005" NAME="Peurala 2005" YEAR="2005">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Peurala S, Tarkka I, Pitkänen K, Sivenius J</AU>
<TI>The effectiveness of body weight-supported gait training and floor walking in patients with chronic stroke</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2005</YR>
<VL>86</VL>
<PG>1557-64</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291003"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peurala SH, Pitkanen K, Sivenius J, Tarkka I</AU>
<TI>Body-weight supported gait exercise compared with floor walking in chronic stroke patients</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2004</YR>
<VL>85</VL>
<PG>E7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291004"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peurala SH, Pitkanen K, Sivenius J, Tarkka IM</AU>
<TI>Body-weight supported gait trainer exercises with or without functional electrical stimulation improves gait in patients with chronic stroke</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>1</NO>
<PG>98</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291005"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291002"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Peurala-2009" MODIFIED="2010-02-01 15:49:59 +0000" MODIFIED_BY="Hazel Fraser" NAME="Peurala 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-02-01 15:49:59 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peurala SH, Airaksinen O, Huuskonen P, Jäkälä P, Juhakoski M, Sandell K, et al</AU>
<TI>Effects of intensive therapy using Gait Trainer or floorwalking exercises early after stroke</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2009</YR>
<VL>41</VL>
<NO>3</NO>
<PG>166-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291007"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291006"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Picelli-2016" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NAME="Picelli 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Picelli A, Bacciga M, Melotti C, Marchina E, Verzini E, Ferrari F, et al</AU>
<TI>Combined effects of robot-assisted gait training and botulinum toxin type A effect on spastic equinus foot in patients with chronic stroke: a pilot, single blind, randomized controlled trial</TI>
<SO>European Journal of Physical and Rehabilitation Medicine</SO>
<YR>2016</YR>
<VL>52</VL>
<NO>6</NO>
<PG>759-766</PG>
<IDENTIFIERS MODIFIED="2017-05-03 08:53:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596549"/><IDENTIFIER MODIFIED="2017-05-03 08:53:52 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="27098300"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596548"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pohl-2007" MODIFIED="2008-08-06 15:19:15 +0100" MODIFIED_BY="Hazel Fraser" NAME="Pohl 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-08-06 15:19:15 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pohl M, Werner C, Holzgraefe M, Kroczek G, Mehrholz J, Wingendorf I, et al</AU>
<TI>Repetitive locomotor training and physiotherapy improve walking and basic activities of daily living in subacute, non-ambulatory stroke patients: a single-blind, randomised multi-centre trial (DEutsche GAngtrainerStudie, DEGAS)</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2007</YR>
<VL>21</VL>
<NO>1</NO>
<PG>17-27</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291009"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291008"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saltuari-2004" MODIFIED="2010-02-01 15:50:21 +0000" MODIFIED_BY="Hazel Fraser" NAME="Saltuari 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-02-01 15:50:21 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saltuari L</AU>
<TI>Efficiency of Lokomat training in stroke patients</TI>
<SO>Neurologie &amp; Rehabilitation</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>4</NO>
<PG>S4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291011"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291010"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Schwartz-2006" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Schwartz 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Schwartz I, Katz-Leurer M, Fisher I, Sajin A, Shochina M, Meiner Z</AU>
<TI>The effectiveness of early locomotor therapy in patients with first CVA</TI>
<SO>Collaborative Evaluation of Rehabilitation in Stroke Across Europe (CERISE) Congress; 2006 February 10-11; Leuven, Belgium</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291013"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291012"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stein-2014" MODIFIED="2017-03-24 14:45:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="Stein 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-03-24 14:45:34 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stein J, Bishop L, Stein DJ, Wong CK</AU>
<TI>Gait training with a robotic leg brace after stroke</TI>
<SO>American Journal of Physical Medicine &amp; Rehabilitation</SO>
<YR>2014</YR>
<VL>93</VL>
<NO>11</NO>
<PG>987-94</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:10:15 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596551"/><IDENTIFIER TYPE="OTHER" VALUE="0894-9115"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596550"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tanaka-2012" MODIFIED="2013-06-14 14:10:54 +0100" MODIFIED_BY="[Empty name]" NAME="Tanaka 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-06-14 14:10:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tanaka N, Saitou H, Takao T, Iizuka N, Okuno J, Yano H, et al</AU>
<TI>Effects of gait rehabilitation with a footpad-type locomotion interface in patients with chronic post-stroke hemiparesis: a pilot study</TI>
<SO>Clinical Rehabiilation</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>8</NO>
<PG>686-95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291015"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291014"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Tong-2006" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Tong 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li LSW, Tong RYU, Ng MFW, So EFM</AU>
<TI>Effectiveness of gait trainer in stroke rehabilitation</TI>
<SO>Journal of the Neurological Sciences</SO>
<YR>2005</YR>
<VL>238(Suppl 1)</VL>
<PG>S81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291017"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ng MFW, Tong RKY, Li LSW</AU>
<TI>A pilot study of randomized clinical controlled trial of gait training in subacute stroke patients with partial body-weight support electromechanical gait trainer and functional electrical stimulation: six-month follow-up</TI>
<SO>Stroke</SO>
<YR>2008</YR>
<VL>39</VL>
<PG>154-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291018"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ng MFW, Tong RKY, So EFM, Li LSW</AU>
<TI>The therapeutic effect of electromechanical gait trainer and functional electrical stimulation for patients with acute stroke</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2006</YR>
<VL>20</VL>
<NO>1</NO>
<PG>97 (Abstract F1D-7)</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291019"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2009-06-30 09:40:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;0003-9993 (Print)&lt;/p&gt;" NOTES_MODIFIED="2009-06-30 09:40:20 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tong RKY, Ng MF, Li LS</AU>
<TI>Effectiveness of gait training using an electromechanical gait trainer, with and without functional electric stimulation, in subacute stroke: a randomized controlled trial</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2006</YR>
<VL>87</VL>
<NO>10</NO>
<PG>1298-304</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291020"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291016"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ucar-2014" MODIFIED="2017-04-30 07:23:11 +0100" MODIFIED_BY="[Empty name]" NAME="Ucar 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-04-30 07:23:11 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;201503&lt;/p&gt;" NOTES_MODIFIED="2017-04-30 07:23:11 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uçar DE, Paker N, Bu&#287;dayc&#305; D</AU>
<TI>Lokomat: a therapeutic chance for patients with chronic hemiplegia</TI>
<SO>NeuroRehabilitation</SO>
<YR>2014</YR>
<VL>34</VL>
<NO>3</NO>
<PG>447-53</PG>
<IDENTIFIERS MODIFIED="2017-04-30 07:23:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-04-30 07:23:11 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="1053" TYPE="OTHER" VALUE="8135"/><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596553"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596552"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Nunen-2012" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NAME="Van Nunen 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Van Nunen M</AU>
<TI>RCT evaluating the effectiveness of robot-assisted treadmill training in restoring walking ability of stroke patients</TI>
<SO>7th World Congress of Neurological Rehabilitation; 2012 May 16-19; Melbourne, Australia</SO>
<YR>2012</YR>
<PG>210</PG>
<ED>Olver, J</ED>
<PB>World Federation for Neurorehabilittaion</PB>
<CY>Melbourne</CY>
<IDENTIFIERS MODIFIED="2017-05-03 08:24:01 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596554"/><IDENTIFIER MODIFIED="2017-05-03 08:24:01 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Abstract ID: 537, Poster No. 296"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-03-24 14:46:37 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Nunen MPM, Gerrits KHL, Konijnenbelt M, Janssen TWJ, de Haan A</AU>
<TI>Recovery of walking ability using a robotic device in subacute stroke patients: a randomized controlled study</TI>
<SO>Disability &amp; Rehabilitation: Assistive Technology</SO>
<YR>2015</YR>
<VL>10</VL>
<NO>2</NO>
<PG>141-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596555"/><IDENTIFIER TYPE="OTHER" VALUE="1748-3107"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291021"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Waldman-2013" MODIFIED="2016-11-28 10:58:32 +0000" MODIFIED_BY="[Empty name]" NAME="Waldman 2013" YEAR="2013">
<REFERENCE MODIFIED="2016-11-28 10:58:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Waldman G, Yang C-Y, Ren Y, Liu L, Guo X, Harvey RL, et al</AU>
<TI>Effects of robot-guided passive stretching and active movement training of ankle and mobility impairments in stroke</TI>
<SO>NeuroRehabilitation</SO>
<YR>2013</YR>
<VL>32</VL>
<NO>3</NO>
<PG>625-34</PG>
<PB>IOS Press</PB>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596557"/><IDENTIFIER TYPE="OTHER" VALUE="1053-8135"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596556"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Watanabe-2014" MODIFIED="2017-03-24 14:47:10 +0000" MODIFIED_BY="Hazel Fraser" NAME="Watanabe 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-03-24 14:47:10 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Watanabe H, Tanaka N, Inuta T, Saitou H, Yanagi H</AU>
<TI>Locomotion improvement using a hybrid assistive limb in recovery phase stroke patients: a randomized controlled pilot study</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2014</YR>
<VL>95</VL>
<NO>11</NO>
<PG>2006-12</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:10:15 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="0003" TYPE="OTHER" VALUE="9993"/><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596559"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596558"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Werner-2002" MODIFIED="2008-08-06 15:19:33 +0100" MODIFIED_BY="Hazel Fraser" NAME="Werner 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-08-06 15:19:33 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Werner C, Von Frankenberg S, Treig T, Konrad M, Hesse S</AU>
<TI>Treadmill training with partial body weight support and an electromechanical gait trainer for restoration of gait in subacute stroke patients: a randomized crossover study</TI>
<SO>Stroke</SO>
<YR>2002</YR>
<VL>33</VL>
<NO>12</NO>
<PG>2895-901</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291024"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291023"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Westlake-2009" MODIFIED="2010-02-01 15:52:15 +0000" MODIFIED_BY="Hazel Fraser" NAME="Westlake 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-02-01 15:52:15 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Westlake K, Patten C</AU>
<TI>Pilot study of Lokomat versus manual-assisted treadmill training for locomotor recovery post-stroke</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2009</YR>
<VL>6</VL>
<PG>18</PG>
<IDENTIFIERS MODIFIED="2009-08-05 11:20:39 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291026"/><IDENTIFIER MODIFIED="2009-08-05 11:20:39 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1186/1743-0003-6-18"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291025"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bae-2014" MODIFIED="2017-03-24 14:47:46 +0000" MODIFIED_BY="Hazel Fraser" NAME="Bae 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-03-24 14:47:46 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Bae Y, Ko Y, Chang W, Lee J, Lee K, Park Y, et al</AU>
<TI>Effects of robot-assisted gait training combined with functional electrical stimulation on recovery of locomotor mobility in chronic stroke patients: a randomized controlled trial</TI>
<SO>Journal of Physical Therapy Science</SO>
<YR>2014</YR>
<VL>26</VL>
<NO>12</NO>
<PG>1949-53</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:18:23 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="0915" TYPE="OTHER" VALUE="5287"/><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596561"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596560"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Byun-2011" MODIFIED="2017-03-24 14:48:03 +0000" MODIFIED_BY="Hazel Fraser" NAME="Byun 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-03-24 14:48:03 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Byun, Seung-Deuk&lt;br&gt;Jung, Tae-Du&lt;br&gt;Kim, Chul-Hyun&lt;br&gt;Lee, Yang-Soo&lt;br&gt;Controlled Clinical Trial&lt;br&gt;Research Support, Non-U.S. Gov't&lt;br&gt;England&lt;br&gt;Clinical rehabilitation&lt;br&gt;Clin Rehabil. 2011 May;25(5):408-15. Epub 2010 Dec 3.&lt;/p&gt;" NOTES_MODIFIED="2017-03-24 14:48:03 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Byun SD, Jung TD, Kim CH, Lee YS</AU>
<TI>Effects of the sliding rehabilitation machine on balance and gait in chronic stroke patients - a controlled clinical trial</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2011</YR>
<VL>25</VL>
<NO>5</NO>
<PG>408-15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="1477-0873" TYPE="OTHER" VALUE="(Electronic)"/><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596563"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596562"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Caldwell-2000" MODIFIED="2008-08-06 15:19:40 +0100" MODIFIED_BY="Hazel Fraser" NAME="Caldwell 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-08-06 15:19:40 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caldwell C, Medley A</AU>
<TI>Effects of bicycling, treadmill, and variable surfaces on gait in people following a CVA</TI>
<SO>Neurology Report</SO>
<YR>2000</YR>
<VL>24</VL>
<NO>5</NO>
<PG>203</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291028"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291027"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Danzl-2013" MODIFIED="2017-03-24 14:48:24 +0000" MODIFIED_BY="Hazel Fraser" NAME="Danzl 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-03-24 14:48:24 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Danzl MM, Chelette KC, Lee K, Lykins D, Sawaki L</AU>
<TI>Brain stimulation paired with novel locomotor training with robotic gait orthosis in chronic stroke: a feasibility study</TI>
<SO>NeuroRehabilitation</SO>
<YR>2013</YR>
<VL>33</VL>
<NO>1</NO>
<PG>67-76</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:13:47 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596565"/><IDENTIFIER TYPE="OTHER" VALUE="1053-8135"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596564"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-David-2006" MODIFIED="2008-08-06 15:19:44 +0100" MODIFIED_BY="Hazel Fraser" NAME="David 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-08-06 15:19:44 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>David D, Regnaux JP, Lejaille M, Louis A, Bussel B, Lofasso F</AU>
<TI>Oxygen consumption during machine-assisted and unassisted walking: a pilot study in hemiplegic and healthy humans</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2006</YR>
<VL>87</VL>
<PG>482-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291030"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291029"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Forrester-2016" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Forrester 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Forrester LW, Roy A, Hafer-Macko C, Krebs HI, Macko RF</AU>
<TI>Task-specific ankle robotics gait training after stroke: a randomized pilot study</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2016</YR>
<VL>13</VL>
<NO>51</NO>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596567"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596566"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gong-2003" MODIFIED="2008-08-06 15:19:48 +0100" MODIFIED_BY="Hazel Fraser" NAME="Gong 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-06 15:19:48 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gong S, Zhang J</AU>
<TI>Effect of early rehabilitation training on daily life activity of patients with hemiplegia after stroke</TI>
<SO>Chinese Journal of Clinical Rehabilitation</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>5</NO>
<PG>848-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291032"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291031"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodman-2014" MODIFIED="2017-03-24 14:49:04 +0000" MODIFIED_BY="Hazel Fraser" NAME="Goodman 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-03-24 14:49:04 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Goodman R, Rietsehel J, Roy A, Jung B, Diaz J, Macko R, et al</AU>
<TI>Increased reward in ankle robotics training enhances motor control and cortical efficiency in stroke</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2014</YR>
<VL>51</VL>
<NO>2</NO>
<PG>213-7</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:13:47 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="0748" TYPE="OTHER" VALUE="7711"/><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596569"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596568"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hesse-2001" MODIFIED="2008-08-06 15:19:51 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hesse 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-08-06 15:19:51 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hesse S, Werner C, Uhlenbrock D, von Frankenberg S, Bardeleben A, Brandl-Hesse B</AU>
<TI>An electromechanical gait trainer for restoration of gait in hemiparetic stroke patients: preliminary results</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2001</YR>
<VL>15</VL>
<PG>37-48</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291034"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291033"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hsieh-2014" MODIFIED="2017-03-24 14:49:25 +0000" MODIFIED_BY="Hazel Fraser" NAME="Hsieh 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-03-24 14:49:25 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2017-03-24 14:49:25 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hsieh YW, Lin KC, Horng YS, Wu CY, Wu TC, Ku FL</AU>
<TI>Sequential combination of robot-assisted therapy and constraint-induced therapy in stroke rehabilitation: a randomized controlled trial</TI>
<SO>Journal of Neurology</SO>
<YR>2014</YR>
<NO>5</NO>
<PG>1037-45</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596571"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596570"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mirelman-2009" MODIFIED="2010-02-01 15:52:42 +0000" MODIFIED_BY="Hazel Fraser" NAME="Mirelman 2009" YEAR="2009">
<REFERENCE MODIFIED="2010-02-01 15:52:42 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mirelman A, Bonato P, Deutsch JE</AU>
<TI>Effects of training with a robot-virtual reality system compared with a robot alone on the gait of individuals after stroke</TI>
<SO>Stroke</SO>
<YR>2009</YR>
<VL>40</VL>
<NO>1</NO>
<PG>169-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291036"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291035"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morone-2016" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Morone 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morone G, Annicchiarico R, Iosa M, Federici A, Paolucci S, Cortes U, et al</AU>
<TI>Overground walking training with the i-Walker, a robotic servo-assistive device, enhances balance in patients with subacute stroke: a randomized controlled trial</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2016</YR>
<VL>13</VL>
<NO>47</NO>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596573"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596572"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01337960" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NAME="NCT01337960" YEAR="2015">
<REFERENCE MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;A7461-P&lt;br&gt;July 2011&lt;br&gt;September 2014&lt;/p&gt;" NOTES_MODIFIED="2017-05-04 14:39:41 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01337960</AU>
<TI>Ankle robotics training after stroke</TI>
<SO>clinicaltrials.gov/show/NCT01337960</SO>
<YR>(first received 15 April 2011)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596574"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291071"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Page-2008" MODIFIED="2010-02-01 15:52:49 +0000" MODIFIED_BY="Hazel Fraser" NAME="Page 2008" YEAR="2008">
<REFERENCE MODIFIED="2010-02-01 15:52:49 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Page SJ, Levine P, Teepen J, Hartman EC</AU>
<TI>Resistance-based, reciprocal upper and lower limb locomotor training in chronic stroke: a randomized, controlled crossover study</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2008</YR>
<VL>22</VL>
<NO>7</NO>
<PG>610-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291038"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291037"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-2015" MODIFIED="2017-03-24 14:50:43 +0000" MODIFIED_BY="Hazel Fraser" NAME="Park 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-24 14:50:43 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park BS, Kim MY, Lee LK, Yang SM, Lee WD, Kim J</AU>
<TI>Effects of conventional overground gait training and a gait trainer with partial body weight support on spatiotemporal gait parameters of patients after stroke</TI>
<SO>Journal of Physical Therapy Science</SO>
<YR>2015</YR>
<VL>27</VL>
<PG>1603-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596576"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596575"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patten-2006" MODIFIED="2017-05-03 09:06:43 +0100" MODIFIED_BY="[Empty name]" NAME="Patten 2006" YEAR="2006">
<REFERENCE MODIFIED="2017-05-03 09:06:43 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2017-05-03 09:06:43 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Westlake KP, Patten C</AU>
<TI>Pilot study of Lokomat versus manual-assisted treadmill training for locomotor recovery post-stroke</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2009</YR>
<VL>6</VL>
<PG>18</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596577"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291039"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pennati-2015" MODIFIED="2017-03-24 16:07:17 +0000" MODIFIED_BY="Hazel Fraser" NAME="Pennati 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-24 16:07:17 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pennati GV, Da Re C, Messineo I, Bonaiuti D</AU>
<TI>How could robotic training and botulinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study</TI>
<SO>European Journal of Physical &amp; Rehabilitation Medicine</SO>
<YR>2015</YR>
<VL>51</VL>
<NO>4</NO>
<PG>381-7</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:13:47 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596579"/><IDENTIFIER TYPE="OTHER" VALUE="1973-9095"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596578"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Picelli-2015" MODIFIED="2017-03-24 14:51:43 +0000" MODIFIED_BY="Hazel Fraser" NAME="Picelli 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-24 14:51:43 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Picelli A, Chemello E, Castellazzi P, Roncari L, Waldner A, Saltuari L, et al</AU>
<TI>Combined effects of transcranial direct current stimulation (tDCS) and transcutaneous spinal direct current stimulation (tsDCS) on robot-assisted gait training in patients with chronic stroke: a pilot, double blind, randomized controlled trial</TI>
<SO>Restorative Neurology &amp; Neuroscience</SO>
<YR>2015</YR>
<VL>33</VL>
<NO>3</NO>
<PG>357-68</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:13:47 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596581"/><IDENTIFIER TYPE="OTHER" VALUE="1878-3627"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596580"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pitkanen-2002" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NAME="Pitkanen 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pitkanen K, Tarkka I, Sivenius J</AU>
<TI>Walking training with partial body weight support versus conventional walking training of chronic stroke patients: preliminary findings</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>4; SupplementAbstracts 3rd World Conference On Neurorehabilitation; April 2-6, 2002 Venice, Italy</NO>
<PG>312</PG>
<IDENTIFIERS MODIFIED="2017-05-04 07:53:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596582"/><IDENTIFIER MODIFIED="2017-05-04 07:53:02 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://journals.sagepub.com/doi/pdf/10.1177/154596830101500402"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291041"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Richards-1993" MODIFIED="2008-08-06 15:20:09 +0100" MODIFIED_BY="Hazel Fraser" NAME="Richards 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-08-06 15:20:09 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richards CL, Malouin F, Wood-Dauphinee S, Williams JI, Bouchard JP, Brunet D</AU>
<TI>Task-specific physical therapy for optimization of gait recovery in acute stroke patients</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1993</YR>
<VL>74</VL>
<PG>612-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291045"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291044"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Richards-2004" MODIFIED="2008-08-06 15:20:16 +0100" MODIFIED_BY="Hazel Fraser" NAME="Richards 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-08-06 15:20:16 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richards CL, Malouin F, Bravo G, Dumas F, Wood-Dauphinee S</AU>
<TI>The role of technology in task-oriented training in persons with subacute stroke: a randomized controlled trial</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>4</NO>
<PG>199-211</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291047"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291046"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shirakawa-2001" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Shirakawa 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Shirakawa R, Uchida SU, Okajima YO, Sakaki TS, Shutou HS</AU>
<TI>Therapeutic effects of power-assist training combined with biofeedback on hemiplegia by Therapeutic Exercise Machine (TEM)</TI>
<SO>1st International Congress of International Society of Physical and Rehabilitation Medicine (ISPRM); 2001 July 7-13; Amsterdam</SO>
<YR>2001</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291049"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291048"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Skvortsova-2008" MODIFIED="2013-07-03 15:40:50 +0100" MODIFIED_BY="Hazel Fraser" NAME="Skvortsova 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-07-03 15:40:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Skvortsova VI, Ivanova GE, Kovrazhkina EA, Rumiantseva NA, Staritsyn AN, Suvorov AIu, et al</AU>
<TI>The use of a robot-assisted Gait Trainer GT1 in patients in the acute period of cerebral stroke: a pilot study</TI>
<SO>Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova</SO>
<YR>2008</YR>
<VL>Suppl 23</VL>
<PG>28-34</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291051"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Skvortsova VI, Ivanova GE, Kovrazhkina EA, Rumyantseva NA, Staritsin AN, Sogomonyan EK</AU>
<TI>The efficacy of gait rehabilitation after stroke training with assistance of a robotic device gait trainer: a pilot study</TI>
<SO>International Journal of Stroke</SO>
<YR>2008</YR>
<VL>3(Suppl 3)</VL>
<PG>355</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291052"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291050"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stoller-2015" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Stoller 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-24 14:52:08 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stoller O, De Bruin ED, Schindelholz M, Schuster-Amft C, De Bie RA, Hunt KJ</AU>
<TI>Feedback-controlled robotics-assisted treadmill exercise for cardiovascular training and assessment early after severe stroke</TI>
<SO>Cerebrovascular Diseases</SO>
<YR>2015</YR>
<VL>39</VL>
<PG>107</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:13:47 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596584"/><IDENTIFIER TYPE="OTHER" VALUE="1015-9770"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stoller O, de Bruin E, Schindelholz M, Schuster-Amft C, de Bie R, Hunt KJ</AU>
<TI>Efficacy of feedback-controlled robotics-assisted treadmill exercise to improve cardiovascular fitness early after stroke</TI>
<SO>Journal of Neurologic Physical Therapy</SO>
<YR>2015</YR>
<VL>39</VL>
<NO>3</NO>
<PG>156</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596585"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596583"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2014" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Wu 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Wu M, Landry J, Kim J, Schmit B, Yen S, MacDonald J</AU>
<TI>Robotic resistance/assistance training improves locomotor function in individuals poststroke: A randomized controlled study</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2014</YR>
<VL>95</VL>
<NO>5</NO>
<PG>799-806</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="0003" TYPE="OTHER" VALUE="9993"/><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596587"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596586"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2017-05-03 10:14:07 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Chernikova-2014" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Chernikova 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Chernikova LA&lt;br&gt;Klochkov AS&lt;br&gt;Russian&lt;/p&gt;" NOTES_MODIFIED="2017-05-02 14:57:24 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Chernikova LA, Klochkov AS</AU>
<TI>The influence of physical training with the use of a Lokomat robotic system on the walking ability of the patients with post-stroke hemiparesis</TI>
<SO>Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kultury</SO>
<YR>2014</YR>
<NO>3</NO>
<PG>13-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596589"/><IDENTIFIER TYPE="OTHER" VALUE="0042-8787"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596588"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Globokar-2005" MODIFIED="2017-05-03 10:01:42 +0100" MODIFIED_BY="[Empty name]" NAME="Globokar 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-05-03 10:01:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Globokar D</AU>
<TI>Gait trainer in neurorehabilitation of patients after stroke</TI>
<SO>3rd World Congress of the International Society of Physical and Rehabilitation Medicine ISPRM; 2005 April 10-15; Sao Paulo, Brazil</SO>
<YR>2005</YR>
<PG>987-1</PG>
<ED>Battistella L, Imamura M; International Society of Physical and Rehabilitation Medicine</ED>
<CY>Sao Paulo, Brazil</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291054"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291053"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Golyk-2006" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Golyk 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Golyk VA, Pivnyk AP, Ipatov AV</AU>
<TI>Constraint-induced movement therapy for walking improvement (comparison of two walking training machine modifications' efficacy) for stroke patients</TI>
<SO>European Journal of Neurology</SO>
<YR>2006</YR>
<VL>13(Suppl 2)</VL>
<PG>263</PG>
<IDENTIFIERS MODIFIED="2013-07-03 12:32:09 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291056"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291055"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jang-2005" MODIFIED="2017-05-03 10:03:43 +0100" MODIFIED_BY="[Empty name]" NAME="Jang 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-05-03 10:03:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Jang SJ, Park SW, Kim ES, Wee HM, Kim YH</AU>
<TI>Electromechanical gait trainer for restoring gait in hemiparetic stroke patients</TI>
<SO>3rd World Congress of the International Society of Physical and Rehabilitation Medicine ISPRM; 2005 April 10-15; Sao Paulo, Brazil</SO>
<YR>2005</YR>
<PG>909-1</PG>
<ED>Battistella L, Imamura M; International Society of Physical and Rehabilitation Medicine</ED>
<CY>Sao Paulo, Brazil</CY>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291058"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291057"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2001" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Kim 2001" YEAR="2001">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kim BO, Lee JJ, Cho KH, Kim SH</AU>
<TI>Gait training robot (gaiTrainer) in rehabilitation</TI>
<SO>1st International Congress of International Society of Physical and Rehabilitation Medicine (ISPRM); 2001 July 7-13; Amsterdam</SO>
<YR>2001</YR>
<IDENTIFIERS MODIFIED="2017-04-30 08:04:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291060"/><IDENTIFIER MODIFIED="2017-04-30 08:04:52 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Abstract Th.139.P"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291059"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2014" MODIFIED="2017-05-03 10:07:10 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-05-03 10:07:10 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;/p&gt;" NOTES_MODIFIED="2017-05-03 10:07:10 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kim JH, Park HI, Jang CH, Lim YH</AU>
<TI>Effects of robot-assisted therapy on lower limb in geriatric patients with subacute stroke</TI>
<SO>European Geriatric Medicine</SO>
<YR>2014</YR>
<VL>5</VL>
<NO>Supplement 1</NO>
<PG>S174</PG>
<IDENTIFIERS MODIFIED="2017-05-03 10:07:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596591"/><IDENTIFIER MODIFIED="2017-05-03 10:07:10 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/S1878-7649(14)70458-9"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596590"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Koeneman-2004" MODIFIED="2017-05-03 10:09:12 +0100" MODIFIED_BY="[Empty name]" NAME="Koeneman 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-05-03 10:09:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Koeneman JB</AU>
<TI>Air muscle device for ankle stroke rehabilitation</TI>
<SO>www.sbir.gov/sbirsearch/detail/210093</SO>
<YR>(accessed May 2017)</YR>
<IDENTIFIERS MODIFIED="2013-07-03 12:36:03 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291062"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-08-10 12:38:26 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291061"/><IDENTIFIER MODIFIED="2009-08-10 12:38:26 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="CN-00602960"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Mehrberg-2001" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Mehrberg 2001" YEAR="2001">
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehrberg RD, Flick C, Dervay J, Carmody J, Carrington C, Jermer M</AU>
<TI>Clinical evaluation of a new over ground partial body weight support assistive device in hemiparetic stroke patients</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2001</YR>
<VL>82</VL>
<PG>1293 (Abstract 10)</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291064"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291063"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ohata-2015" MODIFIED="2017-03-24 14:52:58 +0000" MODIFIED_BY="Hazel Fraser" NAME="Ohata 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-03-24 14:52:58 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ohata K, Tsuboyama T, Watanabe A, Takahashi H</AU>
<TI>Gait training using new robotics device for patients with hemiplegia after stroke: a randomized cross-over trial</TI>
<SO>Physiotherapy</SO>
<YR>2015</YR>
<VL>101</VL>
<PG>eS1123-4</PG>
<IDENTIFIERS MODIFIED="2016-08-29 08:20:57 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596593"/><IDENTIFIER TYPE="OTHER" VALUE="0031-9406"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596592"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sale-2012" MODIFIED="2017-05-03 10:14:07 +0100" MODIFIED_BY="[Empty name]" NAME="Sale 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-05-03 10:14:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01678547</AU>
<TI>Robot Walking Rehabilitation in Stroke Patients</TI>
<SO>clinicaltrials.gov/show/NCT01678547</SO>
<YR>(date first received 31 August 2012</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596595"/><IDENTIFIER TYPE="OTHER" VALUE="NCT01678547"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596594"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2012" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Wu 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2017-05-02 14:57:24 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Wu H, Gu XD, Fu JM, Yao YH, Li JH, Xu ZS</AU>
<TI>Effects of rehabilitation robot for lower-limb on motor function in hemiplegic patients after stroke</TI>
<SO>National Medical Journal of China</SO>
<YR>2012</YR>
<NO>37</NO>
<PG>2628-31</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596597"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596596"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoon-2015" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Yoon 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Yoon Y, Seok TY, Yu K, Lee KJ, Kang SK, Yun SB</AU>
<TI>Gait training with the newly developed active-assistive system for gait is feasible for hemiplegic patients after stroke</TI>
<SO>PM&amp;R</SO>
<YR>2015</YR>
<VL>1</VL>
<PG>S115-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596599"/><IDENTIFIER TYPE="OTHER" VALUE="193-4148"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596598"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2016" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Zhu 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>Zhu L, Song W, Liu L, Zhang R, Zhang Y</AU>
<TI>Rehabilitation effect of lower limb rehabilitation training robot combined with task-oriented training on walking ability after stroke</TI>
<SO>Chinese Journal of Cerebrovascular Diseases</SO>
<YR>2016</YR>
<VL>13</VL>
<NO>5</NO>
<PG>240-4 and 248</PG>
<IDENTIFIERS MODIFIED="2016-09-02 12:48:29 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596601"/><IDENTIFIER TYPE="OTHER" VALUE="1672-5921"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596600"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2017-05-03 09:41:39 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Louie-2015" MODIFIED="2017-05-03 09:41:39 +0100" MODIFIED_BY="[Empty name]" NAME="Louie 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-05-03 09:41:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Louie DR, Eng JJ, Mortenson WB, Yao J</AU>
<TI>Use of a powered robotic exoskeleton to promote walking recovery after stroke: study protocol for a randomized controlled trial</TI>
<SO>International Journal of Stroke</SO>
<YR>2015</YR>
<VL>10, Supplement 4</VL>
<PG>89</PG>
<ED>World Stroke Organization</ED>
<IDENTIFIERS MODIFIED="2017-05-03 09:41:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596603"/><IDENTIFIER MODIFIED="2017-05-03 09:41:35 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="http://onlinelibrary.wiley.com/doi/10.1111/ijs.12633_2/pdf"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596602"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-NCT00284115" MODIFIED="2016-08-31 07:19:53 +0100" MODIFIED_BY="Jan Mehrholz" NAME="NCT00284115" YEAR="2006">
<REFERENCE MODIFIED="2016-08-31 07:19:53 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="NO" TYPE="OTHER">
<AU>Brissot R, Laviolle B</AU>
<TI>Efficacy of a mechanical gait repetitive training technique in hemiparetic stroke patients</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>(last accessed September 2016)</YR>
<IDENTIFIERS MODIFIED="2013-06-14 14:38:22 +0100" MODIFIED_BY="Jenny Bellorini"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291066"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291065"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT00530543" MODIFIED="2017-03-24 14:55:55 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT00530543" YEAR="2007">
<REFERENCE MODIFIED="2017-03-24 14:55:55 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT00530543</AU>
<TI>Effects of gait training with assistance of a robot-driven gait orthosis in hemiparetic patients after stroke</TI>
<SO>clinicaltrials.gov</SO>
<YR>2007</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596605"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596604"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01146587" MODIFIED="2016-08-31 07:20:15 +0100" MODIFIED_BY="Jan Mehrholz" NAME="NCT01146587" YEAR="2012">
<REFERENCE MODIFIED="2016-08-31 07:20:15 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="NO" TYPE="OTHER">
<AU>Waldner A</AU>
<TI>Robot assisted therapy for acute stroke patients: a comparative study of GangTrainer GT I, Lokomat system and conventional physiotherapy</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>(last accessed September 2016)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291068"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-06-14 14:36:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291067"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01187277" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT01187277" YEAR="2012">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;/p&gt;" NOTES_MODIFIED="2017-05-02 14:57:24 +0100" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="YES" TYPE="OTHER">
<AU>Chanubol R, Wongphaet P, Werner C, Chavanich N, Panichareon L</AU>
<TI>Gait rehabilitation in subacute hemiparetic stroke: robot-assisted gait training versus conventional physical therapy</TI>
<SO>Journal of the Neurological Sciences</SO>
<YR>2013</YR>
<VL>333</VL>
<NO>Suppl 1</NO>
<PG>e574</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596606"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-08-31 07:21:43 +0100" MODIFIED_BY="Jan Mehrholz" PRIMARY="NO" TYPE="OTHER">
<AU>Chanubol R</AU>
<TI>Robotic versus conventional training on hemiplegic gait</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>(last accessed September 2016)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291070"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-06-14 14:36:18 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291069"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01678547" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="[Empty name]" NAME="NCT01678547" YEAR="2012">
<REFERENCE MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Bernhard Elsner" PRIMARY="NO" TYPE="OTHER">
<AU>Sale P</AU>
<TI>Effect of robot assisted treatment on gait performance in stroke patients</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>(last accessed December 2012)</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3291074"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2013-06-14 14:36:47 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3291073"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01726998" MODIFIED="2017-03-24 14:57:12 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT01726998" YEAR="2014">
<REFERENCE MODIFIED="2017-03-24 14:57:12 +0000" MODIFIED_BY="Hazel Fraser" NOTES="&lt;p&gt;4-2012-0005&lt;br&gt;March 2012&lt;br&gt;May 2013&lt;/p&gt;" NOTES_MODIFIED="2017-03-24 14:57:12 +0000" NOTES_MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01726998</AU>
<TI>Effects of locomotion training with assistance of a robot-driven gait orthosis in hemiparetic patients after subacute stroke</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2014</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596608"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596607"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02114450" MODIFIED="2017-03-24 14:57:43 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02114450" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 14:57:43 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02114450</AU>
<TI>Human-machine system for the H2 lower limb exoskeleton</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596610"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596609"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02471248" MODIFIED="2017-03-24 15:15:02 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02471248" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 15:15:02 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02471248</AU>
<TI>Interactive exoskeleton robot for walking - ankle joint</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596612"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596611"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02483676" MODIFIED="2017-03-24 15:15:19 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02483676" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 15:15:19 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02483676</AU>
<TI>Ankle robot to reduce foot-drop in stroke</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596614"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596613"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02545088" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="NCT02545088" YEAR="2015">
<REFERENCE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02545088</AU>
<TI>New technology for individualised, intensive training of gait after stroke - study II (HAL-RCT-II)</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2015</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596616"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596615"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02680691" MODIFIED="2017-03-24 15:15:45 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02680691" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 15:15:45 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02680691</AU>
<TI>Robot assisted gait training in patients with infratentorial stroke</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596618"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596617"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02694302" MODIFIED="2017-03-24 15:16:00 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02694302" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 15:16:00 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02694302</AU>
<TI>Clinical trial of robot-assisted-gait-training (RAGT) in stroke patients</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596620"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596619"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02755415" MODIFIED="2017-03-24 15:16:19 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02755415" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 15:16:19 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02755415</AU>
<TI>Clinical applicability of robot-assisted gait training system in acute stroke patients</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596622"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596621"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02781831" MODIFIED="2017-03-24 15:24:14 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02781831" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 15:24:14 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02781831</AU>
<TI>Robot-assisted gait training for patients with stroke</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596624"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596623"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT02843828" MODIFIED="2017-03-24 15:24:45 +0000" MODIFIED_BY="Hazel Fraser" NAME="NCT02843828" YEAR="2016">
<REFERENCE MODIFIED="2017-03-24 15:24:45 +0000" MODIFIED_BY="Hazel Fraser" PRIMARY="NO" TYPE="OTHER">
<AU>NCT02843828</AU>
<TI>Gait pattern analysis and feasibility of gait training with a walking assist robot in stroke patients and elderly adults</TI>
<SO>www.clinicaltrials.gov</SO>
<YR>2016</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="5596626"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="5596625"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Adams-1993" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Adams 1993" TYPE="JOURNAL_ARTICLE">
<AU>Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al</AU>
<TI>Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial (TOAST: Trial of Org 10172 in Acute Stroke Treatment)</TI>
<SO>Stroke</SO>
<YR>1993</YR>
<VL>24</VL>
<NO>1</NO>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Atkins-2004" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Atkins 2004" TYPE="JOURNAL_ARTICLE">
<AU>Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al</AU>
<TI>Grading quality of evidence and strength of recommendations</TI>
<SO>BMJ</SO>
<YR>2004</YR>
<VL>328</VL>
<PG>1490</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bohannon-1988" NAME="Bohannon 1988" TYPE="JOURNAL_ARTICLE">
<AU>Bohannon R</AU>
<TI>Rehabilitation goals of patients with hemiplegia</TI>
<SO>International Journal of Rehabilitation Research</SO>
<YR>1988</YR>
<VL>11</VL>
<NO>2</NO>
<PG>181-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bohannon-1991" NAME="Bohannon 1991" TYPE="JOURNAL_ARTICLE">
<AU>Bohannon RW, Horton MG, Wikholm JB</AU>
<TI>Importance of four variables of walking to patients with stroke</TI>
<SO>International Journal of Rehabilitation Research</SO>
<YR>1991</YR>
<VL>14</VL>
<PG>246-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carr-2003" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Dolores Matthews" NAME="Carr 2003" TYPE="BOOK">
<AU>Carr J, Shepherd R</AU>
<SO>Stroke Rehabilitation: Guidelines for Exercises and Training</SO>
<YR>2003</YR>
<PB>Butterworth Heinemann</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Collen-1991" MODIFIED="2008-08-06 15:25:18 +0100" MODIFIED_BY="Hazel Fraser" NAME="Collen 1991" TYPE="JOURNAL_ARTICLE">
<AU>Collen FM, Wade DT, Robb GF, Bradshaw CM</AU>
<TI>The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment</TI>
<SO>International Disability Studies</SO>
<YR>1991</YR>
<VL>13</VL>
<NO>2</NO>
<PG>50-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Colombo-2000" MODIFIED="2008-08-06 15:25:21 +0100" MODIFIED_BY="Hazel Fraser" NAME="Colombo 2000" TYPE="JOURNAL_ARTICLE">
<AU>Colombo G, Joerg M, Schreier R, Dietz V</AU>
<TI>Treadmill training of paraplegic patients using a robotic orthosis</TI>
<SO>Journal of Rehabilitation Research and Development</SO>
<YR>2000</YR>
<VL>37</VL>
<NO>6</NO>
<PG>693-700</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2011" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Deeks 2011" TYPE="OTHER">
<AU>Deeks JJ, Higgins JPT, Altman DG</AU>
<TI>Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Freivogel-2009" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Freivogel 2009" TYPE="JOURNAL_ARTICLE">
<AU>Freivogel S, Schmalohr D, Mehrholz J</AU>
<TI>Improved walking ability and reduced therapeutic stress with an electromechanical gait device</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2009</YR>
<VL>41</VL>
<PG>734&#8211;9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-French-2007" MODIFIED="2013-01-07 12:11:34 +0000" MODIFIED_BY="Hazel Fraser" NAME="French 2007" TYPE="COCHRANE_REVIEW">
<AU>French B, Thomas LH, Leathley MJ, Sutton CJ, McAdam J, Forster A</AU>
<TI>Repetitive task training for improving functional ability after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-01-07 12:11:34 +0000" MODIFIED_BY="Hazel Fraser"><IDENTIFIER MODIFIED="2013-01-07 12:11:34 +0000" MODIFIED_BY="Hazel Fraser" TYPE="DOI" VALUE="10.1002/14651858.CD006073.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-French-2016" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="French 2016" TYPE="COCHRANE_REVIEW">
<AU>French B, Thomas LH, Coupe J, McMahon NE, Connell L, Harrison J, et al</AU>
<TI>Repetitive task training for improving functional ability after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2016</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2017-02-15 14:25:46 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-02-15 14:25:46 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006073.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-GRADEpro-GDT" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="GRADEpro GDT" TYPE="COMPUTER_PROGRAM">
<TI>GRADEpro GDT: GRADEpro Guideline Development Tool</TI>
<YR>2015</YR>
<PB>McMaster University (developed by Evidence Prime, Inc.). Available from gradepro.org</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hamilton-1994" MODIFIED="2008-08-06 15:25:25 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hamilton 1994" TYPE="JOURNAL_ARTICLE">
<AU>Hamilton BB, Laughlin JA, Fiedler RC, Granger CV</AU>
<TI>Interrater reliability of the 7-level functional independence measure (FIM)</TI>
<SO>Scandinavian Journal of Rehabilitation Medicine</SO>
<YR>1994</YR>
<VL>26</VL>
<NO>3</NO>
<PG>115-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hesse-1999" MODIFIED="2013-06-14 14:44:00 +0100" MODIFIED_BY="Hazel Fraser" NAME="Hesse 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hesse S, Sarkodie-Gyan T, Uhlenbrock D</AU>
<TI>Development of an advanced mechanised gait trainer, controlling movement of the centre of mass, for restoring gait in non-ambulant subjects</TI>
<SO>Biomedizinische Technik [Biomedical Engineering]</SO>
<YR>1999</YR>
<VL>44</VL>
<NO>7-8</NO>
<PG>194-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hesse-2003" NAME="Hesse 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hesse S, Schmidt H, Werner C, Bardeleben A</AU>
<TI>Upper and lower extremity robotic devices for rehabilitation and for studying motor control</TI>
<SO>Current Opinion in Neurology</SO>
<YR>2003</YR>
<VL>16</VL>
<NO>6</NO>
<PG>705-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hesse-2010" MODIFIED="2013-06-14 14:44:12 +0100" MODIFIED_BY="[Empty name]" NAME="Hesse 2010" TYPE="JOURNAL_ARTICLE">
<AU>Hesse S, Waldner A, Tomelleri C</AU>
<TI>Innovative gait robot for the repetitive practice of floor walking and stair climbing up and down in stroke patients</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2010</YR>
<VL>7</VL>
<PG>30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011a" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Higgins 2011a" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011b" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Higgins 2011b" TYPE="OTHER">
<AU>Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al</AU>
<TI>Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Holden-1984" MODIFIED="2013-07-03 15:07:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Holden 1984" TYPE="JOURNAL_ARTICLE">
<AU>Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L</AU>
<TI>Clinical gait assessment in the neurologically impaired: reliability and meaningfulness</TI>
<SO>Physical Therapy</SO>
<YR>1984</YR>
<VL>64</VL>
<NO>1</NO>
<PG>35-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jorgensen-1995" NAME="Jorgensen 1995" TYPE="JOURNAL_ARTICLE">
<AU>Jorgensen H, Nakayama H, Raaschou H, Olsen T</AU>
<TI>Recovery of walking function in stroke patients: the Copenhagen stroke study</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1995</YR>
<VL>76</VL>
<PG>27-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kelley-2013" MODIFIED="2017-05-03 08:30:27 +0100" MODIFIED_BY="[Empty name]" NAME="Kelley 2013" TYPE="OTHER">
<AU>Kelley CP, Childress J, Boake C, Noser EA</AU>
<TI>Over-ground and robotic-assisted locomotor training in adults with chronic stroke: a blinded randomized clinical trial</TI>
<SO>Disability &amp; Rehabilitation: Assistive Technology</SO>
<YR>2013</YR>
<VL>8</VL>
<NO>2</NO>
<PG>161-8</PG>
<PB>Taylor &amp; Francis Ltd</PB>
<CY>Philadelphia, Pennsylvania</CY>
<IDENTIFIERS><IDENTIFIER TYPE="OTHER" VALUE="1748-3107"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kim-2008" MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2008" TYPE="JOURNAL_ARTICLE">
<AU>Kim M, Kim YH, Lee PKWY, Hyong MK, Jung PH</AU>
<TI>Effect of robot-assisted gait therapy on cardiopulmonary fitness in subacute stroke patients</TI>
<SO>Neurorehabilitation and Neural Repair</SO>
<YR>2008</YR>
<VL>22</VL>
<PG>594</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3290977"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kwakkel-1999" MODIFIED="2008-08-06 15:25:37 +0100" MODIFIED_BY="Hazel Fraser" NAME="Kwakkel 1999" TYPE="JOURNAL_ARTICLE">
<AU>Kwakkel G, Wagenaar RC, Twisk JW, Lankhorst GJ, Koetsier JC</AU>
<TI>Intensity of leg and arm training after primary middle-cerebral-artery stroke: a randomised trial</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<NO>9174</NO>
<PG>191-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Louie-2016" MODIFIED="2016-08-29 08:22:19 +0100" MODIFIED_BY="Bernhard Elsner" NAME="Louie 2016" TYPE="OTHER">
<AU>Louie DR, Eng JJ</AU>
<TI>Powered robotic exoskeletons in post-stroke rehabilitation of gait: a scoping review</TI>
<SO>Journal of NeuroEngineering and Rehabilitation</SO>
<YR>2016</YR>
<VL>13</VL>
<NO>1</NO>
<PG>1-10</PG>
<MD>journal article</MD>
<IDENTIFIERS MODIFIED="2016-08-29 08:22:18 +0100" MODIFIED_BY="Bernhard Elsner"><IDENTIFIER TYPE="MEDLINE" VALUE="Louie2016"/><IDENTIFIER TYPE="OTHER" VALUE="1743-0003"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mehrholz-2012a" MODIFIED="2013-06-14 14:44:51 +0100" MODIFIED_BY="[Empty name]" NAME="Mehrholz 2012a" TYPE="JOURNAL_ARTICLE">
<AU>Mehrholz J, Pohl M</AU>
<TI>Electromechanical-assisted gait training after stroke: a systematic review comparing end-effector and exoskeleton devices</TI>
<SO>Journal of Rehabilitation Medicine</SO>
<YR>2012</YR>
<VL>44</VL>
<NO>3</NO>
<PG>193-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mehrholz-2012b" MODIFIED="2013-06-14 14:45:02 +0100" MODIFIED_BY="[Empty name]" NAME="Mehrholz 2012b" TYPE="COCHRANE_REVIEW">
<AU>Mehrholz J, Hädrich A, Platz T, Kugler J, Pohl M</AU>
<TI>Electromechanical and robot-assisted arm training for improving generic activities of daily living, arm function, and arm muscle strength after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>6</NO>
<IDENTIFIERS MODIFIED="2013-05-22 05:10:20 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2013-05-22 05:10:20 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006876.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mehrholz-2014" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Mehrholz 2014" TYPE="COCHRANE_REVIEW">
<AU>Mehrholz J, Pohl M, Elsner B</AU>
<TI>Treadmill training and body weight support for walking after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2017-02-27 13:15:49 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-02-27 13:15:49 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002840.pub3"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-MIT-2005" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="MIT 2005" TYPE="OTHER">
<AU>Massachusetts Institute of Technology</AU>
<TI>MIT develops Anklebot for stroke patients</TI>
<SO>web.mit.edu/newsoffice/2005/stroke-robot.html</SO>
<YR>(accessed 20 December 2005)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nuyens-2002" MODIFIED="2008-08-06 15:25:49 +0100" MODIFIED_BY="Hazel Fraser" NAME="Nuyens 2002" TYPE="JOURNAL_ARTICLE">
<AU>Nuyens GE, De Weerdt WJ, Spaepen AJ Jr, Kiekens C, Feys HM</AU>
<TI>Reduction of spastic hypertonia during repeated passive knee movements in stroke patients</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2002</YR>
<VL>83</VL>
<NO>7</NO>
<PG>930-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pollock-2014" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Pollock 2014" TYPE="COCHRANE_REVIEW">
<AU>Pollock A, Farmer SE, Brady MC, Langhorne P, Mead GE, Mehrholz J</AU>
<TI>Interventions for improving upper limb function after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2017-02-27 12:48:43 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-02-27 12:48:43 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD010820.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2017-03-24 15:29:23 +0000" MODIFIED_BY="Hazel Fraser" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sackett-1996" NAME="Sackett 1996" TYPE="JOURNAL_ARTICLE">
<AU>Sackett DL, Deeks JJ, Altman DG</AU>
<TI>Down with odds ratios!</TI>
<SO>Evidence-based Medicine</SO>
<YR>1996</YR>
<VL>1</VL>
<PG>164-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-2005" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Schmidt 2005" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt H, Hesse S, Bernhardt R, Krüger J</AU>
<TI>HapticWalker - a novel haptic foot device</TI>
<SO>ACM Transactions on Applied Perception</SO>
<YR>2005</YR>
<VL>2</VL>
<NO>2</NO>
<PG>166-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-States-2009" MODIFIED="2013-01-07 12:11:12 +0000" MODIFIED_BY="Hazel Fraser" NAME="States 2009" TYPE="COCHRANE_REVIEW">
<AU>States RA, Pappas E, Salem Y</AU>
<TI>Overground physical therapy gait training for chronic stroke patients with mobility deficits</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-01-07 12:11:12 +0000" MODIFIED_BY="Hazel Fraser"><IDENTIFIER MODIFIED="2013-01-07 12:11:12 +0000" MODIFIED_BY="Hazel Fraser" TYPE="DOI" VALUE="10.1002/14651858.CD006075.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Van-Peppen-2004" MODIFIED="2008-08-06 15:25:55 +0100" MODIFIED_BY="Hazel Fraser" NAME="Van Peppen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Van Peppen RP, Kwakkel G, Wood-Dauphinee S, Hendriks HJ, Van der Wees PJ, Dekker J</AU>
<TI>The impact of physical therapy on functional outcomes after stroke: what's the evidence?</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>8</NO>
<PG>833-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Veneman-2005" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Veneman 2005" TYPE="CONFERENCE_PROC">
<AU>Veneman J, Kruidhof R, van der Helm FCT, van der Kooy H</AU>
<TI>Design of a Series Elastic- and Bowdencable-based actuation system for use as torque-actuator in exoskeleton-type training robots</TI>
<SO>International Conference on Rehabilitation Robotics; 2005 June 28-July 1; Chicago (IL)</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wade-1988" MODIFIED="2008-08-06 15:25:57 +0100" MODIFIED_BY="Hazel Fraser" NAME="Wade 1988" TYPE="JOURNAL_ARTICLE">
<AU>Wade DT, Collin C</AU>
<TI>The Barthel ADL Index: a standard measure of physical disability?</TI>
<SO>International Disability Studies</SO>
<YR>1988</YR>
<VL>10</VL>
<NO>2</NO>
<PG>64-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2006" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="WHO 2006" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Cerebrovascular accident, stroke</TI>
<SO>www.who.int/topics/cerebrovascular_accident/en/</SO>
<YR>(accessed 1 February 2006)</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<REFERENCE ID="REF-Mehrholz-2006" MODIFIED="2013-01-07 12:13:57 +0000" MODIFIED_BY="Hazel Fraser" NAME="Mehrholz 2006" TYPE="COCHRANE_REVIEW">
<AU>Mehrholz J, Werner C, Kugler J, Pohl M</AU>
<TI>Electromechanical-assisted training for walking after stroke [Protocol]</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-01-07 12:13:57 +0000" MODIFIED_BY="Hazel Fraser"><IDENTIFIER MODIFIED="2013-01-07 12:13:57 +0000" MODIFIED_BY="Hazel Fraser" TYPE="DOI" VALUE="10.1002/14651858.CD006185"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mehrholz-2007" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Mehrholz 2007" TYPE="COCHRANE_REVIEW">
<AU>Mehrholz J, Werner C, Kugler J, Pohl M</AU>
<TI>Electromechanical-assisted training for walking after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2010-02-01 16:05:04 +0000" MODIFIED_BY="Hazel Fraser"><IDENTIFIER MODIFIED="2009-05-19 11:19:44 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006185.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mehrholz-2013" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NAME="Mehrholz 2013" TYPE="COCHRANE_REVIEW">
<AU>Mehrholz J, Elsner B, Werner C, Kugler J, Pohl M</AU>
<TI>Electromechanical-assisted training for walking after stroke</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2016-11-30 13:56:03 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-11-30 13:56:03 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006185.pub3"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-05-04 14:41:17 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-05-04 14:41:17 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-05-02 14:54:28 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Aschbacher-2006">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:26 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: not stated<BR/>Blinding of outcome assessors: stated as 'yes' by the investigator<BR/>Adverse events: not stated<BR/>Deaths: not stated<BR/>Dropouts: 4 (1 in treatment group, 3 in control group)<BR/>ITT: unclear</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-03 14:56:07 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Switzerland<BR/>23 participants (12 in treatment group, 11 in control group)<BR/>Not ambulatory at start of study<BR/>Mean age: 57 to 67 years (control and treatment groups, respectively)<BR/>Inclusion criteria: &#8804; 3 months after stroke, ability to stand or walk 5 metres<BR/>Exclusion criteria: orthopaedic problems, contractures, NYHA III-IV</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 14:56:08 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Control group used task-oriented physiotherapy, 5 times a week for 3 weeks (2.5 hours a week)</LI>
<LI>Experimental group used robotic-assisted treadmill training (Lokomat) for the same time and frequency</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 3 weeks and 6 months<BR/>Primary outcomes: walking velocity, step length, endurance, walking ability (FAC)<BR/>Secondary outcomes: isometric knee extension strength, patient acceptance and satisfaction (visual analogue scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-16 12:23:12 +0100" MODIFIED_BY="[Empty name]">
<P>Unpublished data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:54:31 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Bang-2016">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: opaque, closed envelopes<BR/>Blinding of outcome assessors: stated as 'yes' by the investigator<BR/>Adverse events: not stated<BR/>Deaths: not stated<BR/>Dropouts: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:54:29 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Korea<BR/>18 participants (9 in treatment group, 9 in control group)<BR/>Ambulatory at start of study<BR/>Mean age: 54 years (control and treatment group)</P>
<P>Inclusion criteria: &gt; 6 months after stroke, ability to walk over 10 meters, gait speed &gt; 0.4 m/s, MMSE &#8805; 24</P>
<P>Exclusion criteria: uncontrolled health condition, comorbidity or disability other than stroke precluding gait training</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:54:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group used robotic-assisted treadmill training with body weight support (Lokomat) 5 times a week for 4 weeks (1 hour per day)</LI>
<LI>Control group used conventional treadmill training without body weight support for the same time and frequency</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:31 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 2 weeks.</P>
<P>Outcome measures: gait speed, cadence, step length, double support period (GAITRite system), balance, level of balance confidence (ABC scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-11-23 06:23:08 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:54:34 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Brincks-2011">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Randomised cross-over trial<BR/>Method of randomisation: shuffled envelopes<BR/>Blinding of outcome assessors: no<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-03 14:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Denmark<BR/>13 participants (7 in treatment group, 6 in control group)<BR/>All participants were ambulatory at start of study<BR/>Mean age: 59 to 61 years (control and treatment groups, respectively)<BR/>Inclusion criteria: unknown<BR/>Exclusion criteria: unknown</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:54:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Group 1 received 3 weeks of robotic-assisted treadmill training (Lokomat), followed (after cross-over) by 3 weeks of physiotherapy</LI>
<LI>Group 2 received 3 weeks of physiotherapy followed (after cross-over) by 3 weeks of robotic-assisted treadmill training (Lokomat)</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:34 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, after 3 and 6 weeks<BR/>Primary outcomes: single support stance time in impaired extremity and gait asymmetry and swing time ratio<BR/>Secondary outcomes: walking speed</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-03 13:54:17 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:54:37 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Buesing-2015">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:35 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: random number generator<BR/>Blinding of outcome assessors: stated as 'yes' by the investigator<BR/>Adverse events: no adverse events<BR/>Deaths: not stated<BR/>Dropouts: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:54:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>50 participants (25 in treatment group, 25 in control group)<BR/>Ambulatory at start of study<BR/>Mean age: 62 years experimental group and 60 years control group</P>
<P>Inclusion criteria: &gt; 12 months after stroke, medically stable, initial gait speed between 0.4 and 0.8 m/s, &gt; 17 MMSE, sit unsupported for 30 s, walk &#8805; 10 m with maximum 1 person, follow a 3-step command</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:54:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robot-assisted task-specific training (Stride Management Assist) 3 times a week for 6 to 8 weeks, 45 minutes per day (maximum of 18 visits)</LI>
<LI>Control group: functional task-specific training for the same time and frequency</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-03-24 15:32:04 +0000" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after visit 10 and 18, 3-month follow-up<BR/>Outcome measures: gait velocity, cadence, step time, step length, stride length, swing time, stance time, double support time (GAITRite)<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-12-06 07:23:47 +0000" MODIFIED_BY="Jan Mehrholz">
<P>NCT01994395</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chang-2012">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: not stated<BR/>Blinding of outcome assessors: not stated<BR/>Adverse events: not stated<BR/>Deaths: not stated<BR/>Dropouts: 3 (2 in experimental group, 1 in control group)<BR/>ITT analysis: not described</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:54:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Republic of Korea<BR/>48 allocated participants (24 in treatment group, 24 in control group)<BR/>38 participants were non-ambulatory at start of study<BR/>Mean age: 58 years<BR/>Inclusion criteria: first-ever stroke, stroke onset within 1 month, supratentorial lesion, age &gt; 20 years and &lt; 65 years, not an independent ambulator (FAC &lt; 2), and ability to co-operate during exercise testing<BR/>Exclusion criteria: people who met criteria for absolute and relative contraindications to exercise testing established by the American College of Sports Medicine (ACSM) were excluded. Also, people who met contraindications for Lokomat therapy or musculoskeletal disease involving the lower limbs, such as severe painful arthritis, osteoporosis, or joint contracture and other neurological diseases, were also excluded<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:54:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Robotic gait trainer (Lokomat) 40 minutes per day, and 60 minutes conventional physiotherapy for 10 days</LI>
<LI>Conventional physiotherapy, same sessions of conventional gait training by physical therapist</LI>
</UL>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after training:</P>
<UL>
<LI>FAC</LI>
<LI>Exercise and gas exchange capacity</LI>
<LI>Cardiopulmonary function</LI>
<LI>Fugl-Meyer Assessment</LI>
<LI>Motricity Index</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>This study describes the same study protocol and participants as described in the study <LINK REF="REF-Kim-2008" TYPE="REFERENCE">Kim 2008</LINK>, but provides further explanation of participant characteristics; the ID <LINK REF="STD-Chang-2012" TYPE="STUDY">Chang 2012</LINK> therefore replaces the formerly review used ID <LINK REF="REF-Kim-2008" TYPE="REFERENCE">Kim 2008</LINK>.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:54:47 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Cho-2015">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:43 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT, cross-over<BR/>Method of randomisation: not stated<BR/>Blinding of outcome assessors: not stated<BR/>Adverse events: not stated<BR/>Deaths: not stated<BR/>Dropouts: not stated</P>
<P>ITT: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:54:46 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Korea<BR/>20 participants (13 in treatment group, 7 in control group)<BR/>Not ambulatory at start of study<BR/>Mean age: 55 years in control and treatment group</P>
<P>Inclusion criteria: onset period of &gt; 6 months, FAC &lt; 2, independent ambulation before stroke, ability to understand and execute RAGT, no orthopaedic or neurosurgical problems in the lower extremities</P>
<P>Exclusion criteria: weight &gt; 120 kg; femoral length &lt; 35 cm or &gt; 47 cm; history of low-extremity fracture after stroke, instability or subluxation of the hip joint, or pressure ulcers on the hips or lower extremities; any underlying disease preventing execution of RAGT</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:54:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robot-assisted gait training (Lokomat) 3 times per week, 4 weeks (30 minutes/day) and conventional physical therapy 5 times per week, 8 weeks (30 minutes/day)</LI>
<LI>Control group: conventional physical therapy 5 times per week, 8 weeks (30 minutes/day)</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 and 8 weeks:</P>
<UL>
<LI>Primary outcome measures: balance (Berg Balance Scale, Modified Functional Reach Test)</LI>
<LI>Secondary outcome measures: walking ability (FAC), motor function (Modified Ashworth Scale, Fugl-Meyer Assessment of Lower Extremity, Motricity Index), activities of daily living (Modified Barthel Index)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-03-24 15:39:50 +0000" MODIFIED_BY="Hazel Fraser">
<P>Higher dose of intervention in experimental group compared to control group; group differences at baseline (modified forward reach)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:54:52 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Chua-2016">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:49 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: computer-generated sequence<BR/>Blinding of outcome assessors: stated as 'yes' by the investigator<BR/>Adverse events: no<BR/>Deaths: yes<BR/>Dropouts: yes (7 in treatment group, 13 in control group)</P>
<P>ITT: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:54:51 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Singapore<BR/>108 participants (53 in treatment group, 53 in control group)<BR/>Not ambulatory at start of study<BR/>Mean age: 62 years experimental and 61 years control group</P>
<P>Inclusion criteria: unilateral haemorrhagic/ischaemic stroke, age between 18 and 80 years, independent ambulation pre-stroke</P>
<P>Exclusion criteria: &gt; 8 weeks poststroke, FAC &#8805; 4, cardiovascular instability, MMSE &lt; 16, communication deficits, lower limb joint contractures</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:54:51 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: electromechanical gait training (20 minutes) and conventional physiotherapy including stance/gait (25 minutes) 6 days a week for 8 weeks (45 minutes per day)</LI>
<LI>Control group: conventional physiotherapy (including therapy to improve stance/gait), same time and frequency as experimental group</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:52 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and 4, 8, 12, 24, and 48 weeks after baseline</P>
<P>Outcome measures: walking ability (FAC), Barthel Index, gait velocity (10-metre walk test), gait endurance (6-minute walk test), health status (Stroke Impact Scale)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:54:57 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Dias-2006">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:53 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: permuted block randomisation<BR/>Blinding of outcome assessors: stated as blinded<BR/>Adverse events: none stated<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: not stated but probably done because there were no dropouts</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:54:55 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Portugal<BR/>40 participants (20 in treatment group, 20 in control group)<BR/>Ambulatory at start of study<BR/>Mean age: 69 years<BR/>Inclusion criteria: first-ever stroke patients &gt; 12 months after stroke; age &gt; 18 and &lt; 80 years; cognitive (MMSE &gt; 19) and communication capacities to understand the treatment; absence of cardiac, psychological, and orthopaedic contraindications<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 10:22:43 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Control group used the Bobath method, 5 times a week for 5 weeks</LI>
<LI>Experimental group used the Gait Trainer for the same time and frequency</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 weeks and 3 months:</P>
<UL>
<LI>Motricity Index</LI>
<LI>Toulouse Motor Scale</LI>
<LI>Modified Ashworth Scale</LI>
<LI>Berg Balance Scale</LI>
<LI>Rivermead Motor Score</LI>
<LI>Fugl-Meyer Stroke Scale (lower limb and balance)</LI>
<LI>FAC</LI>
<LI>Barthel Index</LI>
<LI>10-metre walking test and gait cycle parameters</LI>
<LI>Timed Up and Go test</LI>
<LI>6-minute walking distance test</LI>
<LI>Step test</LI>
</UL>
<P>After study end and at follow-up, participants rated satisfaction with and efficiency of treatment in a self questionnaire (Likert scale).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:54:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:55:00 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Fisher-2008">
<CHAR_METHODS MODIFIED="2017-05-02 14:54:58 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: blocked randomisation<BR/>Blinding of outcome assessors: stated as 'yes'<BR/>Adverse events: control group 14, experimental group 11<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: stated as 'yes'</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:54:58 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>20 participants (10 in treatment group, 10 in control group)<BR/>5 in treatment group and 7 in control group were ambulatory at start of study<BR/>Mean age: not stated<BR/>Inclusion criteria: subacute, &lt; 2 months after stroke<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 10:24:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Control group received standard physical therapy, 3 to 5 times a week for 24 consecutive sessions</LI>
<LI>Experimental group used the AutoAmbulator for the same time and frequency</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:54:59 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 24 sessions:</P>
<UL>
<LI>Gait test portion of Tinetti's balance and mobility assessment</LI>
<LI>3-minute walk</LI>
<LI>25-foot walk</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:55:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>This trial is described as ongoing; the results of the first 20 participants were reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:55:07 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Forrester-2014">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: not described<BR/>Blinding of outcome assessors: stated as 'no'<BR/>Adverse events: no<BR/>Deaths: not mentioned<BR/>Dropouts: 5 (3 in treatment group, 2 in control group)</P>
<P>ITT: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:55:06 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>39 participants (21 in treatment group, 18 in control group)<BR/>Not ambulatory at start of study<BR/>Mean age: 63 years in experimental group and 60 years in control group</P>
<P>Inclusion criteria: first stroke; residual lower extremity hemiparesis involving the ankle (1/5 to 4/5 MRC); capable of generating at least trace muscle activation in PF-DF; adequate language and neurocognitive function; sit in the chair for 30 to 60 minutes per session of ankle training</P>
<P>Exclusion criteria: total plegia (0/5) at paretic ankle; fixed or painful contractures; dementia; orthopaedic, arthritic, or inflammatory condition limiting ankle movement; deep venous thrombosis or pulmonary thromboembolism; vision impairment; severe receptive or global aphasia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:55:06 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robot-assisted ankle training, daily for 60 minutes/day, 10 sessions until discharge</LI>
<LI>Control group: passive manual moving and stretching ankle, for the same time</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:07 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and at discharge.</P>
<P>Outcome measures: walking ability (Functional Independence Measure walking), balance (Berg Balance Scale), walking velocity, active range of motion, muscle strength, spatiotemporal gait parameters (step time, step length, step symmetry), motor control variables (angular velocity, co-ordination)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-03-24 15:44:16 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear amount of therapy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Geroin-2011">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: software-generated randomisation scheme<BR/>Blinding of outcome assessors: no<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Italy<BR/>30 participants (10 in treatment group 1, 10 in treatment group 2, and 10 in control group)<BR/>5 in both treatment groups and 7 in control group were ambulatory at start of study<BR/>Mean age: not stated<BR/>Inclusion criteria: at least 12 months from their first unilateral ischaemic stroke; age &lt; 75 years; European Stroke Scale score between 75 and 85; MMSE score &#8807; 24; ability to maintain standing position without aids for at least 5 minutes; ability to walk independently for at least 15 metres with the use of walking aids (cane and orthoses)<BR/>Exclusion criteria: preceding epileptic fits; an electroencephalography suspect of elevated cortical excitability; metallic implants within the brain and previous brain surgery; medications altering cortical excitability or with a presumed effect on brain plasticity; posterior circulation stroke; deficits of somatic sensation involving the paretic lower limb; presence of vestibular disorders or paroxysmal vertigo; presence of severe cognitive or communicative disorders; presence of other neurological or orthopaedic conditions involving the lower limbs; presence of cardiovascular comorbidity; performance of any type of rehabilitation treatment in the 3 months before start of study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:55:12 +0100" MODIFIED_BY="Hazel Fraser">
<P>3 arms:</P>
<UL>
<LI>Robot-assisted gait training (Gait Trainer GT 1) combined with transcranial direct current stimulation</LI>
<LI>Robot-assisted gait training (Gait Trainer GT 1) combined with sham transcranial direct current stimulation</LI>
<LI>Walking overground</LI>
</UL>
<P>All participants received 10 x 50-minute treatment sessions, 5 days a week, for 2 consecutive weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:12 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 2 weeks:</P>
<UL>
<LI>Primary outcomes were the 6-minute walk test and the 10-metre walking test</LI>
<LI>Secondary outcomes were spatiotemporal gait parameters, FAC, Rivermead Mobility Index, Motricity Index leg subscore, and Modified Ashworth Scale</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:55:14 +0100" MODIFIED_BY="Hazel Fraser">
<P>We combined the results of both robotic-assisted groups (arms 1 and 2) into a single group, which we compared with the results of the control group (arm 3).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Han-2016">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:15 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: not stated<BR/>Blinding of outcome assessors: stated as 'yes'<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: 4 in control group (2 refused and 2 dropped)</P>
<P>ITT: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Republic of Korea </P>
<P>60 participants (30 in treatment group, 30 in control group)<BR/>Non-ambulatory at start of study<BR/>Mean age: 68 years in experimental group and 63 years in control group</P>
<P>Inclusion criteria: clinical diagnosis of stroke &lt; 3 months after stroke onset, first-ever stroke, dependent ambulation with severe gait impairment (FAC &lt; 2), and sufficient cognition to understand procedures and provide informed consent</P>
<P>Exclusion criteria: contraindications for RAGT therapy; cerebellar or brainstem lesions that could affect autonomic or balance function; musculoskeletal disease involving the lower limbs, such as severe painful arthritis, osteoporosis, amputation, or joint contracture; and other concurrent neurological diseases (e.g. Parkinson's disease, multiple sclerosis, etc.)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:55:18 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: 30 minutes of exoskeletal robot-driven gait orthosis training (Lokomat) and 30 minutes conventional rehabilitation therapy 5 times per week for 4 weeks</LI>
<LI>Control group: 60 minutes conventional rehabilitation therapy. Physical therapy conducted by physical therapists certified in neurodevelopmental techniques was provided for balance and mobility 5 times per week for 4 weeks</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:20 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after the 4-week intervention; all outcome parameters were measured within 3 days before and after 20 sessions of training:</P>
<UL>
<LI>Primary outcomes: brachial&#8211;ankle pulse wave velocity (baPWV, which evaluates arterial stiffness) and cardiopulmonary fitness</LI>
<LI>Secondary outcomes: clinical functional outcomes, including basic ADL function, balance, gait functions, and motor functions of the paretic lower limb</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:55:27 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hidler-2009">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:22 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: randomisation table<BR/>Blinding of outcome assessors: not described<BR/>Adverse events: control group 14; experimental group 11<BR/>Deaths: 1, which study arm not reported<BR/>Dropouts: 9<BR/>ITT: no, described as analysis per protocol<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:55:25 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>72 participants (36 in treatment group, 36 in control group); 63 participants completed all training sessions and were analysed as per protocol<BR/>All participants were ambulatory at start of study<BR/>Mean age: 60 years<BR/>Inclusion criteria: hemiparesis resulting from unilateral ischaemic or haemorrhagic stroke, time since stroke less than 6 months, no prior stroke, age &gt; 18 years, ability to ambulate 5 metres without physical assistance and a self selected walking speed between 0.1 and 0.6 m/s, not receiving any other physical therapy targeting the lower limbs<BR/>Exclusion criteria: severe osteoporosis, contractures limiting range of motion in the lower extremities, not ambulating before stroke, severe cardiac disease (NYHA classification of II-IV), uncontrolled hypertension (systolic &gt; 200 mm Hg, diastolic &gt; 110 mm Hg), stroke of the brainstem or cerebellar lesions, uncontrolled seizures, presence of lower limb non-healing ulcers, lower limb amputation, uncontrolled diabetes, cognitive deficits (&lt; 24 on the MMSE), symptoms of depression (&#8805; 16 on the Center for Epidemiological Studies Depression Scale)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 14:59:00 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Control group received conventional gait training, 3 times a week for 8 to 10 weeks for 24 sessions, each session lasted 1½ hours</LI>
<LI>Experimental group used the Lokomat for the same time and frequency</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:27 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 12 and 24 sessions, and at 3-month follow-up:</P>
<UL>
<LI>Primary outcome measures: self selected walking speed over 5 metres, walking distance in 6 minutes</LI>
<LI>Secondary outcome measures: Berg Balance Scale, FAC, NIHSS, Motor Assessment Scale, Rivermead Mobility Index, Frenchay Activities Index, SF-36, cadence</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:55:27 +0100" MODIFIED_BY="Hazel Fraser"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:55:31 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hornby-2008">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: opaque, sealed envelopes<BR/>Blinding of outcome assessors: not done<BR/>Adverse events: 8 events in control group and 3 events in experimental group<BR/>Deaths: none<BR/>Dropouts: 14 (10 in control group and 4 in experimental group)<BR/>ITT: no ITT; analysis per protocol</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:55:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>62 participants (31 in treatment group, 31 in control group), 48 participants completed all training sessions and were analysed as per protocol<BR/>All participants were ambulatory at start of study<BR/>Mean age: 57 years<BR/>Inclusion criteria: hemiparesis of longer than 6 months' duration after patients with unilateral, supratentorial, ischaemic, or haemorrhage stroke were recruited; no evidence of bilateral or brainstem lesions; able to walk 10 metres overground without physical assistance at speeds of 0.8 m/s at self selected velocity, using assistive devices and bracing below the knee as needed<BR/>Exclusion criteria: significant cardiorespiratory/metabolic disease or other neurological or orthopaedic injury that may limit exercise participation or impair locomotion, size limitations for the harness/counterweight system or robotic orthosis, botulinum toxin therapy in the lower limbs within 6 months before enrolment, scores lower than 23 on the MMSE, patients could not receive concurrent physical therapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 10:33:53 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Control group received therapist-assisted gait training, 12 sessions, each session lasted 30 minutes</LI>
<LI>Experimental group received robotic-assisted gait training using the Lokomat for the same time and frequency</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:31 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 12 sessions and at 6-month follow-up:</P>
<UL>
<LI>Primary outcome measures: self selected walking speed</LI>
<LI>Secondary outcome measures: single-limb stance time, step length asymmetry, 6-minute walk test, modified Emory Functional Ambulation Profile, Berg Balance Scale, Frenchay Activities Index, physical component summary score of the Medical Outcomes Questionnaire Short Form 36, strength, Modified Ashworth Scale, Center for Epidemiological Studies Depression Scale</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-02-19 08:52:01 +0000" MODIFIED_BY="Jenny Bellorini">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Husemann-2007">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:32 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: opaque envelopes, stratified by side of paresis and aetiology<BR/>Blinding of outcome assessors: yes<BR/>Adverse events: 2 (1 in experimental group, 1 in control group)<BR/>Deaths: none<BR/>Dropouts: 2 (1 in experimental group, 1 in control group)<BR/>ITT analysis: not provided for all dropouts</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:55:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Germany<BR/>32 participants (17 in treatment group, 15 in control group)<BR/>Non-ambulatory at start of study<BR/>Mean age: not provided<BR/>Inclusion criteria: not provided<BR/>Exclusion criteria: not provided</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>2 arms:</P>
<UL>
<LI>Robotic gait trainer (Lokomat), 30 minutes per weekday for 4 weeks</LI>
<LI>Conventional physiotherapy, 30 minutes per weekday for 4 weeks</LI>
</UL>
<P>Both groups received additional 30 minutes of physiotherapy daily.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 weeks:</P>
<UL>
<LI>FAC</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:55:34 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2015">
<CHAR_METHODS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: not described<BR/>Blinding of outcome assessors: not described<BR/>Adverse events: not mentioned<BR/>Deaths: none<BR/>Dropouts: 4 (2 in experimental group, 2 in control group)</P>
<P>ITT: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:55:39 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Korea<BR/>30 participants (15 in treatment group, 15 in control group)<BR/>Not ambulatory at start of study<BR/>Mean age: 54 years in experimental group and 50 years in control group</P>
<P>Inclusion criteria: first stroke &lt; 1 year, plateau in recovery of the locomotor functions after a 30-day conventional neurorehabilitation</P>
<P>Exclusion criteria: severe spasticity (Modified Ashworth Scale 2), tremor, severe visual and cognitive impairments, musculoskeletal diseases, cardiopulmonary diseases, body weight of 135 kg; height of 150 cm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:55:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robot-assisted training (Walkbot) (2 x 20 minutes/day) and conventional physical therapy (2 x 20 minutes/day) 5 for 4 weeks</LI>
<LI>Control group: conventional physical therapy (2 x 40 minutes/day) for the same time as experimental group</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 and 8 weeks.</P>
<P>Outcome measures: walking ability (FAC), balance (Berg Balance Scale), modified Barthel Index, spasticity (Modified Ashworth Scale), quality of life (EuroQol-5 dimension)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-12-06 07:25:36 +0000" MODIFIED_BY="Jan Mehrholz">
<P>NCT02053233</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:55:42 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Kyung-2008">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:41 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: unclear<BR/>Blinding of outcome assessors: unclear<BR/>Adverse events: unclear<BR/>Deaths: unclear<BR/>Dropouts: 3 (2 in experimental group, 1 in control group)<BR/>ITT analysis: unclear</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:55:42 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Republic of Korea<BR/>35 participants (18 in treatment group, 17 in control group)<BR/>10 participants in the experimental group and 7 participants in the control group were ambulatory at start of study<BR/>Mean age: not stated<BR/>Inclusion criteria: not stated<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 10:38:36 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Robotic training (Lokomat), 30 minutes, 3 times a week for 4 weeks</LI>
<LI>Conventional physiotherapy, received equal time and sessions of conventional gait training</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-03 14:59:15 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after training</P>
<UL>
<LI>FAC</LI>
<LI>Modified Motor Assessment Scale</LI>
<LI>Gait speed</LI>
<LI>Isometric torque</LI>
<LI>Fugl-Meyer Assessment</LI>
<LI>Motricity Index</LI>
<LI>Ashworth Scale</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-04 07:56:29 +0000" MODIFIED_BY="Hazel Fraser"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:55:47 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Mayr-2008">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:44 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: unclear<BR/>Blinding of outcome assessors: unclear<BR/>Adverse events: not stated<BR/>Deaths: unclear, probably none<BR/>Dropouts: 13 (4 in experimental group, 9 in control group)<BR/>ITT analysis: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:55:46 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Austria<BR/>74 participants (37 in treatment group, 37 in control group)<BR/>Most participants in both groups were non-ambulatory at start of study<BR/>Mean age: not stated<BR/>Inclusion criteria: primary ischaemic lesion of the medial cerebral artery, between 10 days and 6 weeks after stroke, stable cardiovascular system, ability to walk with assistance of 1 therapist<BR/>Exclusion criteria: brainstem lesions, thrombosis, severe contractures, good walking ability with standing only help by therapist<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-11-29 11:42:28 +0000" MODIFIED_BY="[Empty name]">
<P>2 arms:</P>
<UL>
<LI>Add-on robotic training (Lokomat), 45 minutes, 5 times a week for 8 weeks</LI>
<LI>Add-on conventional physiotherapy, received equal time and sessions of conventional gait training</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:47 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after training phase:</P>
<UL>
<LI>Modified Emory Functional Ambulatory Profile</LI>
<LI>Hochzirl Walking Aids Profile</LI>
<LI>Rivermead Motor Index</LI>
<LI>Mobility milestones</LI>
<LI>Gait analysis</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-03-24 15:50:12 +0000" MODIFIED_BY="Hazel Fraser">
<P>Published as conference abstract and unpublished data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:41:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morone-2011">
<CHAR_METHODS MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<P>RCT<BR/>Method of randomisation: by computer program<BR/>Blinding of outcome assessors: stated as 'yes'<BR/>Adverse events: control group 4, experimental group 3<BR/>Deaths: none<BR/>Dropouts: (defined in this study as discontinued intervention) 12 in robotic groups and 9 in control groups<BR/>ITT: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Italy<BR/>48 participants (24 in treatment group , 24 in control group )<BR/>All participants were non-ambulatory at start of study<BR/>Mean age: 62 years<BR/>Inclusion criteria: hemiplegia/hemiparesis in the subacute phase with significant gait deficits (FAC &lt; 3) caused by a first-ever stroke, lesions that were confirmed by computed tomography or magnetic resonance imaging, and age between 18 and 80 years<BR/>
</P>
<P>Exclusion criteria: presence of subarachnoid haemorrhages, sequelae of prior cerebrovascular accidents or other chronic disabling pathologies, orthopaedic injuries that could impair locomotion, spasticity that limited lower extremity range of motion to less than 80%, sacral skin lesions, MMSE score &lt; 24, and hemispatial neglect, as evaluated by a neuropsychologist</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-04 14:41:03 +0100" MODIFIED_BY="[Empty name]">
<P>2 arms (including strata for motor function):</P>
<UL>
<LI>After first week post-admission, participants performed 20 robotic sessions (5 times per week for 4 weeks) instead of a second session of standard physiotherapy. These sessions lasted 40 minutes, 20 of which consisted of active gait-training therapy (the remaining 20 minutes were allocated for the participant's preparation, parameter setting, and rest breaks as needed)</LI>
<LI>After first week of admission, participants performed 2 daily physiotherapy sessions. One session was dedicated to walking training, consisting of 20 sessions of 40-minute therapy (5 times per week), instead of a second session of standard physiotherapy. In light of the participant's ability, the walking therapy was focused on trunk stabilisation, weight transfer to the paretic leg, and walking between parallel bars or on the ground. If necessary, the participant was helped by 1 or 2 therapists and walking aids</LI>
</UL>
<P>The standard physiotherapy, shared by both groups, was focused on facilitation of movement on the paretic side and upper limb exercises, as well as improving balance, standing, sitting, and transferring.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:55:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded by a physician who was blinded to the treatment at baseline, after 4 weeks of the intervention, and at hospital discharge:</P>
<UL>
<LI>Primary outcome: walking ability (as measured by FAC)</LI>
<LI>Secondary outcomes: assessments of mobility function and ability level, evaluated by lower-leg Ashworth (sum of scores for hip, knee, and ankle), Rivermead Mobility Index, Motricity Index, Trunk Control Test, Canadian Neurological Scale, Barthel Index, Rankin Scale, 6-minute walk test on a 20-metre path and 10-metre walk test at a self selected speed</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-02 07:57:45 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Noser-2012">
<CHAR_METHODS MODIFIED="2017-05-02 14:55:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: unclear<BR/>Blinding of outcome assessors: stated as 'yes'<BR/>Adverse events: 4 (2 in experimental group and 2 in control group)<BR/>Deaths: none stated<BR/>Dropouts: 1 in the control group (protocol violation)<BR/>ITT: stated as 'yes'</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:56:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>21 participants (11 in treatment group, 10 in control group); 20 participants completed all training sessions, and 11 in treatment group and 9 in control group completed the study and were analysed as per protocol<BR/>All participants were ambulatory at start of study<BR/>Mean age: unclear<BR/>Inclusion criteria: people with ischaemic or haemorrhagic stroke confirmed by cerebral CT or MRI scan; age &gt; 18; at least 3 months' poststroke at time of enrolment into study; ability to walk at least 10 feet with maximum 1 person assist, but not to walk in the community independently; residual paresis in the lower extremity as defined by NIHSS lower extremity motor score 2 to 4; ability to perform Lokomat ambulation training with assistance of 1 therapist; ability to follow a 3-step command; physician approval for patient participation; ability to give informed consent, completed rehabilitation services (i.e. not receiving concurrent physical, occupational, or speech therapy)<BR/>Exclusion criteria: serious cardiac condition, uncontrolled blood pressure defined as &gt; 200 or diastolic &gt; 100 at rest, history of serious chronic obstructive pulmonary disease or oxygen dependence, severe weight-bearing pain, lower extremity amputation, claudication while walking, life expectancy &lt; 1 year, history of deep vein thrombosis or pulmonary embolism within 6 months, severe orthopaedic problem, any medical or psychiatric condition that the investigators believe would prevent participation in study<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 10:54:37 +0100" MODIFIED_BY="[Empty name]">
<P>2 arms:</P>
<UL>
<LI>Control group received therapist-assisted gait training (duration and frequency unclear)</LI>
<LI>Experimental group received robotic-assisted gait training using the Lokomat (duration and frequency unclear)</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:04 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and at postintervention, 3 months' postintervention</P>
<UL>
<LI>Primary outcome measures: 10-metre walk test</LI>
<LI>Secondary outcome measures: 6-minute walk test</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>NCT00975156; same study as <LINK REF="REF-Kelley-2013" TYPE="REFERENCE">Kelley 2013</LINK>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:12 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Ochi-2015">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:07 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT</P>
<P>Method of randomisation: random number table</P>
<P>Blinding of outcome assessors: stated as 'yes'<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:56:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Japan<BR/>26 participants (13 in treatment group, 13 in control group)<BR/>Not ambulatory at start of study<BR/>Mean age: 62 years in experimental group and 65 years in control group</P>
<P>Inclusion criteria: first-ever stroke &lt; 5 weeks; age between 40 and 85 years; lower extremities Brunnstrom's recovery stage &#8804; grade III; FAC &#8804; 2; independence in walking before stroke</P>
<P>Exclusion criteria: height between 145 and 180 cm; body weight over 100 kg; limitation in range of motion in the lower extremity; severe cardiovascular, respiratory, renal, or musculoskeletal disease; difficulty in communicating</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:56:10 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robot-assisted training (gait-assistance robot) 5 days/week for 4 weeks (20 minutes)</LI>
<LI>Control group: overground conventional gait training for the same time as experimental group</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:11 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 weeks.</P>
<P>Outcome measures: Fugl-Meyer Assessment lower extremity, muscle torque, walking ability (FAC), 10-metre walk test, Functional Independence Measure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:56:12 +0100" MODIFIED_BY="Hazel Fraser">
<P>Clinical group differences in FAC at baseline</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:16 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Peurala-2005">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:14 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: an investigator not involved in the study randomly assigned participants to groups using concealed envelopes<BR/>Blinding of outcome assessors: no<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT analysis: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-03 15:00:09 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Finland<BR/>45 participants (15 in treatment group A, 15 in treatment group B, 15 in control group)<BR/>Ambulatory and non-ambulatory at study onset<BR/>Mean age: 52 years<BR/>Inclusion criteria: first supratentorial stroke with duration of illness longer than 6 months, younger than 65 years of age, slow or difficult walking, no unstable cardiovascular disease, no severe malposition of joints, no severe cognitive or communicative disorders, written informed consent<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:56:14 +0100" MODIFIED_BY="Hazel Fraser">
<P>3 arms:</P>
<UL>
<LI>Gait trainer exercise without functional electrical stimulation</LI>
<LI>Gait trainer exercise with functional electrical stimulation</LI>
<LI>Walking overground</LI>
</UL>
<P>All participants practised gait for 15 sessions over 3 weeks (each session lasting 20 minutes) and received an additional 55 minutes daily physiotherapy.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:16 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 2 and 3 weeks and 6 months:</P>
<UL>
<LI>10-metre walk test</LI>
<LI>6-minute walk test</LI>
<LI>Lower limb spasticity</LI>
<LI>Muscle force</LI>
<LI>Postural sway tests</LI>
<LI>Modified Motor Assessment Scale</LI>
<LI>Functional Independence Measure instrument scores</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:56:16 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Peurala-2009">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:17 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: sealed envelopes (stratified according to ability to walk)<BR/>Blinding of outcome assessors: no<BR/>Adverse events: 2 in treatment group A, 3 in control group<BR/>Deaths: 1 in control group<BR/>Dropouts: 5 in treatment group A, 1 in treatment group B, 3 in control group<BR/>ITT analysis: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-04-28 06:02:30 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Finland<BR/>56 participants (22 in treatment group A, 21 in treatment group B, 13 in control group)<BR/>Non-ambulatory at start of study<BR/>Mean age: 68 years<BR/>Inclusion criteria: first supratentorial stroke or no significant disturbance from an earlier stroke (Modified Rankin Scale 0 to 2), acute phase after stroke with a maximum duration of 10 days, FAC 0 to 3, voluntary movement in the leg of the affected side, Barthel Index 25 to 75 points, age 18 to 85 years, no unstable cardiovascular disease, body mass index &lt; 32, no severe malposition of joints, no severe cognitive or communicative disorders<BR/>Exclusion criteria: not stated</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:56:19 +0100" MODIFIED_BY="Hazel Fraser">
<P>Between June 2003 and December 2004, random allocation to 2 arms took place (2 walking exercise groups)</P>
<UL>
<LI>Gait training with Gait Trainer device (GT-Group)</LI>
<LI>Overground walking training (WALK-Group)</LI>
</UL>
<P>All participants received 55 minutes daily gait-oriented physiotherapy and additional gait training for 15 sessions over 3 weeks (each session lasting maximum of 20 minutes of walking).</P>
<P>Between January 2005 and February 2007, random allocation to 3 arms took place (3 walking exercise groups)</P>
<UL>
<LI>Gait training with Gait Trainer device (GT-Group)</LI>
<LI>Overground walking training (WALK-Group)</LI>
<LI>Control group (CT-Group)</LI>
</UL>
<P>All participants received 55 minutes daily gait-oriented physiotherapy and additional gait training for 15 sessions over 3 weeks (each session lasting maximum of 20 minutes of walking). However, CT-Group received 1 or 2 physiotherapy sessions daily but not at the same intensity as in the other groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:21 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 3 weeks and 6 months:</P>
<UL>
<LI>FAC</LI>
<LI>10-metre walk test</LI>
<LI>6-minute walk test</LI>
<LI>Modified Motor Assessment Scale</LI>
<LI>Rivermead Motor Assessment Scale</LI>
<LI>Rivermead Mobility Index</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:56:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Because we were interested in the effects of automated electromechanical- and robotic-assisted gait-training devices for improving walking after stroke, we combined the results of the CT-Group and the WALK-Group as one group, which we compared with the results from the GT-Group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:28 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Picelli-2016">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:27 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: software generated<BR/>Blinding of outcome assessors: yes<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT analysis: no dropouts</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-03-24 15:53:25 +0000" MODIFIED_BY="Hazel Fraser">
<P>Country: Italy<BR/>22 participants (11 in treatment group, 11 in control group)<BR/>Ambulatory at study onset<BR/>Mean age: 63 years<BR/>Inclusion criteria: age &gt; 18 years, leg spasticity, FAC &gt; 4, duration of illness &gt; 6 months<BR/>Exclusion criteria: participation in other trials, deformities such as contractures, spasticity treatment before the study</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:56:27 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Botulinum toxin injections for spastic triceps surae and additional 30 minutes G-EO gait training for 5 days</LI>
<LI>Botulinum toxin injections for spastic triceps surae without additional gait training</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, 1 month</P>
<P>Primary outcome:</P>
<UL>
<LI>Modified Ashworth Scale</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Tardieu Scale</LI>
<LI>6-minute walk test</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:56:28 +0100" MODIFIED_BY="Hazel Fraser">
<P>1 group received additional gait training (performance bias).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:37 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Pohl-2007">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: lots indicating A or B were prepared in sealed envelopes<BR/>Blinding of outcome assessors: primary outcomes were evaluated by blinded assessors<BR/>Adverse events: 4 (3 in experimental group, 1 in control group)<BR/>Deaths: 2 (1 in experimental group, 1 in control group)<BR/>Dropouts: 11 (5 in experimental group, 6 in control group)<BR/>ITT analysis: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:56:32 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Germany<BR/>155 participants (77 in treatment group, 78 in control group)<BR/>Non-ambulatory at study onset<BR/>Mean age: 63 years<BR/>Inclusion criteria: first supratentorial stroke (ischaemic or haemorrhagic); age between 18 and 79 years; interval between stroke and study onset less than 60 days; able to sit unsupported (i.e. without holding onto supports such as the edge of the bed), with feet supported, could not walk at all, or required the help of 1 or 2 therapists irrespective of the use of an ankle-foot orthosis or a walking aid (FAC 3 or less); understanding the meaning of the study and following instructions, providing written informed consent to participation in the study approved by the local ethical committee<BR/>Exclusion criteria: unstable cardiovascular condition after a 12-lead electrocardiogram examined by a cardiologist, restricted passive range of motion in the major lower limb joints (extension deficit &gt; 20° for the affected hip or knee joints, or a dorsiflexion deficit &gt; 20° for the affected ankle, tested while lying supine and on the non-affected side), prevalence of other neurological or orthopaedic diseases impairing walking ability</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:56:34 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>20 minutes locomotor training with Gait Trainer in combination with 25 minutes physiotherapy weekdays for 4 weeks</LI>
<LI>45 minutes physiotherapy weekdays for 4 weeks</LI>
</UL>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 4 weeks and 6 months.</P>
<P>Primary outcomes:</P>
<UL>
<LI>Gait ability (FAC 0 to 5)</LI>
<LI>Barthel Index (0 to 100)</LI>
</UL>
<P>Participants who were ambulatory (FAC 4 or 5) or reaching a Barthel Index &gt; 75 were defined as responders to therapy.</P>
<P>Secondary outcomes:</P>
<UL>
<LI>Walking velocity</LI>
<LI>Walking endurance</LI>
<LI>Mobility (Rivermead Mobility Index)</LI>
<LI>Leg power (Motricity Index)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:56:37 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:42 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Saltuari-2004">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Cross-over RCT<BR/>Method of randomisation: by random numbers<BR/>Blinding of outcome assessors: unclear<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:56:41 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Austria<BR/>16 participants (8 in treatment group, 8 in control group)<BR/>Ambulatory and non-ambulatory at study onset<BR/>Mean age: 61 years<BR/>Inclusion criteria: not provided<BR/>Exclusion criteria: not provided<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 11:05:21 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms (A: Lokomat, B: physiotherapy):</P>
<UL>
<LI>3 weeks A, 3 weeks B, 3 weeks A</LI>
<LI>3 weeks B, 3 weeks A, 3 weeks B</LI>
</UL>
<P>
<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:42 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 3 weeks (they were additionally recorded after 6 and 9 weeks, but only outcomes of the first phase were included in this review).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:56:42 +0100" MODIFIED_BY="Hazel Fraser">
<P>Unpublished data provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:45 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Schwartz-2006">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:42 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: block sampling method (each block contained 6 participants: 4 experimental group and 2 control group)<BR/>Blinding of outcome assessors: no<BR/>Adverse events: 5 (3 in experimental group, 2 in control group)<BR/>Deaths: none<BR/>Dropouts: 11 (8 in experimental group, 3 in control group)<BR/>ITT: no (stated, but 2 participants from the control group were excluded from analysis)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:56:43 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Israel<BR/>67 participants (at October 2006) (37 in treatment group, 30 in control group)<BR/>Non-ambulatory at study onset<BR/>Mean age: 60 years<BR/>Inclusion criteria: first stroke, until 3 months after stroke<BR/>Exclusion criteria: not provided</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 15:00:25 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Physiotherapy with additional gait training using the Lokomat 3 times a week for 6 weeks</LI>
<LI>Physiotherapy with additional gait training 3 times a week for 6 weeks</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:45 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 3, 6, and 9 weeks:</P>
<UL>
<LI>FAC</LI>
<LI>NIHSS</LI>
<LI>Stroke Activity Scale</LI>
<LI>Functional Independence Measure</LI>
<LI>Gait velocity</LI>
<LI>2-minute walk test</LI>
<LI>Timed Up and Go Test</LI>
<LI>Stair-climbing test</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:56:45 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:56:57 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Stein-2014">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:49 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: not stated<BR/>Blinding of outcome assessors: stated as 'yes'<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none immediately after study end (at 3-month follow-up: 2 in experimental group and 2 in control group)</P>
<P>ITT: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:56:52 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>24 participants (12 in treatment group, 12 in control group)<BR/>Ambulatory at start of study<BR/>Mean age: 58 years in experimental group and 57 years in control group</P>
<P>Inclusion criteria: single stroke, significant leg weakness and gait alterations &lt; 6 months before study entry, independent in household ambulation</P>
<P>Exclusion criteria: ongoing physical therapy for the leg and/or gait and mobility, botulinum toxin injections &lt; 3 months before study entry, no further planned injections, other neurologic disorders, excessive spasticity of lower limb (Ashworth Scale &gt; 3), uncontrolled hypertension, unstable coronary artery disease, contractures of lower limb, impaired cognition (MMSE score &lt; 24)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:56:55 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robotic gait treatment (robotic leg brace), 3 days/week for 6 weeks (60 minutes/day)</LI>
<LI>Control group: group exercises for relaxation/meditation, self stretching, and gentle upper and lower limb active range-of-motion exercises for the same time</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:56:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, after 6, 10, and 19 weeks</P>
<P>Outcome measures: Timed Up and Go Test, 10-metre walk test, 6-minute walk test, Five-Times-Sit-to-Stand Test, Berg Balance Scale, California Functional Evaluation, Emory Functional Ambulation Profile</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:57:05 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Tanaka-2012">
<CHAR_METHODS MODIFIED="2017-05-02 14:56:57 +0100" MODIFIED_BY="Hazel Fraser">
<P>Cross-over RCT<BR/>Method of randomisation: computer-generated randomisation<BR/>Blinding of outcome assessors: no<BR/>Adverse events: none described<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Japan<BR/>12 participants (7 in treatment group, 5 in control group)<BR/>All were ambulatory at study onset<BR/>Mean age: 62 years<BR/>Inclusion criteria: first stroke; more than 6 months since stroke onset; slight-to-moderate motor deficit (Brunnstrom recovery stages III&#8211;VI); could walk with or without walking aids<BR/>Exclusion criteria: higher brain function disorder or cognitive deficit affecting ability to understand and describe symptoms (&lt; 24 on the MMSE); severe heart disorder affecting gait movement intensity; severe bone and joint disease affecting gait movement</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:03 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms (only the first 12 weeks before cross-over are described here; A: no training, B: gait training with Gait Master 4, 1 session: 20 minutes):</P>
<UL>
<LI>4 weeks A; 2 or 3 times a week, 12 gait training sessions B; 4 weeks A</LI>
<LI>4 weeks A; 4 weeks A; 4 weeks follow-up</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:05 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded weekly over a 24-week period:</P>
<UL>
<LI>Gait speed</LI>
<LI>Timed Up and Go Test times</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-02 07:58:00 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Tong-2006">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Randomisation was done by computer-generated random numbers<BR/>Blinding of outcome assessors: no (except for Barthel Index and Functional Independence Measure scores, which were performed by nurses who were blinded)<BR/>Adverse events: 2 (none in experimental group, 2 in control group)<BR/>Deaths: none<BR/>Dropouts: 4 (none in experimental group, 4 in control group)<BR/>ITT: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Hong Kong, China<BR/>50 participants (15 in treatment group A, 15 in treatment group B, 20 in control group)<BR/>Non-ambulatory at study onset<BR/>Mean age: 68 years<BR/>Inclusion criteria: diagnosis of first ischaemic brain injury or intracerebral haemorrhage shown by magnetic resonance imaging or computed tomography less than 6 weeks after onset of stroke; sufficient cognition to follow simple instructions and understand the content and purpose of the study (MMSE score &gt; 21); ability to stand upright, supported or unsupported, for 1 minute; significant gait deficit (FAC score &lt; 3); no skin allergy to electrical stimulation<BR/>Exclusion criteria: recurrent stroke; other neurological, medical, or psychological deficit or condition that would affect ambulation ability or compliance with study protocol (such as Parkinson's disease, major depression, pain, cardiac arrhythmias); aphasia with an inability to follow 2 consecutive step commands or a cognitive deficit; severe hip, knee, or ankle contracture that would preclude passive range of motion of the leg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>3 arms:</P>
<UL>
<LI>Gait trainer</LI>
<LI>Gait trainer + functional electrical stimulation</LI>
<LI>Conventional physiotherapy alone</LI>
</UL>
<P>The study consisted of 1 training session per weekday for 4 weeks.<BR/>Experimental groups 1 and 2 underwent gait training for 20 minutes, with body weight support by an electromechanical gait trainer; group 2 also received functional electrical stimulation to the paretic lower limb during gait training.<BR/>Participants in group 3 received physiotherapy overground gait training based on the principles of proprioceptive neuromuscular facilitation and Bobath concepts.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>5-metre walking speed test</LI>
<LI>Elderly Mobility Scale</LI>
<LI>Berg Balance Scale</LI>
<LI>FAC</LI>
<LI>Motricity Index leg subscale</LI>
<LI>Functional Independence Measure instrument score</LI>
<LI>Barthel Index score</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Ucar-2014">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: random number list</P>
<P>Blinding of outcome assessors: yes<BR/>Adverse events: not described<BR/>Deaths: not described<BR/>Dropouts: not described<BR/>ITT: unknown</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Turkey<BR/>22 participants (11 in treatment group, 11 in control group)<BR/>Ambulatory at start of study<BR/>Mean age: 56 years in experimental group and 62 years in control group</P>
<P>Inclusion criteria: adult male (&gt; 18 years), ability to ambulate 10 metres without personal assistance, and not receiving any other physical therapy</P>
<P>Exclusion criteria: body weight more than 300 pounds (135 kg), FAC score &lt; 3 and not able to walk consistently or independently within the community, cognitive deficits, cardiac disease, spasticity of the lower limbs preventing robotic walking, traumatic stroke, intracranial space occupying lesion-induced strokes, and seizures</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robotic gait treatment (Lokomat), 30-minute sessions, 5 sessions per week for 2 weeks</LI>
<LI>Control group: the conventional exercise group received the equivalent additional time of conventional physiotherapy at home as determined by rehabilitation unit physiotherapists. Home exercise procedure focused on gait in order to raise awareness about trunk stability&#8211;symmetry and body weight support on the paretic leg. Sessions taken 5 days per week for 2 weeks included active and passive range of motion, active-assistive exercises, strengthening of the paretic leg, and balance training</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were assessed at baseline and after 2 and 8 weeks:</P>
<UL>
<LI>Walking speed</LI>
<LI>Timed Up and Go Test</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-09-06 07:30:08 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Nunen-2012">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: stated as block randomisation<BR/>Blinding of outcome assessors: no<BR/>Adverse events: none described<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: unknown</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Country: Hong Kong, China<BR/>50 participants (30 in treatment group , 20 in control group)<BR/>Non-ambulatory at study onset (intervention group: 3 , control group: 2 )</P>
<P>Mean age: 53 years<BR/>Inclusion criteria: unknown<BR/>Exclusion criteria: unknown</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms</P>
<UL>
<LI>60-minute sessions of gait training 2 times a week with the Lokomat, 60-minute sessions of overground gait training 3 times a week for 8 weeks</LI>
<LI>60-minute sessions of overground gait training without device 5 times a week for 8 weeks</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-03 11:13:26 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes were assessed at baseline and after 8 weeks:</P>
<UL>
<LI>Walking speed</LI>
<LI>FAC</LI>
<LI>Berg Balance Scale</LI>
<LI>Rivermead Mobility Index</LI>
<LI>Fugl-Meyer Leg Score</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Waldman-2013">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: unclear<BR/>Blinding of outcome assessors: no<BR/>Adverse events: none described<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: unknown</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>24 participants (12 in treatment group, 12 in control group)<BR/>Ambulatory at study onset</P>
<P>Mean age: 51 years<BR/>Inclusion criteria: people with stroke duration longer than 3 months, with reduced ankle range of motion and strength, and able to walk with or without assistant devices<BR/>Exclusion criteria: unknown</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms</P>
<UL>
<LI>18 sessions (1 hour, 3 times a week over 6 weeks) gait training with portable rehabilitation robot</LI>
<LI>18 sessions (1 hour, 3 times a week over 6 weeks) exercise training without device (instructed exercise for the control group involved stretching the plantar flexors and active movement exercises for ankle mobility and strength)</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes were assessed at baseline and after 6 and 12 weeks :</P>
<UL>
<LI>modified Ashworth scale</LI>
<LI>Stroke Rehabilitation Assessment of Movement (STREAM)</LI>
<LI>Berg Balance Scale</LI>
<LI>6-minute walk test</LI>
<LI>Passive range of motion</LI>
<LI>Plantar flexor strength</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Published and unpublished data provided by the authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Watanabe-2014">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: computer generated<BR/>Blinding of outcome assessors: stated as 'no'<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: 10 (6 in experimental group and 4 in control group)</P>
<P>ITT: no</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Japan<BR/>32 participants (17 in treatment group, 15 in control group)<BR/>Not ambulatory at start of study<BR/>Mean age: 67 years in experimental group and 76 years in control group</P>
<P>Inclusion criteria: stroke &lt; 6 months</P>
<P>Exclusion criteria: not ambulating prior to stroke, FAC 4 or 5, severe cardiac disease, NYHA III or IV, severe disturbance of consciousness (Japan Coma Scale II or III), size limitations for the robotic orthosis, skin disease, pacemaker</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Experimental group: robotic gait treatment (robot suit Hybrid Assistive Limb, single-leg version of the Hybrid Assistive Limb on the paretic side), 20 minutes daily for 12 sessions over 4 weeks</LI>
<LI>Control group: conventional gait rehabilitation for the same amount of time</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline, after 12 training sessions</P>
<P>Primary outcome: </P>
<UL>
<LI>FAC</LI>
</UL>
<P>Secondary outcomes: </P>
<UL>
<LI>Maximum walking speed</LI>
<LI>Timed Up and Go Test</LI>
<LI>6-minute walk test</LI>
<LI>Short Physical Performance Battery</LI>
<LI>Fugl-Meyer Assessment of Lower Extremity</LI>
<LI>Isometric muscle strength (hip flexion and extension, knee flexion and extension)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Werner-2002">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Cross-over RCT<BR/>Method of randomisation: participants randomly assigned to groups (group allocation in envelopes that were drawn by an independent person)<BR/>Blinding of outcome assessors: yes<BR/>Adverse events: none<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: yes<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Germany<BR/>30 participants (15 in treatment group, 15 in control group)<BR/>Non-ambulatory at study onset<BR/>Mean age: 60 years<BR/>Inclusion criteria: first stroke, supratentorial lesion 4 to 12 weeks' poststroke, younger than 75 years of age, not able to walk (FAC of 2 or less), able to sit unsupported on the edge of a bed, able to stand for at least 10 seconds with help, able to provide and did provide written informed consent<BR/>Exclusion criteria: hip and knee extension deficit &gt; 20 degrees; passive dorsiflexion of the affected ankle to less than a neutral position; severe impairment of cognition or communication; evidence of cardiac ischaemia, arrhythmia, decompression, or heart failure; feeling of 'overexertion' or heart rate exceeding the age-predicted maximum (i.e. 190 beats/minute minus age) during training; resting systolic blood pressure exceeding 200 mm Hg at rest or dropping by more than 10 mm Hg with increasing workload</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>2 weeks A, 2 weeks B, 2 weeks A</LI>
<LI>2 weeks B, 2 weeks A, 2 weeks B</LI>
</UL>
<P>Treated as inpatients for five 15- to 20-minute sessions per week for 2 weeks<BR/>A: treadmill training with body weight support: participants walked on a treadmill with partial body weight support provided by a harness<BR/>B: gait trainer with body weight support: participants walked on Gait Trainer with partial body weight support provided by a harness<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes were recorded at baseline and after 2 weeks (additionally after 4 and 6 weeks, but only the first phase was included in this review):</P>
<UL>
<LI>FAC</LI>
<LI>Fast walking speed over 10 metres with personal assistance and gait aids if required</LI>
<LI>Rivermead Motor Assessment Scale</LI>
<LI>Ankle spasticity (Modified Ashworth Scale)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>We used the first treatment phase only.<BR/>Published and unpublished data provided by the authors.<BR/>0% dropouts at the end of first treatment phase (data were analysed as ITT)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-05-04 14:41:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Westlake-2009">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT<BR/>Method of randomisation: computer-generated random order (stratified by fast or slow walking)<BR/>Blinding of outcome assessors: not described<BR/>Adverse events: 1 in control group<BR/>Deaths: none<BR/>Dropouts: none<BR/>ITT: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-03 15:01:22 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: USA<BR/>16 participants (8 in treatment group, 8 in control group)<BR/>All were ambulatory at study onset<BR/>Mean age: 57 years<BR/>Inclusion criteria: hemiparesis resulting from a single cortical or subcortical stroke &gt; 6 months before the study, categorised as at least unlimited household ambulatory, written informed consent<BR/>Exclusion criteria: unstable cardiovascular, orthopaedic, or neurological conditions; uncontrolled diabetes that would preclude exercise of moderate intensity; significant cognitive impairment affecting ability to follow directions</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 11:17:30 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>12 physiotherapy sessions including gait training using the Lokomat (3 times a week over 4 weeks)</LI>
<LI>12 physiotherapy sessions including manual guided gait training (3 times a week over 4 weeks)</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-04 14:41:17 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes were recorded at baseline and after 4 weeks</P>
<UL>
<LI>Self selected and fast walking speed</LI>
<LI>6-minute walk test</LI>
<LI>Absolute step length ratio</LI>
<LI>Lower extremity Fugl-Meyer</LI>
<LI>Short Physical Performance Battery</LI>
<LI>Berg Balance Scale</LI>
<LI>Late-Life Function &amp; Disability Instrument</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-02-19 16:07:51 +0000" MODIFIED_BY="Hazel Fraser">
<P>&#8212;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ABC: Activities-specific Balance Confidence<BR/>ADL: activities of daily living<BR/>CT: computed tomography<BR/>FAC: Functional Ambulation Category<BR/>ITT: intention-to-treat<BR/>MMSE: Mini&#8211;Mental State Examination<BR/>MRC: Medical Research Council<BR/>MRI: magnetic resonance imaging<BR/>NIHSS: National Institutes of Health Stroke Scale<BR/>NYHA: New York Heart Association<BR/>PF-DF: plantar flexion and dorsiflexion<BR/>RAGT: robot-assisted gait training<BR/>RCT: randomised controlled trial<BR/>SF-36: 36-Item Short Form Health Survey<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Bae-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Intervention: both groups received robot-assisted gait training (the experimental group also received functional electrical stimulation on the ankle dorsiflexor of the affected side).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-03-24 13:33:33 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Byun-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-03-24 13:33:33 +0000" MODIFIED_BY="Hazel Fraser">
<P>Uses a sliding rehabilitation machine, not robotic training as experimental condition</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Caldwell-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not investigate electromechanical- and robotic-assisted gait-training devices as stated in the protocol of this review: bicycle training versus treadmill walking versus variable surface training were investigated</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Danzl-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Investigates brain stimulation, and both groups participated in identical locomotor training with a robotic gait orthosis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-14 13:34:29 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-David-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-14 13:34:29 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-03-24 13:34:23 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Forrester-2016">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-03-24 13:34:23 +0000" MODIFIED_BY="Hazel Fraser">
<P>Compared different robotic applications </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Gong-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not investigate electromechanical- and robotic-assisted gait-training devices as stated in the protocol of this review: no electromechanical-assisted devices were compared</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Goodman-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-14 13:34:40 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hesse-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-14 13:34:40 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-03-24 13:38:39 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Hsieh-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-03-24 13:38:39 +0000" MODIFIED_BY="Hazel Fraser">
<P>Investigated upper limbs</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Mirelman-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: experimental and control groups received a kind of assisted stepping therapy in a seated position. This study investigated the effects of virtual reality as an adjunct to stepping training. After discussion, we reached consensus to exclude this study from our review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-03-24 13:38:52 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Morone-2016">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-03-24 13:38:52 +0000" MODIFIED_BY="Hazel Fraser">
<P>Investigated the i-Walker, a rollator vehicle</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-03-24 13:38:58 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01337960">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-03-24 13:38:58 +0000" MODIFIED_BY="Hazel Fraser">
<P>Compared different robotic approaches</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Page-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: the experimental group received a kind of assisted stepping therapy in a seated position. This study investigated the effect of the NuStep apparatus. After discussion, we reached consensus to exclude this study from our review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Park-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Uses a treadmill training approach as experimental condition (Gait Trainer 2 analysis system, Biodex Medical Systems, Inc., Shirley, NY, USA)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Patten-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>According to the information on ClinicalTrials.gov (NCT00125619), this is a 1-arm, non-randomised trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-03-24 13:39:29 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Pennati-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-03-24 13:39:29 +0000" MODIFIED_BY="Hazel Fraser">
<P>Investigated upper limbs</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Picelli-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Both groups received the same robotic treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Pitkanen-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: the study describes preliminary findings of an initial sample of 9 participants; the experimental group received treadmill training or gait training</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Richards-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: the experimental group received a specialised locomotor training including early intensive physiotherapy with tilt table, limb load monitor, resistance exercises, and treadmills to promote functional recovery. After discussion, we reached consensus to exclude this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Richards-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Did not meet inclusion criteria of this review: the experimental group received specialised locomotor training including early intensive physiotherapy with tilt table, limb load monitor, resistance exercises and treadmills to promote functional recovery. After discussion, we reached consensus to exclude this study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-14 13:35:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shirakawa-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-14 13:35:12 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-07-03 15:01:33 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Skvortsova-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-07-03 15:01:33 +0100" MODIFIED_BY="Hazel Fraser">
<P>Not an RCT, control groups were age and sex matched</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-03-24 13:39:43 +0000" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Stoller-2015">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-03-24 13:39:43 +0000" MODIFIED_BY="Hazel Fraser">
<P>Compared 2 treadmill exercise options</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wu-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Compared different modes (resistance versus assistance training) of the same robotic device</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2016-12-06 08:08:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chernikova-2014">
<CHAR_METHODS MODIFIED="2016-12-06 08:08:04 +0000" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-06 08:08:04 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-12-06 08:08:04 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-12-06 08:08:04 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-12-06 08:08:04 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Globokar-2005">
<CHAR_METHODS MODIFIED="2013-06-14 13:35:49 +0100" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>People after stroke, number unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>25 minutes neurophysiotherapy plus 20 minutes of Gait Trainer</LI>
<LI>Not described</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:03:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>This study was presented at the 5th World Congress of Physical Medicine and Rehabilitation.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2013-06-14 13:36:05 +0100" MODIFIED_BY="Jenny Bellorini" STUDY_ID="STD-Golyk-2006">
<CHAR_METHODS MODIFIED="2013-06-14 13:36:05 +0100" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-01 15:03:23 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-02-01 15:03:25 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:03:28 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-02-19 08:59:48 +0000" MODIFIED_BY="Jenny Bellorini">
<P>&#8212;</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Jang-2005">
<CHAR_METHODS MODIFIED="2013-06-14 13:36:07 +0100" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-01 15:03:32 +0000" MODIFIED_BY="Hazel Fraser">
<P>34 non-ambulatory stroke survivors</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-03 15:01:34 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>14 participants: 20 minutes of physiotherapy 2 days per week and 20 minutes of Gait Trainer 3 days per week</LI>
<LI>20 participants: 20 minutes of physiotherapy 5 days per week</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:13:42 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>This study was presented at the 5th World Congress of Physical Medicine and Rehabilitation.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Kim-2001">
<CHAR_METHODS MODIFIED="2013-06-14 13:36:08 +0100" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-01 15:13:51 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-02-01 15:13:52 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:13:53 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Study was found in the Proceedings of the 1st International Congress of International Society of Physical and Rehabilitation Medicine (ISPRM), 2001 July 7-13.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2016-12-06 08:08:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2014">
<CHAR_METHODS MODIFIED="2016-12-06 08:08:26 +0000" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-06 08:08:26 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-12-06 08:08:26 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-12-06 08:08:26 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-12-06 08:08:26 +0000" MODIFIED_BY="[Empty name]">
<P>&#8212;</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2013-06-14 13:36:08 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Koeneman-2004">
<CHAR_METHODS MODIFIED="2013-06-14 13:36:08 +0100" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-01 15:14:25 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-02-01 15:14:28 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-01 15:14:29 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-02-19 16:07:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>&#8212;</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2013-06-14 13:36:09 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Mehrberg-2001">
<CHAR_METHODS MODIFIED="2013-06-14 13:36:09 +0100" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-01 15:14:35 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-02-01 15:14:37 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-19 16:07:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-02-19 16:07:56 +0000" MODIFIED_BY="Hazel Fraser">
<P>&#8212;</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Ohata-2015">
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Probably a randomised cross-over trial</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>23 participants with stroke (stroke onset &lt; 6 months)</P>
<P>Group 1 (N = 13; mean: 60.9 ± 9.6 years)</P>
<P>Group 2 (N = 10; mean: 61.1 ± 14.6 years)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Gait training with the Stride Management Assist device (Honda R&amp;D Co., Ltd. Japan) (20 minutes/time, 5 times per week for 4 weeks)</P>
<P>Conventional rehabilitation (40 minutes/time) 4 weeks</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Brunnstrom Recovery Stage</LI>
<LI>Sensory subscale of Fugl-Meyer Assessment</LI>
<LI>Modified Ashworth Scale</LI>
<LI>Barthel Index</LI>
<LI>Short-Form Berg Balance Scale</LI>
<LI>Functional Reach</LI>
<LI>Activities-specific Balance Confidence Scale</LI>
<LI>Functional Ambulation Category</LI>
<LI>10-metre walk test</LI>
<LI>Timed Up and Go Test</LI>
<LI>Muscle strength measured by hand-held dynamometry</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-03-24 13:42:16 +0000" MODIFIED_BY="Hazel Fraser">
<P>Published as abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Sale-2012">
<CHAR_METHODS MODIFIED="2016-12-06 08:13:32 +0000" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-06 08:13:32 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-12-06 08:13:32 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-12-06 08:13:32 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>No longer at ClinicalTrials.gov</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2016-12-06 08:14:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wu-2012">
<CHAR_METHODS MODIFIED="2016-12-06 08:14:20 +0000" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-06 08:14:20 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-12-06 08:14:20 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-12-06 08:14:20 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-12-06 08:14:22 +0000" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Yoon-2015">
<CHAR_METHODS MODIFIED="2016-12-06 08:14:49 +0000" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-06 08:14:49 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>N = 10 in gait training with active-assistive gait device group</P>
<P>N = 10 in control group</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>10-metre walk test (m/s)</LI>
<LI>Step cycle (cycle/s)</LI>
<LI>Step length (m)</LI>
<LI>Angle of ankle dorsiflexion in swing phase</LI>
<LI>Korean Modified Barthel Index</LI>
<LI>Manual Muscle Test</LI>
<LI>Modified Ashworth Scale of hemiplegic ankle</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-03-24 13:43:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Conference abstract</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2016-12-06 08:18:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2016">
<CHAR_METHODS MODIFIED="2016-12-06 08:18:00 +0000" MODIFIED_BY="[Empty name]">
<P>Probably an RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-12-06 08:18:00 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-12-06 08:18:00 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-12-06 08:18:00 +0000" MODIFIED_BY="[Empty name]">
<P>Unclear</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-12-06 08:18:00 +0000" MODIFIED_BY="[Empty name]">
<P>-</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-Louie-2015">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 13:43:32 +0000" MODIFIED_BY="Hazel Fraser">
<P>Use of a powered robotic exoskeleton to promote walking recovery after stroke: study protocol for a randomised controlled trial</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Single-blind randomised controlled trial to evaluate the efficacy of a powered mobile exoskeleton (Ekso) on improving walking ability in people early after stroke</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>50 individuals admitted for stroke rehabilitation in Canada, within 4 weeks' poststroke and needing second person assist to walk, will be randomly assigned to either a usual care group or exoskeleton group for 5 days/week for 4 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 arms:</P>
<UL>
<LI>Usual care will consist of daily 1-hour physical therapy with approximately 45 minutes of walking-related activities including muscle strengthening and standing</LI>
<LI>Exoskeleton group will receive the same care, except that the 45 minutes of walking-related activities will initially take place with the participant wearing an exoskeleton to ensure early overground walking; participants will transition to walking without the device when able</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Outcomes will be measured at baseline, 4 weeks later at discharge, and at 6 months after program ends.</P>
<P>Primary outcome:</P>
<UL>
<LI>Walking ability (FAC)</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>Walking speed (10-metre walk test)</LI>
<LI>Endurance (6-minute walk test)</LI>
<LI>Quality of life</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2017-03-24 13:45:03 +0000" MODIFIED_BY="Hazel Fraser">
<P>Unknown</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-03-24 13:45:36 +0000" MODIFIED_BY="Hazel Fraser">
<P>Louie DR<SUP>1,2</SUP>
</P>
<P>
<SUP>1</SUP>University of British Columbia, Vancouver, Canada</P>
<P>
<SUP>2</SUP>Rehabilitation Research Program, Vancouver Coastal Health Research Institute, Vancouver, Canada</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Presented at the Canadian Stroke Conference, Toronto, 2015 September 17</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00284115">
<CHAR_STUDY_NAME MODIFIED="2017-04-28 23:04:05 +0100" MODIFIED_BY="[Empty name]">
<P>Efficacy of a mechanical gait repetitive training technique compared with a usual rehabilitation program on gait recovery in hemiparetic stroke patients<BR/>
</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-13 15:20:19 +0100" MODIFIED_BY="Hazel Fraser">
<P>RCT with 2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: France<BR/>Inclusion criteria: men or women aged 18 years or older; hemiplegia secondary to stroke; interval between stroke and study inclusion of 2 months or less; first-time supratentorial stroke; non-ambulatory (FAC stage 0); able to sit unsupported at the edge of the bed; no severe impairment of cognition or communication; written informed consent provided<BR/>Exclusion criteria: orthopaedic or rheumatological disease impairing mobility, or both; other neurologically associated disease; history of myocardial infarction or deep venous embolism or pulmonary embolism within 3 months before study inclusion; chronic pulmonary disease; intolerance to standing up<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>4-week rehabilitation programme comparing physiotherapy and gait trainer therapy with physiotherapy alone</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcomes: walking speed (time needed to walk 10 metres) after the 4-week rehabilitation programme<BR/>Secondary outcomes: FAC; walking endurance (6-minute walk test); time to self sufficient gait recovery; spasticity (Modified Ashworth Scale); Motricity Index; need for mobility and self assistance (Barthel Index, PMSI-SSR scores, need for physical assistance); economic evaluation (healthcare requirements, rehabilitation unit length of stay)</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE>
<P>March 2006</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Principal Investigator:<BR/>Régine Brissot, MD, Service de Médecine Physique et Réadaptation, Hôpital Pontchaillou, Rennes, 35033, France<BR/>Tel: +33 2 9928 4219<BR/>email: regine.brissot@chu-rennes.fr</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Expected total enrolment: 122 participants<BR/>Sponsored by: Rennes University Hospital<BR/>Information derived from: ClinicalTrials.gov identifier: NCT00284115</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT00530543">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 13:46:37 +0000" MODIFIED_BY="Hazel Fraser">
<P>Effects of gait training with assistance of a robot-driven gait orthosis in hemiparetic patients after stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 13:46:49 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>first-ever stroke</LI>
<LI>hemiplegic patient after stroke</LI>
<LI>can stand independently, but cannot walk more than 10 meters independently</LI>
<LI>muscle powers of hip and knee are more than poor on manual muscle test</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>previous gait difficulty before stroke onset</LI>
<LI>arthralgia on lower extremity</LI>
<LI>uncontrolled hypertension or hypotension</LI>
<LI>severe medical illness</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-12-06 07:09:55 +0000" MODIFIED_BY="Jan Mehrholz">
<P>Robot-assisted gait training</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-03-24 13:47:15 +0000" MODIFIED_BY="Hazel Fraser">
<P>Not provided</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:10:17 +0000" MODIFIED_BY="Jan Mehrholz">
<P>Unknown status</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-03-24 13:47:18 +0000" MODIFIED_BY="Hazel Fraser">
<P>Not provided</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>The recruitment status of this study is unknown. The completion date has passed, and the status has not been verified in more than 2 years.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01146587">
<CHAR_STUDY_NAME MODIFIED="2013-06-14 13:50:14 +0100" MODIFIED_BY="[Empty name]">
<P>Comparative study of GangTrainer GT1, Lokomat and conventional physiotherapy (GALOP)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-13 15:20:27 +0100" MODIFIED_BY="[Empty name]">
<P>RCT with 3 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria: first supratentorial stroke (ischaemic, haemorrhagic, or intracerebral haemorrhage) resulting in hemiparesis; interval from stroke 3 to 12 weeks; non-ambulatory (FAC &lt; 3); free sitting on bedside for 1 minute, with both feet on the floor and holding onto bedside by hands; Barthel Index 25 to 65<BR/>Exclusion criteria: unstable cardiovascular system (in case of doubt, only after approval by an internist); manifested heart diseases like labile compensated cardiac insufficiency (NYHA III), angina pectoris, myocardial infarction 120 days before study onset, cardiomyopathy, severe cardiac arrhythmia, severe joint misalignment (severe constriction of movement for hip, knee, or ankle, or any combination of the 3: more than 20° fixed hip and knee extension deficit, or more than 20° fixed plantar flexion of the ankle); severe cognitive dysfunction that prevents comprehension of the aims of study; severe neurological or orthopaedic diseases (e.g. polio, Parkinson's disease) that massively affect mobility; deep vein thrombosis; severe osteoporosis; or malignant tumour disease<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-14 13:53:20 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: 30 minutes of treatment on the GangTrainer GT1 and 30 minutes of conventional physiotherapy every workday for 8 weeks<BR/>Group B: 30 minutes of treatment on the Lokomat and 30 minutes of conventional physiotherapy every workday for 8 weeks<BR/>Group C: 60 minutes of conventional physiotherapy every workday for 8 weeks<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcomes: FAC, modified Emory Functional Ambulation</P>
<P>Secondary outcomes: Barthel Index, 10-metre walk test, 6-minute walk test on the floor, Medical Research Council, Rivermead Visual Gait Assessment, EuroQol-5 Dimensions (EQ-5D)</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-01-03 07:42:24 +0000" MODIFIED_BY="[Empty name]">
<P>August 2010</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-07-03 15:01:58 +0100" MODIFIED_BY="[Empty name]">
<P>Contact: Andreas Waldner, MD; +39 0471 471 471; waldner.andreas@villamelitta.it<BR/>Contact: Christopher Tomelleri, MSc; +39 0471 471 471; christopher.tomelleri@villamelitta.it</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-14 14:54:02 +0100" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 120<BR/>Estimated study completion date: August 2013<BR/>Estimated primary completion date: August 2013 (final data collection date for primary outcome measure)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01187277">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 13:47:46 +0000" MODIFIED_BY="Hazel Fraser">
<P>A randomised controlled trial on hemiplegic gait rehabilitation: robotic locomotor training versus conventional training in subacute stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-13 15:20:23 +0100" MODIFIED_BY="[Empty name]">
<P>RCT with 2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Country: Thailand<BR/>Inclusion criteria: subacute first-time stroke patients (haemorrhage and ischaemic), age 18 to 80 years, impaired FAC at initial score 0 to 2, cardiovascular stable, provided signed informed consent</P>
<P>Exclusion criteria: unstable general medical condition, severe malposition or fixed contracture of joint with an extension deficit &gt; 30°, any functional impairment before stroke, cannot adequately co-operate in training, severe communication problems, severe cognitive-perceptual deficits<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Group A: conventional therapy: 50 minutes individual physiotherapy and 60 minutes individual occupational therapy per workday (5 times per week) for 4 consecutive weeks<BR/>Group B: conventional therapy plus robot-assisted gait training: 30 minutes individual physiotherapy plus 20 minutes robotic-assisted gait training (with Gait Trainer GT1) and 60 minutes individual occupational therapy per workday (5 times per week) for 4 consecutive weeks<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcomes: FAC 0 to 5 and Barthel Index 0 to 100<BR/>Secondary outcome: Berg Balance Scale 0 to 56, Resistance to Passive Movement Scale (REPAS)-Muscle tone 0 to 52</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-01-03 07:23:57 +0000" MODIFIED_BY="[Empty name]">
<P>January 2011<BR/>
</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-07-03 15:02:50 +0100" MODIFIED_BY="[Empty name]">
<P>Principal Investigator:</P>
<P>Ratanapat Chanubol, MD, Rehabilitation Department, Prasat Neurological Institute, Mahidol University</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Study Completion Date: July 2012</P>
<P>Enrolment: 60<BR/>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT01678547">
<CHAR_STUDY_NAME MODIFIED="2013-07-03 11:35:09 +0100" MODIFIED_BY="[Empty name]">
<P>Robot walking rehabilitation in stroke patients</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-06-13 15:20:26 +0100" MODIFIED_BY="[Empty name]">
<P>RCT with 3 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria: between the ages of 18 and 95 years, able to walk 25 feet unassisted or with assistance, first acute event of cerebrovascular stroke, unilateral paresis, ability to understand and follow simple instructions, ability to walk without assistance before stroke, endurance sufficient to stand at least 20 minutes unassisted per participant report<BR/>Exclusion criteria: unable to understand instructions required by the study (Informed Consent Test of Comprehension), medical or neurological comorbidities that could contribute to significant gait dysfunction, uncontrolled hypertension &gt; 190/110 mm Hg, significant symptoms of orthostasis when standing up, circulatory problems, history of vascular claudication or significant (+ 3) pitting oedema, lower extremity injuries or joint problems (hip or leg) that limit range of motion or function or cause pain with movement, bilateral impairment, severe sensory deficits in the paretic upper limb, cognitive impairment or behavioural dysfunction that would influence the ability to comprehend or participate in the study, women who are pregnant or lactating, or both<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Experimental group: Robot G-EO: each participant will be asked to perform 15 sessions (3 to 5 days a week for 4 up to 5 weeks) consisting of a treatment cycle using the G-EO system device, according to individually tailored exercise scheduling<BR/>Control group: Treadmill training: each participant will be asked to perform 15 sessions (3 to 5 days a week for 4 up to 5 weeks) consisting of a treatment cycle using the treadmill system device, according to individually tailored exercise scheduling<BR/>Control group: Ground treatment: each participant will be asked to perform 15 sessions (3 to 5 days a week for 4 up to 5 weeks) of traditional lower limb physiotherapy<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES/>
<CHAR_STARTING_DATE MODIFIED="2013-01-03 07:33:35 +0000" MODIFIED_BY="[Empty name]">
<P>September 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-07-03 15:03:53 +0100" MODIFIED_BY="[Empty name]">
<P>Contact: Patrizio Sale, MD; patrizio.sale@gmail.com<BR/>Contact: Marco Franceschini, MD; marco.franceschini@sanraffaele.it</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-06-14 14:54:19 +0100" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 90<BR/>Estimated study completion date: September 2015<BR/>Estimated primary completion date: August 2014 (final data collection date for primary outcome measure)</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT01726998">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 13:48:42 +0000" MODIFIED_BY="Hazel Fraser">
<P>Effects of locomotion training with assistance of a robot-driven gait orthosis in hemiparetic patients after subacute stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 13:48:48 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised trial</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria</P>
<UL>
<LI>Hemiparesis as result of first stroke</LI>
<LI>No other neurologic or orthopaedic disorder</LI>
<LI>Independent ambulation before the stroke</LI>
<LI>No severe medical illnesses</LI>
<LI>Hemiparesis: lower extremity strength graded &#8804; 3 in more than 2 muscle groups</LI>
<LI>FAC &#8804; 1: indicating a need for personal assistance in ambulation</LI>
<LI>Time since stroke onset &lt; 6 months</LI>
<LI>Age 20 to 80 years old</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Unstable fractures</LI>
<LI>Severe osteoporosis</LI>
<LI>Severe skin problems</LI>
<LI>Severe joint problems</LI>
<LI>Major difference in leg length</LI>
<LI>Body weight over 130 kg</LI>
<LI>Orthostatic circulatory problem</LI>
<LI>Severe cognitive impairment</LI>
</UL>
<P>72 first-ever stroke patients who could not walk independently (FAC &lt; 2), and suffered stroke within 6 months were enrolled and randomly assigned into 2 groups. People with congestive heart failure, malignancies, cardiopulmonary dysfunctions, and who could not walk independently before their stroke were excluded.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>2 groups received 30 minutes of conventional gait training including neurodevelopmental treatment:</P>
<UL>
<LI>the robotic-assisted locomotor training group received additional robotic-assisted gait therapy for 30 minutes with Lokomat (Hocoma, Zurich, Switzerland) daily for 4 weeks;</LI>
<LI>the conventional gait-training group received additional daily conventional gait training with neurodevelopmental treatment for the same period.</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Independent walking ability (FAC &#8805; 3), FAC, Motricity index, Fugl-Meyer Assessment, Modified Barthel Index, Medical Research Council were assessed for lower extremity muscles before, during (2 weeks), and after training. Independent walking ability was followed until 3 months.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:20:14 +0000" MODIFIED_BY="Jan Mehrholz">
<P>March 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-12-06 07:20:46 +0000" MODIFIED_BY="Jan Mehrholz">
<P>Yonsei University</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02114450">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 13:51:27 +0000" MODIFIED_BY="Hazel Fraser">
<P>Human-machine system for the H2 lower limb exoskeleton (H2-NeuroExo)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2016-12-06 06:49:29 +0000" MODIFIED_BY="Jan Mehrholz">
<P>RCT with 2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>Subacute or chronic stroke, i.e. interval of at least 3 months or at least 6 months from stroke to time of enrolment, respectively</LI>
<LI>Cognitive ability to assimilate and participate actively in the treatment protocol (Mini Mental State Examination score &gt; 24 points, out of a total 30 indicating normal cognitive ability)</LI>
<LI>Modified Rankin Scale scores 2 to 4 (mild-moderate functional disability poststroke)</LI>
<LI>Modified Ashworth Scale of Spasticity score &#8804; 2 (range 0 to 4, with 4 reflecting maximum spasticity)</LI>
<LI>Have no skin integrity issues</LI>
<LI>Sufficient passive range of motion at the hip (at least 90° flexion, 15° to 20° extension), knee (90° flexion, complete extension), and ankle (15° dorsiflexion, 15° plantar flexion)</LI>
<LI>Have no contraindications to standing or walking; able to stand with assistive device for at least 5 minutes; and able to walk with assistive device for 10 metres</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Severe cognitive or visual deficit, or both</LI>
<LI>Hemineglect (determined based on medical record or initial clinical assessment)</LI>
<LI>Severe sensory deficit</LI>
<LI>Joint contractures of any extremity that limit normal range of motion during ambulation with assistive devices</LI>
<LI>Skin lesions that may hinder or prevent the application of exoskeleton</LI>
<LI>Uncontrolled angina</LI>
<LI>Severe chronic obstructive pulmonary disease</LI>
<LI>Other medical contraindications; any medical comorbidities that would prevent standard rehabilitation</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Experimental: robot-assisted rehabilitation participants will receive robot-assisted training with the H2 lower limb powered exoskeleton. They will perform walking and other lower limb exercises (as applicable) while wearing the H2 lower limb powered exoskeleton. Training will involve 3 sessions per week for 4 weeks, each lasting about 1.5 hours.</P>
<P>Control: supervised motor practice participants will perform walking and other lower limb exercises (as applicable) under the supervision of a research physical therapist. Training will involve 3 sessions per week for 4 weeks, each lasting about 1.5 hours.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcome measures</P>
<UL>
<LI>Change from baseline in Fugl-Meyer Assessment Lower Extremity</LI>
<LI>Functional Gait Assessment</LI>
<LI>Lower limb joint kinematics during walking</LI>
<LI>Cortical dynamics measured by electroencephalography</LI>
</UL>
<P>Secondary outcome measures</P>
<UL>
<LI>Robotic measure of performance measured by the H2</LI>
<LI>Berg Balance Scale score</LI>
<LI>Distance walked during the 6-minute walk test</LI>
<LI>Timed Up and Go Test score</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 06:52:40 +0000" MODIFIED_BY="Jan Mehrholz">
<P>March 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>clinicaltrials.gov/ct2/show/study/NCT02114450#contacts</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-12-06 06:53:04 +0000" MODIFIED_BY="Jan Mehrholz"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02471248">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 13:53:48 +0000" MODIFIED_BY="Hazel Fraser">
<P>Interactive exoskeleton robot for walking - ankle joint</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 13:53:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>Ischaemic or haemorrhagic stroke with drop-foot problem</LI>
<LI>Sufficient cognition to follow simple instructions and to understand the content and purpose of the study (Mini Mental State Examination &gt; 21)</LI>
<LI>Capable of standing and walking independently for an extended period of time (FAC &gt; 3, Berg Balance Scale &gt; 40)</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Any medical or psychological dysfunctions that would affect ability to comply with test study protocol, such as lower back pain, neuralgia, rotational vertigo, musculoskeletal disorders, injuries, and pregnancy</LI>
<LI>Any severe contractures in hip, knee, or ankle joint that would preclude passive range of motion in the lower extremity</LI>
<LI>Participation in any therapeutic treatment ("outside therapy") performed with the lower extremity during the planned study, including the baseline and the follow-up</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Experimental: ankle robot with power assistance. The ankle robot assists the ankle dorsiflexion when the stroke patient voluntarily performs the swing phase gait movement.</LI>
<LI>Placebo comparator: sham group. The ankle robot provides very low assistance to generate tactile feedback to the stroke patient indicating the patient is performing the swing phase gait movement, but no assistance will be given to support ankle dorsiflexion. </LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Fugl-Meyer Assessment Lower Extremity</LI>
<LI>Timed 10-metre walk test</LI>
<LI>6-minute walk test</LI>
<LI>Berg Balance Scale</LI>
<LI>Modified Ashworth Scale</LI>
<LI>Kinematic and Kinetic Gait Motion Capture</LI>
<LI>Subjective feedback questionnaire</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:30:06 +0000" MODIFIED_BY="Jan Mehrholz">
<P>June 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-12-06 07:27:11 +0000" MODIFIED_BY="Jan Mehrholz">
<P>Raymond KY Tong, Professor, Chinese University of Hong Kong</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02483676">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 13:57:11 +0000" MODIFIED_BY="Hazel Fraser">
<P>Adaptive ankle robot control system to reduce foot-drop in chronic stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 13:57:17 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>Ischaemic or haemorrhagic stroke &gt; 2 months prior in men or women</LI>
<LI>Residual hemiparesis of the lower extremity that includes symptoms of foot-drop</LI>
<LI>Capable of ambulating on a treadmill with handrail support</LI>
<LI>Have completed all conventional physical therapy</LI>
<LI>Adequate language and cognitive function to provide informed consent and participate in testing and training</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Cardiac history of: unstable angina, recent (&lt; 3 months) myocardial infarction, congestive heart failure (NYHA category II or higher), haemodynamic valvular dysfunction, hypertension that is a contraindication for a bout of treadmill training (&gt; 160/100 on 2 assessments)</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Device: treadmill plus Anklebot: this intervention employs the use of the adaptive Anklebot control system to complement treadmill exercise training over a 6-week intervention period</LI>
<LI>Behavioural: treadmill only: this intervention employs the use of a treadmill for gait exercise training over a 6-week intervention period</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Independent gait function indexed by gait velocity, swing-phase dorsiflexion, terminal stance push-off</LI>
<LI>Balance function indexed by measures of postural sway (centre of pressure), asymmetric loading in quiet standing, peak paretic anteroposterior forces in non-paretic gait initiation, and standardised scales for balance and fall risk</LI>
<LI>Long-term mobility outcomes, assessed by repeated measures of all key gait and balance outcomes at 6 weeks and 3 months after cessation of formal training</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:32:09 +0000" MODIFIED_BY="Jan Mehrholz">
<P>September 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>clinicaltrials.gov/ct2/show/study/NCT02483676?term=NCT02483676&amp;rank=1#contacts</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02545088">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 14:10:49 +0000" MODIFIED_BY="Hazel Fraser">
<P>New technology for individualised, intensive training of gait after stroke - phase III trials, study II</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 14:10:57 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>3 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>1 to 10 years since stroke onset</LI>
<LI>Able to walk but not independently, i.e. need for manual support or close supervision due to lower extremity paresis; FAC score 2 to 3 or FAC 4 combined with gait speed &lt; 0.8 m/s according to 10-metre walk test, which corresponds to limitations in community ambulation</LI>
<LI>Ability to understand training instructions as well as written and oral study information and to express informed consent or by proxy</LI>
<LI>Body size compatible with the Hybrid Assistive Limb (HAL) suit</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Contracture restricting gait movements at any lower limb joint</LI>
<LI>Cardiovascular or other somatic condition incompatible with intensive gait training</LI>
<LI>Severe, contagious infections (e.g. methicillin-resistant <I>Staphylococcus aureus</I> or extended-spectrum beta-lactamase bacteria)</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Device: Hybrid Assistive Limb (HAL) intensive gait training is performed 1 session/day, 3 days/week for 6 weeks; each session will not exceed 60 minutes of effective walking time with HAL. In addition, each session will include conventional gait training that will not exceed 30 minutes effective training time.</LI>
<LI>1st control group: conventional gait training performed 1 session/day, 3 days/week for 6 weeks that will not exceed 90 minutes effective training time</LI>
<LI>2nd control group: no intervention</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>FAC</LI>
<LI>Fugl-Meyer Assessment Lower Extremity</LI>
<LI>Modified Ashworth Scale</LI>
<LI>Spasticity measured with NeuroFlexor foot module Spasticity</LI>
<LI>Berg Balance Scale</LI>
<LI>10-metre walk test</LI>
<LI>2-minute walk test</LI>
<LI>6-minute walk test</LI>
<LI>Borg Rating of Perceived Exertion Scale</LI>
<LI>Montreal Cognitive Assessment</LI>
<LI>Hospital Anxiety and Depression Scale</LI>
<LI>Barthel Index</LI>
<LI>Stroke Impact Scale</LI>
<LI>Physical activity in everyday life using SenseWear</LI>
<LI>Gait Deviation Index (Laboratory gait analysis)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:36:59 +0000" MODIFIED_BY="Jan Mehrholz">
<P>October 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>clinicaltrials.gov/ct2/show/study/NCT02545088?term=NCT02545088&amp;rank=1#contacts</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02680691">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 14:14:48 +0000" MODIFIED_BY="Hazel Fraser">
<P>Robot assisted gait training in patients with infratentorial stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 14:15:07 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>Patients with infratentorial stroke</LI>
<LI>Cognitively intact enough to understand and follow the instructions from the investigator</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Chronic neurological pathology</LI>
<LI>Orthopaedic injuries</LI>
<LI>Femur lengths of less than 34 cm</LI>
<LI>Severely limited range of lower extremity joint motion</LI>
<LI>Medical instability</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Experimental: robot, then conventional training: robot-assisted gait training 4 weeks after conventional gait training</LI>
<LI>Active comparator: conventional, then robot training: conventional gait training 4 weeks after robot-assisted gait training</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcome measures</P>
<UL>
<LI>Berg Balance Scale</LI>
</UL>
<P>Secondary outcome measures</P>
<UL>
<LI>Trunk Impairment Scale</LI>
<LI>FAC</LI>
<LI>10-metre walk test</LI>
<LI>Fugl-Meyer Assessment</LI>
<LI>Korean version of Falls Efficacy Scale (assesses fear of falling in the elderly population) (time frame: baseline, 4 weeks from baseline, 8 weeks from baseline, 12 weeks from baseline); designated as safety issue: no perception of balance and stability during activities of daily living</LI>
<LI>Scale for the assessment and rating of ataxia</LI>
<LI>Balance test using force plate</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:40:55 +0000" MODIFIED_BY="Jan Mehrholz">
<P>April 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>clinicaltrials.gov/ct2/show/study/NCT02680691?term=NCT02680691&amp;rank=1#contacts</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02694302">
<CHAR_STUDY_NAME MODIFIED="2017-04-29 05:12:51 +0100" MODIFIED_BY="[Empty name]">
<P>Clinical trial of robot-assisted-gait-training (RAGT) in stroke patients (Walkbot)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 14:18:06 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>Age older than 19 years and younger than 80 years</LI>
<LI>Weight under 100 kg</LI>
<LI>Height less than 200 cm</LI>
<LI>Able to walk independently before onset of stroke</LI>
<LI>Ischaemic or haemorrhagic stroke patients</LI>
<LI>Motor paralysis and gait disturbance after stroke and seeking rehabilitation treatment</LI>
<LI>FAC under 3 (0 ~ 2)</LI>
<LI>Subacute stroke patients, i.e. after 3 days and before 3 months of stroke onset</LI>
<LI>Be informed of the nature of the study and agreed on written consent voluntarily</LI>
<LI>Taking medications or scheduled medications due to stroke</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Contraindications to weight bearing such as fractures, etc.</LI>
<LI>Uncontrolled stage 2 hypertension (systolic over 160 mm Hg or diastolic over 100 mm Hg) or with uncontrolled orthostatic hypotension</LI>
<LI>Cardiopulmonary disease or other underlying diseases that cannot tolerate gait training</LI>
<LI>Severe skin damage and bedsore on wearing part of the trial device</LI>
<LI>Pregnant or breastfeeding</LI>
<LI>Participationin other clinical trials within 30 days</LI>
<LI>People whom the investigator considers inappropriate to participate in the study</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Walkbot (robot-assisted gait training) 30 minutes and conventional physical therapy 30 minutes per day to be administered 5 times a week for 3 weeks</LI>
<LI>Conventional physical therapy 30 minutes to be administered twice a day, 5 times a week for 3 weeks</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Primary outcome measure</P>
<UL>
<LI>FAC</LI>
</UL>
<P>Secondary outcome measures</P>
<UL>
<LI>Motricity Index</LI>
<LI>10-metre walk test</LI>
<LI>6-minute walk test</LI>
<LI>Medical Research Council</LI>
<LI>Modified Ashworth Scale</LI>
<LI>Fugl-Meyer Assessment</LI>
<LI>Modified Barthel Index</LI>
<LI>National Institutes of Health Stroke Scale</LI>
<LI>Beck Depression Inventory</LI>
<LI>Treatment Satisfaction Survey</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:46:06 +0000" MODIFIED_BY="Jan Mehrholz">
<P>March 2014</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-12-06 07:46:35 +0000" MODIFIED_BY="Jan Mehrholz">
<P>P&amp;S Mechanics Co., Ltd.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-12-06 07:42:31 +0000" MODIFIED_BY="Jan Mehrholz"/>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02755415">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 14:19:38 +0000" MODIFIED_BY="Hazel Fraser">
<P>Clinical applicability of robot-assisted gait training system in acute stroke patients</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 14:19:43 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<UL>
<LI>Between the ages of 20 and 80 years</LI>
<LI>Diagnosis of first single unilateral cortical-subcortical acute stroke verified by brain imaging</LI>
<LI>Paresis of a lower limb</LI>
<LI>Ability to walk only a few metres either with or without aid</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Deemed by a physician to be medically unstable</LI>
<LI>Other prior musculoskeletal conditions that affected gait capacity</LI>
<LI>Coexistence of other neurological diseases</LI>
<LI>Cognitive impairments that would impact on the safe participation in the study (Mini Mental State Examination &lt; 23)</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Device: HIWIN Robotic Gait Training System~: the HIWIN Robotic Gait Training System is an automatic training system that combines weight-bearing standing, repetitive stepping, and gait training</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Berg Balance Scale</LI>
<LI>Pittsburgh Sleep Quality Index</LI>
<LI>EuroQol-5 Dimensions (EQ-5D)</LI>
<LI>6-minute walk test</LI>
<LI>Beck Depression Inventory</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:48:51 +0000" MODIFIED_BY="Jan Mehrholz">
<P>May 2016</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2016-12-06 07:49:06 +0000" MODIFIED_BY="Jan Mehrholz">
<P>China Medical University Hospital</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Other study ID: CMUH105-REC1-037</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02781831">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 14:20:49 +0000" MODIFIED_BY="Hazel Fraser">
<P>Robot-assisted gait training for patients with stroke</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 14:20:55 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 arms</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Inclusion criteria</P>
<OL>
<LI>Between the ages of 20 and 65 years</LI>
<LI>Diagnosis of first single unilateral cortical-subcortical stroke verified by brain imaging</LI>
<LI>Paresis of a lower limb</LI>
<LI>Inability to walk without aid or device</LI>
</OL>
<P>Exclusion criteria</P>
<OL>
<LI>Deemed by a physician to be medically unstable</LI>
<LI>Other prior musculoskeletal conditions that affected gait capacity</LI>
<LI>Coexistence of other neurological diseases</LI>
<LI>Cognitive impairments that would impact on the safe participation in the study (Mini Mental State Examination &lt; 23)</LI>
</OL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Standard hospital-based rehabilitation for people with stroke</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Fugl-Meyer Assessment Lower Extremity</LI>
<LI>10-metre walk test</LI>
<LI>Berg Balance Scale</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:50:48 +0000" MODIFIED_BY="Jan Mehrholz">
<P>May 2016</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Principal Investigator: Nai-Hsin Meng, MD, China Medical University Hospital</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-12-06 07:52:48 +0000" MODIFIED_BY="Jan Mehrholz">
<P>HIWIN-CMU-C-105-1</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" STUDY_ID="STD-NCT02843828">
<CHAR_STUDY_NAME MODIFIED="2017-03-24 14:21:51 +0000" MODIFIED_BY="Hazel Fraser">
<P>Gait pattern analysis and feasibility of gait training with a walking assist robot in stroke patients and elderly adults</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-03-24 14:21:57 +0000" MODIFIED_BY="Hazel Fraser">
<P>Randomised</P>
<P>2 treatment groups</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Number of participants: 54 (n = 27 per group)</P>
<P>Inclusion criteria</P>
<UL>
<LI>Elderly adults: age between 65 and 84 years; no neurological or musculoskeletal abnormalities affecting gait; ability to walk at least 10 metres regardless of assist devices; high levels of physical performance (Short Physical Performance Battery &gt; 7); participant is willing to be randomised to either the control group or the treatment group</LI>
<LI>Stroke: age between 50 and 84 years; &#8805; 3 months' poststroke; ability to walk at least 10 metres regardless of assist devices; adequate gait function (FAC &gt; 3); physician approval for patient participation; participant is willing to be randomised to either the control group or the treatment group</LI>
</UL>
<P>Exclusion criteria</P>
<UL>
<LI>Elderly adults: history of any diseases (e.g. lower extremity orthopaedic diseases, neurologic disorders, cardiovascular disease, heart failure, uncontrolled hypertension) that affect walking capacity, efficiency, and endurance; severe visual impairment or dizziness that increases the risk of falls</LI>
<LI>Stroke: serious cardiac conditions (hospitalisation for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnoea at rest or during activities of daily living); advanced liver, kidney, cardiac, or pulmonary disease; history of concussion in last 6 months; history of unexplained, recurring headaches, epilepsy/seizures/skull fractures, or skull deficits</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Group 1 : gait rehabilitation with hip assist robot (Samsung Hip Assist v1): 10 sessions (5 sessions: treadmill gait training/5 sessions: overground gait training), 30 minutes per session</P>
<P>Group 2 : gait rehabilitation without hip assist robot: 10 sessions (5 sessions: treadmill gait training/5 sessions: overground gait training), 30 minutes per session</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<UL>
<LI>Berg Balance Scale</LI>
<LI>Tinetti Performance-Oriented Mobility Assessment</LI>
<LI>Modified Barthel Index</LI>
<LI>FAC</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-12-06 07:58:09 +0000" MODIFIED_BY="Jan Mehrholz">
<P>September 2015</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<P>Yun-Hee Kim, MD, PhD; 82-2-3410-2824 yunkim@skku.edu</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2016-12-06 07:55:03 +0000" MODIFIED_BY="Jan Mehrholz"/>
</ONGOING_CHAR>
<FOOTNOTES>
<P>FAC: Functional Ambulation Category<BR/>NYHA: New York Heart Association<BR/>RCT: randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 15:22:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aschbacher-2006">
<DESCRIPTION>
<P>Method of randomisation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:54:32 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Bang-2016">
<DESCRIPTION>
<P>The randomisation was performed by selection of an opaque, closed envelope in which the group assignment was written, which was given to the physical therapist.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-04 13:34:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brincks-2011">
<DESCRIPTION>
<P>Shuffling envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:54:38 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Buesing-2015">
<DESCRIPTION>
<P>Method of randomisation described as "random number generator".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:54:42 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Chang-2012">
<DESCRIPTION>
<P>Method of randomisation is unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:54:48 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Cho-2015">
<DESCRIPTION>
<P>Method of randomisation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:42:37 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Chua-2016">
<DESCRIPTION>
<P>Authors state: "Randomization was performed using a computer-generated sequence of random numbers."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 15:32:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dias-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 15:33:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:09 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Forrester-2014">
<DESCRIPTION>
<P>Not clearly described; authors only state "blocked randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 15:35:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Geroin-2011">
<DESCRIPTION>
<P>Software-generated list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:20 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Han-2016">
<DESCRIPTION>
<P>Method of randomisation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:07:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hidler-2009">
<DESCRIPTION>
<P>Randomisation table</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-11-29 11:27:53 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hornby-2008">
<DESCRIPTION>
<P>(Probably) shuffling envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:34 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Husemann-2007">
<DESCRIPTION>
<P>Random numbers generated by a computer program, block randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:40 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2015">
<DESCRIPTION>
<P>Method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:10:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kyung-2008">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:47 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>Software-generated list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:16:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morone-2011">
<DESCRIPTION>
<P>Generated electronically by www.random.org</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:12:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Noser-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:12 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Ochi-2015">
<DESCRIPTION>
<P>Method of randomisation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:17 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Peurala-2005">
<DESCRIPTION>
<P>An investigator not involved in the study randomly assigned participants to groups using concealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:24 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Peurala-2009">
<DESCRIPTION>
<P>An investigator not involved in the study randomly assigned participants to groups using concealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:29 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Picelli-2016">
<DESCRIPTION>
<P>Software-generated random order</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:39 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Pohl-2007">
<DESCRIPTION>
<P>Lots indicating A or B were prepared in sealed envelopes; a person not involved in the study allocated participants to groups using the concealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-14 13:19:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saltuari-2004">
<DESCRIPTION>
<P>By random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-14 13:20:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2006">
<DESCRIPTION>
<P>Block sampling</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:55:28 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Stein-2014">
<DESCRIPTION>
<P>Method unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-03 15:00:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tanaka-2012">
<DESCRIPTION>
<P>Computer-generated randomisation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-14 13:22:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tong-2006">
<DESCRIPTION>
<P>Computer-generated random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:57:14 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Ucar-2014">
<DESCRIPTION>
<P>Random number list</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:12:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Nunen-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Waldman-2013">
<DESCRIPTION>
<P>Method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:59:10 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Watanabe-2014">
<DESCRIPTION>
<P>Computer-generated sequence</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-14 13:24:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2002">
<DESCRIPTION>
<P>By envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:12:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Westlake-2009">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 15:22:18 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Aschbacher-2006">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:31:06 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Bang-2016">
<DESCRIPTION>
<P>By sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 15:23:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brincks-2011">
<DESCRIPTION>
<P>Using sealed, shuffled envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:54:38 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Buesing-2015">
<DESCRIPTION>
<P>Allocation concealment not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:54:42 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Chang-2012">
<DESCRIPTION>
<P>Method of concealment is unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:54:48 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Cho-2015">
<DESCRIPTION>
<P>Allocation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:42:43 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Chua-2016">
<DESCRIPTION>
<P>Authors state: "An independent department generated the random group allocation sequence and transferred the sequence to a series of serially numbered opaque envelopes, which were not opened and revealed until after acceptance into the study and the baseline tests, therefore ensuring allocation concealment."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 15:32:12 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Dias-2006">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Stated as concealed, but method not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:44:21 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Forrester-2014">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:45:29 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Geroin-2011">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:20 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Han-2016">
<DESCRIPTION>
<P>Allocation concealment not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:07:14 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Hidler-2009">
<DESCRIPTION>
<P>Not described in sufficient detail</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:31 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Hornby-2008">
<DESCRIPTION>
<P>Opaque, sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:34 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Husemann-2007">
<DESCRIPTION>
<P>Sealed, opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:50:00 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2015">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:55:43 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Kyung-2008">
<DESCRIPTION>
<P>Method neither described nor stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:50:23 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>Described concealed allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:16:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morone-2011">
<DESCRIPTION>
<P>Central allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:12:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Noser-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:12 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Ochi-2015">
<DESCRIPTION>
<P>No allocation concealment described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:22:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peurala-2005">
<DESCRIPTION>
<P>Concealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:25 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Peurala-2009">
<DESCRIPTION>
<P>Allocation was performed by an independent person not otherwise involved with the participants.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:56:29 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Picelli-2016">
<DESCRIPTION>
<P>Sealed, opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-14 13:18:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pohl-2007">
<DESCRIPTION>
<P>Concealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:12:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saltuari-2004">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:12:37 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Schwartz-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:55:31 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Stein-2014">
<DESCRIPTION>
<P>Unclear, not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-13 16:12:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanaka-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-14 13:22:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tong-2006">
<DESCRIPTION>
<P>Concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:57:15 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Ucar-2014">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Van-Nunen-2012">
<DESCRIPTION>
<P>A person not involved in the study was asked to draw 1 of the opaque envelopes inside which group assignment was established each time a new participant entered the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-03-24 15:58:06 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Waldman-2013">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Watanabe-2014">
<DESCRIPTION>
<P>Odd-numbered participants underwent gait training using the Hybrid Assistive Limb, and even-numbered participants underwent conventional gait training (maybe even high risk of bias).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-06-14 13:24:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2002">
<DESCRIPTION>
<P>Concealed envelopes that were drawn by an independent person</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Westlake-2009">
<DESCRIPTION>
<P>Randomisation list was overseen by 1 of the investigators who had no contact with participants until group assignment was revealed.<BR/>Group assignment was not revealed to study personnel until the participant consented and baseline testing was complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-05-02 14:56:57 +0100" MODIFIED_BY="Hazel Fraser" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1" REF_IDS="CMP-001.01">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 15:22:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aschbacher-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-02 14:54:33 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Bang-2016">
<DESCRIPTION>
<P>Described as blinded by an assessor not participating in study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-02 14:54:34 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Brincks-2011">
<DESCRIPTION>
<P>No blinding was done.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:32:17 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Buesing-2015">
<DESCRIPTION>
<P>Evaluated by a research physical therapist, who was blinded to the participant&#8217;s training group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 15:30:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chang-2012">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:40:00 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Cho-2015">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-04-27 23:10:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chua-2016">
<DESCRIPTION>
<P>Authors state: "The data assessors were blinded to group allocation, but it was not possible to blind participants or the health care professionals providing interventions."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 15:32:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Dias-2006">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 15:33:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-02 14:55:09 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Forrester-2014">
<DESCRIPTION>
<P>Authors state "not blinded".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:45:31 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Geroin-2011">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-02 14:55:22 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Han-2016">
<DESCRIPTION>
<P>A physiatrist (rehabilitation doctor) who remained blinded to participant group and treatment throughout the entire study analysed outcome measures.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 16:07:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hidler-2009">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 16:08:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hornby-2008">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-02 14:55:34 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Husemann-2007">
<DESCRIPTION>
<P>Evaluating therapist blinded for group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:50:02 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Kim-2015">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 16:11:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kyung-2008">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:50:25 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>Described as blinded evaluator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 16:16:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Morone-2011">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:51:36 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Noser-2012">
<DESCRIPTION>
<P>Authors state: "Blinded assessors tested the participants at baseline, post-intervention, and 3-month follow-up."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:52:56 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Ochi-2015">
<DESCRIPTION>
<P>Described as blinded assessors</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 16:22:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peurala-2005">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 16:24:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peurala-2009">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:54:11 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Picelli-2016">
<DESCRIPTION>
<P>Blinded evaluator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-02 14:56:40 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Pohl-2007">
<DESCRIPTION>
<P>Blinded primary outcomes (a person not involved in the study rated videotapes of participants)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-13 16:12:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saltuari-2004">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-14 13:20:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Schwartz-2006">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-05-02 14:56:57 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Stein-2014">
<DESCRIPTION>
<P>Performed by 1 physical therapist blinded to group assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-14 13:21:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tanaka-2012">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-14 13:22:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tong-2006">
<DESCRIPTION>
<P>Yes for primary outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:57:18 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Ucar-2014">
<DESCRIPTION>
<P>Stated as blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-14 13:23:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Van-Nunen-2012">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:58:09 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Waldman-2013">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-03-24 15:59:19 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Watanabe-2014">
<DESCRIPTION>
<P>Not done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-14 13:24:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2002">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-06-14 13:26:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Westlake-2009">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-01-02 13:05:32 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2013-01-02 13:05:32 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1" REF_IDS="CMP-001.01">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 15:22:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aschbacher-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:54:33 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Bang-2016">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-04 13:23:03 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Brincks-2011">
<DESCRIPTION>
<P>ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:54:39 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Buesing-2015">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 15:30:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chang-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:40:03 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Cho-2015">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:54:53 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Chua-2016">
<DESCRIPTION>
<P>All data for all participants provided and analysed. Authors state: "An intention-to-treat approach was used. Data from subjects were analysed according to the group to which they were randomised, regardless of whether they completed the intervention. Participants failing to complete either intervention were asked to return for follow-up."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 15:32:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Dias-2006">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:55:01 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Fisher-2008">
<DESCRIPTION>
<P>ITT stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:55:09 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Forrester-2014">
<DESCRIPTION>
<P>5 participants were excluded from analysis after randomisation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:45:33 +0000" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Geroin-2011">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:48:06 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Han-2016">
<DESCRIPTION>
<P>No ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 16:07:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hidler-2009">
<DESCRIPTION>
<P>No ITT, analysis per protocol</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:48:23 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Hornby-2008">
<DESCRIPTION>
<P>'As-treated' analysis done</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:55:35 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Husemann-2007">
<DESCRIPTION>
<P>Insufficient reporting of attrition/exclusions to permit judgement of &#8216;low risk&#8217; or &#8216;high risk&#8217;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:50:04 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Kim-2015">
<DESCRIPTION>
<P>No ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 16:11:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kyung-2008">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:50:27 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Mayr-2008">
<DESCRIPTION>
<P>No ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:55:57 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Morone-2011">
<DESCRIPTION>
<P>ITT done; missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:56:05 +0100" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Noser-2012">
<DESCRIPTION>
<P>1 participant in the control group was not analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:56:13 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Ochi-2015">
<DESCRIPTION>
<P>No dropouts, no participants excluded from analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 16:12:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peurala-2005">
<DESCRIPTION>
<P>Unclear if reasons for missing outcome data are unlikely to be related to true outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-07-03 15:00:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peurala-2009">
<DESCRIPTION>
<P>Unclear whether reasons for missing outcome data are unlikely to be related to true outcome</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:56:29 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Picelli-2016">
<DESCRIPTION>
<P>No dropouts</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:56:40 +0100" MODIFIED_BY="Hazel Fraser" RESULT="YES" STUDY_ID="STD-Pohl-2007">
<DESCRIPTION>
<P>ITT analysis done; missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-14 13:19:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saltuari-2004">
<DESCRIPTION>
<P>No missing outcome data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-02 14:56:45 +0100" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Schwartz-2006">
<DESCRIPTION>
<P>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk was enough to induce clinically relevant bias into intervention effect estimate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:55:37 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Stein-2014">
<DESCRIPTION>
<P>No ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 16:12:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanaka-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-05-04 14:39:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tong-2006">
<DESCRIPTION>
<P>ITT unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:57:20 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Ucar-2014">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-13 16:12:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Van-Nunen-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:58:11 +0000" MODIFIED_BY="Hazel Fraser" RESULT="UNKNOWN" STUDY_ID="STD-Waldman-2013">
<DESCRIPTION>
<P>No ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-03-24 15:59:21 +0000" MODIFIED_BY="Hazel Fraser" RESULT="NO" STUDY_ID="STD-Watanabe-2014">
<DESCRIPTION>
<P>No ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-14 13:25:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Werner-2002">
<DESCRIPTION>
<P>No missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-06-14 13:26:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Westlake-2009">
<DESCRIPTION>
<P>No missing data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="1" READONLY="YES">
<TITLE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">Electromechanical- and robotic-assisted gait training plus physiotherapy compared to physiotherapy (or usual care) for walking after stroke</TITLE>
<TABLE COLS="7" ROWS="16">
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Electromechanical- and robotic-assisted gait training plus physiotherapy compared to physiotherapy (or usual care) for walking after stroke</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>walking after stroke<BR/>
<B>Setting: </B>inpatient and outpatient setting<BR/>
<B>Intervention: </B>electromechanical- and robotic-assisted gait training plus physiotherapy<BR/>
<B>Comparison: </B>physiotherapy (or usual care)</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="BOTTOM">
<P>Anticipated absolute effects* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="BOTTOM">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="BOTTOM">
<P>Risk with physiotherapy (or usual care)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="BOTTOM">
<P>Risk with electromechanical- and robotic-assisted gait training plus physiotherapy</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Independent walking at the end of intervention phase, all electromechanical devices used<BR/>Assessed with FAC</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>OR 1.94<BR/>(1.39 to 2.71)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1472<BR/>(36 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>457 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>615 per 1000<BR/>(530 to 693)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Recovery of independent walking at follow-up after study end<BR/>Assessed with FAC</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>OR 1.93<BR/>(0.72 to 5.13)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>496<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>551 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>703 per 1000<BR/>(469 to 863)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Walking velocity (metres per second) at the end of intervention phase<BR/>Assessed with timed measures of gait<BR/>Scale: 0 to infinity</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean walking velocity (metres per second) at the end of intervention phase was 0.</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>MD 0.04 higher<BR/>(0 to 0.09 higher)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>985<BR/>(24 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1 2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Walking velocity (metres per second) at follow-up<BR/>Assessed with timed measures of gait<BR/>Scale: 0 to infinity</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean walking velocity (metres per second) at follow-up was 0.</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>MD 0.07 higher<BR/>(0.05 lower to 0.19 higher)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>578<BR/>(9 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Walking capacity (metres walked in 6 minutes) at the end of intervention phase<BR/>Assessed with timed measures of gait<BR/>Scale: 0 to infinity</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean walking capacity (metres walked in 6 minutes) at the end of intervention phase was 0.</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>MD 5.84 higher<BR/>(16.73 lower to 28.40 higher)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>594<BR/>(12 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 3 4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Walking capacity (metres walked in 6 minutes) at follow-up</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>The mean walking capacity (metres walked in 6 minutes) at follow-up was 0.</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>MD 0.82 lower<BR/>(32.17 lower to 30.53 higher)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>463<BR/>(7 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Acceptability of electromechanical-assisted gait-training devices during intervention phase<BR/>Assessed with number of dropouts</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>OR 0.67<BR/>(0.43 to 1.05)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>1472<BR/>(36 RCTs)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1 5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>131 per 1000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>92 per 1000<BR/>(61 to 136)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<BR/>
<B>CI:</B> confidence interval; <B>FAC:</B> Functional Ambulation Category; <B>MD:</B> mean difference; <B>OR:</B> odds ratio; <B>RCT:</B> randomised controlled trial; <B>RR:</B> risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect.<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Downgraded due to several ratings of 'unclear' and 'high' risk of bias.<BR/>
<SUP>2</SUP>Downgraded due to statistical heterogeneity and no overlap of several confidence intervals.<BR/>
<SUP>3</SUP>Downgraded because the 95% confidence interval includes no effect and the upper confidence limit crosses the minimal important difference.<BR/>
<SUP>4</SUP>Downgraded due to funnel plot asymmetry.<BR/>
<SUP>5</SUP>Downgraded because the total number of events (157) is less than 300 (a threshold rule-of-thumb value).</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2017-05-04 14:41:46 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<TITLE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">Participant characteristics in studies</TITLE>
<TABLE COLS="9" ROWS="37">
<TR>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Study ID</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental:</P>
<P>age, mean (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control:</P>
<P>age, mean (SD)</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental:</P>
<P>time poststroke</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control:</P>
<P>time poststroke</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental:</P>
<P>sex</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control:</P>
<P>sex</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Experimental:</P>
<P>side paresis</P>
</TH>
<TH ALIGN="LEFT" VALIGN="BOTTOM">
<P>Control:</P>
<P>side paresis</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Aschbacher-2006" TYPE="STUDY">Aschbacher 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>57 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>65 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8804; 3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8804; 3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bang-2016" TYPE="STUDY">Bang 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 male, 5 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 right, 5 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 right, 5 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Brincks-2011" TYPE="STUDY">Brincks 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61 (median) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>59 (median) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 (median) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21 (median) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 male, 2 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 male, 2 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 right, 2 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 right, 5 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Buesing-2015" TYPE="STUDY">Buesing 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 male, 8 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 male, 9 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 right, 12 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 right, 13 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chang-2012" TYPE="STUDY">Chang 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 (5) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 (5) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 male, 7 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 male, 7 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 right, 14 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 right, 11 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cho-2015" TYPE="STUDY">Cho 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (15) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 right, 4 left (4 both)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 right, 1 left (3 both)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>27 (11) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 (14) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>35 male, 18 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>40 male, 13 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24 right, 29 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21 right, 32 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Dias-2006" TYPE="STUDY">Dias 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>70 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>47 (64) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>48 (30) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 male, 6 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Fisher-2008" TYPE="STUDY">Fisher 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Less than 12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Less than 12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Forrester-2014" TYPE="STUDY">Forrester 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>63 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 right, 9 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 right, 9 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Geroin-2011" TYPE="STUDY">Geroin 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>63 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>61 (6) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>26 (6) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>27 (6) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 male, 6 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 male, 1 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Han-2016" TYPE="STUDY">Han 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68 (15) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>63 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22 (8) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 (10) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 right, 10 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 right, 12 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>111 (63) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>139 (61) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21 male, 12 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 male, 12 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22 right, 11 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 right, 17 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>57 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>57 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50 (51) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>73 (87) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15 male, 9 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15 male, 9 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 right, 8 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>16 right, 8 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Husemann-2007" TYPE="STUDY">Husemann 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (13) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>57 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>79 (56) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>89 (61) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 male, 5 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 right, 4 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 right, 3 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kim-2015" TYPE="STUDY">Kim 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 (13) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50 (16) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>80 (60) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>120 (84) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 male, 3 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 right, 5 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 right, 3 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kyung-2008" TYPE="STUDY">Kyung 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>48 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (16) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22 (23) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>29 (12) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 male, 8 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 right, 8 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 right, 4 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Between 10 days and 6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Between 10 days and 6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Morone-2011" TYPE="STUDY">Morone 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (14) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19 (11) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 (14) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15 male, 9 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 male, 11 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 right, 11 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>15 right, 9 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Noser-2012" TYPE="STUDY">Noser 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>67 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>64 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1354 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>525 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ochi-2015" TYPE="STUDY">Ochi 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>66 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>23 (7) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>26 (8) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 male, 2 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 right, 7 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 right, 8 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Peurala-2005" TYPE="STUDY">Peurala 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>52 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>52 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.5 (2.5) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.0 (5.8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>26 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 right, 17 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 right, 5 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Peurala-2009" TYPE="STUDY">Peurala 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>67 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>68 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 (3) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 (3) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 male, 11 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18 male, 16 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 right, 11 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 right, 20 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Picelli-2016" TYPE="STUDY">Picelli 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>65 (3) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 (4) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 (4) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 male, 2 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (12) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>64 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.2 (1.8) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4.5 (1.9) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50 male, 27 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>54 male, 24 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>36 right, 41 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>33 right, 45 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Saltuari-2004" TYPE="STUDY">Saltuari 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (13) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (19) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3.6 (4.6) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1.9 (0.8) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 male, 6 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Schwartz-2006" TYPE="STUDY">Schwartz 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>65 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22 (9) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24 (10) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21 male, 16 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 male, 10 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>17 right, 20 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 right, 22 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Stein-2014" TYPE="STUDY">Stein 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>58 (11) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>57 (15) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>49 (39) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>89 (153) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Tanaka-2012" TYPE="STUDY">Tanaka 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>63 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (37) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>65 (67) months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>10 male, 2 female</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>9 right, 3 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Tong-2006" TYPE="STUDY">Tong 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>71 (14) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>64 (10) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.5 (1.2) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2.7 (1.2) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>19 male, 11 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 male, 8 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 right, 17 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 right, 13 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ucar-2014" TYPE="STUDY">Ucar 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>56 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>62 years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Van-Nunen-2012" TYPE="STUDY">Van Nunen 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>53 (10) years</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>2.1 (1.3) months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>16 male, 14 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Waldman-2013" TYPE="STUDY">Waldman 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 (8) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>53 (7) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>41 (20) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 (22) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Watanabe-2014" TYPE="STUDY">Watanabe 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>67 (17) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>76 (14) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>59 (47) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>51 (34) days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 male, 4 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 male, 7 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 right, 5 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 right, 6 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Werner-2002" TYPE="STUDY">Werner 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 (9) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7.4 (2.0) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6.9 (2.1) weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 male, 7 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 male, 10 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 right, 7 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 right, 7 left</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Westlake-2009" TYPE="STUDY">Westlake 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>59 (17) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>55 (14) years</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>44 (27) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>37 (20) months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 male, 2 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>7 male, 1 female</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 right, 4 left</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 right, 5 left</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>SD: standard deviation<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2017-05-04 14:41:46 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">Demographics of studies including dropouts and adverse events</TITLE>
<TABLE COLS="11" ROWS="37">
<TR>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Criteria</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Stroke severity</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Electromechanical device used</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Duration of study intervention</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Aetiology (ischaemic/haemorrhage)</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Intensity of treatment per day</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Description of the control intervention</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Dropouts</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Reasons for dropout </B>
</P>
<P>
<B>and adverse events in the experimental group</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Reasons for dropout and adverse </B>
</P>
<P>
<B>events in the control group</B>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="BOTTOM">
<P>
<B>Source of information</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Aschbacher-2006" TYPE="STUDY">Aschbacher 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Described as task-oriented physiotherapy, 5 times a week for 3 weeks (2.5 hours a week)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 of 23</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished information in the form of a conference presentation</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Bang-2016" TYPE="STUDY">Bang 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unclear</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13/5</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 minutes, 5 times a week (20 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Described as treadmill training without body weight support</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 18</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Brincks-2011" TYPE="STUDY">Brincks 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean FIM, 92 of 126 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Physiotherapy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 13</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Buesing-2015" TYPE="STUDY">Buesing 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unclear</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Wearable exoskeleton Stride Management Assist system (SMA)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 to 8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unclear</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 times per week for a maximum of 18 sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Functional task-specific training (intensive overground training and mobility training)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chang-2012" TYPE="STUDY">Chang 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes daily for 10 days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Conventional gait training by physical therapists (with equal therapy time and same amount of sessions as experimental group)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 of 40</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Not described by group</P>
<P>(3 participants dropped out:</P>
<P>1 due to aspiration pneumonia, and 2 were unable to co-operate fully with the experimental procedure)</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Cho-2015" TYPE="STUDY">Cho 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Modified Barthel Index, 36 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks (2 phases, cross-over after 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4/14 (2 both)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 3 times a week for 4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bobath (neurophysiological exercises, inhibition of spasticity and synergy pattern)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 20</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Chua-2016" TYPE="STUDY">Chua 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Barthel Index, 49 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Physiotherapy including 25 minutes of stance/gait, 10 minutes cycling, 10 minutes tilt table standing</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 of 106</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 death, 3 refusal, 1 medical problem, 1 transport problem</P>
<P>(1 pain as adverse event)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 death, 6 refusal, 3 medical problem, 1 administrative problem</P>
<P>(no adverse events)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Dias-2006" TYPE="STUDY">Dias 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Barthel Index, 75 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>40 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bobath method, 5 times a week for 5 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 40</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Fisher-2008" TYPE="STUDY">Fisher 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>AutoAmbulator</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>24 sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Minimum of 3 sessions a week up to 5 sessions; number of minutes in each session unclear</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>"Standard" physical therapy, 3 to 5 times a week for 24 consecutive sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 20</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 adverse events,</P>
<P>no details provided</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 adverse events,</P>
<P>no details provided</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Forrester-2014" TYPE="STUDY">Forrester 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean FIM walk 1 point</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Anklebot</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 to 10 sessions (with ca. 200 repetitions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>60 minutes, 8 to 10 sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stretching of the paretic ankle</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 of 34</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Total of 5 dropouts in both groups (1 medical complication, 1 discharge prior study end, 2 time poststroke &gt; 49 days, 1 non-compliance)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Geroin-2011" TYPE="STUDY">Geroin 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean European Stroke Scale, 80 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>50 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Walking exercises according to the Bobath approach</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 30</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Han-2016" TYPE="STUDY">Han 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>33/23</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Neurodevelopmental techniques for balance and mobility</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 0f 60</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 unclear reasons</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hidler-2009" TYPE="STUDY">Hidler 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 to 10 weeks (24 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>47/16</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>45 minutes, 3 days a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Conventional gait training, 3 times a week for 8 to 10 weeks (24 sessions), each session lasted 1.5 hours</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 of 72</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Not described by group</P>
<P>(9 withdrew or were removed because of poor attendance or a decline in health, including 1 death, which according to the authors was unrelated to study)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Hornby-2008" TYPE="STUDY">Hornby 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22/26</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 12 sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Therapist-assisted gait training, 12 sessions, each session lasted 30 minutes</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>14 of 62</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 participants dropped out (2 discontinued secondary</P>
<P>to leg pain during training, 1 experienced pitting oedema, and</P>
<P>1 had travel limitations)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 participants dropped out</P>
<P>(4 discontinued secondary to leg pain, 1 experienced an injury outside therapy, 1 reported fear of</P>
<P>falling during training, 1 presented with significant hypertension,</P>
<P>1 had travel limitations, and</P>
<P>2 experienced</P>
<P>subjective exercise intolerance)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Husemann-2007" TYPE="STUDY">Husemann 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Median Barthel Index, 35 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>22/8</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Conventional physiotherapy, 30 minutes per day for 4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 of 32</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 participant enteritis</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 participant pulmonary embolism</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Information as provided by the authors</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kim-2015" TYPE="STUDY">Kim 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Barthel Index, 20 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Walkbot</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13/13</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Conventional physiotherapy (bed mobility, stretching, balance training, strengthening, symmetry training, treadmill training)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 of 30</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>1 rib fracture, 3 decline in health condition</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Information as provided by the authors</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Kyung-2008" TYPE="STUDY">Kyung 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>18/7</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>45 minutes, 3 days a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Conventional physiotherapy, received equal time and sessions of conventional gait training</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 of 35</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 participant dropped out for</P>
<P>private reasons (travelling);</P>
<P>adverse events not described</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 participants refused after randomisation (reasons not provided); adverse events not described</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Mayr-2008" TYPE="STUDY">Mayr 2008</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Add-on conventional physiotherapy, received equal time and sessions of conventional gait training</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13 of 74</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 participants dropped out (reasons not provided); adverse events not described</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 participants dropped out (reasons not provided)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Morone-2011" TYPE="STUDY">Morone 2011</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Canadian Neurological Scale, 6 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>41/7</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>40 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Focused on trunk stabilisation, weight transfer to the paretic leg, and walking between parallel<BR/>bars or on the ground. The participant was helped by 1 or 2 therapists and walking aids if necessary.</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>21 of 48</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 (hypotension, referred weakness, knee pain, urinary infection, uncontrolled blood pressure, fever, absence of physiotherapist)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 (hypotension, referred weakness, knee pain, ankle pain, uncontrolled blood pressure, fever, absence of physiotherapist)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Information as provided by the authors</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Noser-2012" TYPE="STUDY">Noser 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unclear</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 of 21</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No dropouts;</P>
<P>2 serious adverse events</P>
<P>(1 skin breakdown as a result of therapy,</P>
<P>1 second stroke during the post-treatment phase)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 dropout due to protocol violation;</P>
<P>2 serious adverse events</P>
<P>(1 sudden drop in blood pressure at participant's home leading to brief hospitalisation,</P>
<P>1 sudden chest pain before therapy leading to brief hospitalisation)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Information as provided by the authors</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ochi-2015" TYPE="STUDY">Ochi 2015</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait-assistance robot (consisting of 4 robotic arms for the thighs and legs, thigh cuffs, leg apparatuses, and a treadmill)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
<P/>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10/16</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 5 times a week for 4 weeks, in addition to rehabilitation treatment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Range-of-motion exercises, muscle strengthening, rolling over and sit-to-stand and activity and gait exercises</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 26</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Peurala-2005" TYPE="STUDY">Peurala 2005</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Scandinavian Stroke Scale, 42 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>25/20</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 5 times a week for 3 weeks, in addition to rehabilitation treatment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Walking overground;</P>
<P>all participants practised gait for 15 sessions over 3 weeks (each session lasting 20 minutes)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 45</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Peurala-2009" TYPE="STUDY">Peurala 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>42/14</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 5 times a week for 3 weeks, in addition to rehabilitation treatment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Overground walking training; in the other control group, 1 or 2 physiotherapy sessions daily but not at the same intensity as in the other groups</P>
<P>
<BR/>
<BR/>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>9 of 56</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 dropouts</P>
<P>(2 situation worsened after 1 to 2 treatment days;</P>
<P>1 had 2 unsuccessful attempts in device;</P>
<P>1 had scheduling problems;</P>
<P>1 felt protocol too demanding)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 dropouts</P>
<P>(1 felt protocol too demanding;</P>
<P>2 situation worsened after 1 to 2 treatment days;</P>
<P>1 death)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Picelli-2016" TYPE="STUDY">Picelli 2016</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>G-EO System Evolution</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Experimental group (G-EO) 30 minutes a day for 5 consecutive days</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>5 days in addition to botulinum toxin injection of calf muscles</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 22</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Pohl-2007" TYPE="STUDY">Pohl 2007</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Barthel Index, 37 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>124/31</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Physiotherapy every weekday for 4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11 of 155</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 participants refused therapy,</P>
<P>1 increased cranial pressure,</P>
<P>1 relapsing pancreas tumour,</P>
<P>1 cardiovascular unstable</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 participants refused therapy, 1 participant died, 1 myocardial infarction</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Saltuari-2004" TYPE="STUDY">Saltuari 2004</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13/3</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>A-B-A study: in phase A, 30 minutes, 5 days a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Physiotherapy every weekday for 3 weeks (phase B)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 16</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Schwartz-2006" TYPE="STUDY">Schwartz 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean NIHSS, 11 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>49/67</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 3 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Physiotherapy with additional gait training 3 times a week for 6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 of 46</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 participants with leg wounds,</P>
<P>1 participant with recurrent stroke,</P>
<P>1 refused therapy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 participant with recurrent stroke,</P>
<P>1 with pulmonary embolism</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the authors.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Stein-2014" TYPE="STUDY">Stein 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Bionic leg device (AlterG)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 hour, 3 times a week for 6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Group exercises</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 24</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Tanaka-2012" TYPE="STUDY">Tanaka 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean FIM, 79 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Master4</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 2 or 3 times a week (12 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Non-intervention (non-training)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Tong-2006" TYPE="STUDY">Tong 2006</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Barthel Index, 51 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>39/11</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Conventional physiotherapy alone, based on Bobath concept</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 of 50</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 participants discharged before study end,</P>
<P>1 participant readmitted to an acute ward,</P>
<P>1 participant deteriorating condition</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Ucar-2014" TYPE="STUDY">Ucar 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Conventional physiotherapy at home (focused on gait)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 22</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Van-Nunen-2012" TYPE="STUDY">Van Nunen 2012</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, twice a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Overground therapy</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 30</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unpublished and published information provided by the author.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Waldman-2013" TYPE="STUDY">Waldman 2013</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Portable rehab robot (ankle device)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>6 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>3 times a week, 18 sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Stretching the plantar flexors and active exercises for ankle mobility and strength</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 24</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Watanabe-2014" TYPE="STUDY">Watanabe 2014</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Single-leg version of the Hybrid Assistive Limb (HAL)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>11/11</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 12 sessions</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Aimed to improve walking speed, endurance, balance, postural stability, and symmetry</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>10 of 32</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 withdrew,</P>
<P>1 epilepsy,</P>
<P>1 technical reasons</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 pneumonia,</P>
<P>2 discharged</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Werner-2002" TYPE="STUDY">Werner 2002</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Mean Barthel Index, 38 points</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait Trainer</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>2 weeks</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>13/12</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>20 minutes, 5 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Gait therapy including treadmill training with body weight support</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 30</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<LINK REF="STD-Westlake-2009" TYPE="STUDY">Westlake 2009</LINK>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not stated</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Lokomat</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>4 weeks (12 sessions)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>8/8</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>30 minutes, 3 times a week</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>12 physiotherapy sessions including manually guided gait training (3 times a week over 4 weeks)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0 of 16</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>None</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Published information</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>FIM: Functional Independence Measure<BR/>NIHSS: National Institutes of Health Stroke Scale</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<NAME>Electromechanical- and robotic-assisted gait training plus physiotherapy versus physiotherapy (or usual care)</NAME>
<DICH_OUTCOME CHI2="16.38066524441744" CI_END="2.712352679197486" CI_START="1.3916057803657504" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="OR" EFFECT_SIZE="1.9428138528335006" ESTIMABLE="YES" EVENTS_1="412" EVENTS_2="325" I2="8.42862743250292" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.4333461588937782" LOG_CI_START="0.1435162240247717" LOG_EFFECT_SIZE="0.2884311914592749" METHOD="MH" MODIFIED="2016-12-05 14:24:57 +0000" MODIFIED_BY="Jan Mehrholz" NO="1" P_CHI2="0.3572134235249159" P_Q="1.0" P_Z="9.579216558167862E-5" Q="0.0" RANDOM="YES" SCALE="106.73" SORT_BY="STUDY" STUDIES="36" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.038800414852352506" TOTALS="YES" TOTAL_1="761" TOTAL_2="711" WEIGHT="99.99999999999999" Z="3.901010070154826">
<NAME>Independent walking at the end of intervention phase, all electromechanical devices used</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-16 10:24:42 +0100" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.0" STUDY_ID="STD-Aschbacher-2006" TOTAL_1="11" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-28 14:14:58 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:17:29 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-28 14:15:51 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="44.60390216120258" CI_START="0.4743979556659822" EFFECT_SIZE="4.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.6493728545181054" LOG_CI_START="-0.3238571911549576" LOG_EFFECT_SIZE="0.6627578316815741" MODIFIED="2016-12-05 14:24:57 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="330" O_E="0.0" SE="1.159085096474614" STUDY_ID="STD-Chang-2012" TOTAL_1="24" TOTAL_2="24" VAR="1.3434782608695652" WEIGHT="2.096843773132754"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 08:49:37 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="280" O_E="0.0" SE="0.0" STUDY_ID="STD-Cho-2015" TOTAL_1="13" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.2281669796023875" CI_START="0.49065440130963517" EFFECT_SIZE="1.2585365853658537" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.5089559908716995" LOG_CI_START="-0.30922430105674775" LOG_EFFECT_SIZE="0.09986584490747587" MODIFIED="2016-11-28 14:19:30 +0000" MODIFIED_BY="[Empty name]" ORDER="292" O_E="0.0" SE="0.48060315353653343" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.23097939118926075" WEIGHT="10.743659714376893"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-16 13:45:30 +0100" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="18.57361085218092" CI_START="0.05383982726668248" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="1.268896342120762" LOG_CI_START="-1.268896342120762" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-12-01 11:37:38 +0000" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="1.4907119849998598" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.2222222222222223" WEIGHT="1.2819077466963433"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:35:05 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="689" O_E="0.0" SE="0.0" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:17:36 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.751430751085456" CI_START="0.36344727178959313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.43955858681829196" LOG_CI_START="-0.4395585868182919" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-28 14:23:31 +0000" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Han-2016" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="9.488493553899453"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="36" EVENTS_2="36" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-30 08:56:00 +0100" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.0" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-30 08:55:49 +0100" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-16 13:45:33 +0100" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:50:06 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="694" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2015" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.311173317152111" CI_START="0.7216992505758693" EFFECT_SIZE="2.857142857142857" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="1.053507656979829" LOG_CI_START="-0.14164374568038038" LOG_EFFECT_SIZE="0.4559319556497244" MODIFIED="2009-12-01 11:37:40 +0000" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="0.7020378500174638" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" VAR="0.4928571428571429" WEIGHT="5.451671648210497"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2009-12-01 11:37:40 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="8.01075720222221"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-02 08:17:45 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="6.261977475856322"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 09:24:12 +0000" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.0" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 10:00:09 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="4.405914868725455"/>
<DICH_DATA CI_END="2.051562302092196" CI_START="0.1658627561204261" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.31208471021056267" LOG_CI_START="-0.7802511222772986" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2009-12-01 11:37:41 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.641643475152946" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.4117063492063492" WEIGHT="6.433693487328026"/>
<DICH_DATA CI_END="6.757670374009947" CI_START="0.4306268937396148" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.8297970039171373" LOG_CI_START="-0.365898850875773" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2009-12-01 11:37:41 +0000" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.7023576638952937" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.4933062880324544" WEIGHT="5.447069954593594"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 09:51:58 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2009-12-01 11:37:41 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="17.44089603840391"/>
<DICH_DATA CI_END="19.359572851219983" CI_START="0.05165403222917612" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2868957708233757" LOG_CI_START="-1.2868957708233757" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-12-01 11:37:42 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="1.5118578920369088" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="2.2857142857142856" WEIGHT="1.2468935701783925"/>
<DICH_DATA CI_END="9.114781488652717" CI_START="1.1483685089667286" EFFECT_SIZE="3.235294117647059" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" LOG_CI_END="0.9597462616459747" LOG_CI_START="0.06008127458596511" LOG_EFFECT_SIZE="0.5099137681159699" MODIFIED="2009-12-01 11:37:42 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.5284676668125593" STUDY_ID="STD-Schwartz-2006" TOTAL_1="37" TOTAL_2="30" VAR="0.2792780748663102" WEIGHT="9.112286833621848"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-28 14:26:24 +0000" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.0" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:17:55 +0000" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2009-12-01 11:37:43 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="7.190578450614242"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-28 14:27:00 +0000" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.0" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="10.5953772444188" CI_START="0.4778027136944757" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="1.0251164242136594" LOG_CI_START="-0.3207513879909346" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2013-01-02 08:17:55 +0000" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.625" WEIGHT="4.3664064816325565"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-28 14:29:43 +0000" MODIFIED_BY="[Empty name]" ORDER="344" O_E="0.0" SE="0.0" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 13:25:59 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1031" O_E="0.0" SE="0.0" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2009-12-01 11:37:43 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="1.0209492005074983"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-05 11:21:40 +0100" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.416737424772299" CI_END="5.1342260737491685" CI_START="0.7235716362559426" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="OR" EFFECT_SIZE="1.9274284321578867" ESTIMABLE="YES" EVENTS_1="172" EVENTS_2="136" I2="79.19085357797321" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.7104749879077101" LOG_CI_START="-0.1405184656637467" LOG_EFFECT_SIZE="0.2849782611219817" METHOD="MH" MODIFIED="2016-08-30 08:58:48 +0100" MODIFIED_BY="Jan Mehrholz" NO="2" P_CHI2="0.002389447083273155" P_Q="1.0" P_Z="0.1892859788867284" Q="0.0" RANDOM="YES" SCALE="71.58246572388452" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.7758699192392178" TOTALS="YES" TOTAL_1="249" TOTAL_2="247" WEIGHT="100.00000000000001" Z="1.3126943006008325">
<NAME>Recovery of independent walking at follow-up after study end</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.364238478550702" CI_START="0.290350547460871" EFFECT_SIZE="0.6293706293706294" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="26" LOG_CI_END="0.1348902947088156" LOG_CI_START="-0.5370773507602895" LOG_EFFECT_SIZE="-0.20109352802573693" MODIFIED="2016-08-30 08:58:48 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="294" O_E="0.0" SE="0.39471712124204317" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.1558016058016058" WEIGHT="26.82037341898332"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="33" EVENTS_2="30" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-02-11 13:27:30 +0000" MODIFIED_BY="[Empty name]" ORDER="69" O_E="0.0" SE="0.0" STUDY_ID="STD-Hidler-2009" TOTAL_1="33" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-06-30 09:01:07 +0100" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.566756378616125" CI_START="0.5111078290055214" EFFECT_SIZE="1.5277777777777777" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.6596078440473834" LOG_CI_START="-0.2914874665934702" LOG_EFFECT_SIZE="0.18406018872695656" MODIFIED="2009-12-01 11:39:15 +0000" MODIFIED_BY="[Empty name]" ORDER="72" O_E="0.0" SE="0.5586780934681547" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.31212121212121213" WEIGHT="22.966895119984763"/>
<DICH_DATA CI_END="8.21328754259111" CI_START="2.140123156118655" EFFECT_SIZE="4.192546583850931" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="28" LOG_CI_END="0.9145170274997417" LOG_CI_START="0.33043876609860867" LOG_EFFECT_SIZE="0.6224778967991752" MODIFIED="2009-12-01 11:39:15 +0000" MODIFIED_BY="[Empty name]" ORDER="3219" O_E="0.0" SE="0.34309046198104876" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.11771106510236945" WEIGHT="27.963641397136684"/>
<DICH_DATA CI_END="11.284512146664788" CI_START="1.1202943595907593" EFFECT_SIZE="3.5555555555555554" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="9" LOG_CI_END="1.0524827883503132" LOG_CI_START="0.04933214941084893" LOG_EFFECT_SIZE="0.5509074688805811" MODIFIED="2009-12-01 11:39:16 +0000" MODIFIED_BY="[Empty name]" ORDER="68" O_E="0.0" SE="0.5892556509887895" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.34722222222222215" WEIGHT="22.249090063895245"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="64.960880954703" CI_END="0.08872664245132744" CI_START="-0.004547249212588499" CI_STUDY="95" CI_TOTAL="95" DF="23" EFFECT_MEASURE="MD" EFFECT_SIZE="0.042089696619369475" ESTIMABLE="YES" I2="64.59407621636501" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2016-08-30 14:06:07 +0100" MODIFIED_BY="Jan Mehrholz" NO="3" P_CHI2="7.107082580448676E-6" P_Q="1.0" P_Z="0.07691702079291" Q="0.0" RANDOM="YES" SCALE="0.5961836566310131" SORT_BY="STUDY" STUDIES="24" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0067479906917696075" TOTALS="YES" TOTAL_1="518" TOTAL_2="467" UNITS="" WEIGHT="100.0" Z="1.7688613184796553">
<NAME>Walking velocity (metres per second) at the end of intervention phase</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.20087230594797423" CI_START="-0.020872305947974276" EFFECT_SIZE="0.08999999999999997" ESTIMABLE="YES" MEAN_1="0.64" MEAN_2="0.55" MODIFIED="2016-08-29 13:25:00 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="276" SD_1="0.12" SD_2="0.12" SE="0.0565685424949238" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" WEIGHT="5.691525038865667"/>
<CONT_DATA CI_END="0.006419334384588415" CI_START="-0.4864193343845884" EFFECT_SIZE="-0.24" ESTIMABLE="YES" MEAN_1="0.35" MEAN_2="0.59" MODIFIED="2013-01-02 08:18:29 +0000" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="0.16" SD_2="0.27" SE="0.1257264604494331" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" WEIGHT="2.510259493069563"/>
<CONT_DATA CI_END="0.15230845892196135" CI_START="-0.18030845892196137" EFFECT_SIZE="-0.014000000000000012" ESTIMABLE="YES" MEAN_1="0.873" MEAN_2="0.887" MODIFIED="2016-08-29 14:27:15 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="277" SD_1="0.3" SD_2="0.3" SE="0.08485281374238571" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" WEIGHT="4.059311434873486"/>
<CONT_DATA CI_END="0.13191631867665615" CI_START="-0.27191631867665605" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.56" MEAN_2="0.63" MODIFIED="2016-08-30 09:06:31 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="295" SD_1="0.45" SD_2="0.6" SE="0.10302042296151677" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" WEIGHT="3.2612517482588306"/>
<CONT_DATA CI_END="0.19431744816081065" CI_START="-0.18631744816081064" EFFECT_SIZE="0.0040000000000000036" ESTIMABLE="YES" MEAN_1="0.179" MEAN_2="0.175" MODIFIED="2013-01-03 13:38:12 +0000" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="0.233" SD_2="0.2" SE="0.09710252313920581" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" WEIGHT="3.500007460482857"/>
<CONT_DATA CI_END="0.06684825304028584" CI_START="0.005151746959714109" EFFECT_SIZE="0.035999999999999976" ESTIMABLE="YES" MEAN_1="0.372" MEAN_2="0.336" MODIFIED="2016-08-30 09:37:51 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="690" SD_1="0.049" SD_2="0.049" SE="0.015739193823770717" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" WEIGHT="8.09341932762386"/>
<CONT_DATA CI_END="0.3859798942291955" CI_START="0.036020105770804445" EFFECT_SIZE="0.21099999999999997" ESTIMABLE="YES" MEAN_1="0.591" MEAN_2="0.38" MODIFIED="2013-01-02 08:18:29 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="0.276" SD_2="0.204" SE="0.08927709672698815" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" WEIGHT="3.8468361993047435"/>
<CONT_DATA CI_END="-0.05684577053901928" CI_START="-0.22315422946098062" EFFECT_SIZE="-0.13999999999999996" ESTIMABLE="YES" MEAN_1="0.46" MEAN_2="0.6" MODIFIED="2009-06-30 09:16:58 +0100" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="0.18" SD_2="0.18" SE="0.042426406871192854" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="6.623689724314379"/>
<CONT_DATA CI_END="0.08320697319172114" CI_START="-0.16320697319172123" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="0.52" MEAN_2="0.56" MODIFIED="2009-06-30 09:08:46 +0100" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="0.21" SD_2="0.28" SE="0.06286185570937122" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="5.2917136233992945"/>
<CONT_DATA CI_END="0.10747787047570843" CI_START="-0.10747787047570843" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.2" ORDER="3220" SD_1="0.12" SD_2="0.18" SE="0.0548366558383114" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" WEIGHT="5.804095409235222"/>
<CONT_DATA CI_END="0.31292122285473445" CI_START="-0.1509212228547343" EFFECT_SIZE="0.08100000000000007" ESTIMABLE="YES" MEAN_1="0.68" MEAN_2="0.599" MODIFIED="2013-01-04 14:24:54 +0000" MODIFIED_BY="[Empty name]" ORDER="969" SD_1="0.356" SD_2="0.344" SE="0.11832932884690707" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" WEIGHT="2.728661551891066"/>
<CONT_DATA CI_END="0.2565651762955159" CI_START="0.10343482370448408" EFFECT_SIZE="0.18" ESTIMABLE="YES" MEAN_1="0.425" MEAN_2="0.245" MODIFIED="2013-01-02 08:18:35 +0000" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="0.16" SD_2="0.105" SE="0.03906458327778074" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" WEIGHT="6.843004191406122"/>
<CONT_DATA CI_END="0.11603239432733897" CI_START="-0.256032394327339" EFFECT_SIZE="-0.07" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.27" MODIFIED="2013-01-02 08:18:35 +0000" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="0.1" SD_2="0.27" SE="0.09491623100972199" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="9" WEIGHT="3.5932566412245546"/>
<CONT_DATA CI_END="0.4313463247557775" CI_START="-0.04534632475577746" EFFECT_SIZE="0.193" ESTIMABLE="YES" MEAN_1="0.38" MEAN_2="0.187" MODIFIED="2016-08-30 12:39:20 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1017" SD_1="0.432" SD_2="0.075" SE="0.12160750229893144" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" WEIGHT="2.62900498812355"/>
<CONT_DATA CI_END="0.28951139188500596" CI_START="-0.049511391885005945" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.39" ORDER="3221" SD_1="0.38" SD_2="0.2" SE="0.08648699324175861" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" WEIGHT="3.9794261421158748"/>
<CONT_DATA CI_END="0.2519212961488334" CI_START="-0.011921296148833388" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.44" MEAN_2="0.32" ORDER="3222" SD_1="0.47" SD_2="0.36" SE="0.06730802055007731" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" WEIGHT="5.020165741421354"/>
<CONT_DATA CI_END="0.12572157463123623" CI_START="-0.18572157463123623" EFFECT_SIZE="-0.03" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.23" ORDER="3223" SD_1="0.12" SD_2="0.19" SE="0.07945124291035352" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" WEIGHT="4.33515397275918"/>
<CONT_DATA CI_END="0.22088777409012023" CI_START="-0.2768877740901203" EFFECT_SIZE="-0.028000000000000025" ESTIMABLE="YES" MEAN_1="0.493" MEAN_2="0.521" MODIFIED="2016-08-30 12:58:16 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1020" SD_1="0.364" SD_2="0.247" SE="0.12698589160480256" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" WEIGHT="2.4753302916946804"/>
<CONT_DATA CI_END="0.3283496624492471" CI_START="-0.3883496624492472" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.88" MODIFIED="2013-01-03 11:32:55 +0000" MODIFIED_BY="[Empty name]" ORDER="771" SD_1="0.45" SD_2="0.15" SE="0.18283482006601323" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" WEIGHT="1.40926040259536"/>
<CONT_DATA CI_END="0.4734686697266201" CI_START="0.1665313302733799" EFFECT_SIZE="0.32" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.19" MODIFIED="2009-06-30 09:36:16 +0100" MODIFIED_BY="[Empty name]" ORDER="3224" SD_1="0.31" SD_2="0.26" SE="0.07830178051084682" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" WEIGHT="4.396190450764086"/>
<CONT_DATA CI_END="0.1615280173990117" CI_START="-0.1375280173990118" EFFECT_SIZE="0.011999999999999955" ESTIMABLE="YES" MEAN_1="0.282" MEAN_2="0.27" MODIFIED="2013-01-02 08:18:35 +0000" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="0.209" SD_2="0.208" SE="0.07629120666423958" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" WEIGHT="4.504910197904564"/>
<CONT_DATA CI_END="0.5452780772776304" CI_START="-0.1052780772776305" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.63" MODIFIED="2016-08-30 13:23:54 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1027" SD_1="0.43" SD_2="0.5" SE="0.16596125226962455" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" WEIGHT="1.6511337333861307"/>
<CONT_DATA CI_END="0.1172110523495531" CI_START="-0.07721105234955307" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.27" MEAN_2="0.25" ORDER="3225" SD_1="0.12" SD_2="0.15" SE="0.04959838707054898" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" WEIGHT="6.148924342334247"/>
<CONT_DATA CI_END="0.4012426113380885" CI_START="-0.26124261133808857" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.72" MEAN_2="0.65" MODIFIED="2009-08-05 11:22:44 +0100" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="0.38" SD_2="0.29" SE="0.1690044378115557" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" WEIGHT="1.6034678929513282"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="39.038532907987914" CI_END="0.18997132716435916" CI_START="-0.052076392571552985" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0689474672964031" ESTIMABLE="YES" I2="79.50742662677503" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2016-08-30 13:07:14 +0100" MODIFIED_BY="Jan Mehrholz" NO="4" P_CHI2="4.835139280734424E-6" P_Q="1.0" P_Z="0.26416784568767293" Q="0.0" RANDOM="YES" SCALE="1.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.025100812735173245" TOTALS="YES" TOTAL_1="296" TOTAL_2="282" UNITS="" WEIGHT="100.00000000000003" Z="1.1165943052357012">
<NAME>Walking velocity (metres per second) at follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.2823084589219613" CI_START="-0.05030845892196137" EFFECT_SIZE="0.11599999999999999" ESTIMABLE="YES" MEAN_1="0.989" MEAN_2="0.873" MODIFIED="2016-08-29 14:29:15 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="278" SD_1="0.3" SD_2="0.3" SE="0.08485281374238571" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" WEIGHT="11.804086081615592"/>
<CONT_DATA CI_END="0.43872627128003755" CI_START="-0.21872627128003758" EFFECT_SIZE="0.10999999999999999" ESTIMABLE="YES" MEAN_1="0.73" MEAN_2="0.62" MODIFIED="2016-08-30 09:07:32 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="296" SD_1="1.1" SD_2="0.53" SE="0.16772056725173953" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" WEIGHT="7.162772893632874"/>
<CONT_DATA CI_END="-0.06200180077299733" CI_START="-0.25799819922700273" EFFECT_SIZE="-0.16000000000000003" ESTIMABLE="YES" MEAN_1="0.49" MEAN_2="0.65" MODIFIED="2009-06-30 09:18:49 +0100" MODIFIED_BY="[Empty name]" ORDER="83" SD_1="0.24" SD_2="0.18" SE="0.049999999999999996" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="13.814142999718337"/>
<CONT_DATA CI_END="0.09493329205295056" CI_START="-0.1349332920529506" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.52" MODIFIED="2009-06-30 09:19:33 +0100" MODIFIED_BY="[Empty name]" ORDER="84" SD_1="0.21" SD_2="0.25" SE="0.058640512254066766" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="13.35977415879587"/>
<CONT_DATA CI_END="0.24205444868135995" CI_START="-0.2980544486813598" EFFECT_SIZE="-0.027999999999999914" ESTIMABLE="YES" MEAN_1="0.676" MEAN_2="0.704" MODIFIED="2013-01-04 14:26:20 +0000" MODIFIED_BY="[Empty name]" ORDER="970" SD_1="0.397" SD_2="0.417" SE="0.13778541381959816" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" WEIGHT="8.648658261557436"/>
<CONT_DATA CI_END="0.12846544743893692" CI_START="-0.26846544743893697" EFFECT_SIZE="-0.07000000000000003" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="0.28" MODIFIED="2013-01-02 08:18:47 +0000" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="0.1" SD_2="0.29" SE="0.10125974201791822" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="9" WEIGHT="10.784573741126431"/>
<CONT_DATA CI_END="0.2861117868088533" CI_START="0.05388821319114678" EFFECT_SIZE="0.17000000000000004" ESTIMABLE="YES" MEAN_1="0.53" MEAN_2="0.36" ORDER="3226" SD_1="0.31" SD_2="0.42" SE="0.059241796137443445" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" WEIGHT="13.326676038184846"/>
<CONT_DATA CI_END="0.3998187805307727" CI_START="-0.06581878053077259" EFFECT_SIZE="0.16700000000000004" ESTIMABLE="YES" MEAN_1="0.662" MEAN_2="0.495" MODIFIED="2016-08-30 13:07:14 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1020" SD_1="0.307" SD_2="0.274" SE="0.11878727485158781" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" WEIGHT="9.723785248473726"/>
<CONT_DATA CI_END="0.559814098146119" CI_START="0.20018590185388105" EFFECT_SIZE="0.38000000000000006" ESTIMABLE="YES" MEAN_1="0.68" MEAN_2="0.3" MODIFIED="2009-06-30 09:35:00 +0100" MODIFIED_BY="[Empty name]" ORDER="85" SD_1="0.31" SD_2="0.34" SE="0.09174357261892038" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" WEIGHT="11.37553057689489"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="23.375261676399482" CI_END="28.404737860992842" CI_START="-16.73447899522387" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="5.835129432884485" ESTIMABLE="YES" I2="52.941703274680336" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2016-11-29 11:19:10 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.015640198478075518" P_Q="1.0" P_Z="0.612345963388041" Q="0.0" RANDOM="YES" SCALE="194.5051270237203" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="751.5270796221615" TOTALS="YES" TOTAL_1="306" TOTAL_2="288" UNITS="" WEIGHT="100.0" Z="0.5067276009689181">
<NAME>Walking capacity (metres walked in 6 minutes) at the end of intervention phase</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="38.83731354086406" CI_START="-62.43731354086408" EFFECT_SIZE="-11.800000000000011" ESTIMABLE="YES" MEAN_1="145.1" MEAN_2="156.9" MODIFIED="2016-08-30 09:08:39 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="297" SD_1="121.0" SD_2="144.0" SE="25.835838791061843" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" WEIGHT="9.344672182775257"/>
<CONT_DATA CI_END="-21.565507309490293" CI_START="-78.4344926905097" EFFECT_SIZE="-50.0" ESTIMABLE="YES" MEAN_1="168.0" MEAN_2="218.0" MODIFIED="2009-08-10 13:16:50 +0100" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="59.0" SD_2="64.0" SE="14.50766081152376" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="13.784058569317239"/>
<CONT_DATA CI_END="27.843753434891312" CI_START="-63.84375343489131" EFFECT_SIZE="-18.0" ESTIMABLE="YES" MEAN_1="186.0" MEAN_2="204.0" MODIFIED="2009-08-10 13:19:40 +0100" MODIFIED_BY="[Empty name]" ORDER="87" SD_1="88.0" SD_2="96.0" SE="23.390099918417373" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="10.211005042994586"/>
<CONT_DATA CI_END="29.00005446360526" CI_START="-55.48005446360526" EFFECT_SIZE="-13.240000000000002" ESTIMABLE="YES" MEAN_1="57.02" MEAN_2="70.26" MODIFIED="2013-01-02 08:18:55 +0000" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="25.5" SD_2="60.4" SE="21.551444208561698" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="9" WEIGHT="10.904888030311158"/>
<CONT_DATA CI_END="79.55737103512627" CI_START="-21.417371035126287" EFFECT_SIZE="29.069999999999993" ESTIMABLE="YES" MEAN_1="164.14" MEAN_2="135.07" ORDER="3227" SD_1="103.41" SD_2="67.87" SE="25.759336106869423" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" WEIGHT="9.370738025035827"/>
<CONT_DATA CI_END="97.33115338182054" CI_START="-15.531153381820594" EFFECT_SIZE="40.89999999999998" ESTIMABLE="YES" MEAN_1="199.7" MEAN_2="158.8" MODIFIED="2016-11-29 09:52:53 +0000" MODIFIED_BY="[Empty name]" ORDER="340" SD_1="53.2" SD_2="79.3" SE="28.791933845184047" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" WEIGHT="8.389897791115466"/>
<CONT_DATA CI_END="78.33771529487515" CI_START="5.4622847051248655" EFFECT_SIZE="41.900000000000006" ESTIMABLE="YES" MEAN_1="134.4" MEAN_2="92.5" ORDER="3228" SD_1="125.5" SD_2="104.9" SE="18.59101268303458" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" WEIGHT="12.086059782246313"/>
<CONT_DATA CI_END="75.04509802762875" CI_START="-29.045098027628768" EFFECT_SIZE="22.999999999999993" ESTIMABLE="YES" MEAN_1="81.38" MEAN_2="58.38" ORDER="3229" SD_1="61.53" SD_2="43.07" SE="26.554109380658957" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" WEIGHT="9.103267569681913"/>
<CONT_DATA CI_END="95.82498530859081" CI_START="-58.62498530859082" EFFECT_SIZE="18.599999999999994" ESTIMABLE="YES" MEAN_1="213.4" MEAN_2="194.8" MODIFIED="2016-08-30 13:03:44 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1023" SD_1="108.2" SD_2="83.2" SE="39.40122671525173" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.755359490545194"/>
<CONT_DATA CI_END="99.02728081811098" CI_START="-83.02728081811098" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="216.5" MEAN_2="208.5" MODIFIED="2016-11-29 10:24:25 +0000" MODIFIED_BY="[Empty name]" ORDER="361" SD_1="106.6" SD_2="120.5" SE="46.44334362065964" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.559121006385985"/>
<CONT_DATA CI_END="115.82748199518429" CI_START="-71.42748199518431" EFFECT_SIZE="22.19999999999999" ESTIMABLE="YES" MEAN_1="156.7" MEAN_2="134.5" MODIFIED="2016-11-29 11:19:10 +0000" MODIFIED_BY="[Empty name]" ORDER="364" SD_1="137.9" SD_2="132.1" SE="47.77000125191377" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" WEIGHT="4.3712722223517115"/>
<CONT_DATA CI_END="211.1117938991949" CI_START="-79.71179389919487" EFFECT_SIZE="65.70000000000002" ESTIMABLE="YES" MEAN_1="278.1" MEAN_2="212.4" MODIFIED="2009-08-05 11:23:40 +0100" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="176.5" SD_2="113.5" SE="74.19105404292353" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" WEIGHT="2.1196602872393617"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.275157804586101" CI_END="30.533109260870496" CI_START="-32.1702858360058" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8185882875676536" ESTIMABLE="YES" I2="57.968940994316625" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2016-11-29 10:25:55 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.026709101983650063" P_Q="1.0" P_Z="0.9591865699897538" Q="0.0" RANDOM="YES" SCALE="278.15736054395603" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="985.7403393333338" TOTALS="YES" TOTAL_1="232" TOTAL_2="231" UNITS="" WEIGHT="100.0" Z="0.0511743761026058">
<NAME>Walking capacity (metres walked in 6 minutes) at follow-up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="51.69660569996122" CI_START="-55.29660569996124" EFFECT_SIZE="-1.8000000000000114" ESTIMABLE="YES" MEAN_1="159.2" MEAN_2="161.0" MODIFIED="2016-08-30 09:09:32 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="298" SD_1="142.0" SD_2="139.0" SE="27.294688127912362" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" WEIGHT="14.784070452224165"/>
<CONT_DATA CI_END="-14.42031886015377" CI_START="-97.57968113984623" EFFECT_SIZE="-56.0" ESTIMABLE="YES" MEAN_1="180.0" MEAN_2="236.0" MODIFIED="2009-08-10 13:18:17 +0100" MODIFIED_BY="[Empty name]" ORDER="101" SD_1="89.0" SD_2="91.0" SE="21.214512852185777" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="17.82104768671906"/>
<CONT_DATA CI_END="39.34812110169067" CI_START="-59.34812110169067" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="193.0" MEAN_2="203.0" MODIFIED="2009-08-10 13:20:35 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="94.0" SD_2="104.0" SE="25.17807546003006" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="15.797844694989216"/>
<CONT_DATA CI_END="24.427217704360693" CI_START="-62.567217704360694" EFFECT_SIZE="-19.07" ESTIMABLE="YES" MEAN_1="57.82" MEAN_2="76.89" MODIFIED="2013-01-02 08:19:05 +0000" MODIFIED_BY="[Empty name]" ORDER="193" SD_1="25.99" SD_2="62.29" SE="22.192865811546127" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="9" WEIGHT="17.309082461865327"/>
<CONT_DATA CI_END="97.7097984367113" CI_START="9.090201563288716" EFFECT_SIZE="53.400000000000006" ESTIMABLE="YES" MEAN_1="165.5" MEAN_2="112.1" ORDER="3230" SD_1="152.5" SD_2="127.7" SE="22.607455436029092" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" WEIGHT="17.094299916882093"/>
<CONT_DATA CI_END="120.14008062955158" CI_START="-42.7400806295516" EFFECT_SIZE="38.69999999999999" ESTIMABLE="YES" MEAN_1="252.7" MEAN_2="214.0" MODIFIED="2016-08-30 13:08:36 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1025" SD_1="108.4" SD_2="94.7" SE="41.55182507022606" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" WEIGHT="9.433852796813635"/>
<CONT_DATA CI_END="113.9350907972362" CI_START="-74.53509079723622" EFFECT_SIZE="19.69999999999999" ESTIMABLE="YES" MEAN_1="219.7" MEAN_2="200.0" MODIFIED="2016-11-29 10:25:55 +0000" MODIFIED_BY="[Empty name]" ORDER="363" SD_1="115.5" SD_2="120.0" SE="48.08001143926653" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" WEIGHT="7.759801990506504"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="23.78803162496703" CI_END="1.0511838037530132" CI_START="0.42654843588112357" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="OR" EFFECT_SIZE="0.6696124306749522" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="93" I2="24.331696359828815" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.021678660820270073" LOG_CI_START="-0.3700316462279147" LOG_EFFECT_SIZE="-0.17417649270382232" METHOD="MH" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="7" P_CHI2="0.1620957197459354" P_Q="1.0" P_Z="0.08132994033111526" Q="0.0" RANDOM="YES" SCALE="192.96" SORT_BY="STUDY" STUDIES="36" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.2299934352201109" TOTALS="YES" TOTAL_1="761" TOTAL_2="711" WEIGHT="100.00000000000001" Z="1.7430210362629126">
<NAME>Acceptability of electromechanical-assisted gait training devices during intervention phase: dropouts</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4273444546123293" CI_START="0.02625939738239119" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.534957754041735" LOG_CI_START="-1.5807152446024102" LOG_EFFECT_SIZE="-0.5228787452803376" MODIFIED="2009-12-01 11:40:34 +0000" MODIFIED_BY="[Empty name]" ORDER="99" O_E="0.0" SE="1.2427567921538165" STUDY_ID="STD-Aschbacher-2006" TOTAL_1="11" TOTAL_2="12" VAR="1.5444444444444445" WEIGHT="2.9836261342795933"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 08:50:55 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="291" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:32:54 +0000" MODIFIED_BY="[Empty name]" ORDER="195" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 08:51:07 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="281" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.599830948521582" CI_START="0.14173001147239686" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5562821063650373" LOG_CI_START="-0.8485381777215133" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2013-01-03 11:21:39 +0000" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="0.8251983888449983" STUDY_ID="STD-Chang-2012" TOTAL_1="24" TOTAL_2="24" VAR="0.680952380952381" WEIGHT="5.81182671617907"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 08:51:24 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="282" O_E="0.0" SE="0.0" STUDY_ID="STD-Cho-2015" TOTAL_1="13" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.2879351714618394" CI_START="0.17022356881394457" EFFECT_SIZE="0.4682274247491639" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="13" LOG_CI_END="0.10989400325285585" LOG_CI_START="-0.7689803085452391" LOG_EFFECT_SIZE="-0.3295431526461916" MODIFIED="2016-08-30 08:57:18 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="283" O_E="0.0" SE="0.5162551212482084" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2665193502150024" WEIGHT="10.662886005610657"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:35:17 +0000" MODIFIED_BY="[Empty name]" ORDER="3231" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="219.24704405352577" CI_START="0.4380446742832863" EFFECT_SIZE="9.8" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.340933746804799" LOG_CI_START="-0.3584815954198092" LOG_EFFECT_SIZE="0.9912260756924949" MODIFIED="2009-12-01 11:40:35 +0000" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="1.5856499343441837" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.5142857142857142" WEIGHT="1.9291985045968072"/>
<DICH_DATA CI_END="9.019731760754187" CI_START="0.19709874139639916" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9551936221809109" LOG_CI_START="-0.705316148964311" LOG_EFFECT_SIZE="0.12493873660829993" MODIFIED="2016-08-30 09:40:14 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="691" O_E="0.0" SE="0.9753916592266354" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" VAR="0.9513888888888888" WEIGHT="4.481410567417939"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:32:36 +0000" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.8774871341257486" CI_START="0.004963980659077508" EFFECT_SIZE="0.0965391621129326" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2735769695924046" LOG_CI_START="-2.304169919291011" LOG_EFFECT_SIZE="-1.015296474849303" MODIFIED="2016-11-29 11:26:47 +0000" MODIFIED_BY="[Empty name]" ORDER="367" O_E="0.0" SE="1.5141812825830094" STUDY_ID="STD-Han-2016" TOTAL_1="30" TOTAL_2="30" VAR="2.2927449565247278" WEIGHT="2.0986160311934245"/>
<DICH_DATA CI_END="1.9798076629979084" CI_START="0.10435941536617445" EFFECT_SIZE="0.45454545454545453" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.29662300088979954" LOG_CI_START="-0.9814683625342121" LOG_EFFECT_SIZE="-0.3424226808222062" MODIFIED="2009-12-01 11:40:36 +0000" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.7507571935295483" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.5636363636363636" WEIGHT="6.670943100991457"/>
<DICH_DATA CI_END="1.13265990405373" CI_START="0.08545382696993456" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.054099526840219014" LOG_CI_START="-1.0682684830344302" LOG_EFFECT_SIZE="-0.5070844780971057" MODIFIED="2009-12-01 11:40:37 +0000" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="0.6592845248116208" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.4346560846560847" WEIGHT="7.965490191596014"/>
<DICH_DATA CI_END="15.326426844443326" CI_START="0.04995456591224856" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1854409165883406" LOG_CI_START="-1.3014248105437143" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2009-12-01 11:40:37 +0000" MODIFIED_BY="[Empty name]" ORDER="3232" O_E="0.0" SE="1.4607972383012544" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="2.1339285714285716" WEIGHT="2.239608251258879"/>
<DICH_DATA CI_END="8.209886041079294" CI_START="0.12180437036474837" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.9143371288522161" LOG_CI_START="-0.9143371288522161" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:50:25 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="285" O_E="0.0" SE="1.0741723110591492" STUDY_ID="STD-Kim-2015" TOTAL_1="15" TOTAL_2="15" VAR="1.1538461538461537" WEIGHT="3.8257752367057924"/>
<DICH_DATA CI_END="0.4864352199264486" CI_START="0.005620463091425037" EFFECT_SIZE="0.05228758169934641" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.31297498787603706" LOG_CI_START="-2.250227899775273" LOG_EFFECT_SIZE="-1.281601443825655" MODIFIED="2009-12-01 11:40:38 +0000" MODIFIED_BY="[Empty name]" ORDER="97" O_E="0.0" SE="1.1379519500061837" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" VAR="1.2949346405228759" WEIGHT="3.4718091401414637"/>
<DICH_DATA CI_END="1.3575782733605566" CI_START="0.10475102174348923" EFFECT_SIZE="0.3771043771043771" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.13276487893018143" LOG_CI_START="-0.979841732224243" LOG_EFFECT_SIZE="-0.42353842664703073" MODIFIED="2016-11-29 12:04:14 +0000" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="0.6535506308836577" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.4271284271284271" WEIGHT="8.056738840648642"/>
<DICH_DATA CI_END="5.265186257345822" CI_START="0.5275744564406074" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.7214137390745397" LOG_CI_START="-0.2777162398418268" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2013-01-04 08:22:01 +0000" MODIFIED_BY="[Empty name]" ORDER="187" O_E="0.0" SE="0.5868938953886337" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.34444444444444444" WEIGHT="9.216417333958606"/>
<DICH_DATA CI_END="7.57071061818991" CI_START="0.010015493982173902" EFFECT_SIZE="0.2753623188405797" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8791366460884618" LOG_CI_START="-1.9993276256573145" LOG_EFFECT_SIZE="-0.5600954897844264" MODIFIED="2013-01-04 09:24:03 +0000" MODIFIED_BY="[Empty name]" ORDER="196" O_E="0.0" SE="1.690824161851413" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="2.8588863463005336" WEIGHT="1.7139738694577782"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:05:24 +0000" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="0.0" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3233" O_E="0.0" SE="0.0" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="9.339704265976655" CI_START="0.5209926156594928" EFFECT_SIZE="2.2058823529411766" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.970333124871653" LOG_CI_START="-0.28316843217276316" LOG_EFFECT_SIZE="0.34358234634944496" MODIFIED="2009-12-01 11:40:39 +0000" MODIFIED_BY="[Empty name]" ORDER="88" O_E="0.0" SE="0.7363130195406693" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.542156862745098" WEIGHT="6.856513874791487"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:00:40 +0000" MODIFIED_BY="[Empty name]" ORDER="645" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8537392283166456" CI_START="0.24334544570636224" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.45541428521963356" LOG_CI_START="-0.6137767773148833" LOG_EFFECT_SIZE="-0.0791812460476248" MODIFIED="2009-12-01 11:40:39 +0000" MODIFIED_BY="[Empty name]" ORDER="3234" O_E="0.0" SE="0.6280481227138924" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.39444444444444443" WEIGHT="8.47844021612988"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3235" O_E="0.0" SE="0.0" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="9.967717889424831" CI_START="0.28890325592868416" EFFECT_SIZE="1.696969696969697" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9985957379025885" LOG_CI_START="-0.5392475636459625" LOG_EFFECT_SIZE="0.22967408712831294" MODIFIED="2009-12-01 11:40:40 +0000" MODIFIED_BY="[Empty name]" ORDER="3236" O_E="0.0" SE="0.9033367677767334" STUDY_ID="STD-Schwartz-2006" TOTAL_1="37" TOTAL_2="30" VAR="0.816017316017316" WEIGHT="5.061381276587976"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:58:33 +0000" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="0.0" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:30:26 +0000" MODIFIED_BY="[Empty name]" ORDER="197" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1408944460879" CI_START="0.0029529493539625215" EFFECT_SIZE="0.05804311774461028" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.05724546597641195" LOG_CI_START="-2.529744001556163" LOG_EFFECT_SIZE="-1.2362492677898758" MODIFIED="2009-12-01 11:40:40 +0000" MODIFIED_BY="[Empty name]" ORDER="3237" O_E="0.0" SE="1.5196104190330284" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="2.309215825633736" WEIGHT="2.0850031200825736"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 11:59:48 +0000" MODIFIED_BY="[Empty name]" ORDER="644" O_E="0.0" SE="0.0" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:30:20 +0000" MODIFIED_BY="[Empty name]" ORDER="198" O_E="0.0" SE="0.0" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:45:57 +0000" MODIFIED_BY="[Empty name]" ORDER="392" O_E="0.0" SE="0.0" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.8327592021377965" CI_START="0.3292959598658229" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.8345961157284643" LOG_CI_START="-0.48241359761710184" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2016-11-29 12:02:18 +0000" MODIFIED_BY="[Empty name]" ORDER="288" O_E="0.0" SE="0.7736180249224086" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.5984848484848485" WEIGHT="6.390341588371973"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3238" O_E="0.0" SE="0.0" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-05 11:24:21 +0100" MODIFIED_BY="[Empty name]" ORDER="95" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8143142750778147" CI_END="0.016863241240211383" CI_START="-0.012539431550473327" CI_STUDY="95" CI_TOTAL="95" DF="35" EFFECT_MEASURE="RD" EFFECT_SIZE="0.002161904844869029" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-1.7730589470630556" LOG_CI_START="NaN" LOG_EFFECT_SIZE="-2.6651634252105296" METHOD="MH" MODIFIED="2016-11-30 07:00:29 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.7731764424637987" Q="0.0" RANDOM="YES" SCALE="0.2527804319112084" SORT_BY="STUDY" STUDIES="36" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="761" TOTAL_2="711" WEIGHT="99.99999999999999" Z="0.28822247991607">
<NAME>Death from all causes until the end of intervention phase</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.1539830164746612" CI_START="-0.1539830164746612" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:18 +0100" MODIFIED_BY="[Empty name]" ORDER="167" O_E="0.0" SE="0.07856420714322282" STUDY_ID="STD-Aschbacher-2006" TOTAL_1="11" TOTAL_2="12" VAR="0.006172334644043224" WEIGHT="0.9115237405564809"/>
<DICH_DATA CI_END="0.19103365880544243" CI_START="-0.19103365880544243" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:47:49 +0000" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="0.09746794344808964" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0095" WEIGHT="0.5922346908110142"/>
<DICH_DATA CI_END="0.2540361136080607" CI_START="-0.2540361136080607" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:29:56 +0000" MODIFIED_BY="[Empty name]" ORDER="555" O_E="0.0" SE="0.12961264370767278" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.01679943740889213" WEIGHT="0.3349058320087915"/>
<DICH_DATA CI_END="0.0746548727053014" CI_START="-0.0746548727053014" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:48:25 +0000" MODIFIED_BY="[Empty name]" ORDER="394" O_E="0.0" SE="0.038089920679241815" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0014508420573509332" WEIGHT="3.8779063056508494"/>
<DICH_DATA CI_END="0.07761061416358196" CI_START="-0.07761061416358196" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:29:49 +0000" MODIFIED_BY="[Empty name]" ORDER="556" O_E="0.0" SE="0.03959797974644666" STUDY_ID="STD-Chang-2012" TOTAL_1="24" TOTAL_2="24" VAR="0.001568" WEIGHT="3.588156608867752"/>
<DICH_DATA CI_END="0.19386938240252483" CI_START="-0.19386938240252483" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:49:01 +0000" MODIFIED_BY="[Empty name]" ORDER="395" O_E="0.0" SE="0.09891476778743985" STUDY_ID="STD-Cho-2015" TOTAL_1="13" TOTAL_2="7" VAR="0.009784131286443148" WEIGHT="0.5750361884963988"/>
<DICH_DATA CI_END="0.08190479543590416" CI_START="-0.0441689463793004" EFFECT_SIZE="0.018867924528301886" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 08:57:43 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="293" O_E="0.0" SE="0.032162259819480905" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.0010344109566957959" WEIGHT="5.439066094849207"/>
<DICH_DATA CI_END="0.09221383405689625" CI_START="-0.09221383405689625" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3239" O_E="0.0" SE="0.04704873905044542" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0022135838462369077" WEIGHT="2.54168351122964"/>
<DICH_DATA CI_END="0.17408193796294572" CI_START="-0.17408193796294572" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:21 +0100" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="0.08881894735621768" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="0.007888805409466567" WEIGHT="0.713191575996178"/>
<DICH_DATA CI_END="0.09517784398938751" CI_START="-0.09517784398938751" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:49:48 +0000" MODIFIED_BY="[Empty name]" ORDER="396" O_E="0.0" SE="0.048561016804460795" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" VAR="0.002358172353083124" WEIGHT="2.385843238026595"/>
<DICH_DATA CI_END="0.13929808382818423" CI_START="-0.13929808382818423" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:29:42 +0000" MODIFIED_BY="[Empty name]" ORDER="557" O_E="0.0" SE="0.07107175689295811" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.005051194627851738" WEIGHT="1.1138413736192656"/>
<DICH_DATA CI_END="0.0627126957943536" CI_START="-0.0627126957943536" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 11:26:28 +0000" MODIFIED_BY="[Empty name]" ORDER="366" O_E="0.0" SE="0.03199686131430135" STUDY_ID="STD-Han-2016" TOTAL_1="30" TOTAL_2="30" VAR="0.0010237991339666342" WEIGHT="5.495442783689632"/>
<DICH_DATA CI_END="0.10141519131686665" CI_START="-0.04585963576131109" EFFECT_SIZE="0.027777777777777776" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:25 +0100" MODIFIED_BY="[Empty name]" ORDER="168" O_E="0.0" SE="0.037570799320768844" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.0014115649616014846" WEIGHT="3.9858098746808097"/>
<DICH_DATA CI_END="0.06076848377034642" CI_START="-0.06076848377034642" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:32 +0100" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.031004898176538172" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="9.613037109375E-4" WEIGHT="5.8527076289112845"/>
<DICH_DATA CI_END="0.11415730735949331" CI_START="-0.11415730735949331" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3240" O_E="0.0" SE="0.058244594421097313" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0033924327792781207" WEIGHT="1.6584645676905192"/>
<DICH_DATA CI_END="0.12056853005506211" CI_START="-0.12056853005506211" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 11:29:06 +0000" MODIFIED_BY="[Empty name]" ORDER="368" O_E="0.0" SE="0.061515686515717274" STUDY_ID="STD-Kim-2015" TOTAL_1="15" TOTAL_2="15" VAR="0.0037841796875" WEIGHT="1.4867765347637538"/>
<DICH_DATA CI_END="0.10461391122811728" CI_START="-0.10461391122811728" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:40 +0100" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.05337542529010658" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" VAR="0.002848936024899749" WEIGHT="1.9748528971978634"/>
<DICH_DATA CI_END="0.05123754703037039" CI_START="-0.05123754703037039" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:43 +0100" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.02614208599470481" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="6.834086601545414E-4" WEIGHT="8.2325991617261"/>
<DICH_DATA CI_END="0.07761061416358196" CI_START="-0.07761061416358196" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:29:34 +0000" MODIFIED_BY="[Empty name]" ORDER="558" O_E="0.0" SE="0.03959797974644666" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.001568" WEIGHT="3.588156608867752"/>
<DICH_DATA CI_END="0.16713734661541962" CI_START="-0.16713734661541962" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 09:24:29 +0000" MODIFIED_BY="[Empty name]" ORDER="559" O_E="0.0" SE="0.08527572339786735" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="0.00727194900102958" WEIGHT="0.773689359194909"/>
<DICH_DATA CI_END="0.1374747446715621" CI_START="-0.1374747446715621" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:53:32 +0000" MODIFIED_BY="[Empty name]" ORDER="397" O_E="0.0" SE="0.07014146471871184" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.004919825072886298" WEIGHT="1.14358325333789"/>
<DICH_DATA CI_END="0.09609800376031115" CI_START="-0.09609800376031115" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3241" O_E="0.0" SE="0.04903049470210674" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.002403989410733317" WEIGHT="2.3403720239301715"/>
<DICH_DATA CI_END="0.07139663666251884" CI_START="-0.07139663666251884" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:48 +0100" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.03642752480437723" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.0013269645633735183" WEIGHT="4.239924499868461"/>
<DICH_DATA CI_END="0.15989141359795075" CI_START="-0.15989141359795075" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:54:33 +0000" MODIFIED_BY="[Empty name]" ORDER="398" O_E="0.0" SE="0.08157875086438007" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.006655092592592593" WEIGHT="0.8454021464655311"/>
<DICH_DATA CI_END="0.035702456992692144" CI_START="-0.03536945665969181" EFFECT_SIZE="1.665001665001678E-4" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3242" O_E="0.0" SE="0.01813092337741666" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="3.2873038251775397E-4" WEIGHT="17.115027578568206"/>
<DICH_DATA CI_END="0.21163806869411805" CI_START="-0.21163806869411805" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3243" O_E="0.0" SE="0.10798059064528334" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="0.011659807956104253" WEIGHT="0.4825319236719622"/>
<DICH_DATA CI_END="0.05726328858651305" CI_START="-0.05726328858651305" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:23:57 +0100" MODIFIED_BY="[Empty name]" ORDER="3244" O_E="0.0" SE="0.0292165004245989" STUDY_ID="STD-Schwartz-2006" TOTAL_1="37" TOTAL_2="30" VAR="8.536038970605878E-4" WEIGHT="6.5911479341633"/>
<DICH_DATA CI_END="0.14783867756078112" CI_START="-0.14783867756078112" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:56:04 +0000" MODIFIED_BY="[Empty name]" ORDER="399" O_E="0.0" SE="0.07542928274545539" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.005689576695493855" WEIGHT="0.9888661079409665"/>
<DICH_DATA CI_END="0.27756647232585885" CI_START="-0.27756647232585885" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:29:21 +0000" MODIFIED_BY="[Empty name]" ORDER="560" O_E="0.0" SE="0.14161814937175773" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.020055700231481483" WEIGHT="0.2805301982861276"/>
<DICH_DATA CI_END="0.07426542617911538" CI_START="-0.07426542617911538" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-11 09:24:00 +0100" MODIFIED_BY="[Empty name]" ORDER="3245" O_E="0.0" SE="0.03789121982082915" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.001435744539510396" WEIGHT="3.9186842839208973"/>
<DICH_DATA CI_END="0.15989141359795075" CI_START="-0.15989141359795075" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:59:00 +0000" MODIFIED_BY="[Empty name]" ORDER="400" O_E="0.0" SE="0.08157875086438007" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.006655092592592593" WEIGHT="0.8454021464655311"/>
<DICH_DATA CI_END="0.1212545709944118" CI_START="-0.1212545709944118" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 14:29:09 +0000" MODIFIED_BY="[Empty name]" ORDER="561" O_E="0.0" SE="0.06186571383497471" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.0038273665483109813" WEIGHT="1.4700001924789494"/>
<DICH_DATA CI_END="0.14783867756078112" CI_START="-0.14783867756078112" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 06:59:35 +0000" MODIFIED_BY="[Empty name]" ORDER="401" O_E="0.0" SE="0.07542928274545539" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" VAR="0.005689576695493855" WEIGHT="0.9888661079409665"/>
<DICH_DATA CI_END="0.11415730735949331" CI_START="-0.11415730735949331" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 07:00:29 +0000" MODIFIED_BY="[Empty name]" ORDER="402" O_E="0.0" SE="0.058244594421097313" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.0033924327792781207" WEIGHT="1.6584645676905192"/>
<DICH_DATA CI_END="0.12056853005506211" CI_START="-0.12056853005506211" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="3246" O_E="0.0" SE="0.061515686515717274" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="0.0037841796875" WEIGHT="1.4867765347637538"/>
<DICH_DATA CI_END="0.21163806869411805" CI_START="-0.21163806869411805" EFFECT_SIZE="0.0" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-08-05 11:30:44 +0100" MODIFIED_BY="[Empty name]" ORDER="96" O_E="0.0" SE="0.10798059064528334" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.011659807956104253" WEIGHT="0.4825319236719622"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2016-12-05 14:25:47 +0000" MODIFIED_BY="Jan Mehrholz" NO="2">
<NAME>Planned sensitivity analysis by trial methodology</NAME>
<DICH_OUTCOME CHI2="58.80905282244579" CI_END="2.226730970967312" CI_START="1.4526689543400737" CI_STUDY="95" CI_TOTAL="95" DF="48" EFFECT_MEASURE="OR" EFFECT_SIZE="1.7985279956652724" ESTIMABLE="YES" EVENTS_1="1253" EVENTS_2="980" I2="18.379913131878013" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.3476677496419699" LOG_CI_START="0.1621666551211536" LOG_EFFECT_SIZE="0.25491720238156174" METHOD="MH" MODIFIED="2016-12-05 14:25:47 +0000" MODIFIED_BY="Jan Mehrholz" NO="1" P_CHI2="0.1363808707124965" P_Q="0.9568348778682578" P_Z="7.172365061665871E-8" Q="0.6543667890972802" RANDOM="YES" SCALE="78.3" SORT_BY="STUDY" STUDIES="36" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0889633870344359" TOTALS="SUB" TOTAL_1="2292" TOTAL_2="2157" WEIGHT="500.0" Z="5.386798789497197">
<NAME>Regaining independent walking ability</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="12.828798673596465" CI_END="3.077768326763272" CI_START="1.0554102753008188" DF="8" EFFECT_SIZE="1.802306388231858" ESTIMABLE="YES" EVENTS_1="268" EVENTS_2="208" I2="37.64030285653197" ID="CMP-002.01.01" LOG_CI_END="0.48823592602339977" LOG_CI_START="0.023421318081319316" LOG_EFFECT_SIZE="0.2558286220523595" MODIFIED="2016-11-29 12:24:41 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.11787752224671266" P_Z="0.030968024172481717" STUDIES="20" TAU2="0.23329333552427223" TOTAL_1="490" TOTAL_2="459" WEIGHT="100.0" Z="2.1574833358060657">
<NAME>All studies with adequate sequence generation process</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:23:26 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:23:34 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.756705021132648" CI_START="0.36275190574765587" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4403902972816345" LOG_CI_START="-0.4403902972816345" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:10:02 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="292" O_E="0.0" SE="0.5173748811807234" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2676767676767677" WEIGHT="14.880685287776794"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="36" EVENTS_2="36" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.0" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2016-11-29 12:23:52 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="13.400422516611592"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="11.340593157592826"/>
<DICH_DATA CI_END="2.051562302092196" CI_START="0.1658627561204261" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.31208471021056267" LOG_CI_START="-0.7802511222772986" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.641643475152946" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.4117063492063492" WEIGHT="11.557801687039833"/>
<DICH_DATA CI_END="6.757670374009947" CI_START="0.4306268937396148" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.8297970039171373" LOG_CI_START="-0.365898850875773" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.7023576638952937" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.4933062880324544" WEIGHT="10.259816001319095"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:24:09 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="20.668772809401787"/>
<DICH_DATA CI_END="19.359572851219983" CI_START="0.05165403222917612" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2868957708233757" LOG_CI_START="-1.2868957708233757" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="1.5118578920369088" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="2.2857142857142856" WEIGHT="2.959410833641835"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="12.474966193493811"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:24:33 +0000" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.0" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:24:41 +0000" MODIFIED_BY="[Empty name]" ORDER="1031" O_E="0.0" SE="0.0" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2013-01-04 14:00:11 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="2.457531513122426"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.638992557152186" CI_END="3.1152077604427975" CI_START="1.1236573804889278" DF="8" EFFECT_SIZE="1.8709425944635323" ESTIMABLE="YES" EVENTS_1="228" EVENTS_2="166" I2="36.70381587911499" ID="CMP-002.01.02" LOG_CI_END="0.4934870160690247" LOG_CI_START="0.05063390870097028" LOG_EFFECT_SIZE="0.2720604623849975" MODIFIED="2016-11-29 12:26:47 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.12488924650998623" P_Z="0.016033521880025436" STUDIES="17" TAU2="0.21121896976138574" TOTAL_1="430" TOTAL_2="401" WEIGHT="100.00000000000001" Z="2.408151592571953">
<NAME>All studies with adequate concealed allocation</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:25:45 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.756705021132648" CI_START="0.36275190574765587" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4403902972816345" LOG_CI_START="-0.4403902972816345" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:10:13 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="292" O_E="0.0" SE="0.5173748811807234" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2676767676767677" WEIGHT="14.130372971879128"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2016-11-29 12:26:11 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="12.666667994669893"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-04 13:30:59 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="10.651971976005472"/>
<DICH_DATA CI_END="2.051562302092196" CI_START="0.1658627561204261" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.31208471021056267" LOG_CI_START="-0.7802511222772986" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.641643475152946" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.4117063492063492" WEIGHT="10.863220965007377"/>
<DICH_DATA CI_END="6.757670374009947" CI_START="0.4306268937396148" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.8297970039171373" LOG_CI_START="-0.365898850875773" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.7023576638952937" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.4933062880324544" WEIGHT="9.605014596402695"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:26:22 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="19.98492668299049"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="11.75833242061048"/>
<DICH_DATA CI_END="10.5953772444188" CI_START="0.4778027136944757" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="1.0251164242136594" LOG_CI_START="-0.3207513879909346" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.625" WEIGHT="8.092348570584514"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="2.247143821849961"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 13:20:09 +0000" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.662818846554766" CI_END="2.9825968545848527" CI_START="1.1032470085399873" DF="8" EFFECT_SIZE="1.8139848559184595" ESTIMABLE="YES" EVENTS_1="200" EVENTS_2="157" I2="31.40594820811072" ID="CMP-002.01.03" LOG_CI_END="0.4745945555205098" LOG_CI_START="0.04267275852907586" LOG_EFFECT_SIZE="0.2586336570247928" MODIFIED="2016-11-29 12:29:14 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.16689399734390464" P_Z="0.018912928356896088" STUDIES="16" TAU2="0.17022789515574457" TOTAL_1="388" TOTAL_2="374" WEIGHT="100.00000000000001" Z="2.347242748522516">
<NAME>All studies with blinded assessors for primary outcome</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:28:04 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:28:04 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.756705021132648" CI_START="0.36275190574765587" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4403902972816345" LOG_CI_START="-0.4403902972816345" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:10:22 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="292" O_E="0.0" SE="0.5173748811807234" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2676767676767677" WEIGHT="14.699612186037719"/>
<DICH_DATA CI_END="18.57361085218092" CI_START="0.05383982726668248" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="1.268896342120762" LOG_CI_START="-1.268896342120762" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:01:58 +0000" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="1.4907119849998598" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.2222222222222223" WEIGHT="2.6905592184928273"/>
<DICH_DATA CI_END="2.751430751085456" CI_START="0.36344727178959313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.43955858681829196" LOG_CI_START="-0.4395585868182919" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:28:16 +0000" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Han-2016" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="14.733597715762038"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:01:58 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2016-11-29 12:28:29 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="13.050400498635105"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-04 14:01:58 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="10.831496218869082"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:28:39 +0000" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.0" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:28:39 +0000" MODIFIED_BY="[Empty name]" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="8.155616894555"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:28:57 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2013-01-04 14:01:58 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="21.628864067418288"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:29:05 +0000" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.0" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2013-01-04 14:01:58 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="12.042777965601145"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:29:14 +0000" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.0" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2013-01-04 14:01:58 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="2.167075234628795"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="8.500770029850719" CI_END="4.286572588522864" CI_START="1.1560782108170884" DF="6" EFFECT_SIZE="2.2261206545641428" ESTIMABLE="YES" EVENTS_1="186" EVENTS_2="141" I2="29.418158838189797" ID="CMP-002.01.04" LOG_CI_END="0.6321101824376529" LOG_CI_START="0.06298721589879376" LOG_EFFECT_SIZE="0.34754869916822334" MODIFIED="2016-11-30 12:58:46 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.2036616257155871" P_Z="0.01667489372083831" STUDIES="14" TAU2="0.21212439656388885" TOTAL_1="300" TOTAL_2="290" WEIGHT="99.99999999999997" Z="2.3937987861783228">
<NAME>All studies without incomplete outcome data</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:30:08 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:30:08 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.756705021132648" CI_START="0.36275190574765587" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4403902972816345" LOG_CI_START="-0.4403902972816345" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:10:28 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="292" O_E="0.0" SE="0.5173748811807234" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2676767676767677" WEIGHT="23.293037709440124"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="18.57361085218092" CI_START="0.05383982726668248" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="1.268896342120762" LOG_CI_START="-1.268896342120762" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="1.4907119849998598" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.2222222222222223" WEIGHT="4.590975880527573"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="17.567271423755496"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:30:24 +0000" MODIFIED_BY="[Empty name]" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="13.446105501360616"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 12:58:46 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="32.918166423946644"/>
<DICH_DATA CI_END="19.359572851219983" CI_START="0.05165403222917612" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2868957708233757" LOG_CI_START="-1.2868957708233757" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="1.5118578920369088" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="2.2857142857142856" WEIGHT="4.474278779884096"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="3.710164281085431"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:04:11 +0000" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.23649547635922" CI_END="2.343921438753086" CI_START="1.1664123597603608" DF="14" EFFECT_SIZE="1.6534748067233704" ESTIMABLE="YES" EVENTS_1="371" EVENTS_2="308" I2="0.0" ID="CMP-002.01.05" LOG_CI_END="0.36994305133590005" LOG_CI_START="0.06685211295202247" LOG_EFFECT_SIZE="0.2183975821439613" MODIFIED="2016-12-05 14:25:47 +0000" MODIFIED_BY="Jan Mehrholz" NO="5" P_CHI2="0.6673656916509176" P_Z="0.004734351139981652" STUDIES="35" TAU2="0.0" TOTAL_1="684" TOTAL_2="633" WEIGHT="100.00000000000001" Z="2.8245740212176633">
<NAME>All studies excluding the largest study Pohl 2007</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.0" STUDY_ID="STD-Aschbacher-2006" TOTAL_1="11" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="44.60390216120258" CI_START="0.4743979556659822" EFFECT_SIZE="4.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.6493728545181054" LOG_CI_START="-0.3238571911549576" LOG_EFFECT_SIZE="0.6627578316815741" MODIFIED="2016-12-05 14:25:47 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="330" O_E="0.0" SE="1.159085096474614" STUDY_ID="STD-Chang-2012" TOTAL_1="24" TOTAL_2="24" VAR="1.3434782608695652" WEIGHT="2.3593396441147014"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="0.0" STUDY_ID="STD-Cho-2015" TOTAL_1="13" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.2281669796023875" CI_START="0.49065440130963517" EFFECT_SIZE="1.2585365853658537" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.5089559908716995" LOG_CI_START="-0.30922430105674775" LOG_EFFECT_SIZE="0.09986584490747587" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="292" O_E="0.0" SE="0.48060315353653343" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.23097939118926075" WEIGHT="13.722962492695373"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="18.57361085218092" CI_START="0.05383982726668248" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="1.268896342120762" LOG_CI_START="-1.268896342120762" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="1.4907119849998598" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.2222222222222223" WEIGHT="1.4263746848441268"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="689" O_E="0.0" SE="0.0" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.751430751085456" CI_START="0.36344727178959313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.43955858681829196" LOG_CI_START="-0.4395585868182919" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Han-2016" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="11.886455707034392"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="36" EVENTS_2="36" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.0" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="694" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2015" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.311173317152111" CI_START="0.7216992505758693" EFFECT_SIZE="2.857142857142857" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="1.053507656979829" LOG_CI_START="-0.14164374568038038" LOG_EFFECT_SIZE="0.4559319556497244" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="0.7020378500174638" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" VAR="0.4928571428571429" WEIGHT="6.431319029893003"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="9.812897094750753"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="7.4746979150618165"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.0" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="5.120319381491738"/>
<DICH_DATA CI_END="2.051562302092196" CI_START="0.1658627561204261" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.31208471021056267" LOG_CI_START="-0.7802511222772986" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.641643475152946" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.4117063492063492" WEIGHT="7.698986250724926"/>
<DICH_DATA CI_END="6.757670374009947" CI_START="0.4306268937396148" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.8297970039171373" LOG_CI_START="-0.365898850875773" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.7023576638952937" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.4933062880324544" WEIGHT="6.425463446894687"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="19.359572851219983" CI_START="0.05165403222917612" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2868957708233757" LOG_CI_START="-1.2868957708233757" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="1.5118578920369088" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="2.2857142857142856" WEIGHT="1.386753165820679"/>
<DICH_DATA CI_END="9.114781488652717" CI_START="1.1483685089667286" EFFECT_SIZE="3.235294117647059" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" LOG_CI_END="0.9597462616459747" LOG_CI_START="0.06008127458596511" LOG_EFFECT_SIZE="0.5099137681159699" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.5284676668125593" STUDY_ID="STD-Schwartz-2006" TOTAL_1="37" TOTAL_2="30" VAR="0.2792780748663102" WEIGHT="11.349696976367289"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.0" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="8.701196334561125"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.0" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="10.5953772444188" CI_START="0.4778027136944757" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="1.0251164242136594" LOG_CI_START="-0.3207513879909346" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.625" WEIGHT="5.071554435001341"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="344" O_E="0.0" SE="0.0" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1031" O_E="0.0" SE="0.0" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="1.131983440744059"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-29 12:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="3">
<NAME>Subgroup analysis comparing participants in acute and chronic phases of stroke</NAME>
<DICH_OUTCOME CHI2="18.57802710545507" CI_END="2.5049195534364768" CI_START="1.3483889650557734" CI_STUDY="95" CI_TOTAL="95" DF="17" EFFECT_MEASURE="OR" EFFECT_SIZE="1.8378264020864923" ESTIMABLE="YES" EVENTS_1="427" EVENTS_2="340" I2="8.494051044805046" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.3987937828740683" LOG_CI_START="0.12981518968474287" LOG_EFFECT_SIZE="0.2643044862794056" METHOD="IV" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.35328351662517354" P_Q="0.4354089895999902" P_Z="1.1724778002169071E-4" Q="0.6083524682433247" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="36" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.03846875012621315" TOTALS="SUB" TOTAL_1="827" TOTAL_2="777" WEIGHT="200.0" Z="3.851810420432775">
<NAME>Independent walking at the end of intervention phase, all electromechanical devices used</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="14.73415873758255" CI_END="2.6297656925956847" CI_START="1.3797668241173286" DF="14" EFFECT_SIZE="1.904852607905781" ESTIMABLE="YES" EVENTS_1="215" EVENTS_2="151" I2="4.982698711599497" ID="CMP-003.01.01" LOG_CI_END="0.41991705535444435" LOG_CI_START="0.13980569831749473" LOG_EFFECT_SIZE="0.27986137683596957" MODIFIED="2016-11-30 09:53:56 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.39656527914634965" P_Z="8.987000538051254E-5" STUDIES="20" TAU2="0.020444266552606335" TOTAL_1="579" TOTAL_2="564" WEIGHT="100.00000000000001" Z="3.916429701848448">
<NAME>Acute phase: less than or equal to 3 months after stroke</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.0" STUDY_ID="STD-Aschbacher-2006" TOTAL_1="11" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="44.60390216120258" CI_START="0.4743979556659822" EFFECT_SIZE="4.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.6493728545181054" LOG_CI_START="-0.3238571911549576" LOG_EFFECT_SIZE="0.6627578316815741" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.159085096474614" STUDY_ID="STD-Chang-2012" TOTAL_1="24" TOTAL_2="24" VAR="1.3434782608695652" WEIGHT="1.9849379567599201"/>
<DICH_DATA CI_END="3.2281669796023875" CI_START="0.49065440130963517" EFFECT_SIZE="1.2585365853658537" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.5089559908716995" LOG_CI_START="-0.30922430105674775" LOG_EFFECT_SIZE="0.09986584490747587" MODIFIED="2016-11-30 09:53:56 +0000" MODIFIED_BY="[Empty name]" ORDER="292" O_E="0.0" SE="0.48060315353653343" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.23097939118926075" WEIGHT="10.767887234938478"/>
<DICH_DATA CI_END="2.756705021132648" CI_START="0.36275190574765587" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4403902972816345" LOG_CI_START="-0.4403902972816345" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:11:13 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="292" O_E="0.0" SE="0.5173748811807234" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2676767676767677" WEIGHT="9.396403848130367"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:53:56 +0000" MODIFIED_BY="[Empty name]" ORDER="689" O_E="0.0" SE="0.0" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.751430751085456" CI_START="0.36344727178959313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.43955858681829196" LOG_CI_START="-0.4395585868182919" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:53:56 +0000" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Han-2016" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="9.429461861323704"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="36" EVENTS_2="36" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.0" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:53:56 +0000" MODIFIED_BY="[Empty name]" ORDER="694" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2015" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="7.882433164330582"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="6.090606733375585"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 10:01:03 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="4.233519854937839"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:53:56 +0000" MODIFIED_BY="[Empty name]" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="4.233519854937839"/>
<DICH_DATA CI_END="6.757670374009947" CI_START="0.4306268937396148" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.8297970039171373" LOG_CI_START="-0.365898850875773" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.7023576638952937" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.4933062880324544" WEIGHT="5.269681113914883"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="18.313705891922666"/>
<DICH_DATA CI_END="19.359572851219983" CI_START="0.05165403222917612" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2868957708233757" LOG_CI_START="-1.2868957708233757" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="1.5118578920369088" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="2.2857142857142856" WEIGHT="1.1739442598597511"/>
<DICH_DATA CI_END="9.114781488652717" CI_START="1.1483685089667286" EFFECT_SIZE="3.235294117647059" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" LOG_CI_END="0.9597462616459747" LOG_CI_START="0.06008127458596511" LOG_EFFECT_SIZE="0.5099137681159699" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.5284676668125593" STUDY_ID="STD-Schwartz-2006" TOTAL_1="37" TOTAL_2="30" VAR="0.2792780748663102" WEIGHT="9.0326986701877"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="7.036887504480478"/>
<DICH_DATA CI_END="10.5953772444188" CI_START="0.4778027136944757" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="1.0251164242136594" LOG_CI_START="-0.3207513879909346" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.625" WEIGHT="4.194477718766033"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:53:56 +0000" MODIFIED_BY="[Empty name]" ORDER="1031" O_E="0.0" SE="0.0" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2013-01-04 14:06:02 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="0.9598343321341765"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.8045371075503747" CI_END="3.647635418328085" CI_START="0.3965960761637604" DF="2" EFFECT_SIZE="1.2027626092396102" ESTIMABLE="YES" EVENTS_1="212" EVENTS_2="189" I2="28.68698386569391" ID="CMP-003.01.02" LOG_CI_END="0.5620114240311331" LOG_CI_START="-0.4016515869256146" LOG_EFFECT_SIZE="0.0801799185527593" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.246038466863842" P_Z="0.7443102301605453" STUDIES="16" TAU2="0.2847146928553743" TOTAL_1="248" TOTAL_2="213" WEIGHT="100.0" Z="0.32615084497378616">
<NAME>Chronic phase: more than 3 months after stroke</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="0.0" STUDY_ID="STD-Cho-2015" TOTAL_1="13" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="18.57361085218092" CI_START="0.05383982726668248" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="1.268896342120762" LOG_CI_START="-1.268896342120762" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="1.4907119849998598" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.2222222222222223" WEIGHT="12.781510391590787"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.311173317152111" CI_START="0.7216992505758693" EFFECT_SIZE="2.857142857142857" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="1.053507656979829" LOG_CI_START="-0.14164374568038038" LOG_EFFECT_SIZE="0.4559319556497244" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="0.7020378500174638" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" VAR="0.4928571428571429" WEIGHT="41.208334406512044"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.0" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.051562302092196" CI_START="0.1658627561204261" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.31208471021056267" LOG_CI_START="-0.7802511222772986" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.641643475152946" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.4117063492063492" WEIGHT="46.01015520189717"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.0" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.0" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="344" O_E="0.0" SE="0.0" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-04 14:06:07 +0000" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="4">
<NAME>Post hoc sensitivity analysis: ambulatory status at study onset</NAME>
<DICH_OUTCOME CHI2="17.22615677555838" CI_END="2.6735497989404267" CI_START="1.2550981832976997" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="OR" EFFECT_SIZE="1.8318208142736176" ESTIMABLE="YES" EVENTS_1="409" EVENTS_2="324" I2="12.92311921087935" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.42708827790844056" LOG_CI_START="0.09867770095373608" LOG_EFFECT_SIZE="0.2628829894310883" METHOD="MH" MODIFIED="2016-11-30 10:00:42 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3055255822538635" P_Q="0.8675313256950864" P_Z="0.0017022862977736069" Q="0.28420733834953393" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="36" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.06350424481977043" TOTALS="SUB" TOTAL_1="761" TOTAL_2="711" WEIGHT="300.0" Z="3.1377868289803637">
<NAME>Recovery of independent walking: ambulatory status at study onset</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.19646600754523" CI_START="0.4522011641261028" DF="0" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="229" EVENTS_2="213" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2016-11-30 09:56:44 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5730405943195487" STUDIES="15" TAU2="0.0" TOTAL_1="257" TOTAL_2="243" WEIGHT="100.0" Z="0.563579132527594">
<NAME>Studies that included independent walkers</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:56:44 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:56:44 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="36" EVENTS_2="36" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="0.0" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="74" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="188" O_E="0.0" SE="0.0" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:56:44 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:56:44 +0000" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.0" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:56:44 +0000" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.0" STUDY_ID="STD-Ucar-2014" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:56:44 +0000" MODIFIED_BY="[Empty name]" ORDER="344" O_E="0.0" SE="0.0" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:13:20 +0000" MODIFIED_BY="[Empty name]" ORDER="92" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.755928111195634" CI_END="3.253673910726608" CI_START="1.110515508003078" DF="7" EFFECT_SIZE="1.900856474289135" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="48" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="0.5123740249780822" LOG_CI_START="0.045524627713970936" LOG_EFFECT_SIZE="0.2789493263460266" MODIFIED="2013-07-03 15:54:13 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5685200742644156" P_Z="0.019169711860848104" STUDIES="9" TAU2="0.0" TOTAL_1="176" TOTAL_2="164" WEIGHT="100.00000000000001" Z="2.3422141545172415">
<NAME>Studies that included dependent and independent walkers</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:14:48 +0000" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.0" STUDY_ID="STD-Aschbacher-2006" TOTAL_1="11" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="44.60390216120258" CI_START="0.4743979556659822" EFFECT_SIZE="4.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.6493728545181054" LOG_CI_START="-0.3238571911549576" LOG_EFFECT_SIZE="0.6627578316815741" MODIFIED="2013-01-07 10:07:59 +0000" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.159085096474614" STUDY_ID="STD-Chang-2012" TOTAL_1="24" TOTAL_2="24" VAR="1.3434782608695652" WEIGHT="5.5975523703176"/>
<DICH_DATA CI_END="18.57361085218092" CI_START="0.05383982726668248" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="1.268896342120762" LOG_CI_START="-1.268896342120762" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:14:48 +0000" MODIFIED_BY="[Empty name]" ORDER="73" O_E="0.0" SE="1.4907119849998598" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.2222222222222223" WEIGHT="3.3840854656202706"/>
<DICH_DATA CI_END="11.311173317152111" CI_START="0.7216992505758693" EFFECT_SIZE="2.857142857142857" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="1.053507656979829" LOG_CI_START="-0.14164374568038038" LOG_EFFECT_SIZE="0.4559319556497244" MODIFIED="2013-01-07 09:14:48 +0000" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="0.7020378500174638" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" VAR="0.4928571428571429" WEIGHT="15.258356366725856"/>
<DICH_DATA CI_END="2.051562302092196" CI_START="0.1658627561204261" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.31208471021056267" LOG_CI_START="-0.7802511222772986" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-01-07 10:07:50 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.641643475152946" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.4117063492063492" WEIGHT="18.265907091540736"/>
<DICH_DATA CI_END="6.757670374009947" CI_START="0.4306268937396148" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.8297970039171373" LOG_CI_START="-0.365898850875773" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2013-01-07 09:14:48 +0000" MODIFIED_BY="[Empty name]" ORDER="65" O_E="0.0" SE="0.7023576638952937" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.4933062880324544" WEIGHT="15.244463948746285"/>
<DICH_DATA CI_END="19.359572851219983" CI_START="0.05165403222917612" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2868957708233757" LOG_CI_START="-1.2868957708233757" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:14:48 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="1.5118578920369088" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="2.2857142857142856" WEIGHT="3.290083091575263"/>
<DICH_DATA CI_END="9.114781488652717" CI_START="1.1483685089667286" EFFECT_SIZE="3.235294117647059" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" LOG_CI_END="0.9597462616459747" LOG_CI_START="0.06008127458596511" LOG_EFFECT_SIZE="0.5099137681159699" MODIFIED="2013-01-07 09:14:48 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.5284676668125593" STUDY_ID="STD-Schwartz-2006" TOTAL_1="37" TOTAL_2="30" VAR="0.2792780748663102" WEIGHT="26.92724778771302"/>
<DICH_DATA CI_END="10.5953772444188" CI_START="0.4778027136944757" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="1.0251164242136594" LOG_CI_START="-0.3207513879909346" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2013-01-07 09:14:48 +0000" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.625" WEIGHT="12.032303877760963"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="10.997156838614897" CI_END="3.4835758458893826" CI_START="1.037773047282888" DF="6" EFFECT_SIZE="1.9013577046494146" ESTIMABLE="YES" EVENTS_1="103" EVENTS_2="63" I2="45.44044348870352" ID="CMP-004.01.03" LOG_CI_END="0.5420252706170057" LOG_CI_START="0.016102387144881276" LOG_EFFECT_SIZE="0.2790638288809435" MODIFIED="2016-11-30 10:00:42 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.08846443543567328" P_Z="0.03752718791570125" STUDIES="12" TAU2="0.28223825334275404" TOTAL_1="328" TOTAL_2="304" WEIGHT="100.0" Z="2.079981956227194">
<NAME>Studies that included dependent walkers</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:57:47 +0000" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="0.0" STUDY_ID="STD-Cho-2015" TOTAL_1="13" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.756705021132648" CI_START="0.36275190574765587" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4403902972816345" LOG_CI_START="-0.4403902972816345" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:11:43 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="292" O_E="0.0" SE="0.5173748811807234" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2676767676767677" WEIGHT="17.354965595141792"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:57:47 +0000" MODIFIED_BY="[Empty name]" ORDER="689" O_E="0.0" SE="0.0" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.751430751085456" CI_START="0.36344727178959313" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.43955858681829196" LOG_CI_START="-0.4395585868182919" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:57:47 +0000" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="0.5163977794943222" STUDY_ID="STD-Han-2016" TOTAL_1="30" TOTAL_2="30" VAR="0.26666666666666666" WEIGHT="17.386902398108727"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 09:15:45 +0000" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:57:47 +0000" MODIFIED_BY="[Empty name]" ORDER="694" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2015" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-07 10:08:15 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="13.512357128088007"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:57:47 +0000" MODIFIED_BY="[Empty name]" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="10.589044566663082"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2013-01-07 09:15:53 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="23.29886386721955"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2013-01-07 09:15:53 +0000" MODIFIED_BY="[Empty name]" ORDER="7" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="14.761643416025523"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 09:57:47 +0000" MODIFIED_BY="[Empty name]" ORDER="1031" O_E="0.0" SE="0.0" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2013-01-07 09:15:53 +0000" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="3.0962230287533203"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="64.960880954703" CI_END="0.08771169883542212" CI_START="-6.549979981268286E-4" CI_STUDY="95" CI_TOTAL="95" DF="23" EFFECT_MEASURE="MD" EFFECT_SIZE="0.04352835041864765" ESTIMABLE="YES" I2="64.59407621636501" I2_Q="56.06544638935596" ID="CMP-004.02" MODIFIED="2016-11-30 10:00:21 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="7.107082580448676E-6" P_Q="0.1026827180921821" P_Z="0.05349437973475355" Q="4.5522256074896355" RANDOM="YES" SCALE="1.02" SORT_BY="STUDY" STUDIES="24" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0067479906917696075" TOTALS="SUB" TOTAL_1="518" TOTAL_2="467" UNITS="" WEIGHT="300.0" Z="1.930908411970841">
<NAME>Walking velocity: ambulatory status at study onset</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="21.852094701071476" CI_END="0.06491635989624792" CI_START="-0.10287789882382337" DF="9" EFFECT_SIZE="-0.018980769463787725" ESTIMABLE="YES" I2="58.81401703993758" ID="CMP-004.02.01" MODIFIED="2016-11-30 10:00:21 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.00935974707255105" P_Z="0.6574623231829939" STUDIES="10" TAU2="0.009354936046757883" TOTAL_1="166" TOTAL_2="151" WEIGHT="100.00000000000001" Z="0.4434195166348869">
<NAME>Studies that included independent walkers</NAME>
<CONT_DATA CI_END="0.20087230594797423" CI_START="-0.020872305947974276" EFFECT_SIZE="0.08999999999999997" ESTIMABLE="YES" MEAN_1="0.64" MEAN_2="0.55" MODIFIED="2016-11-30 09:59:03 +0000" MODIFIED_BY="[Empty name]" ORDER="276" SD_1="0.12" SD_2="0.12" SE="0.0565685424949238" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" WEIGHT="14.59430827195659"/>
<CONT_DATA CI_END="0.006419334384588415" CI_START="-0.4864193343845884" EFFECT_SIZE="-0.24" ESTIMABLE="YES" MEAN_1="0.35" MEAN_2="0.59" MODIFIED="2013-01-07 09:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="0.16" SD_2="0.27" SE="0.1257264604494331" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" WEIGHT="7.28201384714199"/>
<CONT_DATA CI_END="0.15230845892196135" CI_START="-0.18030845892196137" EFFECT_SIZE="-0.014000000000000012" ESTIMABLE="YES" MEAN_1="0.873" MEAN_2="0.887" MODIFIED="2016-11-30 09:59:03 +0000" MODIFIED_BY="[Empty name]" ORDER="277" SD_1="0.3" SD_2="0.3" SE="0.08485281374238571" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" WEIGHT="11.068034722910841"/>
<CONT_DATA CI_END="0.3859798942291955" CI_START="0.036020105770804445" EFFECT_SIZE="0.21099999999999997" ESTIMABLE="YES" MEAN_1="0.591" MEAN_2="0.38" MODIFIED="2013-01-07 09:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="0.276" SD_2="0.204" SE="0.08927709672698815" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" WEIGHT="10.575876075741272"/>
<CONT_DATA CI_END="-0.05684577053901928" CI_START="-0.22315422946098062" EFFECT_SIZE="-0.13999999999999996" ESTIMABLE="YES" MEAN_1="0.46" MEAN_2="0.6" MODIFIED="2013-01-07 09:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="0.18" SD_2="0.18" SE="0.042426406871192854" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="16.425966606445893"/>
<CONT_DATA CI_END="0.08320697319172114" CI_START="-0.16320697319172123" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="0.52" MEAN_2="0.56" MODIFIED="2013-01-07 09:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="0.21" SD_2="0.28" SE="0.06286185570937122" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="13.769957010627397"/>
<CONT_DATA CI_END="0.11603239432733897" CI_START="-0.256032394327339" EFFECT_SIZE="-0.07" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.27" MODIFIED="2013-01-07 09:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="0.1" SD_2="0.27" SE="0.09491623100972199" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="9" WEIGHT="9.977692117399506"/>
<CONT_DATA CI_END="0.22088777409012023" CI_START="-0.2768877740901203" EFFECT_SIZE="-0.028000000000000025" ESTIMABLE="YES" MEAN_1="0.493" MEAN_2="0.521" MODIFIED="2016-11-30 09:59:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1020" SD_1="0.364" SD_2="0.247" SE="0.12698589160480256" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" WEIGHT="7.191054576907324"/>
<CONT_DATA CI_END="0.3283496624492471" CI_START="-0.3883496624492472" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.88" MODIFIED="2013-01-07 09:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="771" SD_1="0.45" SD_2="0.15" SE="0.18283482006601323" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" WEIGHT="4.282739256633942"/>
<CONT_DATA CI_END="0.4012426113380885" CI_START="-0.26124261133808857" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.72" MEAN_2="0.65" MODIFIED="2013-01-07 09:24:05 +0000" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="0.38" SD_2="0.29" SE="0.1690044378115557" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" WEIGHT="4.832357514235239"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9661483135507127" CI_END="0.10788824926175072" CI_START="-0.046892173477994493" DF="4" EFFECT_SIZE="0.03049803789187811" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.02" MODIFIED="2013-07-03 15:54:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7419853476379412" P_Z="0.4398863082745943" STUDIES="5" TAU2="0.0" TOTAL_1="82" TOTAL_2="64" WEIGHT="99.99999999999997" Z="0.7723852255879602">
<NAME>Studies that included dependent and independent walkers</NAME>
<CONT_DATA CI_END="0.19431744816081065" CI_START="-0.18631744816081064" EFFECT_SIZE="0.0040000000000000036" ESTIMABLE="YES" MEAN_1="0.179" MEAN_2="0.175" MODIFIED="2013-01-07 10:09:42 +0000" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="0.233" SD_2="0.2" SE="0.09710252313920581" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" WEIGHT="16.535405659162794"/>
<CONT_DATA CI_END="0.31292122285473445" CI_START="-0.1509212228547343" EFFECT_SIZE="0.08100000000000007" ESTIMABLE="YES" MEAN_1="0.68" MEAN_2="0.599" MODIFIED="2013-01-07 09:24:35 +0000" MODIFIED_BY="[Empty name]" ORDER="969" SD_1="0.356" SD_2="0.344" SE="0.11832932884690707" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" WEIGHT="11.135022042968732"/>
<CONT_DATA CI_END="0.28951139188500596" CI_START="-0.049511391885005945" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.39" MODIFIED="2013-01-07 10:10:24 +0000" MODIFIED_BY="[Empty name]" ORDER="3221" SD_1="0.38" SD_2="0.2" SE="0.08648699324175861" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" WEIGHT="20.84367465503744"/>
<CONT_DATA CI_END="0.12572157463123623" CI_START="-0.18572157463123623" EFFECT_SIZE="-0.03" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.23" MODIFIED="2013-01-07 09:24:35 +0000" MODIFIED_BY="[Empty name]" ORDER="3223" SD_1="0.12" SD_2="0.19" SE="0.07945124291035352" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" WEIGHT="24.698722601137437"/>
<CONT_DATA CI_END="0.1615280173990117" CI_START="-0.1375280173990118" EFFECT_SIZE="0.011999999999999955" ESTIMABLE="YES" MEAN_1="0.282" MEAN_2="0.27" MODIFIED="2013-01-07 09:24:35 +0000" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="0.209" SD_2="0.208" SE="0.07629120666423958" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" WEIGHT="26.787175041693576"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="29.14483783804153" CI_END="0.16808516118905426" CI_START="0.02778655771089572" DF="8" EFFECT_SIZE="0.09793585944997499" ESTIMABLE="YES" I2="72.5508851877778" ID="CMP-004.02.03" MODIFIED="2016-11-30 10:00:14 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="2.9906428596093715E-4" P_Z="0.006213105982498665" STUDIES="9" TAU2="0.006668550279646251" TOTAL_1="270" TOTAL_2="252" WEIGHT="100.0" Z="2.736317433791282">
<NAME>Studies that included dependent walkers</NAME>
<CONT_DATA CI_END="0.13191631867665615" CI_START="-0.27191631867665605" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.56" MEAN_2="0.63" MODIFIED="2016-11-30 09:59:44 +0000" MODIFIED_BY="[Empty name]" ORDER="295" SD_1="0.45" SD_2="0.6" SE="0.10302042296151677" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" WEIGHT="7.4124641833185745"/>
<CONT_DATA CI_END="0.06684825304028584" CI_START="0.005151746959714109" EFFECT_SIZE="0.035999999999999976" ESTIMABLE="YES" MEAN_1="0.372" MEAN_2="0.336" MODIFIED="2016-08-30 09:45:39 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="690" SD_1="0.049" SD_2="0.049" SE="0.015739193823770717" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" WEIGHT="18.521596840126296"/>
<CONT_DATA CI_END="0.10747787047570843" CI_START="-0.10747787047570843" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.2" MODIFIED="2013-01-07 09:24:48 +0000" MODIFIED_BY="[Empty name]" ORDER="3220" SD_1="0.12" SD_2="0.18" SE="0.0548366558383114" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" WEIGHT="13.239519036999464"/>
<CONT_DATA CI_END="0.2565651762955159" CI_START="0.10343482370448408" EFFECT_SIZE="0.18" ESTIMABLE="YES" MEAN_1="0.425" MEAN_2="0.245" MODIFIED="2013-01-07 10:10:12 +0000" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="0.16" SD_2="0.105" SE="0.03906458327778074" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" WEIGHT="15.632311133405137"/>
<CONT_DATA CI_END="0.4313463247557775" CI_START="-0.04534632475577746" EFFECT_SIZE="0.193" ESTIMABLE="YES" MEAN_1="0.38" MEAN_2="0.187" MODIFIED="2016-08-30 12:44:19 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1017" SD_1="0.432" SD_2="0.075" SE="0.12160750229893144" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" WEIGHT="5.970116959516236"/>
<CONT_DATA CI_END="0.2519212961488334" CI_START="-0.011921296148833388" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.44" MEAN_2="0.32" MODIFIED="2013-01-07 09:24:48 +0000" MODIFIED_BY="[Empty name]" ORDER="3222" SD_1="0.47" SD_2="0.36" SE="0.06730802055007731" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" WEIGHT="11.438639792529587"/>
<CONT_DATA CI_END="0.4734686697266201" CI_START="0.1665313302733799" EFFECT_SIZE="0.32" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.19" MODIFIED="2013-01-07 09:24:48 +0000" MODIFIED_BY="[Empty name]" ORDER="3224" SD_1="0.31" SD_2="0.26" SE="0.07830178051084682" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" WEIGHT="10.008064224457978"/>
<CONT_DATA CI_END="0.5452780772776304" CI_START="-0.1052780772776305" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.63" MODIFIED="2016-11-30 09:59:44 +0000" MODIFIED_BY="[Empty name]" ORDER="1027" SD_1="0.43" SD_2="0.5" SE="0.16596125226962455" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" WEIGHT="3.7443464543132823"/>
<CONT_DATA CI_END="0.1172110523495531" CI_START="-0.07721105234955307" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.27" MEAN_2="0.25" MODIFIED="2013-01-07 09:24:48 +0000" MODIFIED_BY="[Empty name]" ORDER="3225" SD_1="0.12" SD_2="0.15" SE="0.04959838707054898" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" WEIGHT="14.032941375333436"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Post hoc sensitivity analysis: type of device</NAME>
<DICH_OUTCOME CHI2="15.372864142406565" CI_END="3.0036919389790073" CI_START="1.317246031293373" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="OR" EFFECT_SIZE="1.9891207318430908" ESTIMABLE="YES" EVENTS_1="374" EVENTS_2="289" I2="8.930438268946075" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.4776553890305212" LOG_CI_START="0.11966689876884568" LOG_EFFECT_SIZE="0.2986611438996834" METHOD="MH" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.353150657310523" P_Q="0.8505390866502607" P_Z="0.0010743304517048186" Q="0.03550613454916482" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="32" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.043854119242971515" TOTALS="SUB" TOTAL_1="698" TOTAL_2="654" WEIGHT="200.0" Z="3.270301149609783">
<NAME>Different devices for regaining walking ability</NAME>
<GROUP_LABEL_1>device</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="12.116059494835001" CI_END="3.633966888222104" CI_START="0.9882148516131459" DF="6" EFFECT_SIZE="1.8950303557493458" ESTIMABLE="YES" EVENTS_1="159" EVENTS_2="102" I2="50.47894901343327" ID="CMP-005.01.01" LOG_CI_END="0.5603809658096763" LOG_CI_START="-0.005148623503504529" LOG_EFFECT_SIZE="0.27761617115308584" MODIFIED="2016-11-30 10:02:07 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.05942921035199056" P_Z="0.05431991349791996" STUDIES="11" TAU2="0.36174787174043016" TOTAL_1="312" TOTAL_2="286" WEIGHT="99.99999999999999" Z="1.9242766683411594">
<NAME>All studies using end-effector devices</NAME>
<DICH_DATA CI_END="2.756705021132648" CI_START="0.36275190574765587" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.4403902972816345" LOG_CI_START="-0.4403902972816345" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:13:12 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="292" O_E="0.0" SE="0.5173748811807234" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" VAR="0.2676767676767677" WEIGHT="17.5324306527685"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.0" STUDY_ID="STD-Dias-2006" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.0" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="19.063965104342156" CI_START="1.484601962136074" EFFECT_SIZE="5.32" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="10" LOG_CI_END="1.2802132343842707" LOG_CI_START="0.17161003020582574" LOG_EFFECT_SIZE="0.7259116322950482" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.6511990098087833" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" VAR="0.4240601503759398" WEIGHT="14.0433076923865"/>
<DICH_DATA CI_END="2.051562302092196" CI_START="0.1658627561204261" EFFECT_SIZE="0.5833333333333334" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" LOG_CI_END="0.31208471021056267" LOG_CI_START="-0.7802511222772986" LOG_EFFECT_SIZE="-0.23408320603336796" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.641643475152946" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" VAR="0.4117063492063492" WEIGHT="14.267610859007995"/>
<DICH_DATA CI_END="6.757670374009947" CI_START="0.4306268937396148" EFFECT_SIZE="1.7058823529411764" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.8297970039171373" LOG_CI_START="-0.365898850875773" LOG_EFFECT_SIZE="0.23194907652068214" MODIFIED="2013-01-03 11:28:48 +0000" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.7023576638952937" STUDY_ID="STD-Peurala-2009" TOTAL_1="22" TOTAL_2="34" VAR="0.4933062880324544" WEIGHT="12.906017373983648"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-11-30 10:02:07 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.0" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.225549216641086" CI_START="2.0302972852119012" EFFECT_SIZE="4.086601307189542" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="17" LOG_CI_END="0.9151649052595091" LOG_CI_START="0.30755963391037355" LOG_EFFECT_SIZE="0.6113622695849413" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="149" O_E="0.0" SE="0.35691034408508293" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" VAR="0.1273849937149323" WEIGHT="22.561035295496634"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="850" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.662876331186194" CI_START="0.43767326893944175" EFFECT_SIZE="1.4285714285714286" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6686538972482634" LOG_CI_START="-0.35884997727677703" LOG_EFFECT_SIZE="0.1549019599857432" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="152" O_E="0.0" SE="0.6035608621222173" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" VAR="0.3642857142857142" WEIGHT="15.199494973953527"/>
<DICH_DATA CI_END="85.2030780302855" CI_START="0.12070204188872896" EFFECT_SIZE="3.206896551724138" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9304552842904308" LOG_CI_START="-0.9182853829804729" LOG_EFFECT_SIZE="0.506084950654979" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="153" O_E="0.0" SE="1.6733643694486577" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" VAR="2.800148312940304" WEIGHT="3.4901031524031865"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.249301033673267" CI_END="3.4990445369375576" CI_START="1.20646741360944" DF="7" EFFECT_SIZE="2.054624834996232" ESTIMABLE="YES" EVENTS_1="166" EVENTS_2="138" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="0.5439494703546198" LOG_CI_START="0.08151559621519346" LOG_EFFECT_SIZE="0.3127325332849066" MODIFIED="2016-08-30 10:01:34 +0100" MODIFIED_BY="Jan Mehrholz" NO="2" P_CHI2="0.861022208052807" P_Z="0.008026576124416963" STUDIES="16" TAU2="0.0" TOTAL_1="299" TOTAL_2="286" WEIGHT="100.0" Z="2.650949838711792">
<NAME>All studies using exoskeleton devices</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="155" O_E="0.0" SE="0.0" STUDY_ID="STD-Aschbacher-2006" TOTAL_1="11" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.0" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="44.60390216120258" CI_START="0.4743979556659822" EFFECT_SIZE="4.6" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.6493728545181054" LOG_CI_START="-0.3238571911549576" LOG_EFFECT_SIZE="0.6627578316815741" MODIFIED="2013-01-03 11:24:13 +0000" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.159085096474614" STUDY_ID="STD-Chang-2012" TOTAL_1="24" TOTAL_2="24" VAR="1.3434782608695652" WEIGHT="5.492168330378116"/>
<DICH_DATA CI_END="18.57361085218092" CI_START="0.05383982726668248" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="1.268896342120762" LOG_CI_START="-1.268896342120762" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="156" O_E="0.0" SE="1.4907119849998598" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" VAR="2.2222222222222223" WEIGHT="3.3203739406046826"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="36" EVENTS_2="36" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="157" O_E="0.0" SE="0.0" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="31" EVENTS_2="31" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="158" O_E="0.0" SE="0.0" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="159" O_E="0.0" SE="0.0" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 09:50:50 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="694" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2015" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.311173317152111" CI_START="0.7216992505758693" EFFECT_SIZE="2.857142857142857" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="7" LOG_CI_END="1.053507656979829" LOG_CI_START="-0.14164374568038038" LOG_EFFECT_SIZE="0.4559319556497244" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="161" O_E="0.0" SE="0.7020378500174638" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" VAR="0.4928571428571429" WEIGHT="14.971090231389871"/>
<DICH_DATA CI_END="4.19646600754523" CI_START="0.4522011641261028" EFFECT_SIZE="1.3775510204081634" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="7" LOG_CI_END="0.6228837095662877" LOG_CI_START="-0.3446683239612652" LOG_EFFECT_SIZE="0.13910769280251128" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="162" O_E="0.0" SE="0.5683448539538939" STUDY_ID="STD-Mayr-2008" TOTAL_1="37" TOTAL_2="37" VAR="0.323015873015873" WEIGHT="22.842867404651383"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="10" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-07 10:19:06 +0000" MODIFIED_BY="[Empty name]" ORDER="399" O_E="0.0" SE="0.0" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.674356080337033" CI_START="0.21393320979686625" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.6697217927449456" LOG_CI_START="-0.6697217927449456" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-08-30 10:01:34 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="696" O_E="0.0" SE="0.7867957924694432" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" VAR="0.6190476190476191" WEIGHT="11.919291068837323"/>
<DICH_DATA CI_END="19.359572851219983" CI_START="0.05165403222917612" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2868957708233757" LOG_CI_START="-1.2868957708233757" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="163" O_E="0.0" SE="1.5118578920369088" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" VAR="2.2857142857142856" WEIGHT="3.2281413311434415"/>
<DICH_DATA CI_END="9.114781488652717" CI_START="1.1483685089667286" EFFECT_SIZE="3.235294117647059" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" LOG_CI_END="0.9597462616459747" LOG_CI_START="0.06008127458596511" LOG_EFFECT_SIZE="0.5099137681159699" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.5284676668125593" STUDY_ID="STD-Schwartz-2006" TOTAL_1="37" TOTAL_2="30" VAR="0.2792780748663102" WEIGHT="26.42029368195631"/>
<DICH_DATA CI_END="10.5953772444188" CI_START="0.4778027136944757" EFFECT_SIZE="2.25" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="8" LOG_CI_END="1.0251164242136594" LOG_CI_START="-0.3207513879909346" LOG_EFFECT_SIZE="0.3521825181113625" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="851" O_E="0.0" SE="0.7905694150420949" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" VAR="0.625" WEIGHT="11.805774011038872"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="164" O_E="0.0" SE="0.0" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="37" EVENTS_2="37" I2="0.0" ID="CMP-005.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2016-12-05 14:26:52 +0000" MODIFIED_BY="Jan Mehrholz" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="3" TAU2="0.0" TOTAL_1="54" TOTAL_2="52" WEIGHT="0.0" Z="0.0">
<NAME>All studies using mobile devices</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-12-05 14:26:52 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="340" O_E="0.0" SE="0.0" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-12-05 14:26:52 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="342" O_E="0.0" SE="0.0" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-12-05 14:26:52 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="1031" O_E="0.0" SE="0.0" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" I2="0.0" ID="CMP-005.01.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="33" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>All studies using ankle devices</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-12-05 14:26:54 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="689" O_E="0.0" SE="0.0" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2016-12-05 14:26:54 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="344" O_E="0.0" SE="0.0" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="64.9861566338663" CI_END="0.05999473194808537" CI_START="0.009707097995377376" CI_STUDY="95" CI_TOTAL="95" DF="24" EFFECT_MEASURE="MD" EFFECT_SIZE="0.03485091497173137" ESTIMABLE="YES" I2="63.06905771452738" I2_Q="56.29503113602639" ID="CMP-005.02" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.2229301356136979E-5" P_Q="0.07635426288218294" P_Z="0.006594957103625173" Q="6.864208070567753" RANDOM="YES" SCALE="0.74" SORT_BY="STUDY" STUDIES="24" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.004255698536583527" TOTALS="SUB" TOTAL_1="539" TOTAL_2="485" UNITS="" WEIGHT="400.0" Z="2.716633605673267">
<NAME>Different devices for regaining walking speed</NAME>
<GROUP_LABEL_1>device</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours experimental</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="29.221148009321457" CI_END="0.18135205299271662" CI_START="0.036318513928031274" DF="8" EFFECT_SIZE="0.10883528346037395" ESTIMABLE="YES" I2="72.62256774631844" ID="CMP-005.02.01" MODIFIED="2016-11-29 10:02:11 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="2.899704133040304E-4" P_Z="0.0032655183441183382" STUDIES="9" TAU2="0.007154885157763144" TOTAL_1="280" TOTAL_2="239" WEIGHT="100.00000000000001" Z="2.9415711318249294">
<NAME>All studies using end-effector devices</NAME>
<CONT_DATA CI_END="0.13191631867665615" CI_START="-0.27191631867665605" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.56" MEAN_2="0.63" MODIFIED="2016-08-30 09:12:55 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="295" SD_1="0.45" SD_2="0.6" SE="0.10302042296151677" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" WEIGHT="7.7044191918099285"/>
<CONT_DATA CI_END="0.06684825304028584" CI_START="0.005151746959714109" EFFECT_SIZE="0.035999999999999976" ESTIMABLE="YES" MEAN_1="0.372" MEAN_2="0.336" MODIFIED="2016-08-30 09:46:11 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="690" SD_1="0.049" SD_2="0.049" SE="0.015739193823770717" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" WEIGHT="18.492515867836566"/>
<CONT_DATA CI_END="0.3859798942291955" CI_START="0.036020105770804445" EFFECT_SIZE="0.21099999999999997" ESTIMABLE="YES" MEAN_1="0.591" MEAN_2="0.38" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="0.276" SD_2="0.204" SE="0.08927709672698815" STUDY_ID="STD-Geroin-2011" TOTAL_1="20" TOTAL_2="10" WEIGHT="9.050595278693468"/>
<CONT_DATA CI_END="0.2565651762955159" CI_START="0.10343482370448408" EFFECT_SIZE="0.18" ESTIMABLE="YES" MEAN_1="0.425" MEAN_2="0.245" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="0.16" SD_2="0.105" SE="0.03906458327778074" STUDY_ID="STD-Morone-2011" TOTAL_1="24" TOTAL_2="24" WEIGHT="15.769380068093708"/>
<CONT_DATA CI_END="0.28951139188500596" CI_START="-0.049511391885005945" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.39" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="3221" SD_1="0.38" SD_2="0.2" SE="0.08648699324175861" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" WEIGHT="9.353871449078508"/>
<CONT_DATA CI_END="0.2519212961488334" CI_START="-0.011921296148833388" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.44" MEAN_2="0.32" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="3222" SD_1="0.47" SD_2="0.36" SE="0.06730802055007731" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" WEIGHT="11.71500638366637"/>
<CONT_DATA CI_END="0.3283496624492471" CI_START="-0.3883496624492472" EFFECT_SIZE="-0.030000000000000027" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.88" MODIFIED="2013-01-03 11:33:35 +0000" MODIFIED_BY="[Empty name]" ORDER="771" SD_1="0.45" SD_2="0.15" SE="0.18283482006601323" STUDY_ID="STD-Tanaka-2012" TOTAL_1="7" TOTAL_2="5" WEIGHT="3.3731191463823853"/>
<CONT_DATA CI_END="0.4734686697266201" CI_START="0.1665313302733799" EFFECT_SIZE="0.32" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.19" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="3224" SD_1="0.31" SD_2="0.26" SE="0.07830178051084682" STUDY_ID="STD-Tong-2006" TOTAL_1="33" TOTAL_2="21" WEIGHT="10.303498281113628"/>
<CONT_DATA CI_END="0.1172110523495531" CI_START="-0.07721105234955307" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.27" MEAN_2="0.25" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="3225" SD_1="0.12" SD_2="0.15" SE="0.04959838707054898" STUDY_ID="STD-Werner-2002" TOTAL_1="15" TOTAL_2="15" WEIGHT="14.237594333325445"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="19.527463292796387" CI_END="0.043659386912621945" CI_START="-0.07607918818471682" DF="11" EFFECT_SIZE="-0.016209900636047433" ESTIMABLE="YES" I2="43.66907859425929" ID="CMP-005.02.02" MODIFIED="2016-11-30 13:24:47 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.052258011160781104" P_Z="0.5956476357038024" STUDIES="12" TAU2="0.004402108096200114" TOTAL_1="184" TOTAL_2="176" WEIGHT="100.0" Z="0.5306697764492107">
<NAME>All studies using exoskeleton devices</NAME>
<CONT_DATA CI_END="0.20087230594797423" CI_START="-0.020872305947974276" EFFECT_SIZE="0.08999999999999997" ESTIMABLE="YES" MEAN_1="0.64" MEAN_2="0.55" MODIFIED="2016-11-29 10:02:11 +0000" MODIFIED_BY="[Empty name]" ORDER="276" SD_1="0.12" SD_2="0.12" SE="0.0565685424949238" STUDY_ID="STD-Bang-2016" TOTAL_1="9" TOTAL_2="9" WEIGHT="12.27376933985117"/>
<CONT_DATA CI_END="0.006419334384588415" CI_START="-0.4864193343845884" EFFECT_SIZE="-0.24" ESTIMABLE="YES" MEAN_1="0.35" MEAN_2="0.59" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="0.16" SD_2="0.27" SE="0.1257264604494331" STUDY_ID="STD-Brincks-2011" TOTAL_1="7" TOTAL_2="6" WEIGHT="4.617020268825982"/>
<CONT_DATA CI_END="0.19431744816081065" CI_START="-0.18631744816081064" EFFECT_SIZE="0.0040000000000000036" ESTIMABLE="YES" MEAN_1="0.179" MEAN_2="0.175" MODIFIED="2013-01-03 13:39:40 +0000" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="0.233" SD_2="0.2" SE="0.09710252313920581" STUDY_ID="STD-Fisher-2008" TOTAL_1="10" TOTAL_2="10" WEIGHT="6.746183692496719"/>
<CONT_DATA CI_END="-0.05684577053901928" CI_START="-0.22315422946098062" EFFECT_SIZE="-0.13999999999999996" ESTIMABLE="YES" MEAN_1="0.46" MEAN_2="0.6" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="81" SD_1="0.18" SD_2="0.18" SE="0.042426406871192854" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="15.044323610957706"/>
<CONT_DATA CI_END="0.08320697319172114" CI_START="-0.16320697319172123" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="0.52" MEAN_2="0.56" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="82" SD_1="0.21" SD_2="0.28" SE="0.06286185570937122" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="11.169456254977566"/>
<CONT_DATA CI_END="0.10747787047570843" CI_START="-0.10747787047570843" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.2" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="3220" SD_1="0.12" SD_2="0.18" SE="0.0548366558383114" STUDY_ID="STD-Husemann-2007" TOTAL_1="17" TOTAL_2="15" WEIGHT="12.59338901124143"/>
<CONT_DATA CI_END="0.31292122285473445" CI_START="-0.1509212228547343" EFFECT_SIZE="0.08100000000000007" ESTIMABLE="YES" MEAN_1="0.68" MEAN_2="0.599" MODIFIED="2013-01-07 10:14:31 +0000" MODIFIED_BY="[Empty name]" ORDER="969" SD_1="0.356" SD_2="0.344" SE="0.11832932884690707" STUDY_ID="STD-Kyung-2008" TOTAL_1="18" TOTAL_2="17" WEIGHT="5.069921472800054"/>
<CONT_DATA CI_END="0.11603239432733897" CI_START="-0.256032394327339" EFFECT_SIZE="-0.07" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.27" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="0.1" SD_2="0.27" SE="0.09491623100972199" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="9" WEIGHT="6.9573586397878175"/>
<CONT_DATA CI_END="0.4313463247557775" CI_START="-0.04534632475577746" EFFECT_SIZE="0.193" ESTIMABLE="YES" MEAN_1="0.38" MEAN_2="0.187" MODIFIED="2016-08-30 12:44:05 +0100" MODIFIED_BY="Jan Mehrholz" ORDER="1017" SD_1="0.432" SD_2="0.075" SE="0.12160750229893144" STUDY_ID="STD-Ochi-2015" TOTAL_1="13" TOTAL_2="13" WEIGHT="4.862122232695409"/>
<CONT_DATA CI_END="0.12572157463123623" CI_START="-0.18572157463123623" EFFECT_SIZE="-0.03" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.23" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="3223" SD_1="0.12" SD_2="0.19" SE="0.07945124291035352" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" WEIGHT="8.7083466265524"/>
<CONT_DATA CI_END="0.1615280173990117" CI_START="-0.1375280173990118" EFFECT_SIZE="0.011999999999999955" ESTIMABLE="YES" MEAN_1="0.282" MEAN_2="0.27" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="0.209" SD_2="0.208" SE="0.07629120666423958" STUDY_ID="STD-Van-Nunen-2012" TOTAL_1="16" TOTAL_2="14" WEIGHT="9.127602841761703"/>
<CONT_DATA CI_END="0.4012426113380885" CI_START="-0.26124261133808857" EFFECT_SIZE="0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.72" MEAN_2="0.65" MODIFIED="2013-01-02 08:21:10 +0000" MODIFIED_BY="[Empty name]" ORDER="93" SD_1="0.38" SD_2="0.29" SE="0.1690044378115557" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" WEIGHT="2.8305060080520392"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7548958705766322" CI_END="0.14541253250943664" CI_START="-0.10910169839504404" DF="2" EFFECT_SIZE="0.018155417057196296" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.03" MODIFIED="2016-12-05 14:26:42 +0000" MODIFIED_BY="Jan Mehrholz" NO="3" P_CHI2="0.4158432033909838" P_Z="0.7797670782084953" STUDIES="3" TAU2="0.0" TOTAL_1="54" TOTAL_2="52" WEIGHT="100.0" Z="0.2796225847957681">
<NAME>All studies using mobile devices</NAME>
<CONT_DATA CI_END="0.15230845892196135" CI_START="-0.18030845892196137" EFFECT_SIZE="-0.014000000000000012" ESTIMABLE="YES" MEAN_1="0.873" MEAN_2="0.887" MODIFIED="2016-12-05 14:26:42 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="277" SD_1="0.3" SD_2="0.3" SE="0.08485281374238571" STUDY_ID="STD-Buesing-2015" TOTAL_1="25" TOTAL_2="25" WEIGHT="58.55115562545372"/>
<CONT_DATA CI_END="0.22088777409012023" CI_START="-0.2768877740901203" EFFECT_SIZE="-0.028000000000000025" ESTIMABLE="YES" MEAN_1="0.493" MEAN_2="0.521" MODIFIED="2016-12-05 14:26:41 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="1020" SD_1="0.364" SD_2="0.247" SE="0.12698589160480256" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" WEIGHT="26.14309628195241"/>
<CONT_DATA CI_END="0.5452780772776304" CI_START="-0.1052780772776305" EFFECT_SIZE="0.21999999999999997" ESTIMABLE="YES" MEAN_1="0.85" MEAN_2="0.63" MODIFIED="2016-12-05 14:26:41 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="1027" SD_1="0.43" SD_2="0.5" SE="0.16596125226962455" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" WEIGHT="15.305748092593866"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.06684825304028584" CI_START="0.005151746959714109" DF="0" EFFECT_SIZE="0.035999999999999976" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.04" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.022179274771876437" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="18" WEIGHT="100.0" Z="2.2872836056971106">
<NAME>All studies using ankle devices</NAME>
<CONT_DATA CI_END="0.06684825304028584" CI_START="0.005151746959714109" EFFECT_SIZE="0.035999999999999976" ESTIMABLE="YES" MEAN_1="0.372" MEAN_2="0.336" MODIFIED="2016-12-05 14:26:40 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="690" SD_1="0.049" SD_2="0.049" SE="0.015739193823770717" STUDY_ID="STD-Forrester-2014" TOTAL_1="21" TOTAL_2="18" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="23.37526167639948" CI_END="28.40473786099284" CI_START="-16.734478995223874" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="MD" EFFECT_SIZE="5.835129432884483" ESTIMABLE="YES" I2="52.941703274680336" I2_Q="37.694173760395906" ID="CMP-005.03" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.015640198478075518" P_Q="0.1858592472430748" P_Z="0.6123459633880411" Q="4.81495901918251" RANDOM="YES" SCALE="216.25" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="751.5270796221614" TOTALS="YES" TOTAL_1="306" TOTAL_2="288" UNITS="" WEIGHT="100.0" Z="0.5067276009689179">
<NAME>Different devices for regaining walking capacity</NAME>
<GROUP_LABEL_1>device</GROUP_LABEL_1>
<GROUP_LABEL_2>control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.1339060640943153" CI_END="51.36061823233846" CI_START="3.6435918971765773" DF="3" EFFECT_SIZE="27.50210506475752" ESTIMABLE="YES" I2="4.272816777391619" ID="CMP-005.03.01" MODIFIED="2016-11-29 10:00:26 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3714370265418069" P_Z="0.023865780910255225" STUDIES="4" TAU2="26.327422977897843" TOTAL_1="171" TOTAL_2="157" WEIGHT="39.19136778117286" Z="2.259283093097569">
<NAME>All studies using end-effector devices</NAME>
<CONT_DATA CI_END="38.83731354086406" CI_START="-62.43731354086408" EFFECT_SIZE="-11.800000000000011" ESTIMABLE="YES" MEAN_1="145.1" MEAN_2="156.9" MODIFIED="2016-11-29 09:59:24 +0000" MODIFIED_BY="[Empty name]" ORDER="297" SD_1="121.0" SD_2="144.0" SE="25.835838791061843" STUDY_ID="STD-Chua-2016" TOTAL_1="53" TOTAL_2="53" WEIGHT="9.344672182775255"/>
<CONT_DATA CI_END="79.55737103512627" CI_START="-21.417371035126287" EFFECT_SIZE="29.069999999999993" ESTIMABLE="YES" MEAN_1="164.14" MEAN_2="135.07" MODIFIED="2016-11-29 09:59:24 +0000" MODIFIED_BY="[Empty name]" ORDER="3227" SD_1="103.41" SD_2="67.87" SE="25.759336106869423" STUDY_ID="STD-Peurala-2005" TOTAL_1="30" TOTAL_2="15" WEIGHT="9.370738025035825"/>
<CONT_DATA CI_END="97.33115338182054" CI_START="-15.531153381820594" EFFECT_SIZE="40.89999999999998" ESTIMABLE="YES" MEAN_1="199.7" MEAN_2="158.8" MODIFIED="2016-11-29 09:59:24 +0000" MODIFIED_BY="[Empty name]" ORDER="340" SD_1="53.2" SD_2="79.3" SE="28.791933845184047" STUDY_ID="STD-Picelli-2016" TOTAL_1="11" TOTAL_2="11" WEIGHT="8.389897791115464"/>
<CONT_DATA CI_END="78.33771529487515" CI_START="5.4622847051248655" EFFECT_SIZE="41.900000000000006" ESTIMABLE="YES" MEAN_1="134.4" MEAN_2="92.5" MODIFIED="2016-11-29 09:59:24 +0000" MODIFIED_BY="[Empty name]" ORDER="3228" SD_1="125.5" SD_2="104.9" SE="18.59101268303458" STUDY_ID="STD-Pohl-2007" TOTAL_1="77" TOTAL_2="78" WEIGHT="12.086059782246314"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.11745179536937" CI_END="15.051578084862282" CI_START="-46.338036027584764" DF="4" EFFECT_SIZE="-15.643228971361243" ESTIMABLE="YES" I2="50.72345237354147" ID="CMP-005.03.02" MODIFIED="2016-11-29 10:00:26 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.08736937065528161" P_Z="0.31785699803150425" STUDIES="5" TAU2="573.6869117761368" TOTAL_1="94" TOTAL_2="92" WEIGHT="46.122879499544254" Z="0.998871415924574">
<NAME>All studies using exoskeleton devices</NAME>
<CONT_DATA CI_END="-21.565507309490293" CI_START="-78.4344926905097" EFFECT_SIZE="-50.0" ESTIMABLE="YES" MEAN_1="168.0" MEAN_2="218.0" MODIFIED="2016-11-29 09:59:34 +0000" MODIFIED_BY="[Empty name]" ORDER="86" SD_1="59.0" SD_2="64.0" SE="14.50766081152376" STUDY_ID="STD-Hidler-2009" TOTAL_1="36" TOTAL_2="36" WEIGHT="13.784058569317239"/>
<CONT_DATA CI_END="27.843753434891312" CI_START="-63.84375343489131" EFFECT_SIZE="-18.0" ESTIMABLE="YES" MEAN_1="186.0" MEAN_2="204.0" MODIFIED="2016-11-29 09:59:34 +0000" MODIFIED_BY="[Empty name]" ORDER="87" SD_1="88.0" SD_2="96.0" SE="23.390099918417373" STUDY_ID="STD-Hornby-2008" TOTAL_1="31" TOTAL_2="31" WEIGHT="10.211005042994584"/>
<CONT_DATA CI_END="29.00005446360526" CI_START="-55.48005446360526" EFFECT_SIZE="-13.240000000000002" ESTIMABLE="YES" MEAN_1="57.02" MEAN_2="70.26" MODIFIED="2016-11-29 10:00:03 +0000" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="25.5" SD_2="60.4" SE="21.551444208561698" STUDY_ID="STD-Noser-2012" TOTAL_1="11" TOTAL_2="9" WEIGHT="10.904888030311158"/>
<CONT_DATA CI_END="75.04509802762875" CI_START="-29.045098027628768" EFFECT_SIZE="22.999999999999993" ESTIMABLE="YES" MEAN_1="81.38" MEAN_2="58.38" MODIFIED="2016-11-29 10:00:06 +0000" MODIFIED_BY="[Empty name]" ORDER="3229" SD_1="61.53" SD_2="43.07" SE="26.554109380658957" STUDY_ID="STD-Saltuari-2004" TOTAL_1="8" TOTAL_2="8" WEIGHT="9.103267569681913"/>
<CONT_DATA CI_END="211.1117938991949" CI_START="-79.71179389919487" EFFECT_SIZE="65.70000000000002" ESTIMABLE="YES" MEAN_1="278.1" MEAN_2="212.4" MODIFIED="2016-11-29 10:00:26 +0000" MODIFIED_BY="[Empty name]" ORDER="94" SD_1="176.5" SD_2="113.5" SE="74.19105404292353" STUDY_ID="STD-Westlake-2009" TOTAL_1="8" TOTAL_2="8" WEIGHT="2.1196602872393617"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0033799028957007043" CI_END="79.63235681827572" CI_START="-39.51727193876654" DF="1" EFFECT_SIZE="20.057542439754588" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.03" MODIFIED="2016-12-05 14:26:23 +0000" MODIFIED_BY="Jan Mehrholz" NO="3" P_CHI2="0.9536395917034026" P_Z="0.5093326505698038" STUDIES="2" TAU2="0.0" TOTAL_1="29" TOTAL_2="27" WEIGHT="10.126631712896904" Z="0.6598771848540759">
<NAME>All studies using mobile devices</NAME>
<CONT_DATA CI_END="95.82498530859081" CI_START="-58.62498530859082" EFFECT_SIZE="18.599999999999994" ESTIMABLE="YES" MEAN_1="213.4" MEAN_2="194.8" MODIFIED="2016-12-05 14:26:23 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="1023" SD_1="108.2" SD_2="83.2" SE="39.40122671525173" STUDY_ID="STD-Stein-2014" TOTAL_1="12" TOTAL_2="12" WEIGHT="5.755359490545193"/>
<CONT_DATA CI_END="115.82748199518429" CI_START="-71.42748199518431" EFFECT_SIZE="22.19999999999999" ESTIMABLE="YES" MEAN_1="156.7" MEAN_2="134.5" MODIFIED="2016-12-05 14:26:23 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="364" SD_1="137.9" SD_2="132.1" SE="47.77000125191377" STUDY_ID="STD-Watanabe-2014" TOTAL_1="17" TOTAL_2="15" WEIGHT="4.371272222351711"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="99.02728081811098" CI_START="-83.02728081811098" DF="0" EFFECT_SIZE="8.0" ESTIMABLE="YES" I2="0.0" ID="CMP-005.03.04" MODIFIED="2017-05-04 14:39:41 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.8632387217952856" STUDIES="1" TAU2="0.0" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.559121006385984" Z="0.1722528865566285">
<NAME>All studies using ankle devices</NAME>
<CONT_DATA CI_END="99.02728081811098" CI_START="-83.02728081811098" EFFECT_SIZE="8.0" ESTIMABLE="YES" MEAN_1="216.5" MEAN_2="208.5" MODIFIED="2016-12-05 14:26:24 +0000" MODIFIED_BY="Jan Mehrholz" ORDER="361" SD_1="106.6" SD_2="120.5" SE="46.44334362065964" STUDY_ID="STD-Waldman-2013" TOTAL_1="12" TOTAL_2="12" WEIGHT="4.559121006385984"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-05-04 14:39:59 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAQnCAYAAADRveqbAAB89ElEQVR42uydDYRVW/z3L7mu5Eok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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-05-04 14:39:59 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAPEAAAVfCAIAAADkh5lnAABAJklEQVR42u2dsW4USRPHV0JCBA4c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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2016-12-05 14:24:58 +0000" MODIFIED_BY="Jan Mehrholz" NO="3" REF_ID="CMP-001.01" SETTINGS="SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_STUDY_NAMES:NO;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;DISTINGUISH_SUBGROUPS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Electromechanical- and robotic-assisted gait training plus physiotherapy versus physiotherapy (or usual care), outcome: 1.1 Independent walking at the end of intervention phase, all electromechanical devices used.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="4" REF_ID="CMP-001.03" SETTINGS="SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_STUDY_NAMES:NO;SHOW_EFFECT_ESTIMATE:YES;SHOW_CI_LINES:YES;DISTINGUISH_SUBGROUPS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Electromechanical- and robotic-assisted gait training plus physiotherapy versus physiotherapy (or usual care), outcome: 1.3 Walking velocity (metres per second) at the end of intervention phase.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2013-07-03 15:07:31 +0100" MODIFIED_BY="Hazel Fraser">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2013-07-03 15:07:31 +0100" MODIFIED_BY="Hazel Fraser" NO="1">
<TITLE MODIFIED="2010-07-28 14:13:00 +0100" MODIFIED_BY="Hazel Fraser">Feedback, 30 June 2010</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2013-07-03 15:07:01 +0100" MODIFIED_BY="Hazel Fraser">
<P>It appears that the P value for the walking capacity outcome is incorrect in your abstract. The P value is reported as P = 0.073 in the abstract but is reported as P = 0.73 in the results section and in the forest plot.<BR/>
</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2013-07-03 15:07:31 +0100" MODIFIED_BY="Hazel Fraser">
<P>The feedback from Meghan Malone-Moses, above, is accurate. I am sorry for this error which occurred in the abstract. The printed P value in the abstract (P = 0.073) was not correct and has now been changed to P = 0.73 as reported correctly in the Results section and in the forest plot. There is no change to the conclusions because the P value for the walking capacity outcome remains non-significant.<BR/>
</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2010-07-28 14:13:19 +0100" MODIFIED_BY="Hazel Fraser">
<P>Commenter: Meghan Malone-Moses, MPH, Medical Writer, DynaMed<BR/>Responder: Jan Mehrholz<BR/>
</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">
<APPENDIX ID="APP-01" MODIFIED="2016-09-02 13:36:51 +0100" MODIFIED_BY="Bernhard Elsner" NO="1">
<TITLE MODIFIED="2013-05-22 14:56:54 +0100" MODIFIED_BY="Bernhard Elsner">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:19:33 +0100" MODIFIED_BY="Bernhard Elsner">
<P>#1MeSH descriptor: [Cerebrovascular Disorders] explode all trees<BR/>#2MeSH descriptor: [Brain Injuries] this term only<BR/>#3MeSH descriptor: [Brain Injury, Chronic] this term only<BR/>#4stroke* or cva or poststroke or post-stroke<BR/>#5cerebrovasc* or cerebral vascular<BR/>#6cerebral or cerebellar or brain* or vertebrobasilar<BR/>#7infarct* or isch?emi* or thrombo* or emboli* or apoplexy<BR/>#8#6 and #7<BR/>#9cerebral or brain or subarachnoid<BR/>#10haemorrhage or hemorrhage or haematoma or hematoma or bleed*<BR/>#11#9 and #10<BR/>#12MeSH descriptor: [Hemiplegia] this term only<BR/>#13MeSH descriptor: [Paresis] explode all trees<BR/>#14hempar* or hemipleg* or brain injur*<BR/>#15MeSH descriptor: [Gait Disorders, Neurologic] this term only<BR/>#16#1 or #2 or #3 or #4 or #5 or #8 or #11 or #12 or #13 or #14 or #15<BR/>#17MeSH descriptor: [Physical Therapy Modalities] this term only<BR/>#18MeSH descriptor: [Exercise Therapy] this term only<BR/>#19MeSH descriptor: [Motion Therapy, Continuous Passive] this term only<BR/>#20MeSH descriptor: [Musculoskeletal Manipulations] this term only<BR/>#21MeSH descriptor: [Exercise] this term only<BR/>#22MeSH descriptor: [Exercise Test] this term only<BR/>#23MeSH descriptor: [Robotics] this term only<BR/>#24MeSH descriptor: [Automation] this term only<BR/>#25MeSH descriptor: [Orthotic Devices] this term only<BR/>#26MeSH descriptor: [Man-Machine Systems] this term only<BR/>#27MeSH descriptor: [Self-Help Devices] this term only<BR/>#28MeSH descriptor: [Therapy, Computer-Assisted] this term only<BR/>#29MeSH descriptor: [Body Weight] this term only<BR/>#30MeSH descriptor: [Weight-Bearing] this term only<BR/>#31((gait or locomot*) near/5 (train* or therapy or rehabilitat* or re-educat* or machine* or powered or device*))<BR/>#32(electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device*)<BR/>#33((body-weight or body weight) near/3 (support* or relief))<BR/>#34(robot* or orthos* or orthotic or automat* or computer aided or computer assisted or power-assist*)<BR/>#35(bws or harness or treadmill or exercise* or fitness train* or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator)<BR/>#36(continuous passive or cpm) near/3 therap*<BR/>#37#17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or#30 or #31 or #32 or #33 or #34 or #35 or #36<BR/>#38MeSH descriptor: [Gait] this term only<BR/>#39MeSH descriptor: [Walking] explode all trees<BR/>#40MeSH descriptor: [Locomotion] this term only<BR/>#41MeSH descriptor: [Range of Motion, Articular] this term only<BR/>#42MeSH descriptor: [Recovery of Function] this term only<BR/>#43walk* or gait* or ambulat* or mobil* or locomot* or balanc* or stride<BR/>#44#38 or #39 or #40 or #41 or #42 or #43<BR/>#45#16 and #37 and #44<BR/>#46MeSH descriptor: [Animals] explode all trees<BR/>#47#45 not #46<BR/>#48#47 in Trials<BR/>#49#48 Publication Year from 2012 to 2016<BR/>
</P>
<P>Number of records retrieved until 2012: 1140</P>
<P>Number of records retrieved until 2016: 861</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2016-09-02 13:36:51 +0100" MODIFIED_BY="Bernhard Elsner" NO="2">
<TITLE MODIFIED="2016-09-02 12:55:46 +0100" MODIFIED_BY="Bernhard Elsner">MEDLINE search strategy (OvidSP)</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:36:31 +0100" MODIFIED_BY="Bernhard Elsner">
<P>1. exp cerebrovascular disorders/ or brain injury, chronic/</P>
<P>2. (stroke$ or cva or poststroke or post-stroke).tw.</P>
<P>3. (cerebrovasc$ or cerebral vascular).tw.</P>
<P>4. (cerebral or cerebellar or brain$ or vertebrobasilar).tw.</P>
<P>5. (infarct$ or isch?emi$ or thrombo$ or emboli$ or apoplexy).tw.</P>
<P>6. 4 and 5</P>
<P>7. (cerebral or brain or subarachnoid).tw.</P>
<P>8. (haemorrhage or hemorrhage or haematoma or hematoma or bleed$).tw.</P>
<P>9. 7 and 8</P>
<P>10. hemiplegia/ or exp paresis/</P>
<P>11. (hempar$ or hemipleg$ or brain injur$).tw.</P>
<P>12. Gait Disorders, Neurologic/</P>
<P>13. 1 or 2 or 3 or 6 or 9 or 10 or 11 or 12</P>
<P>14. physical therapy modalities/ or exercise therapy/ or motion therapy, continuous passive/ or musculoskeletal manipulations/</P>
<P>15. *exercise/ or *exercise test/</P>
<P>16. robotics/ or automation/ or orthotic devices/ or man-machine systems/ or self-help devices/ or therapy, computer-assisted/</P>
<P>17. body weight/ or weight-bearing/</P>
<P>18. ((gait or locomot$) adj5 (train$ or therapy or rehabilitat$ or re-educat$ or machine$ or powered or device$)).tw.</P>
<P>19. (electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device$).tw.</P>
<P>20. ((body-weight or body weight) adj3 (support$ or relief)).tw.</P>
<P>21. (robot$ or orthos$ or orthotic or automat$ or computer aided or computer assisted or power-assist$).tw.</P>
<P>22. (bws or harness or treadmill or exercise$ or fitness train$ or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator).tw.</P>
<P>23. ((continuous passive or cpm) adj3 therap$).tw.</P>
<P>24. or/14-23</P>
<P>25. gait/ or exp walking/ or locomotion/</P>
<P>26. "Range of Motion, Articular"/</P>
<P>27. recovery of function/</P>
<P>28. (walk$ or gait$ or ambulat$ or mobil$ or locomot$ or balanc$ or stride).tw.</P>
<P>29. or/25-28</P>
<P>30. 13 and 24 and 29</P>
<P>31. Randomized Controlled Trials as Topic/</P>
<P>32. random allocation/</P>
<P>33. Controlled Clinical Trials as Topic/</P>
<P>34. control groups/</P>
<P>35. clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical trials, phase iv as topic/</P>
<P>36. double-blind method/</P>
<P>37. single-blind method/</P>
<P>38. Placebos/</P>
<P>39. placebo effect/</P>
<P>40. cross-over studies/</P>
<P>41. Therapies, Investigational/</P>
<P>42. Research Design/</P>
<P>43. evaluation studies as topic/</P>
<P>44. randomized controlled trial.pt.</P>
<P>45. controlled clinical trial.pt.</P>
<P>46. (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.</P>
<P>47. (evaluation studies or comparative study).pt.</P>
<P>48. random$.tw.</P>
<P>49. (controlled adj5 (trial$ or stud$)).tw.</P>
<P>50. (clinical$ adj5 trial$).tw.</P>
<P>51. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.</P>
<P>52. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.</P>
<P>53. ((multicenter or multicentre or therapeutic) adj5 (trial$ or stud$)).tw.</P>
<P>54. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.</P>
<P>55. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.</P>
<P>56. (coin adj5 (flip or flipped or toss$)).tw.</P>
<P>57. versus.tw.</P>
<P>58. (cross-over or cross over or crossover).tw.</P>
<P>59. placebo$.tw.</P>
<P>60. sham.tw.</P>
<P>61. (assign$ or alternate or allocat$ or counterbalance$ or multiple baseline).tw.</P>
<P>62. or/31-61</P>
<P>63. 30 and 62</P>
<P>64. exp animals/ not humans.sh.</P>
<P>65. 63 not 64</P>
<P>66. limit 65 to ed=20120719-20160815</P>
<P>Number of records retrieved until 2012: 1928</P>
<P>Number of records retrieved until 2016: 1094</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="3">
<TITLE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">Embase search strategy (OvidSP)</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:12:59 +0100" MODIFIED_BY="Bernhard Elsner">
<P>1. cerebrovascular disease/ or exp basal ganglion hemorrhage/ or exp brain hematoma/ or exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp carotid artery disease/ or cerebral artery disease/ or exp cerebrovascular accident/ or exp intracranial aneurysm/ or exp occlusive cerebrovascular disease/ or stroke patient/</P>
<P>2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).tw.</P>
<P>3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw.</P>
<P>4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or bleed$)).tw.</P>
<P>5. hemiparesis/ or hemiplegia/ or paresis/</P>
<P>6. (hemipleg$ or hemipar$ or paresis or paretic or hemineglect or hemi-neglect or ((unilateral or spatial or hemi?spatial or visual) adj5 neglect)).tw.</P>
<P>7. Gait Disorders, Neurologic/</P>
<P>8. or/1-7</P>
<P>9. physical therapy modalities/ or exercise therapy/ or motion therapy, continuous passive/ or musculoskeletal manipulations/</P>
<P>10. *exercise/ or *exercise test/</P>
<P>11. robotics/ or automation/ or orthotic devices/ or man-machine systems/ or self-help devices/ or therapy, computer-assisted/</P>
<P>12. body weight/ or weight-bearing/</P>
<P>13. ((gait or locomot$) adj5 (train$ or therapy or rehabilitat$ or re-educat$ or machine$ or powered or device$)).tw.</P>
<P>14. (electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device$).tw.</P>
<P>15. ((body-weight or body weight) adj3 (support$ or relief)).tw.</P>
<P>16. (robot$ or orthos$ or orthotic or automat$ or computer aided or computer assisted or power-assist$).tw.</P>
<P>17. (bws or harness or treadmill or exercise$ or fitness train$ or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator).tw.</P>
<P>18. ((continuous passive or cpm) adj3 therap$).tw.</P>
<P>19. or/9-18</P>
<P>20. gait/ or exp walking/ or locomotion/</P>
<P>21. "Range of Motion, Articular"/</P>
<P>22. recovery of function/</P>
<P>23. (walk$ or gait$ or ambulat$ or mobil$ or locomot$ or balanc$ or stride).tw.</P>
<P>24. or/20-23</P>
<P>25. 19 and 24</P>
<P>26. Randomized Controlled Trial/ or "randomized controlled trial (topic)"/</P>
<P>27. Randomization/</P>
<P>28. Controlled clinical trial/ or "controlled clinical trial (topic)"/</P>
<P>29. control group/ or controlled study/</P>
<P>30. clinical trial/ or "clinical trial (topic)"/ or phase 1 clinical trial/ or phase 2 clinical trial/ or phase 3 clinical trial/ or phase 4 clinical trial/</P>
<P>31. Crossover Procedure/</P>
<P>32. Double Blind Procedure/</P>
<P>33. Single Blind Procedure/ or triple blind procedure/</P>
<P>34. placebo/ or placebo effect/</P>
<P>35. (random$ or RCT or RCTs).tw.</P>
<P>36. (controlled adj5 (trial$ or stud$)).tw.</P>
<P>37. (clinical$ adj5 trial$).tw.</P>
<P>38. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.</P>
<P>39. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.</P>
<P>40. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.</P>
<P>41. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.</P>
<P>42. (cross-over or cross over or crossover).tw.</P>
<P>43. (placebo$ or sham).tw.</P>
<P>44. trial.ti.</P>
<P>45. (assign$ or allocat$).tw.</P>
<P>46. controls.tw.</P>
<P>47. or/26-46</P>
<P>48. 8 and 25 and 47</P>
<P>49. (exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/) not (human/ or normal human/ or human cell/)</P>
<P>50. 48 not 49</P>
<P>51. limit 50 to dd=20120719-20160815</P>
<P>Number of records retrieved until 2012: 2315</P>
<P>Number of records retrieved until 2016: 1601</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2016-09-02 13:37:02 +0100" MODIFIED_BY="Bernhard Elsner" NO="4">
<TITLE MODIFIED="2013-05-22 14:56:54 +0100" MODIFIED_BY="Bernhard Elsner">CINAHL search strategy (via EBSCOHost)</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:35:56 +0100" MODIFIED_BY="Bernhard Elsner">
<P>S1 .(MH "Cerebrovascular Disorders") OR (MH "Basal Ganglia Cerebrovascular Disease+") OR (MH "Carotid Artery Diseases+") OR (MH "Cerebral Ischemia+") OR (MH "Cerebral Vasospasm") OR (MH "Intracranial Arterial Diseases+") OR (MH "Intracranial Embolism and Thrombosis") OR (MH "Intracranial Hemorrhage+") OR (MH "Stroke") OR (MH "Vertebral Artery Dissections")</P>
<P>S2 .(MH "Stroke Patients") OR (MH "Stroke Units")</P>
<P>S3 .TI ( stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH ) or AB ( stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH )</P>
<P>S4 .TI ( brain* or cerebr* or cerebell* or intracran* or intracerebral ) or AB ( brain* or cerebr* or cerebell* or intracran* or intracerebral )</P>
<P>S5 .TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* ) or AB ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus* )</P>
<P>S6 .S4 and S5</P>
<P>S7 .TI ( brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid ) or AB ( brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid )</P>
<P>S8 .TI ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* ) or AB ( haemorrhage* or hemorrhage* or haematoma* or hematoma* or bleed* )</P>
<P>S9 .S7 and S8</P>
<P>S10 .(MH "Hemiplegia")</P>
<P>S11 .TI ( hemipleg* or hemipar* or paresis or paretic ) or AB ( hemipleg* or hemipar* or paresis or paretic )</P>
<P>S12 .S1 OR S2 OR S3 OR S6 OR S9 OR S10 OR S11</P>
<P>S13 .(MM "PhysicalTherapy") OR (MM "TherapeuticExercise") OR (MM "Motion Therapy, Continuous Passive") OR (MM "Robotics") OR (MM "Automation") OR (MM "Orthoses") OR (MM "Assistive Technology Devices") OR (MM "Therapy, Computer Assisted") OR (MM "Body Weight") OR (MM "Weight-Bearing")</P>
<P>S14 *exercise or (*exercise test)</P>
<P>S15 "man-machine systems"</P>
<P>S16 ((gait or locomot*) N5 (train* or therapy or rehabilitat* or re-educat* or machine* or powered or device*))</P>
<P>S17 electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device*</P>
<P>S18 ((body-weight or body weight) N3 (support* or relief))</P>
<P>S19 robot* or orthos* or orthotic or automat* or computer aided or computer assisted or power-assist*</P>
<P>S20 bws or harness or treadmill or exercise* or fitness train* or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator</P>
<P>S21 (continuous passive or cpm) N3 therap*</P>
<P>S22 S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21</P>
<P>S23 (MM "Gait")</P>
<P>S24 (MH "Walking+")</P>
<P>S25 (MM "Locomotion")</P>
<P>S26 (MM "Range of Motion")</P>
<P>S27 (MM "Recovery")</P>
<P>S28 walk* or gait* or ambulat* or mobil* or locomot* or balanc* or stride</P>
<P>S29 S23 OR S24 OR S25 OR S26 OR S27 OR S28</P>
<P>S30 S22 AND S29</P>
<P>S31 .(MH "Randomized Controlled Trials") or (MH "Random Assignment") or (MH "Random Sample+")</P>
<P>S32 .(MH "Clinical Trials") or (MH "Intervention Trials") or (MH "Therapeutic Trials")</P>
<P>S33 .(MH "Double-Blind Studies") or (MH "Single-Blind Studies") or (MH "Triple-Blind Studies")</P>
<P>S34 .(MH "Control (Research)") or (MH "Control Group") or (MH "Placebos") or (MH "Placebo Effect")</P>
<P>S35 .(MH "Crossover Design") OR (MH "Quasi-Experimental Studies")</P>
<P>S36 .PT (clinical trial or randomized controlled trial)</P>
<P>S37 .TI (random* or RCT or RCTs) or AB (random* or RCT or RCTs)</P>
<P>S38 .TI (controlled N5 (trial* or stud*)) or AB (controlled N5 (trial* or stud*))</P>
<P>S39 .TI (clinical* N5 trial*) or AB (clinical* N5 trial*)</P>
<P>S40 .TI ((control or treatment or experiment* or intervention) N5 (group* or subject* or patient*)) or AB ((control or treatment or experiment* or intervention) N5 (group* or subject* or patient*))</P>
<P>S41 .TI ((control or experiment* or conservative) N5 (treatment or therapy or procedure or manage*)) or AB ((control or experiment* or conservative) N5 (treatment or therapy or procedure or manage*))</P>
<P>S42 .TI ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*)) or AB ((singl* or doubl* or tripl* or trebl*) N5 (blind* or mask*))</P>
<P>S43 .TI (cross-over or cross over or crossover) or AB (cross-over or cross over or crossover)</P>
<P>S44 .TI (placebo* or sham) or AB (placebo* or sham)</P>
<P>S45 .TI trial</P>
<P>S46 .TI (assign* or allocat*) or AB (assign* or allocat*)</P>
<P>S47 .TI controls or AB controls</P>
<P>S48 .TI (quasi-random* or quasi random* or pseudo-random* or pseudo random*) or AB (quasi-random* or quasi random* or pseudo-random* or pseudo random*)</P>
<P>S49 .S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48</P>
<P>S50 .S12 AND S30 AND S49</P>
<P>S51 .EM 201207-</P>
<P>S52 .S50 AND S51</P>
<P>Number of records retrieved until 2012: 787</P>
<P>Number of records retrieved until 2016: 382</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2016-09-02 13:37:17 +0100" MODIFIED_BY="Bernhard Elsner" NO="5">
<TITLE MODIFIED="2016-09-02 13:00:43 +0100" MODIFIED_BY="Bernhard Elsner">AMED search strategy (OvidSP)</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:12:04 +0100" MODIFIED_BY="Bernhard Elsner">
<P>1. cerebrovascular disorders/ or cerebral hemorrhage/ or cerebral infarction/ or cerebral ischemia/ or cerebrovascular accident/ or stroke/</P>
<P>2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).af.</P>
<P>3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).af.</P>
<P>4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or bleed$)).af.</P>
<P>5. hemiplegia/</P>
<P>6. (hemipleg$ or hemipar$ or paresis or paretic or hemineglect or hemi-neglect or ((unilateral or spatial or hemi?spatial or visual) adj5 neglect)).af.</P>
<P>7. or/1-6</P>
<P>8. physical therapy modalities/ or exercise therapy/ or motion therapy, continuous passive.mp or musculoskeletal manipulations/</P>
<P>9. exercise/ or exercise test/</P>
<P>10. robotics/ or orthotic devices/ or myoelectric prosthesis/ or therapy, computer-assisted/</P>
<P>11. body weight/ or weight-bearing/</P>
<P>12. ((gait or locomot$) adj5 (train$ or therapy or rehabilitat$ or re-educat$ or machine$ or powered or device$)).af.</P>
<P>13. (electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device$).af.</P>
<P>14. ((body-weight or body weight) adj3 (support$ or relief)).af.</P>
<P>15. (robot$ or orthos$ or orthotic or automat$ or computer aided or computer assisted or power-assist$).af.</P>
<P>16. (bws or harness or treadmill or exercise$ or fitness train$ or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator).af.</P>
<P>17. ((continuous passive or cpm) adj3 therap$).af.</P>
<P>18. or/8-17</P>
<P>19. gait/ or exp walking/ or locomotion/</P>
<P>20. "Range of Motion"/</P>
<P>21. recovery of function/</P>
<P>22. (walk$ or gait$ or ambulat$ or mobil$ or locomot$ or balanc$ or stride).af.</P>
<P>23. or/19-22</P>
<P>24. 7 and 18 and 23</P>
<P>25. exp animals/ not humans.sh.</P>
<P>26. 24 not 25</P>
<P>27. limit 26 to up=201207-201609</P>
<P>Number of records retrieved until 2012: 383</P>
<P>Number of records retrieved until 2016: 392</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2016-09-02 13:37:27 +0100" MODIFIED_BY="Bernhard Elsner" NO="6">
<TITLE MODIFIED="2016-09-02 13:04:04 +0100" MODIFIED_BY="Bernhard Elsner">Web of Science search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:11:14 +0100" MODIFIED_BY="Bernhard Elsner">
<P>#1.TS=(stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc* or cva* or apoplex* or SAH)</P>
<P>#2.TS=((brain* or cerebr* or cerebell* or intracran* or intracerebral) NEAR/5 (isch$emi* or infarct* or thrombo* or emboli* or occlus*))</P>
<P>#3.TS=((brain* or cerebr* or cerebell* or intracran* or intracerebral) NEAR/5 (h$emorrhage* or h$ematoma* or bleed*))</P>
<P>#4.TS=(hemipleg* or hemipar* or paresis or paretic)</P>
<P>#5.#4 OR #3 OR #2 OR #1</P>
<P>#6.TS=(Neurologic NEAR/5 Gait NEAR/5 Disorders)</P>
<P>#7.TS= (robotics or automation or orthotic devices or man-machine system* or self-help devices or (computer-assisted NEAR/5 therapy))</P>
<P>#8.TS=((gait or locomot*) NEAR/5 (train* or therapy or rehabilitat* or re-educat* or machine* or powered or device$))</P>
<P>#9.TS=(electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device$)</P>
<P>#10.TS=((body-weight or (body NEAR/3 weight)) NEAR/3 (support$ or relief))</P>
<P>#11.TS=(robot* or orthos* or orthotic or automat* or computer aided or computer assisted or power-assist*)</P>
<P>#12.TS=(bws or harness or treadmill or exercise$ or fitness train* or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator)</P>
<P>#13.TS=(((continuous NEAR/3 passive) or cpm) NEAR/3 therap*)</P>
<P>#14. #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13</P>
<P>#15.TS=((gait or walk* or locomot* or ambulat* or mobil* or balance* or stride) or (range of motion) or recovery of function)</P>
<P>#16.#14 and #15</P>
<P>#17.TS=(random* or RCT or RCTs)</P>
<P>#18.TS=(controlled NEAR/5 (trial$ or stud*))</P>
<P>#19.TS=(clinical* NEAR/5 trial*)</P>
<P>#20.TS=((control or treatment or experiment* or intervention) NEAR/5 (group$ or subject$ or patient$))</P>
<P>#21.TS=(quasi-random* or quasi random* or pseudo-random* or pseudo random*)</P>
<P>#22.TS=((control$ or experiment* or conservative) NEAR/5 (treatment or therapy or manage* or procedure))</P>
<P>#23.TS=((singl$ or doubl* or tripl* or trebl*) NEAR/5 (blind* or mask*))</P>
<P>#24.TS=(cross-over or cross over or crossover)</P>
<P>#25.TS=(placebo* or sham)</P>
<P>#26.TI=trial</P>
<P>#27.TS=(assign* or allocat*)</P>
<P>#28.TS=controls</P>
<P>#29.#17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28</P>
<P>#30.#5 and #16 and #29</P>
<P>Number of records retrieved until 2016: 3806</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2016-09-02 13:37:27 +0100" MODIFIED_BY="Bernhard Elsner" NO="7">
<TITLE MODIFIED="2013-05-22 14:56:54 +0100" MODIFIED_BY="Bernhard Elsner">PEDro search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:16:02 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Abstract&amp;Title: Stroke AND gait<BR/>Method: Clinical Trial</P>
<P>Published since: 2012<BR/>All other fields not mentioned here have been left blank.</P>
<P>Number of records retrieved until 2012: 165</P>
<P>Number of records retrieved until 2016: 166</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-08" MODIFIED="2016-09-02 13:37:25 +0100" MODIFIED_BY="Bernhard Elsner" NO="8">
<TITLE MODIFIED="2013-05-22 14:56:54 +0100" MODIFIED_BY="Bernhard Elsner">COMPENDEX search strategy (via DIALOG)</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:15:25 +0100" MODIFIED_BY="Bernhard Elsner">
<P>1.       CEREBROVASCULAR (W) DISORDER? ?/TI,AB,DE<BR/>2.       BRAIN (W) INJUR???/TI,AB,DE<BR/>3.       CHRONIC (W) BRAIN (W) INJUR???/TI,AB,DE<BR/>4.       (STROKE? OR CVA OR POSTSTROKE? OR CEREBROVASC?)/TI,AB,DE<BR/>5.       CEREBRAL (W) VASCULAR/TI,AB,DE<BR/>6.       (CEREBRAL OR CEREBELLAR OR BRAIN? OR<BR/>7.       (INFARCT? OR ISCHAEMI?  OR ISCHEMI? OR THROMBO? OR<BR/>8.       S6 AND S7<BR/>9.       (CEREBRAL OR BRAIN OR SUBARACHNOID)/TI,AB,DE<BR/>10.   (HAEMORRHAGE OR HEMORRHAGE OR HAEMATOMA OR HEMATOMA OR<BR/>11.   S9 AND S10<BR/>12.    (HEMIPLEG? OR HEMIPAR? OR PARESIS)/TI,AB,DE<BR/>13.   BRAIN (W) INJUR???/TI,AB,DE<BR/>14.   GAIT (W) DISORDER? ?/TI,AB,DE<BR/>15.   NEUROLOGIC??/TI,AB,DE<BR/>16.   S14 AND S15<BR/>17.   S1 OR S2 OR S3 OR S4 OR S5 OR S8 OR S16 OR S11-S13<BR/>18.   PHYSICAL (W) THERAPY (W) MODALIT???/TI,AB,DE<BR/>19.   EXERCISE (W) THERAP?/TI,AB,DE<BR/>20.   MOTION (W) THERAP? /TI,AB,DE<BR/>21.   CONTINUOUS (3W) PASSIVE (3W) MOTION (3W) THERAP?<BR/>22.   EXERCISE?/TI,AB,DE<BR/>23.   (ROBOTICS OR AUTOMATION) /TI,AB,DE<BR/>24.   ORTHOTIC (W) DEVICE? ?/TI,AB,DE<BR/>25.   BODY (W) WEIGHT/TI,AB,DE<BR/>26.   WEIGHT (W) BEARING/TI,AB,DE<BR/>27.   GAIT (5N) TRAIN???/TI,AB,DE<BR/>28.   GAIT (5N) THERAP?/TI,AB,DE<BR/>29.   GAIT (5N) REHABILITAT?/TI,AB,DE<BR/>30.   GAIT (5N) EDUCAT?/TI,AB,DE<BR/>31.   LOCOMOT? (5N) TRAIN?/TI,AB,DE<BR/>32.   LOCOMOT? (5N) THERAP?/TI,AB,DE<BR/>33.   LOCOMOT? (5N) REHABILITAT?/TI,AB,DE<BR/>34.   LOCOMOT? (5N) EDUCAT?/TI,AB,DE<BR/>35.   (ELECTROMECHANICAL OR MECHANICAL OR  MECHANI?ED OR<BR/>36.   ((BODY (W) WEIGHT (3N) SUPPORT?))/TI,AB,DE<BR/>37.   ((BODY (W) WEIGHT (3N) RELIEF))/TI,AB,DE<BR/>38.   (ROBOT? OR ORTHOS? OR ORTHOTIC OR AUTOMAT?)/TI,AB,DE<BR/>39.   COMPUTER (W) AIDED/TI,AB,DE<BR/>40.   (COMPUTER (W) ASSISTED)/TI,AB,DE<BR/>41.   (BWS OR HARNESS OR TREADMILL OR LO?OMAT OR     GAITRAINER<BR/>42.   FITNESS (W) TRAIN?/TI,AB,DE<BR/>43.   CONTINUOUS (W) PASSIVE/TI,AB,DE<BR/>44.   THERAP?/TI,AB,DE<BR/>45.   S43 AND S44<BR/>46.   CPM (3N) THERAP?/TI,AB,DE<BR/>47.   S18-S42<BR/>48.   S48 OR S45 OR S46<BR/>49.   (GAIT OR  WALKING OR LOCOMOTION)/TI,AB,DE<BR/>50.   RANGE (1W) MOTION/TI,AB,DE<BR/>51.   ARTICULAR/TI,AB,DE<BR/>52.   S51 AND S52<BR/>53.   RECOVERY (3N) FUNCTION/TI,AB,DE<BR/>54.   (WALK? OR GAIT? ? OR AMBULAT? OR MOBIL? OR LOCOMOT? OR<BR/>55.   S50 OR S53 OR S54 OR S55<BR/>56.   S17 AND S49 AND S56<BR/>57.   S57 AND HUMAN</P>
<P>Number of records retrieved until 2012: 701</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-09" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="9">
<TITLE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">SPORTDiscus search strategy (via EBSCOHost)</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:15:28 +0100" MODIFIED_BY="Bernhard Elsner">
<P>S1 .DE "CEREBROVASCULAR disease" OR DE "BRAIN -- Hemorrhage" OR DE "CEREBRAL embolism &amp; thrombosis"<BR/>S2 .DE "CEREBROVASCULAR disease -- Patients"<BR/>S3 .DE "HEMIPLEGIA" OR DE "HEMIPLEGICS"<BR/>S4 .TI ( stroke* or poststroke* cva* or cerebrovascular* or cerebral vascular ) OR AB ( stroke* or poststroke* cva* or cerebrovascular* or cerebral vascular )<BR/>S5 .TI ( cerebral or cerebellar or brain* or vertebrobasilar ) OR AB ( cerebral or cerebellar or brain* or vertebrobasilar )<BR/>S6 .TI ( infarct* or ischemi* or ischaemi* or thrombo* or emboli* or apoplexy ) OR AB ( infarct* or ischemi* or ischaemi* or thrombo* or emboli* or apoplexy )<BR/>S7 .S5 and S6<BR/>S8 .TI ( cerebral or brain or subarachnoid ) OR AB ( cerebral or brain or subarachnoid )<BR/>S9 .TI ( haemorrhage or hemorrhage or haematoma or hematoma or bleed* ) OR AB ( haemorrhage or hemorrhage or haematoma or hematoma or bleed* )<BR/>S10 .S8 and S9<BR/>S11 .TI ( hempar$ or hemipleg* or brain injur* ) OR AB ( hempar$ or hemipleg* or brain injur* )<BR/>S12 .DE "GAIT disorders"<BR/>S13 .S1 or S2 or S3 or S4 or S7 or S10 or S11 or S12<BR/>S14 .DE "PHYSICAL therapy"<BR/>S15 .DE "EXERCISE" OR DE "LEG exercises" OR DE "STRENGTH training" OR DE "TREADMILL exercise"<BR/>S16 .DE "EXERCISE therapy"<BR/>S17 .DE "MANIPULATION (Therapeutics)"<BR/>S18 .TI ( gait or locomot* ) OR AB ( gait or locomot* )<BR/>S19 .TI ( train* or therapy or rehabilitat* or re-educat* or machine* or powered or device* ) OR AB ( train* or therapy or rehabilitat* or re-educat* or machine* or powered or device* )<BR/>S20 .S18 and S19<BR/>S21 .TI ( electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device* ) OR AB ( electromechanical or electro-mechanical or mechanical or mechanised or mechanized or driven or assistive device* )<BR/>S22 .TI ( body-weight or body weight ) OR AB ( body-weight or body weight )<BR/>S23 .TI ( support* or relief ) OR AB ( support* or relief )<BR/>S24 .S22 and S23<BR/>S25 .TI ( robot* or orthos* or orthotic or automat* or computer aided or computer assisted or power-assist* ) OR AB ( robot* or orthos* or orthotic or automat* or computer aided or computer assisted or power-assist* )<BR/>S26 .TI ( bws or harness or treadmill or exercise* or fitness train* or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator ) OR AB ( bws or harness or treadmill or exercise* or fitness train* or Lokomat or Locomat or GaiTrainer or GT1 or Kinetron or Haptic Walker or Anklebot or LOPES or AutoAmbulator )<BR/>S27 .TI ( continuous passive or cpm ) OR AB ( continuous passive or cpm )<BR/>S28 .TI Therapy OR AB therapy<BR/>S29 .S27 and S28<BR/>S30 .S14 or S15 or S16 or S17 or S20 or S21 or S24 or S25 or S26 or S29<BR/>S31 .DE "WALKING" OR DE "FITNESS walking" OR DE "GAIT in humans"<BR/>S32 .DE "LOCOMOTION" OR DE "HUMAN locomotion"<BR/>S33 .DE "JOINTS -- Range of motion"<BR/>S34 .TI ( walk* or gait* or ambulat* or mobil* or locomot* or balanc* or stride ) OR AB ( walk* or gait* or ambulat* or mobil* or locomot* or balanc* or stride )<BR/>S35 .S31 or S32 or S33 or S34<BR/>S36 .S13 and S30 and S35<BR/>S37 .TI ( random* or RCT or trial* or placebo* or sham or double-blind* or single-blind or control or controls or assign* or allocat* ) OR AB ( random* or RCT or trial* or placebo* or sham or double-blind* or single-blind or control or controls or assign* or allocat* )<BR/>S38 .S36 and S37</P>
<P>Number of records retrieved until 2012: 461</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-10" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="10">
<TITLE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">Inspec search strategy (TecFinder)</TITLE>
<APPENDIX_BODY MODIFIED="2016-09-02 13:09:46 +0100" MODIFIED_BY="Bernhard Elsner">
<P>Robot AND gait AND stroke</P>
<P>publication year: 2012 - 2016</P>
<P>Number of records retrieved until 2012: 81</P>
<P>Number of records retrieved until 2016: 20</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-11" MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser" NO="11">
<TITLE MODIFIED="2017-05-02 14:57:24 +0100" MODIFIED_BY="Hazel Fraser">World Health Organization International Clinical Trials Registry Platform (WHO ICTRP)</TITLE>
<APPENDIX_BODY MODIFIED="2017-03-21 14:31:22 +0000" MODIFIED_BY="Hazel Fraser">
<P>Robot AND gait AND stroke</P>
<P>Robot AND Walking AND stroke</P>
<P>publication year: 2012 - 2016</P>
<P>Number of records retrieved until 2016: 10</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>

<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;36 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;&lt;p&gt;(23 for 2013 version; 13 for 2016 version)&lt;/p&gt;" WIDTH="175">
<FLOWCHARTBOX TEXT="&lt;p&gt;36 studies included in qualitative synthesis&lt;/p&gt;&lt;p&gt;(23 for 2013 version; 13 for 2016 version)&lt;/p&gt;" WIDTH="150">
<FLOWCHARTBOX TEXT="&lt;p&gt;191 full-text articles assessed for eligibility&lt;/p&gt;&lt;p&gt;(136 for 2013 version; 55 for 2016 version)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;11,830 records screened&lt;/p&gt;&lt;p&gt;(4747 for 2013 version; 7083 for 2016 version)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;11,830 records after 3780 duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;15,610 records identified through database searching&lt;/p&gt;&lt;p&gt;(7288 for 2013 version; 8322 for 2016 version)&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;33 additional records identified through other sources&lt;/p&gt;&lt;p&gt;(31 for 2013 version; 2 for 2016 version)&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;11,639 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;155 full-text articles excluded:&lt;br&gt;- irrelevant participant characteristics&amp;#160;(7)&lt;br&gt;- irrelevant intervention&amp;#160;(34)&lt;br&gt;- irrelevant study type&amp;#160;(54)&lt;br&gt;- multiple publication&amp;#160;(21)&lt;br&gt;- ongoing&amp;#160;(27)&lt;br&gt;- awaiting classification (12)&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
<EXTENSION ID="AFF_D2C58DF182E26AA201E74FE96B163441_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="D2C58DF182E26AA201E74FE96B163441"><ADDRESS><DEPARTMENT>Department of Public Health, Dresden Medical School</DEPARTMENT><ORGANISATION>Technical University Dresden</ORGANISATION><CITY>Dresden</CITY><COUNTRY CODE="DE">Germany</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>